,docid,isValid,passage,passageid
0,AIMed.d0,False,"Cytokines measurements during PROTEIN1 treatment showed a trend to decreasing levels of PROTEIN2 at 4, 12, and 24 weeks.",AIMed.d0.s5
1,AIMed.d0,False,Levels of PROTEIN1 were slightly increased following PROTEIN2 treatment (P = 0.09).,AIMed.d0.s6
2,AIMed.d0,False,"In patients with a complete response to PROTEIN1 the levels of PROTEIN2 were higher at 24 weeks following PROTEIN treatment than that of pre-treatment (P = 0.04), and the levels of PROTEIN decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1/Th2 type cytokines in the supernatant.",AIMed.d0.s7
3,AIMed.d0,False,"In patients with a complete response to PROTEIN1 the levels of PROTEIN were higher at 24 weeks following PROTEIN2 treatment than that of pre-treatment (P = 0.04), and the levels of PROTEIN decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1/Th2 type cytokines in the supernatant.",AIMed.d0.s7
4,AIMed.d0,False,"In patients with a complete response to PROTEIN1 the levels of PROTEIN were higher at 24 weeks following PROTEIN treatment than that of pre-treatment (P = 0.04), and the levels of PROTEIN2 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1/Th2 type cytokines in the supernatant.",AIMed.d0.s7
5,AIMed.d0,False,"In patients with a complete response to PROTEIN the levels of PROTEIN1 were higher at 24 weeks following PROTEIN2 treatment than that of pre-treatment (P = 0.04), and the levels of PROTEIN decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1/Th2 type cytokines in the supernatant.",AIMed.d0.s7
6,AIMed.d0,False,"In patients with a complete response to PROTEIN the levels of PROTEIN1 were higher at 24 weeks following PROTEIN treatment than that of pre-treatment (P = 0.04), and the levels of PROTEIN2 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1/Th2 type cytokines in the supernatant.",AIMed.d0.s7
7,AIMed.d0,False,"In patients with a complete response to PROTEIN the levels of PROTEIN were higher at 24 weeks following PROTEIN1 treatment than that of pre-treatment (P = 0.04), and the levels of PROTEIN2 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1/Th2 type cytokines in the supernatant.",AIMed.d0.s7
8,AIMed.d1,False,"This study describes the distributions of PROTEIN as well as mRNAs for PROTEIN ( PROTEIN . collagen types II ( PROTEIN1 and III ( PROTEIN2 in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
9,AIMed.d1,False,"This study describes the distributions of PROTEIN as well as mRNAs for PROTEIN1 ( PROTEIN . collagen types II ( PROTEIN and III ( PROTEIN2 in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
10,AIMed.d1,False,"This study describes the distributions of PROTEIN1 as well as mRNAs for PROTEIN ( PROTEIN . collagen types II ( PROTEIN and III ( PROTEIN2 in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
11,AIMed.d1,False,"This study describes the distributions of PROTEIN as well as mRNAs for PROTEIN ( PROTEIN1 . collagen types II ( PROTEIN and III ( PROTEIN2 in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
12,AIMed.d1,False,"This study describes the distributions of PROTEIN as well as mRNAs for PROTEIN1 ( PROTEIN . collagen types II ( PROTEIN2 and III ( PROTEIN in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
13,AIMed.d1,False,"This study describes the distributions of PROTEIN1 as well as mRNAs for PROTEIN ( PROTEIN . collagen types II ( PROTEIN2 and III ( PROTEIN in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
14,AIMed.d1,False,"This study describes the distributions of PROTEIN as well as mRNAs for PROTEIN ( PROTEIN1 . collagen types II ( PROTEIN2 and III ( PROTEIN in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
15,AIMed.d1,False,"This study describes the distributions of PROTEIN1 as well as mRNAs for PROTEIN2 ( PROTEIN . collagen types II ( PROTEIN and III ( PROTEIN in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
16,AIMed.d1,False,"This study describes the distributions of PROTEIN as well as mRNAs for PROTEIN1 ( PROTEIN2 . collagen types II ( PROTEIN and III ( PROTEIN in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
17,AIMed.d1,False,"This study describes the distributions of PROTEIN1 as well as mRNAs for PROTEIN ( PROTEIN2 . collagen types II ( PROTEIN and III ( PROTEIN in a growing ""cartilage cap"" of osteochondroma.",AIMed.d1.s12
18,AIMed.d1,False," PROTEIN1 was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for PROTEIN and PROTEIN2 respectively.",AIMed.d1.s14
19,AIMed.d1,False," PROTEIN1 was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for PROTEIN2 and PROTEIN respectively.",AIMed.d1.s14
20,AIMed.d1,False," PROTEIN was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for PROTEIN1 and PROTEIN2 respectively.",AIMed.d1.s14
21,AIMed.d1,False,This is the first study to provide observational evidence of the involvement of PROTEIN1 signaling in the pathogenesis of cartilage cap of osteochondroma. and suggests the role of PROTEIN2 in the growth of cartilage cap in osteochondroma.,AIMed.d1.s16
22,AIMed.d2,False,The molar ratio of serum PROTEIN ( PROTEIN1 to PROTEIN2 ( PROTEIN is not useful to assess vitamin A status during infection in hospitalised children.,AIMed.d2.s17
23,AIMed.d2,False,The molar ratio of serum PROTEIN ( PROTEIN1 to PROTEIN ( PROTEIN2 is not useful to assess vitamin A status during infection in hospitalised children.,AIMed.d2.s17
24,AIMed.d2,False,The molar ratio of serum PROTEIN1 ( PROTEIN2 to PROTEIN ( PROTEIN is not useful to assess vitamin A status during infection in hospitalised children.,AIMed.d2.s17
25,AIMed.d2,False,The molar ratio of serum PROTEIN ( PROTEIN to PROTEIN1 ( PROTEIN2 is not useful to assess vitamin A status during infection in hospitalised children.,AIMed.d2.s17
26,AIMed.d2,False,The molar ratio of serum PROTEIN1 ( PROTEIN to PROTEIN2 ( PROTEIN is not useful to assess vitamin A status during infection in hospitalised children.,AIMed.d2.s17
27,AIMed.d2,False,The molar ratio of serum PROTEIN1 ( PROTEIN to PROTEIN ( PROTEIN2 is not useful to assess vitamin A status during infection in hospitalised children.,AIMed.d2.s17
28,AIMed.d2,False,OBJECTIVE: To assess the usefulness of the molar ratio of serum PROTEIN1 ( PROTEIN to PROTEIN2 ( PROTEIN to determine vitamin A (VA) status during infection.,AIMed.d2.s18
29,AIMed.d2,False,OBJECTIVE: To assess the usefulness of the molar ratio of serum PROTEIN ( PROTEIN1 to PROTEIN2 ( PROTEIN to determine vitamin A (VA) status during infection.,AIMed.d2.s18
30,AIMed.d2,False,OBJECTIVE: To assess the usefulness of the molar ratio of serum PROTEIN ( PROTEIN to PROTEIN1 ( PROTEIN2 to determine vitamin A (VA) status during infection.,AIMed.d2.s18
31,AIMed.d2,False,OBJECTIVE: To assess the usefulness of the molar ratio of serum PROTEIN1 ( PROTEIN2 to PROTEIN ( PROTEIN to determine vitamin A (VA) status during infection.,AIMed.d2.s18
32,AIMed.d2,False,OBJECTIVE: To assess the usefulness of the molar ratio of serum PROTEIN1 ( PROTEIN to PROTEIN ( PROTEIN2 to determine vitamin A (VA) status during infection.,AIMed.d2.s18
33,AIMed.d2,False,OBJECTIVE: To assess the usefulness of the molar ratio of serum PROTEIN ( PROTEIN1 to PROTEIN ( PROTEIN2 to determine vitamin A (VA) status during infection.,AIMed.d2.s18
34,AIMed.d2,False,"DESIGN: We took advantage of previously collected data during a randomised double-blind, placebo-controlled clinical trial to conduct a secondary analysis of the PROTEIN1 PROTEIN2 ratio and its relationship to infection and VA status.",AIMed.d2.s19
35,AIMed.d2,False,MAIN OUTCOME MEASURES: PROTEIN1 PROTEIN2 molar ratio after 7 days hospitalisation.,AIMed.d2.s23
36,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN1 ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN2 PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
37,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN1 PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN2 PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
38,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN1 PROTEIN2 ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
39,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN1 PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN2 ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
40,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN1 PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN2 PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
41,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN1 ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN2 PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
42,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN1 ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN2 ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
43,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN1 ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN2 ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
44,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN1 PROTEIN2 ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
45,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN1 ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN2 PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
46,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN1 PROTEIN2 ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
47,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN1 PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN2 PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
48,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN1 ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN2 ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
49,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN1 PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN2 ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
50,AIMed.d2,False,"RESULTS: After 7 days hospitalisation, molar PROTEIN1 PROTEIN ratio (mean+/-s.d.) of infected children (C-reactive proteins>10 mg/l) was 0.67+/-0.31 in the high-dose group (n=81), 0.74+/-0.44 in the low dose group (n=71) and 0.73+/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol/l, changes in PROTEIN PROTEIN ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar PROTEIN PROTEIN2 ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.",AIMed.d2.s24
51,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN1 PROTEIN PROTEIN and PROTEIN PROTEIN2 ,AIMed.d8.s60
52,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN PROTEIN1 PROTEIN and PROTEIN PROTEIN2 ,AIMed.d8.s60
53,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN PROTEIN PROTEIN1 and PROTEIN PROTEIN2 ,AIMed.d8.s60
54,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN PROTEIN PROTEIN and PROTEIN1 PROTEIN2 ,AIMed.d8.s60
55,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN1 PROTEIN2 PROTEIN and PROTEIN PROTEIN ,AIMed.d8.s60
56,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN1 PROTEIN PROTEIN2 and PROTEIN PROTEIN ,AIMed.d8.s60
57,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN1 PROTEIN PROTEIN and PROTEIN2 PROTEIN ,AIMed.d8.s60
58,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN PROTEIN1 PROTEIN2 and PROTEIN PROTEIN ,AIMed.d8.s60
59,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN PROTEIN1 PROTEIN and PROTEIN2 PROTEIN ,AIMed.d8.s60
60,AIMed.d8,False,Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of PROTEIN PROTEIN PROTEIN1 and PROTEIN2 PROTEIN ,AIMed.d8.s60
61,AIMed.d8,False,The PROTEIN1 PROTEIN2 PROTEIN and PROTEIN genes are among those most frequently altered in pancreatic ductal carcinoma.,AIMed.d8.s61
62,AIMed.d8,False,The PROTEIN1 PROTEIN PROTEIN and PROTEIN2 genes are among those most frequently altered in pancreatic ductal carcinoma.,AIMed.d8.s61
63,AIMed.d8,False,The PROTEIN1 PROTEIN PROTEIN2 and PROTEIN genes are among those most frequently altered in pancreatic ductal carcinoma.,AIMed.d8.s61
64,AIMed.d8,False,The PROTEIN PROTEIN1 PROTEIN and PROTEIN2 genes are among those most frequently altered in pancreatic ductal carcinoma.,AIMed.d8.s61
65,AIMed.d8,False,The PROTEIN PROTEIN1 PROTEIN2 and PROTEIN genes are among those most frequently altered in pancreatic ductal carcinoma.,AIMed.d8.s61
66,AIMed.d8,False,The PROTEIN PROTEIN PROTEIN1 and PROTEIN2 genes are among those most frequently altered in pancreatic ductal carcinoma.,AIMed.d8.s61
67,AIMed.d8,False,"These cell lines showed mutations in PROTEIN1 and PROTEIN2 at frequencies of 91% and 95%, respectively.",AIMed.d8.s63
68,AIMed.d8,False,The most typical mutational profile involved PROTEIN1 PROTEIN2 and PROTEIN concurrently aberrated in 20 cases (91%).,AIMed.d8.s66
69,AIMed.d8,False,The most typical mutational profile involved PROTEIN1 PROTEIN and PROTEIN2 concurrently aberrated in 20 cases (91%).,AIMed.d8.s66
70,AIMed.d8,False,The most typical mutational profile involved PROTEIN PROTEIN1 and PROTEIN2 concurrently aberrated in 20 cases (91%).,AIMed.d8.s66
71,AIMed.d9,False,We investigated the mechanism of calcium-stimulated PROTEIN1 release from gastrinoma cells in vitro with a particular focus on the PROTEIN2 ( PROTEIN .,AIMed.d9.s73
72,AIMed.d9,False,We investigated the mechanism of calcium-stimulated PROTEIN1 release from gastrinoma cells in vitro with a particular focus on the PROTEIN ( PROTEIN2 .,AIMed.d9.s73
73,AIMed.d9,False,We investigated the mechanism of calcium-stimulated PROTEIN release from gastrinoma cells in vitro with a particular focus on the PROTEIN1 ( PROTEIN2 .,AIMed.d9.s73
74,AIMed.d9,False,Our results demonstrated that PROTEIN1 was expressed in human gastrinoma cells and could be involved in the mechanism of calcium-evoked PROTEIN2 release.,AIMed.d9.s80
75,AIMed.d10,False, PROTEIN1 and PROTEIN2 involvement in the osteogenic properties of the HeLa cell line.,AIMed.d10.s81
76,AIMed.d10,False,We postulate that the mechanism of bone induction is based on the secretion of bone morphogenetic proteins PROTEIN1 and PROTEIN2 by the grafted HeLa cells.,AIMed.d10.s84
77,AIMed.d12,False,Soluble PROTEIN1 receptor and PROTEIN in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.,AIMed.d12.s96
78,AIMed.d12,False,Soluble PROTEIN1 and PROTEIN2 in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.,AIMed.d12.s96
79,AIMed.d12,False,Soluble PROTEIN1 receptor and PROTEIN2 in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.,AIMed.d12.s96
80,AIMed.d12,False,MAIN OUTCOME MEASURES: Measurement of soluble PROTEIN ( PROTEIN1 and PROTEIN2 in serum samples and fluid of recent blisters.,AIMed.d12.s102
81,AIMed.d12,False,MAIN OUTCOME MEASURES: Measurement of soluble PROTEIN1 ( PROTEIN and PROTEIN2 in serum samples and fluid of recent blisters.,AIMed.d12.s102
82,AIMed.d12,False,MAIN OUTCOME MEASURES: Measurement of soluble PROTEIN1 ( PROTEIN2 and PROTEIN in serum samples and fluid of recent blisters.,AIMed.d12.s102
83,AIMed.d12,False,"RESULTS: In the blister fluid of patients with TEN, we found significantly higher levels of PROTEIN1 than in patients with burns, whereas PROTEIN2 levels were higher in the blister fluid of burned patients.",AIMed.d12.s103
84,AIMed.d12,False,"No significant differences were found in serum samples of patients with TEN and burns, in either PROTEIN1 or PROTEIN2 ",AIMed.d12.s104
85,AIMed.d12,False,"In TEN we also found significantly higher levels of PROTEIN1 in the blister fluid compared with serum samples, pointing to a predominantly local production contrasting with the low concentration of PROTEIN2 in the blister fluid of burned patients.",AIMed.d12.s105
86,AIMed.d14,False,Concentrations of PROTEIN1 ( PROTEIN2 and PROTEIN ( PROTEIN in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.,AIMed.d14.s117
87,AIMed.d14,False,Concentrations of PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN2 in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.,AIMed.d14.s117
88,AIMed.d14,False,Concentrations of PROTEIN ( PROTEIN1 and PROTEIN2 ( PROTEIN in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.,AIMed.d14.s117
89,AIMed.d14,False,Concentrations of PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN2 in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.,AIMed.d14.s117
90,AIMed.d14,False,Concentrations of PROTEIN1 ( PROTEIN and PROTEIN2 ( PROTEIN in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.,AIMed.d14.s117
91,AIMed.d14,False,Concentrations of PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN2 in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.,AIMed.d14.s117
92,AIMed.d14,False,"Correlations between PROTEIN1 and PROTEIN2 in CSF as markers for astrogliosis and neurodegeneration, and clinical and biological data were investigated.",AIMed.d14.s118
93,AIMed.d14,False,"Abnormal levels of PROTEIN1 and PROTEIN2 were significantly associated with increasing CSF cell number and protein concentration, and with the absence of lymph nodes or the absence of trypanosomes in lymph node aspirate.",AIMed.d14.s119
94,AIMed.d15,False,"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely PROTEIN PROTEIN and PROTEIN1 versus PROTEIN2 ",AIMed.d15.s126
95,AIMed.d15,False,"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely PROTEIN1 PROTEIN and PROTEIN2 versus PROTEIN ",AIMed.d15.s126
96,AIMed.d15,False,"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely PROTEIN PROTEIN1 and PROTEIN2 versus PROTEIN ",AIMed.d15.s126
97,AIMed.d15,False,"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely PROTEIN1 PROTEIN and PROTEIN versus PROTEIN2 ",AIMed.d15.s126
98,AIMed.d15,False,"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely PROTEIN PROTEIN1 and PROTEIN versus PROTEIN2 ",AIMed.d15.s126
99,AIMed.d15,False,"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely PROTEIN1 PROTEIN2 and PROTEIN versus PROTEIN ",AIMed.d15.s126
100,AIMed.d15,False,MATERIALS AND METHODS: We measured levels of PROTEIN PROTEIN1 PROTEIN and PROTEIN2 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.,AIMed.d15.s128
101,AIMed.d15,False,MATERIALS AND METHODS: We measured levels of PROTEIN1 PROTEIN2 PROTEIN and PROTEIN in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.,AIMed.d15.s128
102,AIMed.d15,False,MATERIALS AND METHODS: We measured levels of PROTEIN PROTEIN1 PROTEIN2 and PROTEIN in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.,AIMed.d15.s128
103,AIMed.d15,False,MATERIALS AND METHODS: We measured levels of PROTEIN1 PROTEIN PROTEIN and PROTEIN2 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.,AIMed.d15.s128
104,AIMed.d15,False,MATERIALS AND METHODS: We measured levels of PROTEIN PROTEIN PROTEIN1 and PROTEIN2 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.,AIMed.d15.s128
105,AIMed.d15,False,MATERIALS AND METHODS: We measured levels of PROTEIN1 PROTEIN PROTEIN2 and PROTEIN in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.,AIMed.d15.s128
106,AIMed.d15,False, PROTEIN1 PROTEIN and PROTEIN2 levels were statistically greater in patients.,AIMed.d15.s131
107,AIMed.d15,False, PROTEIN1 PROTEIN2 and PROTEIN levels were statistically greater in patients.,AIMed.d15.s131
108,AIMed.d15,False, PROTEIN PROTEIN1 and PROTEIN2 levels were statistically greater in patients.,AIMed.d15.s131
109,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN1 ( PROTEIN , PROTEIN2 ( PROTEIN , and PROTEIN ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
110,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , and PROTEIN2 ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
111,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN1 ( PROTEIN2 , PROTEIN ( PROTEIN , and PROTEIN ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
112,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN2 , and PROTEIN ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
113,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN1 ( PROTEIN , PROTEIN ( PROTEIN , and PROTEIN ( PROTEIN2 an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
114,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , and PROTEIN2 ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
115,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN1 , PROTEIN2 ( PROTEIN , and PROTEIN ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
116,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN2 , and PROTEIN ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
117,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN , PROTEIN1 ( PROTEIN , and PROTEIN ( PROTEIN2 an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
118,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , and PROTEIN2 ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
119,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , and PROTEIN2 ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
120,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN , and PROTEIN1 ( PROTEIN2 an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
121,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN2 , and PROTEIN ( PROTEIN an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
122,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN1 , PROTEIN ( PROTEIN , and PROTEIN ( PROTEIN2 an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
123,AIMed.d16,False,"METHODS: The genes for dopamine synthetic enzymes, PROTEIN ( PROTEIN , PROTEIN ( PROTEIN1 , and PROTEIN ( PROTEIN2 an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.",AIMed.d16.s136
124,AIMed.d16,False,Expressions of PROTEIN1 PROTEIN and PROTEIN2 were detected by Western blot analysis.,AIMed.d16.s137
125,AIMed.d16,False,Expressions of PROTEIN1 PROTEIN2 and PROTEIN were detected by Western blot analysis.,AIMed.d16.s137
126,AIMed.d16,False,Expressions of PROTEIN PROTEIN1 and PROTEIN2 were detected by Western blot analysis.,AIMed.d16.s137
127,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN and PROTEIN1 were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN2 and AAV- PROTEIN ",AIMed.d16.s139
128,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN and PROTEIN1 were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN and AAV- PROTEIN2 ",AIMed.d16.s139
129,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN1 and PROTEIN2 were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN and AAV- PROTEIN ",AIMed.d16.s139
130,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN and PROTEIN1 were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN2 AAV- PROTEIN and AAV- PROTEIN ",AIMed.d16.s139
131,AIMed.d16,False,"RESULTS: PROTEIN1 PROTEIN and PROTEIN2 were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN and AAV- PROTEIN ",AIMed.d16.s139
132,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN1 and AAV- PROTEIN2 ",AIMed.d16.s139
133,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN1 and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN2 and AAV- PROTEIN ",AIMed.d16.s139
134,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN1 AAV- PROTEIN2 and AAV- PROTEIN ",AIMed.d16.s139
135,AIMed.d16,False,"RESULTS: PROTEIN1 PROTEIN and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN2 and AAV- PROTEIN ",AIMed.d16.s139
136,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN1 and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN and AAV- PROTEIN2 ",AIMed.d16.s139
137,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN1 AAV- PROTEIN and AAV- PROTEIN2 ",AIMed.d16.s139
138,AIMed.d16,False,"RESULTS: PROTEIN1 PROTEIN and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN and AAV- PROTEIN2 ",AIMed.d16.s139
139,AIMed.d16,False,"RESULTS: PROTEIN PROTEIN1 and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN2 AAV- PROTEIN and AAV- PROTEIN ",AIMed.d16.s139
140,AIMed.d16,False,"RESULTS: PROTEIN1 PROTEIN2 and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN AAV- PROTEIN and AAV- PROTEIN ",AIMed.d16.s139
141,AIMed.d16,False,"RESULTS: PROTEIN1 PROTEIN and PROTEIN were effectively coexpressed in transduced cells with three separate AAV vectors, AAV- PROTEIN2 AAV- PROTEIN and AAV- PROTEIN ",AIMed.d16.s139
142,AIMed.d16,False,"CONCLUSION: The triple transduction of PROTEIN1 PROTEIN and PROTEIN2 genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.",AIMed.d16.s141
143,AIMed.d16,False,"CONCLUSION: The triple transduction of PROTEIN PROTEIN1 and PROTEIN2 genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.",AIMed.d16.s141
144,AIMed.d16,False,"CONCLUSION: The triple transduction of PROTEIN1 PROTEIN2 and PROTEIN genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.",AIMed.d16.s141
145,AIMed.d17,False,This overview summarizes the current knowledge on PROTEIN1 ( PROTEIN2 in the progression of atherosclerosis and the influence of MMPs in aneurysm formation.,AIMed.d17.s146
146,AIMed.d17,False,"In addition, a possible role for PROTEIN1 the product of PROTEIN2 in atherosclerotic lesion development is put into perspective.",AIMed.d17.s147
147,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 (Immunotech, France), PROTEIN2 and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
148,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN2 sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
149,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
150,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 (Immunotech, France), PROTEIN and PROTEIN2 ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
151,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN2 PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
152,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
153,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
154,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
155,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
156,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
157,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN1 and PROTEIN ( PROTEIN2 sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
158,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN2 and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
159,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN1 and PROTEIN2 ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
160,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN1 and PROTEIN ( PROTEIN sP- and PROTEIN2 PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
161,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN2 and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
162,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN (Immunotech, France), PROTEIN2 and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
163,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN1 and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
164,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN (Immunotech, France), PROTEIN2 and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
165,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN1 and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
166,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN2 sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
167,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN1 ( PROTEIN2 sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
168,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN1 sP- and PROTEIN2 PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
169,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN2 sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
170,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN2 sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
171,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN1 sP- and PROTEIN PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
172,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN2 sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
173,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN1 sP- and PROTEIN PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
174,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN2 ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
175,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN2 PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
176,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
177,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
178,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
179,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
180,AIMed.d18,False,"Cytokines PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
181,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN1 ( PROTEIN sP- and PROTEIN2 PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
182,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN2 ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
183,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN2 ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
184,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN1 ( PROTEIN sP- and PROTEIN PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
185,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN (Immunotech, France), PROTEIN and PROTEIN2 ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
186,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN1 ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
187,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN2 PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
188,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN2 PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
189,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN1 PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
190,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN2 PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
191,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN1 PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
192,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
193,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
194,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
195,AIMed.d18,False,"Cytokines PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
196,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
197,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
198,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
199,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN2 and PROTEIN (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
200,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN1 and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
201,AIMed.d18,False,"Cytokines PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN (Immunotech, France), PROTEIN and PROTEIN ( PROTEIN sP- and PROTEIN PROTEIN and PROTEIN2 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).",AIMed.d18.s151
202,AIMed.d18,False, PROTEIN1 and sP- and PROTEIN2 levels were not related to function of lymphocytes (by MDM data) as seen in both tests; it is probable that another cell-cell communication mechanism had been switched on.,AIMed.d18.s156
203,AIMed.d18,False,We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of PROTEIN1 PROTEIN and PROTEIN2 which are the active participants in the pro- and anti-inflammatory program in atherogenesis.,AIMed.d18.s157
204,AIMed.d18,False,We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of PROTEIN1 PROTEIN2 and PROTEIN which are the active participants in the pro- and anti-inflammatory program in atherogenesis.,AIMed.d18.s157
205,AIMed.d18,False,We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of PROTEIN PROTEIN1 and PROTEIN2 which are the active participants in the pro- and anti-inflammatory program in atherogenesis.,AIMed.d18.s157
206,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN1 and beta, PROTEIN and 2, PROTEIN2 and its receptor antagonist ( PROTEIN , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
207,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN1 and beta, PROTEIN and 2, PROTEIN and its receptor antagonist ( PROTEIN , PROTEIN2 (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
208,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN1 and beta, PROTEIN and 2, PROTEIN and its receptor antagonist ( PROTEIN2 , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
209,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN1 and beta, PROTEIN and 2, PROTEIN and its receptor antagonist ( PROTEIN , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN2 ",AIMed.d20.s168
210,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN1 and beta, PROTEIN2 and 2, PROTEIN and its receptor antagonist ( PROTEIN , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
211,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN and 2, PROTEIN1 and its receptor antagonist ( PROTEIN , PROTEIN2 (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
212,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN and 2, PROTEIN1 and its receptor antagonist ( PROTEIN2 , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
213,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN and 2, PROTEIN1 and its receptor antagonist ( PROTEIN , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN2 ",AIMed.d20.s168
214,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN1 and 2, PROTEIN2 and its receptor antagonist ( PROTEIN , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
215,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN and 2, PROTEIN and its receptor antagonist ( PROTEIN1 , PROTEIN2 (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
216,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN and 2, PROTEIN and its receptor antagonist ( PROTEIN , PROTEIN1 (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN2 ",AIMed.d20.s168
217,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN1 and 2, PROTEIN and its receptor antagonist ( PROTEIN , PROTEIN2 (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
218,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN and 2, PROTEIN and its receptor antagonist ( PROTEIN1 , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN2 ",AIMed.d20.s168
219,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN1 and 2, PROTEIN and its receptor antagonist ( PROTEIN2 , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN ",AIMed.d20.s168
220,AIMed.d20,False,"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN and beta, PROTEIN1 and 2, PROTEIN and its receptor antagonist ( PROTEIN , PROTEIN (the receptor for lipopolysaccharide), P and E selectins, and PROTEIN2 ",AIMed.d20.s168
221,AIMed.d22,False,Present data concerning the PROTEIN1 PROTEIN2 system of extrarenal origin.,AIMed.d22.s181
222,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN1 forming enzymes, starting with PROTEIN2 PROTEIN D and PROTEIN and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
223,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN1 forming enzymes, starting with PROTEIN PROTEIN D and PROTEIN and ending with the conversion enzyme and PROTEIN2 ",AIMed.d22.s182
224,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN1 forming enzymes, starting with PROTEIN PROTEIN D and PROTEIN2 and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
225,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN1 forming enzymes, starting with PROTEIN PROTEIN2 D and PROTEIN and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
226,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN1 of renal origin, we present the main extrarenal PROTEIN2 forming enzymes, starting with PROTEIN PROTEIN D and PROTEIN and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
227,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN1 PROTEIN D and PROTEIN and ending with the conversion enzyme and PROTEIN2 ",AIMed.d22.s182
228,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN1 PROTEIN D and PROTEIN2 and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
229,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN1 PROTEIN2 D and PROTEIN and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
230,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN1 of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN2 PROTEIN D and PROTEIN and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
231,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN PROTEIN D and PROTEIN1 and ending with the conversion enzyme and PROTEIN2 ",AIMed.d22.s182
232,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN PROTEIN1 D and PROTEIN and ending with the conversion enzyme and PROTEIN2 ",AIMed.d22.s182
233,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN1 of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN PROTEIN D and PROTEIN and ending with the conversion enzyme and PROTEIN2 ",AIMed.d22.s182
234,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN PROTEIN1 D and PROTEIN2 and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
235,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN1 of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN PROTEIN D and PROTEIN2 and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
236,AIMed.d22,False,"After a brief historical incursion regarding PROTEIN1 of renal origin, we present the main extrarenal PROTEIN forming enzymes, starting with PROTEIN PROTEIN2 D and PROTEIN and ending with the conversion enzyme and PROTEIN ",AIMed.d22.s182
237,AIMed.d22,False,"In the end we refer to the relations between circulating PROTEIN1 of renal origin and the extrarenal PROTEIN2 specific to tissue underlying the fact that the two PROTEIN components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.",AIMed.d22.s184
238,AIMed.d22,False,"In the end we refer to the relations between circulating PROTEIN of renal origin and the extrarenal PROTEIN1 specific to tissue underlying the fact that the two PROTEIN2 components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.",AIMed.d22.s184
239,AIMed.d22,False,"In the end we refer to the relations between circulating PROTEIN1 of renal origin and the extrarenal PROTEIN specific to tissue underlying the fact that the two PROTEIN2 components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.",AIMed.d22.s184
240,AIMed.d22,False,"While the circulating PROTEIN1 of renal origin is acutely activated to contribute to the accomplishment of short term homeostatic reactions, tissue PROTEIN2 in paracrine or autocrine ways, exerts local-regional adaptive actions of long duration.",AIMed.d22.s185
241,AIMed.d23,False,"In the present study, we examined the presence of glucocorticoid receptors (GRs) and PROTEIN1 ( PROTEIN2 in the nasal polyps of nonallergic patients as compared with normal controls.",AIMed.d23.s189
242,AIMed.d23,False,"In contrast, in normal nasal tissues, PROTEIN1 labeling was only found in the vascular wall, and the expression was weaker--a finding demonstrating that PROTEIN2 is upregulated in nasal polyps.",AIMed.d23.s194
243,AIMed.d23,False,"Therefore, 1) the presence of GRs and PROTEIN1 in nasal polyps from nonallergic patients, as well as upregulation of PROTEIN2 expression, suggests that inflammation may play an important role in the pathophysiology of nasal polyps; and 2) glucocorticoid could be a potential treatment method for suppressing inflammatory processes.",AIMed.d23.s195
244,AIMed.d25,False,"Assaying of PROTEIN1 complement factors, and PROTEIN2 in the diagnosis of malignant serous effusions.",AIMed.d25.s203
245,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN1 ( PROTEIN2 , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
246,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN1 in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN2 ( PROTEIN , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
247,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN1 PROTEIN2 ( PROTEIN , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
248,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN1 ( PROTEIN , and complement factors PROTEIN and PROTEIN2 can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
249,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN1 ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN2 ( PROTEIN , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
250,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN1 ( PROTEIN , and complement factors PROTEIN2 and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
251,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN1 in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN2 , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
252,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN1 PROTEIN ( PROTEIN2 , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
253,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN1 , and complement factors PROTEIN and PROTEIN2 can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
254,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN1 ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN2 , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
255,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN1 , and complement factors PROTEIN2 and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
256,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN1 in pleural and peritoneal effusions of different causes and to verify whether PROTEIN2 PROTEIN ( PROTEIN , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
257,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN1 in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN , and complement factors PROTEIN and PROTEIN2 can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
258,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN1 ( PROTEIN2 in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
259,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN1 in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN , and complement factors PROTEIN2 and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
260,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN1 PROTEIN ( PROTEIN , and complement factors PROTEIN and PROTEIN2 can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
261,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN1 ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN2 PROTEIN ( PROTEIN , and complement factors PROTEIN and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
262,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN1 PROTEIN ( PROTEIN , and complement factors PROTEIN2 and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
263,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN1 ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN , and complement factors PROTEIN and PROTEIN2 can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
264,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN , and complement factors PROTEIN1 and PROTEIN2 can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
265,AIMed.d25,False,"The objective of this study was to measure the concentrations of PROTEIN1 ( PROTEIN in pleural and peritoneal effusions of different causes and to verify whether PROTEIN PROTEIN ( PROTEIN , and complement factors PROTEIN2 and PROTEIN can be used in the differential diagnosis of serous effusion.",AIMed.d25.s204
266,AIMed.d25,False, PROTEIN1 PROTEIN and complement factors PROTEIN and PROTEIN2 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.,AIMed.d25.s206
267,AIMed.d25,False, PROTEIN PROTEIN1 and complement factors PROTEIN and PROTEIN2 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.,AIMed.d25.s206
268,AIMed.d25,False, PROTEIN PROTEIN and complement factors PROTEIN1 and PROTEIN2 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.,AIMed.d25.s206
269,AIMed.d25,False, PROTEIN1 PROTEIN2 and complement factors PROTEIN and PROTEIN concentrations were measured simultaneously in blood and serous effusion using commercially available methods.,AIMed.d25.s206
270,AIMed.d25,False, PROTEIN1 PROTEIN and complement factors PROTEIN2 and PROTEIN concentrations were measured simultaneously in blood and serous effusion using commercially available methods.,AIMed.d25.s206
271,AIMed.d25,False, PROTEIN PROTEIN1 and complement factors PROTEIN2 and PROTEIN concentrations were measured simultaneously in blood and serous effusion using commercially available methods.,AIMed.d25.s206
272,AIMed.d25,False,"Their order of selection was PROTEIN effusion, PROTEIN serum, PROTEIN1 effusion, and PROTEIN2 effusion.",AIMed.d25.s210
273,AIMed.d25,False,"Their order of selection was PROTEIN1 effusion, PROTEIN serum, PROTEIN effusion, and PROTEIN2 effusion.",AIMed.d25.s210
274,AIMed.d25,False,"Their order of selection was PROTEIN effusion, PROTEIN1 serum, PROTEIN effusion, and PROTEIN2 effusion.",AIMed.d25.s210
275,AIMed.d25,False,"Their order of selection was PROTEIN1 effusion, PROTEIN serum, PROTEIN2 effusion, and PROTEIN effusion.",AIMed.d25.s210
276,AIMed.d25,False,"Their order of selection was PROTEIN effusion, PROTEIN1 serum, PROTEIN2 effusion, and PROTEIN effusion.",AIMed.d25.s210
277,AIMed.d25,False,"Their order of selection was PROTEIN1 effusion, PROTEIN2 serum, PROTEIN effusion, and PROTEIN effusion.",AIMed.d25.s210
278,AIMed.d25,False,"Determination of PROTEIN1 complement factors PROTEIN and PROTEIN and PROTEIN2 may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.",AIMed.d25.s212
279,AIMed.d25,False,"Determination of PROTEIN complement factors PROTEIN and PROTEIN1 and PROTEIN2 may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.",AIMed.d25.s212
280,AIMed.d25,False,"Determination of PROTEIN complement factors PROTEIN1 and PROTEIN and PROTEIN2 may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.",AIMed.d25.s212
281,AIMed.d25,False,"Determination of PROTEIN1 complement factors PROTEIN and PROTEIN2 and PROTEIN may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.",AIMed.d25.s212
282,AIMed.d25,False,"Determination of PROTEIN1 complement factors PROTEIN2 and PROTEIN and PROTEIN may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.",AIMed.d25.s212
283,AIMed.d25,False,"Determination of PROTEIN complement factors PROTEIN1 and PROTEIN2 and PROTEIN may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.",AIMed.d25.s212
284,AIMed.d26,False,Differential expression of PROTEIN1 and PROTEIN2 by NK cells in cancer patients and correlation of impaired PROTEIN expression withprogression of cancer.,AIMed.d26.s214
285,AIMed.d26,False,Differential expression of PROTEIN1 and PROTEIN by NK cells in cancer patients and correlation of impaired PROTEIN2 expression withprogression of cancer.,AIMed.d26.s214
286,AIMed.d26,False,Differential expression of PROTEIN and PROTEIN1 by NK cells in cancer patients and correlation of impaired PROTEIN2 expression withprogression of cancer.,AIMed.d26.s214
287,AIMed.d26,False," PROTEIN1 has been identified as an effector molecule co-localized with PROTEIN2 in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of PROTEIN and to induce a cytotoxic effect against tumor cells.",AIMed.d26.s215
288,AIMed.d26,False," PROTEIN has been identified as an effector molecule co-localized with PROTEIN1 in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of PROTEIN2 and to induce a cytotoxic effect against tumor cells.",AIMed.d26.s215
289,AIMed.d26,False," PROTEIN1 has been identified as an effector molecule co-localized with PROTEIN in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of PROTEIN2 and to induce a cytotoxic effect against tumor cells.",AIMed.d26.s215
290,AIMed.d26,False,The aim of the present study was to elucidate whether intracellular expression of PROTEIN1 and PROTEIN2 by NK cells might be associated with progression of cancer.,AIMed.d26.s216
291,AIMed.d26,False,Flow cytometric analysis demonstrated high levels of PROTEIN1 and PROTEIN expression by PROTEIN2 -) PROTEIN +) cells in healthy controls.,AIMed.d26.s217
292,AIMed.d26,False,Flow cytometric analysis demonstrated high levels of PROTEIN and PROTEIN1 expression by PROTEIN2 -) PROTEIN +) cells in healthy controls.,AIMed.d26.s217
293,AIMed.d26,False,Flow cytometric analysis demonstrated high levels of PROTEIN and PROTEIN expression by PROTEIN1 -) PROTEIN2 +) cells in healthy controls.,AIMed.d26.s217
294,AIMed.d26,False,Flow cytometric analysis demonstrated high levels of PROTEIN1 and PROTEIN2 expression by PROTEIN -) PROTEIN +) cells in healthy controls.,AIMed.d26.s217
295,AIMed.d26,False,Flow cytometric analysis demonstrated high levels of PROTEIN1 and PROTEIN expression by PROTEIN -) PROTEIN2 +) cells in healthy controls.,AIMed.d26.s217
296,AIMed.d26,False,Flow cytometric analysis demonstrated high levels of PROTEIN and PROTEIN1 expression by PROTEIN -) PROTEIN2 +) cells in healthy controls.,AIMed.d26.s217
297,AIMed.d26,False,"In contrast, cancer patients exhibited significantly decreased levels of PROTEIN1 expression ( P<0.005), despite having equally high levels of PROTEIN2 expression in comparison with healthy controls.",AIMed.d26.s218
298,AIMed.d26,False,"The tumor-free patients expressed PROTEIN1 at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of PROTEIN2 compared to healthy controls ( P<0.0001).",AIMed.d26.s219
299,AIMed.d26,False,"In conclusion, impaired expression of PROTEIN1 by NK cells correlates with progression of cancer, and determination of PROTEIN2 expression might prove informative for assessing the immunological condition of cancer patients.",AIMed.d26.s223
300,AIMed.d27,False," PROTEIN1 a member of the PROTEIN2 superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types.",AIMed.d27.s226
301,AIMed.d27,False,"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as PROTEIN and PROTEIN1 and regulators of apoptosis such as PROTEIN2 and members of the PROTEIN family.",AIMed.d27.s229
302,AIMed.d27,False,"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as PROTEIN and PROTEIN and regulators of apoptosis such as PROTEIN1 and members of the PROTEIN2 family.",AIMed.d27.s229
303,AIMed.d27,False,"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as PROTEIN1 and PROTEIN and regulators of apoptosis such as PROTEIN2 and members of the PROTEIN family.",AIMed.d27.s229
304,AIMed.d27,False,"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as PROTEIN and PROTEIN1 and regulators of apoptosis such as PROTEIN and members of the PROTEIN2 family.",AIMed.d27.s229
305,AIMed.d27,False,"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as PROTEIN1 and PROTEIN2 and regulators of apoptosis such as PROTEIN and members of the PROTEIN family.",AIMed.d27.s229
306,AIMed.d27,False,"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as PROTEIN1 and PROTEIN and regulators of apoptosis such as PROTEIN and members of the PROTEIN2 family.",AIMed.d27.s229
307,AIMed.d29,False,We have probed an epitope sequence (His18-Pro19-Lys20-Phe21) in PROTEIN1 ( PROTEIN2 by site-directed mutagenesis.,AIMed.d29.s243
308,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 ( PROTEIN and B ( PROTEIN and to the PROTEIN2 ,AIMed.d29.s244
309,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN1 reduced up to 77-fold the binding affinity to PROTEIN2 ( PROTEIN and B ( PROTEIN and to the PROTEIN ,AIMed.d29.s244
310,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 ( PROTEIN and B ( PROTEIN and to the PROTEIN ,AIMed.d29.s244
311,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 ( PROTEIN2 and B ( PROTEIN and to the PROTEIN ,AIMed.d29.s244
312,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 ( PROTEIN and B ( PROTEIN2 and to the PROTEIN ,AIMed.d29.s244
313,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN1 reduced up to 77-fold the binding affinity to PROTEIN ( PROTEIN and B ( PROTEIN and to the PROTEIN2 ,AIMed.d29.s244
314,AIMed.d29,True,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 receptor subtypes A ( PROTEIN and B ( PROTEIN and to the PROTEIN2 ,AIMed.d29.s244
315,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN ( PROTEIN1 and B ( PROTEIN and to the PROTEIN2 ,AIMed.d29.s244
316,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN ( PROTEIN and B ( PROTEIN1 and to the PROTEIN2 ,AIMed.d29.s244
317,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN1 reduced up to 77-fold the binding affinity to PROTEIN2 receptor subtypes A ( PROTEIN and B ( PROTEIN and to the PROTEIN ,AIMed.d29.s244
318,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN1 reduced up to 77-fold the binding affinity to PROTEIN ( PROTEIN2 and B ( PROTEIN and to the PROTEIN ,AIMed.d29.s244
319,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN1 reduced up to 77-fold the binding affinity to PROTEIN ( PROTEIN and B ( PROTEIN2 and to the PROTEIN ,AIMed.d29.s244
320,AIMed.d29,True,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 receptor subtypes A ( PROTEIN2 and B ( PROTEIN and to the PROTEIN ,AIMed.d29.s244
321,AIMed.d29,True,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 receptor subtypes A ( PROTEIN and B ( PROTEIN2 and to the PROTEIN ,AIMed.d29.s244
322,AIMed.d29,False,This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN ( PROTEIN1 and B ( PROTEIN2 and to the PROTEIN ,AIMed.d29.s244
323,AIMed.d29,False,These Ala mutants triggered neutrophil degranulation and induced calcium responses mediated by PROTEIN1 and PROTEIN2 ,AIMed.d29.s245
324,AIMed.d29,False,"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A/F21D, H18A/F21S, and H18D/F21D, reduced up to 431-fold the binding affinity to PROTEIN PROTEIN1 and the PROTEIN2 ",AIMed.d29.s246
325,AIMed.d29,False,"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A/F21D, H18A/F21S, and H18D/F21D, reduced up to 431-fold the binding affinity to PROTEIN1 PROTEIN2 and the PROTEIN ",AIMed.d29.s246
326,AIMed.d29,False,"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A/F21D, H18A/F21S, and H18D/F21D, reduced up to 431-fold the binding affinity to PROTEIN1 PROTEIN and the PROTEIN2 ",AIMed.d29.s246
327,AIMed.d29,False,This study demonstrates that PROTEIN recognizes and activates PROTEIN1 PROTEIN2 and the PROTEIN by distinct mechanisms.,AIMed.d29.s249
328,AIMed.d29,False,This study demonstrates that PROTEIN recognizes and activates PROTEIN1 PROTEIN and the PROTEIN2 by distinct mechanisms.,AIMed.d29.s249
329,AIMed.d29,True,This study demonstrates that PROTEIN1 recognizes and activates PROTEIN2 PROTEIN and the PROTEIN by distinct mechanisms.,AIMed.d29.s249
330,AIMed.d29,False,This study demonstrates that PROTEIN recognizes and activates PROTEIN PROTEIN1 and the PROTEIN2 by distinct mechanisms.,AIMed.d29.s249
331,AIMed.d29,True,This study demonstrates that PROTEIN1 recognizes and activates PROTEIN PROTEIN2 and the PROTEIN by distinct mechanisms.,AIMed.d29.s249
332,AIMed.d29,True,This study demonstrates that PROTEIN1 recognizes and activates PROTEIN PROTEIN and the PROTEIN2 by distinct mechanisms.,AIMed.d29.s249
333,AIMed.d30,True,Isolation of human PROTEIN1 and its binding specificity with PROTEIN2 ,AIMed.d30.s250
334,AIMed.d30,True,We screened proteins for interaction with PROTEIN1 and cloned the full-length cDNA of human PROTEIN2 which encoded 1225 amino acids.,AIMed.d30.s251
335,AIMed.d30,False,"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that PROTEIN1 interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PROTEIN but not with that of PROTEIN2 ",AIMed.d30.s252
336,AIMed.d30,True,"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that PROTEIN1 interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PROTEIN2 but not with that of PROTEIN ",AIMed.d30.s252
337,AIMed.d30,False,"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that PROTEIN interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PROTEIN1 but not with that of PROTEIN2 ",AIMed.d30.s252
338,AIMed.d30,False,These results suggest that PROTEIN1 and PROTEIN2 partly differ in function.,AIMed.d30.s253
339,AIMed.d30,False,We also found another PROTEIN1 PROTEIN interacted with PROTEIN2 ,AIMed.d30.s255
340,AIMed.d30,True,We also found another PROTEIN PROTEIN1 interacted with PROTEIN2 ,AIMed.d30.s255
341,AIMed.d30,False,We also found another PROTEIN1 PROTEIN2 interacted with PROTEIN ,AIMed.d30.s255
342,AIMed.d32,False,Shared and unique determinants of PROTEIN2 PROTEIN1 are important for binding PROTEIN and PROTEIN mimetic peptide.,AIMed.d32.s268
343,AIMed.d32,False,Shared and unique determinants of PROTEIN1 PROTEIN are important for binding PROTEIN and PROTEIN2 ,AIMed.d32.s268
344,AIMed.d32,False,Shared and unique determinants of PROTEIN1 PROTEIN are important for binding PROTEIN2 and PROTEIN mimetic peptide.,AIMed.d32.s268
345,AIMed.d32,False,Shared and unique determinants of the PROTEIN1 ( PROTEIN2 receptor are important for binding PROTEIN and PROTEIN mimetic peptide.,AIMed.d32.s268
346,AIMed.d32,False,Shared and unique determinants of PROTEIN1 PROTEIN are important for binding PROTEIN and PROTEIN2 mimetic peptide.,AIMed.d32.s268
347,AIMed.d32,False,Shared and unique determinants of PROTEIN PROTEIN1 are important for binding PROTEIN and PROTEIN2 ,AIMed.d32.s268
348,AIMed.d32,True,Shared and unique determinants of PROTEIN PROTEIN1 are important for binding PROTEIN2 and PROTEIN ,AIMed.d32.s268
349,AIMed.d32,False,Shared and unique determinants of PROTEIN PROTEIN1 are important for binding PROTEIN and PROTEIN ,AIMed.d32.s268
350,AIMed.d32,False,Shared and unique determinants of PROTEIN PROTEIN1 are important for binding PROTEIN and PROTEIN2 mimetic peptide.,AIMed.d32.s268
351,AIMed.d32,False,Shared and unique determinants of PROTEIN PROTEIN are important for binding PROTEIN1 and PROTEIN2 ,AIMed.d32.s268
352,AIMed.d32,False,Shared and unique determinants of the PROTEIN1 ( PROTEIN receptor are important for binding PROTEIN and PROTEIN2 ,AIMed.d32.s268
353,AIMed.d32,False,Shared and unique determinants of PROTEIN PROTEIN are important for binding PROTEIN and PROTEIN1 mimetic peptide.,AIMed.d32.s268
354,AIMed.d32,False,Shared and unique determinants of the PROTEIN1 ( PROTEIN receptor are important for binding PROTEIN2 and PROTEIN ,AIMed.d32.s268
355,AIMed.d32,False,Shared and unique determinants of PROTEIN PROTEIN are important for binding PROTEIN1 and PROTEIN2 mimetic peptide.,AIMed.d32.s268
356,AIMed.d32,False,Shared and unique determinants of the PROTEIN1 ( PROTEIN receptor are important for binding PROTEIN and PROTEIN2 mimetic peptide.,AIMed.d32.s268
357,AIMed.d32,True,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN1 is crucial for binding PROTEIN2 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
358,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN1 PROTEIN ( PROTEIN is crucial for binding PROTEIN2 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
359,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN1 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
360,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN receptor ( PROTEIN is crucial for binding PROTEIN2 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
361,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN1 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
362,AIMed.d32,True,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN1 ( PROTEIN is crucial for binding PROTEIN2 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
363,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN1 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
364,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN1 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
365,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN1 Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
366,AIMed.d32,True,We have shown previously that Phe93 in the extracellular domain of PROTEIN1 PROTEIN ( PROTEIN2 is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
367,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN1 is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
368,AIMed.d32,True,We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN receptor ( PROTEIN2 is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
369,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN1 is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
370,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN1 ( PROTEIN2 is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
371,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN1 is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
372,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN1 is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
373,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN1 is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
374,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN1 PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
375,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN2 receptor ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
376,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN1 PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
377,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN2 PROTEIN1 ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
378,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN1 PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
379,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN1 PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
380,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN1 PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
381,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN receptor ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
382,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN1 ( PROTEIN binding protein or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
383,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN1 ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
384,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN1 ( PROTEIN2 or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
385,AIMed.d32,True,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN1 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN2 ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
386,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN1 ( PROTEIN2 binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
387,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN receptor ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
388,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN1 ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
389,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN receptor ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
390,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN receptor ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
391,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of the PROTEIN1 ( PROTEIN receptor ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
392,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN1 ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
393,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN1 or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
394,AIMed.d32,True,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN1 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
395,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN1 binding protein or PROTEIN2 and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
396,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN1 ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
397,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN1 ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN2 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
398,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN1 ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
399,AIMed.d32,True,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN1 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
400,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN1 binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
401,AIMed.d32,False,We have shown previously that Phe93 in the extracellular domain of PROTEIN PROTEIN ( PROTEIN is crucial for binding PROTEIN Substitution of Phe93 with alanine resulted in a dramatic decrease in PROTEIN1 binding to the Escherichia coli-expressed extracellular domain of the PROTEIN ( PROTEIN2 binding protein or PROTEIN and no detectable binding to full-length mutant receptor expressed in COS cells.,AIMed.d32.s269
402,AIMed.d32,True,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN1 bound to an PROTEIN ( PROTEIN2 , suggesting that Phe93 is also important for PROTEIN binding.",AIMed.d32.s270
403,AIMed.d32,False,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an PROTEIN ( PROTEIN1 , suggesting that Phe93 is also important for PROTEIN2 binding.",AIMed.d32.s270
404,AIMed.d32,False,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an PROTEIN1 mimetic peptide ( PROTEIN2 , suggesting that Phe93 is also important for PROTEIN binding.",AIMed.d32.s270
405,AIMed.d32,False,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an PROTEIN1 ( PROTEIN2 , suggesting that Phe93 is also important for PROTEIN binding.",AIMed.d32.s270
406,AIMed.d32,True,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN1 bound to an PROTEIN ( PROTEIN , suggesting that Phe93 is also important for PROTEIN2 binding.",AIMed.d32.s270
407,AIMed.d32,False,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN1 bound to an PROTEIN2 mimetic peptide ( PROTEIN , suggesting that Phe93 is also important for PROTEIN binding.",AIMed.d32.s270
408,AIMed.d32,False,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN1 bound to an PROTEIN2 ( PROTEIN , suggesting that Phe93 is also important for PROTEIN binding.",AIMed.d32.s270
409,AIMed.d32,False,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an PROTEIN1 mimetic peptide ( PROTEIN , suggesting that Phe93 is also important for PROTEIN2 binding.",AIMed.d32.s270
410,AIMed.d32,False,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an PROTEIN1 ( PROTEIN , suggesting that Phe93 is also important for PROTEIN2 binding.",AIMed.d32.s270
411,AIMed.d32,False,"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the PROTEIN bound to an PROTEIN1 ( PROTEIN , suggesting that Phe93 is also important for PROTEIN binding.",AIMed.d32.s270
412,AIMed.d32,False,We used alanine substitution of PROTEIN residues that contact PROTEIN1 in the crystal structure to investigate the function of these residues in both PROTEIN2 and PROTEIN binding.,AIMed.d32.s271
413,AIMed.d32,True,We used alanine substitution of PROTEIN1 residues that contact PROTEIN2 in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN binding.,AIMed.d32.s271
414,AIMed.d32,False,We used alanine substitution of PROTEIN residues that contact PROTEIN1 in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN2 binding.,AIMed.d32.s271
415,AIMed.d32,True,We used alanine substitution of PROTEIN1 residues that contact PROTEIN in the crystal structure to investigate the function of these residues in both PROTEIN2 and PROTEIN binding.,AIMed.d32.s271
416,AIMed.d32,False,We used alanine substitution of PROTEIN residues that contact PROTEIN in the crystal structure to investigate the function of these residues in both PROTEIN1 and PROTEIN2 binding.,AIMed.d32.s271
417,AIMed.d32,True,We used alanine substitution of PROTEIN1 residues that contact PROTEIN in the crystal structure to investigate the function of these residues in both PROTEIN and PROTEIN2 binding.,AIMed.d32.s271
418,AIMed.d32,False,"Our results indicate that Phe93 and Phe205 are important for both PROTEIN1 and PROTEIN2 binding, Met150 is not important for PROTEIN binding but is critical for PROTEIN binding, and Thr151 is not important for binding either ligand.",AIMed.d32.s273
419,AIMed.d32,False,"Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN1 binding, Met150 is not important for PROTEIN binding but is critical for PROTEIN2 binding, and Thr151 is not important for binding either ligand.",AIMed.d32.s273
420,AIMed.d32,False,"Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN1 binding, Met150 is not important for PROTEIN2 binding but is critical for PROTEIN binding, and Thr151 is not important for binding either ligand.",AIMed.d32.s273
421,AIMed.d32,False,"Our results indicate that Phe93 and Phe205 are important for both PROTEIN1 and PROTEIN binding, Met150 is not important for PROTEIN binding but is critical for PROTEIN2 binding, and Thr151 is not important for binding either ligand.",AIMed.d32.s273
422,AIMed.d32,False,"Our results indicate that Phe93 and Phe205 are important for both PROTEIN1 and PROTEIN binding, Met150 is not important for PROTEIN2 binding but is critical for PROTEIN binding, and Thr151 is not important for binding either ligand.",AIMed.d32.s273
423,AIMed.d32,False,"Our results indicate that Phe93 and Phe205 are important for both PROTEIN and PROTEIN binding, Met150 is not important for PROTEIN1 binding but is critical for PROTEIN2 binding, and Thr151 is not important for binding either ligand.",AIMed.d32.s273
424,AIMed.d32,False,"Thus, Phe93 and Phe205 are important binding determinants for both PROTEIN1 and PROTEIN2 even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the PROTEIN for productive ligand binding.",AIMed.d32.s274
425,AIMed.d32,True,"Thus, Phe93 and Phe205 are important binding determinants for both PROTEIN and PROTEIN1 even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the PROTEIN2 for productive ligand binding.",AIMed.d32.s274
426,AIMed.d32,True,"Thus, Phe93 and Phe205 are important binding determinants for both PROTEIN1 and PROTEIN even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the PROTEIN2 for productive ligand binding.",AIMed.d32.s274
427,AIMed.d33,True,Native PROTEIN1 and PROTEIN2 formed a heterodimer in solution of physiological ionic strength with a free-energy change DeltaG degrees of -8.3 kcal/mol and a dissociation constant Kd of 0.6 microM (at 20 degrees C) that was ionic strength- and temperature-dependent.,AIMed.d33.s277
428,AIMed.d33,True,"A van't Hoff plot of the change in Kd was linear between 10 and 37 degrees C and yielded values of DeltaH degrees = -12.9 kcal/mol and DeltaS degrees = -15.9 cal mol-1 deg-1, suggesting that electrostatic forces play a prominent role in the interaction of PROTEIN1 with PROTEIN2 ",AIMed.d33.s278
429,AIMed.d33,True,Native PROTEIN1 also formed a heterodimer with PROTEIN2 and low concentrations of polyionic ligands such as protamine and suramin inhibited the interaction.,AIMed.d33.s279
430,AIMed.d33,False,Suramin induced high-affinity trimerization of PROTEIN1 (Kd = 0.10 microM at 20 degrees C) and dimerization of PROTEIN2 (Kd = 0.86 microM at 20 degrees C).,AIMed.d33.s280
431,AIMed.d33,False,Analysis of sedimentation equilibria and also of the fluorescence enhancement of suramin when bound to protein provided evidence for two suramin-binding sites on each PROTEIN1 and three on each PROTEIN2 in the oligomers.,AIMed.d33.s282
432,AIMed.d35,False,Most familial early-onset Alzheimer's disease cases are caused by mutations in the PROTEIN1 ( PROTEIN2 gene.,AIMed.d35.s292
433,AIMed.d35,False,"Although numerous studies revealed predominant localization of PROTEIN1 to endoplasmic reticulum and Golgi, there are conflicting reports on the localization of PROTEIN2 to the cell surface.",AIMed.d35.s294
434,AIMed.d35,True,"Cell surface PROTEIN1 formed complexes in vivo with actin-binding protein PROTEIN2 ( PROTEIN , which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.",AIMed.d35.s299
435,AIMed.d35,True,"Cell surface PROTEIN1 formed complexes in vivo with actin-binding protein PROTEIN ( PROTEIN2 , which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.",AIMed.d35.s299
436,AIMed.d35,False,"Cell surface PROTEIN formed complexes in vivo with actin-binding protein PROTEIN1 ( PROTEIN2 , which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.",AIMed.d35.s299
437,AIMed.d36,True,Molecular determinants of the interaction between the C-terminal domain of Alzheimer's PROTEIN1 and PROTEIN2 alpha-helices.,AIMed.d36.s301
438,AIMed.d36,False,"In a previous work, we predicted and demonstrated that the 29-42-residue fragment of PROTEIN1 ( PROTEIN2 has in vitro capacities close to those of the tilted fragment of viral fusion proteins.",AIMed.d36.s302
439,AIMed.d36,False,We further demonstrated that PROTEIN and E3 but not PROTEIN1 can decrease the fusogenic activity of PROTEIN2 29-42) via a direct interaction.,AIMed.d36.s303
440,AIMed.d36,True,We further demonstrated that PROTEIN1 and E3 but not PROTEIN can decrease the fusogenic activity of PROTEIN2 29-42) via a direct interaction.,AIMed.d36.s303
441,AIMed.d36,False,We further demonstrated that PROTEIN1 and E3 but not PROTEIN2 can decrease the fusogenic activity of PROTEIN 29-42) via a direct interaction.,AIMed.d36.s303
442,AIMed.d36,False,"Therefore, we suggested that this fragment is implicated in the neurotoxicity of PROTEIN1 and in the protective effects of PROTEIN2 in Alzheimer's disease.",AIMed.d36.s304
443,AIMed.d36,False,"In this study, we simulated interactions of all amphipathic helices of PROTEIN1 and A-I with PROTEIN2 and simian immunodeficiency virus (SIV) fusogenic fragments by molecular modeling.",AIMed.d36.s306
444,AIMed.d37,False, PROTEIN1 binds multiple CC-chemokines: PROTEIN2 acts as a natural antagonist.,AIMed.d37.s310
445,AIMed.d37,True, PROTEIN1 was first characterized as a receptor for PROTEIN2 PROTEIN and PROTEIN and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).,AIMed.d37.s311
446,AIMed.d37,True, PROTEIN1 was first characterized as a receptor for PROTEIN PROTEIN and PROTEIN2 and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).,AIMed.d37.s311
447,AIMed.d37,True, PROTEIN1 was first characterized as a receptor for PROTEIN PROTEIN2 and PROTEIN and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).,AIMed.d37.s311
448,AIMed.d37,False, PROTEIN was first characterized as a receptor for PROTEIN1 PROTEIN and PROTEIN2 and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).,AIMed.d37.s311
449,AIMed.d37,False, PROTEIN was first characterized as a receptor for PROTEIN1 PROTEIN2 and PROTEIN and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).,AIMed.d37.s311
450,AIMed.d37,False, PROTEIN was first characterized as a receptor for PROTEIN PROTEIN1 and PROTEIN2 and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).,AIMed.d37.s311
451,AIMed.d37,False,All CC-chemokines currently available were tested for their ability to compete with [(125)I]- PROTEIN1 binding on a stable cell line expressing recombinant PROTEIN2 and/or to induce a functional response in these cells.,AIMed.d37.s314
452,AIMed.d37,True,"We found that in addition to PROTEIN1 PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN2 binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
453,AIMed.d37,False,"We found that in addition to PROTEIN1 PROTEIN and PROTEIN2 five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
454,AIMed.d37,False,"We found that in addition to PROTEIN1 PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
455,AIMed.d37,False,"We found that in addition to PROTEIN1 PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
456,AIMed.d37,False,"We found that in addition to PROTEIN1 PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
457,AIMed.d37,False,"We found that in addition to PROTEIN1 PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
458,AIMed.d37,False,"We found that in addition to PROTEIN1 PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
459,AIMed.d37,False,"We found that in addition to PROTEIN1 PROTEIN2 and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
460,AIMed.d37,True,"We found that in addition to PROTEIN PROTEIN and PROTEIN1 five other CC-chemokines could compete for [(125)I]- PROTEIN2 binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
461,AIMed.d37,True,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN1 binding: PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
462,AIMed.d37,True,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN1 binding: PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
463,AIMed.d37,True,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN1 binding: PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
464,AIMed.d37,True,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN1 binding: PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
465,AIMed.d37,True,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN1 binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
466,AIMed.d37,True,"We found that in addition to PROTEIN PROTEIN1 and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN2 binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
467,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN1 five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
468,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN1 five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
469,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN1 five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
470,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN1 five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
471,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN1 five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
472,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN1 and PROTEIN2 five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
473,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN1 PROTEIN2 PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
474,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN1 PROTEIN2 PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
475,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN1 PROTEIN PROTEIN2 and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
476,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
477,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN1 and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
478,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN1 PROTEIN PROTEIN2 PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
479,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN1 PROTEIN2 and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
480,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
481,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN1 and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
482,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN1 PROTEIN PROTEIN PROTEIN2 and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
483,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
484,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN1 and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
485,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
486,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN1 and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
487,AIMed.d37,False,"We found that in addition to PROTEIN PROTEIN1 and PROTEIN five other CC-chemokines could compete for [(125)I]- PROTEIN binding: PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.",AIMed.d37.s315
488,AIMed.d37,True,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN1 could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN2 ",AIMed.d37.s316
489,AIMed.d37,False,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN by PROTEIN1 and may therefore be considered as a natural antagonist for PROTEIN2 ",AIMed.d37.s316
490,AIMed.d37,False,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN1 by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN2 ",AIMed.d37.s316
491,AIMed.d37,False,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN1 with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN2 ",AIMed.d37.s316
492,AIMed.d37,False,"Among these ligands, PROTEIN1 had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN2 ",AIMed.d37.s316
493,AIMed.d37,False,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN1 could also inhibit the activation of PROTEIN by PROTEIN2 and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
494,AIMed.d37,False,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN1 could also inhibit the activation of PROTEIN2 by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
495,AIMed.d37,False,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN1 with high affinity without eliciting a functional response, PROTEIN2 could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
496,AIMed.d37,False,"Among these ligands, PROTEIN1 had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN2 could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
497,AIMed.d37,True,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN1 by PROTEIN2 and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
498,AIMed.d37,False,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN1 with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN by PROTEIN2 and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
499,AIMed.d37,False,"Among these ligands, PROTEIN1 had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN by PROTEIN2 and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
500,AIMed.d37,False,"Among these ligands, PROTEIN had the remarkable property of binding PROTEIN1 with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN2 by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
501,AIMed.d37,False,"Among these ligands, PROTEIN1 had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN2 by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
502,AIMed.d37,True,"Among these ligands, PROTEIN1 had the remarkable property of binding PROTEIN2 with high affinity without eliciting a functional response, PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN ",AIMed.d37.s316
503,AIMed.d37,False,"Chemokines that could compete with high affinity for PROTEIN1 binding could also compete for monomeric PROTEIN2 binding, although with variable potencies; maximal PROTEIN binding inhibition was 80% for PROTEIN but only 30% for PROTEIN ",AIMed.d37.s318
504,AIMed.d37,False,"Chemokines that could compete with high affinity for PROTEIN1 binding could also compete for monomeric PROTEIN binding, although with variable potencies; maximal PROTEIN binding inhibition was 80% for PROTEIN2 but only 30% for PROTEIN ",AIMed.d37.s318
505,AIMed.d37,False,"Chemokines that could compete with high affinity for PROTEIN1 binding could also compete for monomeric PROTEIN binding, although with variable potencies; maximal PROTEIN binding inhibition was 80% for PROTEIN but only 30% for PROTEIN2 ",AIMed.d37.s318
506,AIMed.d37,False,"Chemokines that could compete with high affinity for PROTEIN1 binding could also compete for monomeric PROTEIN binding, although with variable potencies; maximal PROTEIN2 binding inhibition was 80% for PROTEIN but only 30% for PROTEIN ",AIMed.d37.s318
507,AIMed.d37,False,"Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN1 binding, although with variable potencies; maximal PROTEIN binding inhibition was 80% for PROTEIN2 but only 30% for PROTEIN ",AIMed.d37.s318
508,AIMed.d37,False,"Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN1 binding, although with variable potencies; maximal PROTEIN binding inhibition was 80% for PROTEIN but only 30% for PROTEIN2 ",AIMed.d37.s318
509,AIMed.d37,False,"Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN1 binding, although with variable potencies; maximal PROTEIN2 binding inhibition was 80% for PROTEIN but only 30% for PROTEIN ",AIMed.d37.s318
510,AIMed.d37,False,"Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding, although with variable potencies; maximal PROTEIN binding inhibition was 80% for PROTEIN1 but only 30% for PROTEIN2 ",AIMed.d37.s318
511,AIMed.d37,True,"Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding, although with variable potencies; maximal PROTEIN1 binding inhibition was 80% for PROTEIN2 but only 30% for PROTEIN ",AIMed.d37.s318
512,AIMed.d37,True,"Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding, although with variable potencies; maximal PROTEIN1 binding inhibition was 80% for PROTEIN but only 30% for PROTEIN2 ",AIMed.d37.s318
513,AIMed.d37,True," PROTEIN1 could compete efficiently for PROTEIN2 binding but was, however, found to be a weak inhibitor of HIV infection, probably as a consequence of its inability to downregulate the receptor.",AIMed.d37.s319
514,AIMed.d39,True, PROTEIN1 suppresses the function of PROTEIN homodimers via interaction with PROTEIN2 PROTEIN ,AIMed.d39.s334
515,AIMed.d39,False, PROTEIN suppresses the function of PROTEIN homodimers via interaction with PROTEIN1 PROTEIN2 ,AIMed.d39.s334
516,AIMed.d39,False, PROTEIN suppresses the function of PROTEIN1 homodimers via interaction with PROTEIN2 PROTEIN ,AIMed.d39.s334
517,AIMed.d39,True, PROTEIN1 suppresses the function of PROTEIN homodimers via interaction with PROTEIN PROTEIN2 ,AIMed.d39.s334
518,AIMed.d39,False, PROTEIN1 suppresses the function of PROTEIN2 homodimers via interaction with PROTEIN PROTEIN ,AIMed.d39.s334
519,AIMed.d39,False, PROTEIN suppresses the function of PROTEIN1 homodimers via interaction with PROTEIN PROTEIN2 ,AIMed.d39.s334
520,AIMed.d39,False, PROTEIN1 ( PROTEIN2 is the causative gene for an autosomal dominant familial Alzheimer's disease (AD) mapped to chromosome 14.,AIMed.d39.s335
521,AIMed.d39,True,Here we show that PROTEIN PROTEIN1 a negative regulator of PROTEIN2 is a candidate to mediate the function of PROTEIN in the cell.,AIMed.d39.s336
522,AIMed.d39,False,Here we show that PROTEIN PROTEIN1 a negative regulator of PROTEIN is a candidate to mediate the function of PROTEIN2 in the cell.,AIMed.d39.s336
523,AIMed.d39,False,Here we show that PROTEIN1 PROTEIN2 a negative regulator of PROTEIN is a candidate to mediate the function of PROTEIN in the cell.,AIMed.d39.s336
524,AIMed.d39,False,Here we show that PROTEIN PROTEIN a negative regulator of PROTEIN1 is a candidate to mediate the function of PROTEIN2 in the cell.,AIMed.d39.s336
525,AIMed.d39,True,Here we show that PROTEIN1 PROTEIN a negative regulator of PROTEIN2 is a candidate to mediate the function of PROTEIN in the cell.,AIMed.d39.s336
526,AIMed.d39,False,Here we show that PROTEIN1 PROTEIN a negative regulator of PROTEIN is a candidate to mediate the function of PROTEIN2 in the cell.,AIMed.d39.s336
527,AIMed.d39,True,We screened for proteins that bind to PROTEIN1 from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the PROTEIN2 PROTEIN gene.,AIMed.d39.s337
528,AIMed.d39,False,We screened for proteins that bind to PROTEIN from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the PROTEIN1 PROTEIN2 gene.,AIMed.d39.s337
529,AIMed.d39,True,We screened for proteins that bind to PROTEIN1 from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the PROTEIN PROTEIN2 gene.,AIMed.d39.s337
530,AIMed.d39,False,"The binding of PROTEIN1 PROTEIN2 to full-length PROTEIN was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.",AIMed.d39.s338
531,AIMed.d39,True,"The binding of PROTEIN PROTEIN1 to full-length PROTEIN2 was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.",AIMed.d39.s338
532,AIMed.d39,True,"The binding of PROTEIN1 PROTEIN to full-length PROTEIN2 was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.",AIMed.d39.s338
533,AIMed.d39,False,"Immunoelectronmicroscopic analysis showed that PROTEIN1 PROTEIN and PROTEIN2 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.",AIMed.d39.s339
534,AIMed.d39,False,"Immunoelectronmicroscopic analysis showed that PROTEIN PROTEIN1 and PROTEIN2 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.",AIMed.d39.s339
535,AIMed.d39,False,"Immunoelectronmicroscopic analysis showed that PROTEIN1 PROTEIN2 and PROTEIN are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.",AIMed.d39.s339
536,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN1 PROTEIN but not by PROTEIN PROTEIN2 heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
537,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN PROTEIN1 heterodimers, consistent with the reported function of PROTEIN PROTEIN2 ",AIMed.d39.s340
538,AIMed.d39,True,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN1 PROTEIN2 heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
539,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN1 but not by PROTEIN PROTEIN2 heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
540,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN1 suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN PROTEIN2 heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
541,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN PROTEIN1 heterodimers, consistent with the reported function of PROTEIN2 PROTEIN ",AIMed.d39.s340
542,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN1 PROTEIN but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN2 ",AIMed.d39.s340
543,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN1 PROTEIN but not by PROTEIN2 PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
544,AIMed.d39,True,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN1 PROTEIN2 but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
545,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN1 suppresses transactivation by PROTEIN2 PROTEIN but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
546,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN1 PROTEIN but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN2 PROTEIN ",AIMed.d39.s340
547,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN1 PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN2 ",AIMed.d39.s340
548,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN1 but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN2 ",AIMed.d39.s340
549,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN1 suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN2 ",AIMed.d39.s340
550,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN1 PROTEIN2 ",AIMed.d39.s340
551,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN1 but not by PROTEIN2 PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
552,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN1 suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN2 PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
553,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN1 PROTEIN heterodimers, consistent with the reported function of PROTEIN2 PROTEIN ",AIMed.d39.s340
554,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN1 suppresses transactivation by PROTEIN PROTEIN2 but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN PROTEIN ",AIMed.d39.s340
555,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN PROTEIN1 but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN2 PROTEIN ",AIMed.d39.s340
556,AIMed.d39,False,"Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN1 suppresses transactivation by PROTEIN PROTEIN but not by PROTEIN PROTEIN heterodimers, consistent with the reported function of PROTEIN2 PROTEIN ",AIMed.d39.s340
557,AIMed.d39,False,"By monitoring fluorescent recombinant protein and by gel mobility shift assays, PROTEIN1 was shown to accelerate the translocation of PROTEIN from the cytoplasm to the nucleus and to thereby suppress the binding of PROTEIN2 homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).",AIMed.d39.s341
558,AIMed.d39,False,"By monitoring fluorescent recombinant protein and by gel mobility shift assays, PROTEIN was shown to accelerate the translocation of PROTEIN1 from the cytoplasm to the nucleus and to thereby suppress the binding of PROTEIN2 homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).",AIMed.d39.s341
559,AIMed.d39,False,"By monitoring fluorescent recombinant protein and by gel mobility shift assays, PROTEIN1 was shown to accelerate the translocation of PROTEIN2 from the cytoplasm to the nucleus and to thereby suppress the binding of PROTEIN homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).",AIMed.d39.s341
560,AIMed.d39,False," PROTEIN suppressed PROTEIN1 associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PROTEIN2 ",AIMed.d39.s342
561,AIMed.d39,False," PROTEIN1 suppressed PROTEIN2 associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PROTEIN ",AIMed.d39.s342
562,AIMed.d39,False," PROTEIN1 suppressed PROTEIN associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PROTEIN2 ",AIMed.d39.s342
563,AIMed.d39,False,"Collectively, the novel function of PROTEIN via PROTEIN1 PROTEIN2 influences PROTEIN mediated transcription and apoptosis.",AIMed.d39.s343
564,AIMed.d39,False,"Collectively, the novel function of PROTEIN1 via PROTEIN2 PROTEIN influences PROTEIN mediated transcription and apoptosis.",AIMed.d39.s343
565,AIMed.d39,False,"Collectively, the novel function of PROTEIN via PROTEIN1 PROTEIN influences PROTEIN2 mediated transcription and apoptosis.",AIMed.d39.s343
566,AIMed.d39,False,"Collectively, the novel function of PROTEIN1 via PROTEIN PROTEIN2 influences PROTEIN mediated transcription and apoptosis.",AIMed.d39.s343
567,AIMed.d39,False,"Collectively, the novel function of PROTEIN via PROTEIN PROTEIN1 influences PROTEIN2 mediated transcription and apoptosis.",AIMed.d39.s343
568,AIMed.d39,False,"Collectively, the novel function of PROTEIN1 via PROTEIN PROTEIN influences PROTEIN2 mediated transcription and apoptosis.",AIMed.d39.s343
569,AIMed.d40,True,We have crystallized a complex between human PROTEIN1 and a two-domain extracellular fragment of human PROTEIN2 ,AIMed.d40.s347
570,AIMed.d41,False,Crystal structure of the hereditary haemochromatosis protein PROTEIN complexed with PROTEIN1 receptor.,AIMed.d41.s352
571,AIMed.d41,True,Crystal structure of the hereditary haemochromatosis protein PROTEIN1 complexed with PROTEIN2 ,AIMed.d41.s352
572,AIMed.d41,False,Crystal structure of the hereditary haemochromatosis protein PROTEIN1 complexed with PROTEIN2 receptor.,AIMed.d41.s352
573,AIMed.d41,False," PROTEIN binds to the PROTEIN1 ( PROTEIN , a receptor by which cells acquire iron-loaded PROTEIN2 ",AIMed.d41.s354
574,AIMed.d41,False," PROTEIN binds to the PROTEIN1 receptor ( PROTEIN , a receptor by which cells acquire iron-loaded PROTEIN ",AIMed.d41.s354
575,AIMed.d41,False," PROTEIN binds to the PROTEIN1 ( PROTEIN2 , a receptor by which cells acquire iron-loaded PROTEIN ",AIMed.d41.s354
576,AIMed.d41,True," PROTEIN1 binds to the PROTEIN2 ( PROTEIN , a receptor by which cells acquire iron-loaded PROTEIN ",AIMed.d41.s354
577,AIMed.d41,False," PROTEIN binds to the PROTEIN1 receptor ( PROTEIN , a receptor by which cells acquire iron-loaded PROTEIN2 ",AIMed.d41.s354
578,AIMed.d41,False," PROTEIN binds to the PROTEIN receptor ( PROTEIN1 , a receptor by which cells acquire iron-loaded PROTEIN2 ",AIMed.d41.s354
579,AIMed.d41,False," PROTEIN1 binds to the PROTEIN receptor ( PROTEIN , a receptor by which cells acquire iron-loaded PROTEIN2 ",AIMed.d41.s354
580,AIMed.d41,False," PROTEIN binds to the PROTEIN1 receptor ( PROTEIN2 , a receptor by which cells acquire iron-loaded PROTEIN ",AIMed.d41.s354
581,AIMed.d41,False," PROTEIN1 binds to the PROTEIN2 receptor ( PROTEIN , a receptor by which cells acquire iron-loaded PROTEIN ",AIMed.d41.s354
582,AIMed.d41,True," PROTEIN1 binds to the PROTEIN receptor ( PROTEIN2 , a receptor by which cells acquire iron-loaded PROTEIN ",AIMed.d41.s354
583,AIMed.d41,False,The 2.8 A crystal structure of a complex between the extracellular portions of PROTEIN1 and PROTEIN shows two PROTEIN molecules which grasp each side of a twofold symmetric PROTEIN2 dimer.,AIMed.d41.s355
584,AIMed.d41,False,The 2.8 A crystal structure of a complex between the extracellular portions of PROTEIN and PROTEIN1 shows two PROTEIN molecules which grasp each side of a twofold symmetric PROTEIN2 dimer.,AIMed.d41.s355
585,AIMed.d41,True,The 2.8 A crystal structure of a complex between the extracellular portions of PROTEIN and PROTEIN shows two PROTEIN1 molecules which grasp each side of a twofold symmetric PROTEIN2 dimer.,AIMed.d41.s355
586,AIMed.d41,True,The 2.8 A crystal structure of a complex between the extracellular portions of PROTEIN1 and PROTEIN2 shows two PROTEIN molecules which grasp each side of a twofold symmetric PROTEIN dimer.,AIMed.d41.s355
587,AIMed.d41,False,The 2.8 A crystal structure of a complex between the extracellular portions of PROTEIN1 and PROTEIN shows two PROTEIN2 molecules which grasp each side of a twofold symmetric PROTEIN dimer.,AIMed.d41.s355
588,AIMed.d41,False,The 2.8 A crystal structure of a complex between the extracellular portions of PROTEIN and PROTEIN1 shows two PROTEIN2 molecules which grasp each side of a twofold symmetric PROTEIN dimer.,AIMed.d41.s355
589,AIMed.d41,False,"On a cell membrane containing both proteins, PROTEIN1 would 'lie down' parallel to the membrane, such that the PROTEIN helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the PROTEIN2 dimerization domain.",AIMed.d41.s356
590,AIMed.d41,False,"On a cell membrane containing both proteins, PROTEIN1 would 'lie down' parallel to the membrane, such that the PROTEIN2 helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the PROTEIN dimerization domain.",AIMed.d41.s356
591,AIMed.d41,True,"On a cell membrane containing both proteins, PROTEIN would 'lie down' parallel to the membrane, such that the PROTEIN1 helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the PROTEIN2 dimerization domain.",AIMed.d41.s356
592,AIMed.d41,True,"The structures of PROTEIN1 alone and complexed with PROTEIN2 differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between PROTEIN chains.",AIMed.d41.s357
593,AIMed.d41,False,"The structures of PROTEIN1 alone and complexed with PROTEIN differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between PROTEIN2 chains.",AIMed.d41.s357
594,AIMed.d41,False,"The structures of PROTEIN alone and complexed with PROTEIN1 differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between PROTEIN2 chains.",AIMed.d41.s357
595,AIMed.d41,False,The PROTEIN PROTEIN1 complex suggests a binding site for transferrin on PROTEIN and sheds light upon the function of PROTEIN2 in regulating iron homeostasis.,AIMed.d41.s358
596,AIMed.d41,False,The PROTEIN1 PROTEIN complex suggests a binding site for transferrin on PROTEIN and sheds light upon the function of PROTEIN2 in regulating iron homeostasis.,AIMed.d41.s358
597,AIMed.d41,False,The PROTEIN PROTEIN complex suggests a binding site for transferrin on PROTEIN1 and sheds light upon the function of PROTEIN2 in regulating iron homeostasis.,AIMed.d41.s358
598,AIMed.d41,True,The PROTEIN1 PROTEIN2 complex suggests a binding site for transferrin on PROTEIN and sheds light upon the function of PROTEIN in regulating iron homeostasis.,AIMed.d41.s358
599,AIMed.d41,False,The PROTEIN PROTEIN1 complex suggests a binding site for transferrin on PROTEIN2 and sheds light upon the function of PROTEIN in regulating iron homeostasis.,AIMed.d41.s358
600,AIMed.d41,False,The PROTEIN1 PROTEIN complex suggests a binding site for transferrin on PROTEIN2 and sheds light upon the function of PROTEIN in regulating iron homeostasis.,AIMed.d41.s358
601,AIMed.d42,False,"The BMP receptors belong to the family of serine/threonine kinase receptors, whose activation has been investigated intensively for the PROTEIN1 ( PROTEIN2 receptor subfamily.",AIMed.d42.s361
602,AIMed.d42,False,"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN and PROTEIN and the PROTEIN1 ( PROTEIN2 .",AIMed.d42.s364
603,AIMed.d42,False,"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN1 and PROTEIN and the PROTEIN ( PROTEIN2 .",AIMed.d42.s364
604,AIMed.d42,False,"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN and PROTEIN1 and the PROTEIN ( PROTEIN2 .",AIMed.d42.s364
605,AIMed.d42,False,"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN1 and PROTEIN and the PROTEIN2 ( PROTEIN .",AIMed.d42.s364
606,AIMed.d42,False,"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN and PROTEIN1 and the PROTEIN2 ( PROTEIN .",AIMed.d42.s364
607,AIMed.d42,False,"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN1 and PROTEIN2 and the PROTEIN ( PROTEIN .",AIMed.d42.s364
608,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN2 PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
609,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
610,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
611,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN2 and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
612,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
613,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
614,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
615,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
616,AIMed.d42,True,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN2 and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
617,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
618,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN1 PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
619,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
620,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN and homomeric ( PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
621,AIMed.d42,True,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN2 and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
622,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
623,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
624,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN and homomeric ( PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
625,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
626,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN2 PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
627,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
628,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN1 PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
629,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
630,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN1 and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
631,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
632,AIMed.d42,True,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN1 PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
633,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
634,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
635,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
636,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
637,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and also PROTEIN2 PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
638,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN1 and homomeric ( PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
639,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
640,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
641,AIMed.d42,True,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
642,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
643,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN and homomeric ( PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
644,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
645,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
646,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN1 and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
647,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN1 and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
648,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN1 and homomeric ( PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
649,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN1 and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
650,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN2 and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
651,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN1 and homomeric ( PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
652,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN1 and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
653,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
654,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
655,AIMed.d42,True,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
656,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
657,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
658,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
659,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
660,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
661,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
662,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
663,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and also PROTEIN PROTEIN2 oligomers in the absence of ligand.",AIMed.d42.s367
664,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
665,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
666,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
667,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
668,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
669,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
670,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
671,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
672,AIMed.d42,False,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN1 and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
673,AIMed.d42,True,"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric ( PROTEIN PROTEIN and PROTEIN PROTEIN and homomeric ( PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN and also PROTEIN PROTEIN oligomers in the absence of ligand.",AIMed.d42.s367
674,AIMed.d42,True," PROTEIN1 binding significantly increased hetero- and homo-oligomerization (except for the PROTEIN2 homo-oligomer, which binds ligand poorly in the absence of PROTEIN .",AIMed.d42.s368
675,AIMed.d42,False," PROTEIN1 binding significantly increased hetero- and homo-oligomerization (except for the PROTEIN homo-oligomer, which binds ligand poorly in the absence of PROTEIN2 .",AIMed.d42.s368
676,AIMed.d42,True," PROTEIN binding significantly increased hetero- and homo-oligomerization (except for the PROTEIN1 homo-oligomer, which binds ligand poorly in the absence of PROTEIN2 .",AIMed.d42.s368
677,AIMed.d43,True,"Although the individual amino acids in PROTEIN1 involved in binding to PROTEIN2 ( PROTEIN and those in PROTEIN involved in binding to PROTEIN have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
678,AIMed.d43,False,"Although the individual amino acids in PROTEIN involved in binding to PROTEIN1 ( PROTEIN2 and those in PROTEIN involved in binding to PROTEIN have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
679,AIMed.d43,False,"Although the individual amino acids in PROTEIN involved in binding to PROTEIN1 ( PROTEIN and those in PROTEIN2 involved in binding to PROTEIN have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
680,AIMed.d43,False,"Although the individual amino acids in PROTEIN involved in binding to PROTEIN1 ( PROTEIN and those in PROTEIN involved in binding to PROTEIN2 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
681,AIMed.d43,True,"Although the individual amino acids in PROTEIN1 involved in binding to PROTEIN ( PROTEIN2 and those in PROTEIN involved in binding to PROTEIN have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
682,AIMed.d43,False,"Although the individual amino acids in PROTEIN1 involved in binding to PROTEIN ( PROTEIN and those in PROTEIN2 involved in binding to PROTEIN have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
683,AIMed.d43,False,"Although the individual amino acids in PROTEIN1 involved in binding to PROTEIN ( PROTEIN and those in PROTEIN involved in binding to PROTEIN2 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
684,AIMed.d43,False,"Although the individual amino acids in PROTEIN involved in binding to PROTEIN ( PROTEIN1 and those in PROTEIN2 involved in binding to PROTEIN have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
685,AIMed.d43,False,"Although the individual amino acids in PROTEIN involved in binding to PROTEIN ( PROTEIN1 and those in PROTEIN involved in binding to PROTEIN2 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
686,AIMed.d43,True,"Although the individual amino acids in PROTEIN involved in binding to PROTEIN ( PROTEIN and those in PROTEIN1 involved in binding to PROTEIN2 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.",AIMed.d43.s375
687,AIMed.d43,False,"In this study, a minimum set of residues in the human PROTEIN second immunoglobulin-like domain, which does not bind PROTEIN1 ( PROTEIN , were substituted with those from human PROTEIN2 ",AIMed.d43.s376
688,AIMed.d43,False,"In this study, a minimum set of residues in the human PROTEIN1 second immunoglobulin-like domain, which does not bind PROTEIN ( PROTEIN , were substituted with those from human PROTEIN2 ",AIMed.d43.s376
689,AIMed.d43,False,"In this study, a minimum set of residues in the human PROTEIN second immunoglobulin-like domain, which does not bind PROTEIN ( PROTEIN1 , were substituted with those from human PROTEIN2 ",AIMed.d43.s376
690,AIMed.d43,False,"In this study, a minimum set of residues in the human PROTEIN1 second immunoglobulin-like domain, which does not bind PROTEIN2 ( PROTEIN , were substituted with those from human PROTEIN ",AIMed.d43.s376
691,AIMed.d43,False,"In this study, a minimum set of residues in the human PROTEIN second immunoglobulin-like domain, which does not bind PROTEIN1 ( PROTEIN2 , were substituted with those from human PROTEIN ",AIMed.d43.s376
692,AIMed.d43,False,"In this study, a minimum set of residues in the human PROTEIN1 second immunoglobulin-like domain, which does not bind PROTEIN ( PROTEIN2 , were substituted with those from human PROTEIN ",AIMed.d43.s376
693,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN maintained PROTEIN2 binding equivalent to PROTEIN and also bound PROTEIN although with lower affinity compared with PROTEIN ,AIMed.d43.s377
694,AIMed.d43,True,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN maintained PROTEIN1 binding equivalent to PROTEIN2 and also bound PROTEIN although with lower affinity compared with PROTEIN ,AIMed.d43.s377
695,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN maintained PROTEIN1 binding equivalent to PROTEIN and also bound PROTEIN2 although with lower affinity compared with PROTEIN ,AIMed.d43.s377
696,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN maintained PROTEIN1 binding equivalent to PROTEIN and also bound PROTEIN although with lower affinity compared with PROTEIN2 ,AIMed.d43.s377
697,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN1 maintained PROTEIN2 binding equivalent to PROTEIN and also bound PROTEIN although with lower affinity compared with PROTEIN ,AIMed.d43.s377
698,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN maintained PROTEIN binding equivalent to PROTEIN2 and also bound PROTEIN although with lower affinity compared with PROTEIN ,AIMed.d43.s377
699,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN maintained PROTEIN binding equivalent to PROTEIN and also bound PROTEIN2 although with lower affinity compared with PROTEIN ,AIMed.d43.s377
700,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN maintained PROTEIN binding equivalent to PROTEIN and also bound PROTEIN although with lower affinity compared with PROTEIN2 ,AIMed.d43.s377
701,AIMed.d43,True,The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN2 maintained PROTEIN binding equivalent to PROTEIN and also bound PROTEIN although with lower affinity compared with PROTEIN ,AIMed.d43.s377
702,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN maintained PROTEIN binding equivalent to PROTEIN1 and also bound PROTEIN2 although with lower affinity compared with PROTEIN ,AIMed.d43.s377
703,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN maintained PROTEIN binding equivalent to PROTEIN1 and also bound PROTEIN although with lower affinity compared with PROTEIN2 ,AIMed.d43.s377
704,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN1 maintained PROTEIN binding equivalent to PROTEIN2 and also bound PROTEIN although with lower affinity compared with PROTEIN ,AIMed.d43.s377
705,AIMed.d43,True,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN maintained PROTEIN binding equivalent to PROTEIN and also bound PROTEIN1 although with lower affinity compared with PROTEIN2 ,AIMed.d43.s377
706,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN1 maintained PROTEIN binding equivalent to PROTEIN and also bound PROTEIN2 although with lower affinity compared with PROTEIN ,AIMed.d43.s377
707,AIMed.d43,False,The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN1 maintained PROTEIN binding equivalent to PROTEIN and also bound PROTEIN although with lower affinity compared with PROTEIN2 ,AIMed.d43.s377
708,AIMed.d44,False,Characterization of the PROTEIN1 binding domain on the human PROTEIN molecule using anti- PROTEIN2 antibodies.,AIMed.d44.s379
709,AIMed.d44,True,Characterization of the PROTEIN1 binding domain on the human PROTEIN2 molecule using anti- PROTEIN antibodies.,AIMed.d44.s379
710,AIMed.d44,False,Characterization of the PROTEIN binding domain on the human PROTEIN1 molecule using anti- PROTEIN2 antibodies.,AIMed.d44.s379
711,AIMed.d44,True, PROTEIN1 and its counter-receptor PROTEIN ( PROTEIN2 are members of the TNF-receptor/ PROTEIN superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
712,AIMed.d44,False, PROTEIN1 and its counter-receptor PROTEIN2 ligand ( PROTEIN are members of the TNF-receptor/ PROTEIN superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
713,AIMed.d44,False, PROTEIN1 and its counter-receptor PROTEIN ( PROTEIN are members of the TNF-receptor/ PROTEIN2 superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
714,AIMed.d44,True, PROTEIN1 and its counter-receptor PROTEIN2 ( PROTEIN are members of the TNF-receptor/ PROTEIN superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
715,AIMed.d44,False, PROTEIN and its counter-receptor PROTEIN1 ligand ( PROTEIN2 are members of the TNF-receptor/ PROTEIN superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
716,AIMed.d44,False, PROTEIN and its counter-receptor PROTEIN ( PROTEIN1 are members of the TNF-receptor/ PROTEIN2 superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
717,AIMed.d44,False, PROTEIN and its counter-receptor PROTEIN1 ( PROTEIN2 are members of the TNF-receptor/ PROTEIN superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
718,AIMed.d44,False, PROTEIN and its counter-receptor PROTEIN1 ligand ( PROTEIN are members of the TNF-receptor/ PROTEIN2 superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
719,AIMed.d44,False, PROTEIN and its counter-receptor PROTEIN1 ( PROTEIN are members of the TNF-receptor/ PROTEIN superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
720,AIMed.d44,False, PROTEIN and its counter-receptor PROTEIN1 ( PROTEIN are members of the TNF-receptor/ PROTEIN2 superfamily and function to regulate lymphocyte survival and differentiation.,AIMed.d44.s380
721,AIMed.d44,False,"Using a soluble PROTEIN1 PROTEIN chimeric protein, we assessed the ability of anti- PROTEIN MAb to inhibit the binding of PROTEIN to PROTEIN2 expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
722,AIMed.d44,False,"Using a soluble PROTEIN1 PROTEIN2 chimeric protein, we assessed the ability of anti- PROTEIN MAb to inhibit the binding of PROTEIN to PROTEIN expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
723,AIMed.d44,False,"Using a soluble PROTEIN1 PROTEIN chimeric protein, we assessed the ability of anti- PROTEIN2 MAb to inhibit the binding of PROTEIN to PROTEIN expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
724,AIMed.d44,False,"Using a soluble PROTEIN1 PROTEIN chimeric protein, we assessed the ability of anti- PROTEIN MAb to inhibit the binding of PROTEIN2 to PROTEIN expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
725,AIMed.d44,False,"Using a soluble PROTEIN PROTEIN1 chimeric protein, we assessed the ability of anti- PROTEIN MAb to inhibit the binding of PROTEIN to PROTEIN2 expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
726,AIMed.d44,False,"Using a soluble PROTEIN PROTEIN chimeric protein, we assessed the ability of anti- PROTEIN1 MAb to inhibit the binding of PROTEIN to PROTEIN2 expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
727,AIMed.d44,True,"Using a soluble PROTEIN PROTEIN chimeric protein, we assessed the ability of anti- PROTEIN MAb to inhibit the binding of PROTEIN1 to PROTEIN2 expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
728,AIMed.d44,False,"Using a soluble PROTEIN PROTEIN1 chimeric protein, we assessed the ability of anti- PROTEIN2 MAb to inhibit the binding of PROTEIN to PROTEIN expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
729,AIMed.d44,False,"Using a soluble PROTEIN PROTEIN1 chimeric protein, we assessed the ability of anti- PROTEIN MAb to inhibit the binding of PROTEIN2 to PROTEIN expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
730,AIMed.d44,False,"Using a soluble PROTEIN PROTEIN chimeric protein, we assessed the ability of anti- PROTEIN1 MAb to inhibit the binding of PROTEIN2 to PROTEIN expressed by the CD30+ Karpas 299 cell line.",AIMed.d44.s383
731,AIMed.d44,True," PROTEIN1 binding by PROTEIN2 is blocked by MAb that recognize epitopes belonging to cluster Group A (like Ber-H2, Ber-H8, and HRS-4) as well as cluster Group C (like HeFi-1 and M44).",AIMed.d44.s384
732,AIMed.d44,True,"Cluster Group B antibodies, including M67 and Ki-1, do not affect PROTEIN1 binding to PROTEIN2 ",AIMed.d44.s385
733,AIMed.d44,False,The pattern of PROTEIN1 binding inhibition shows only limited correspondence to the functional capacity of some anti- PROTEIN MAb to trigger PROTEIN2 signaling.,AIMed.d44.s386
734,AIMed.d44,False,The pattern of PROTEIN1 binding inhibition shows only limited correspondence to the functional capacity of some anti- PROTEIN2 MAb to trigger PROTEIN signaling.,AIMed.d44.s386
735,AIMed.d44,False,The pattern of PROTEIN binding inhibition shows only limited correspondence to the functional capacity of some anti- PROTEIN1 MAb to trigger PROTEIN2 signaling.,AIMed.d44.s386
736,AIMed.d44,False,"Finally, we demonstrate that the anti- PROTEIN1 MAb M81 also completely inhibits PROTEIN PROTEIN2 interaction.",AIMed.d44.s387
737,AIMed.d44,True,"Finally, we demonstrate that the anti- PROTEIN MAb M81 also completely inhibits PROTEIN1 PROTEIN2 interaction.",AIMed.d44.s387
738,AIMed.d44,False,"Finally, we demonstrate that the anti- PROTEIN1 MAb M81 also completely inhibits PROTEIN2 PROTEIN interaction.",AIMed.d44.s387
739,AIMed.d44,False,This information is useful for applying these MAbs in functional studies to further investigate the PROTEIN1 PROTEIN system and for designing assays for soluble PROTEIN2 ,AIMed.d44.s388
740,AIMed.d44,False,This information is useful for applying these MAbs in functional studies to further investigate the PROTEIN1 PROTEIN2 system and for designing assays for soluble PROTEIN ,AIMed.d44.s388
741,AIMed.d44,False,This information is useful for applying these MAbs in functional studies to further investigate the PROTEIN PROTEIN1 system and for designing assays for soluble PROTEIN2 ,AIMed.d44.s388
742,AIMed.d46,False, PROTEIN1 antagonists emerge from alterations in the low-affinity binding epitope for receptor PROTEIN2 ,AIMed.d46.s402
743,AIMed.d46,False, PROTEIN1 ( PROTEIN2 induces bone formation and regeneration in adult vertebrates and regulates important developmental processes in all animals.,AIMed.d46.s403
744,AIMed.d46,False," PROTEIN1 is a homodimeric cysteine knot protein that, as a member of the PROTEIN2 ( PROTEIN superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.",AIMed.d46.s404
745,AIMed.d46,False," PROTEIN is a homodimeric cysteine knot protein that, as a member of the PROTEIN1 ( PROTEIN2 superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.",AIMed.d46.s404
746,AIMed.d46,False," PROTEIN1 is a homodimeric cysteine knot protein that, as a member of the PROTEIN ( PROTEIN2 superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.",AIMed.d46.s404
747,AIMed.d46,False,The binding epitopes of PROTEIN for PROTEIN1 (type I) and PROTEIN or PROTEIN (type II) were characterized using PROTEIN2 mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
748,AIMed.d46,False,The binding epitopes of PROTEIN for PROTEIN1 (type I) and PROTEIN or PROTEIN2 (type II) were characterized using PROTEIN mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
749,AIMed.d46,False,The binding epitopes of PROTEIN for PROTEIN1 (type I) and PROTEIN2 or PROTEIN (type II) were characterized using PROTEIN mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
750,AIMed.d46,True,The binding epitopes of PROTEIN1 for PROTEIN2 (type I) and PROTEIN or PROTEIN (type II) were characterized using PROTEIN mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
751,AIMed.d46,False,The binding epitopes of PROTEIN for PROTEIN (type I) and PROTEIN or PROTEIN1 (type II) were characterized using PROTEIN2 mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
752,AIMed.d46,False,The binding epitopes of PROTEIN for PROTEIN (type I) and PROTEIN1 or PROTEIN (type II) were characterized using PROTEIN2 mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
753,AIMed.d46,False,The binding epitopes of PROTEIN1 for PROTEIN (type I) and PROTEIN or PROTEIN (type II) were characterized using PROTEIN2 mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
754,AIMed.d46,False,The binding epitopes of PROTEIN for PROTEIN (type I) and PROTEIN1 or PROTEIN2 (type II) were characterized using PROTEIN mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
755,AIMed.d46,True,The binding epitopes of PROTEIN1 for PROTEIN (type I) and PROTEIN or PROTEIN2 (type II) were characterized using PROTEIN mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
756,AIMed.d46,True,The binding epitopes of PROTEIN1 for PROTEIN (type I) and PROTEIN2 or PROTEIN (type II) were characterized using PROTEIN mutant proteins for analysis of interactions with receptor ectodomains.,AIMed.d46.s405
757,AIMed.d46,True,A large epitope 1 for high-affinity PROTEIN1 binding was detected spanning the interface of the PROTEIN2 dimer.,AIMed.d46.s406
758,AIMed.d47,True,Crystal structure of the PROTEIN1 PROTEIN2 ectodomain complex.,AIMed.d47.s411
759,AIMed.d47,False,Bone morphogenetic proteins (BMPs) belong to the large PROTEIN1 ( PROTEIN2 superfamily of multifunctional cytokines.,AIMed.d47.s412
760,AIMed.d47,False,Here we report the crystal structure of human dimeric PROTEIN in complex with two high affinity PROTEIN1 extracellular domains( PROTEIN .,AIMed.d47.s415
761,AIMed.d47,False,Here we report the crystal structure of human dimeric PROTEIN in complex with two high affinity PROTEIN1 extracellular domains( PROTEIN2 .,AIMed.d47.s415
762,AIMed.d47,False,Here we report the crystal structure of human dimeric PROTEIN1 in complex with two high affinity PROTEIN2 extracellular domains( PROTEIN .,AIMed.d47.s415
763,AIMed.d47,False,Here we report the crystal structure of human dimeric PROTEIN in complex with two high affinity PROTEIN1 ( PROTEIN2 .,AIMed.d47.s415
764,AIMed.d47,True,Here we report the crystal structure of human dimeric PROTEIN1 in complex with two high affinity PROTEIN2 ( PROTEIN .,AIMed.d47.s415
765,AIMed.d47,True,Here we report the crystal structure of human dimeric PROTEIN1 in complex with two high affinity PROTEIN extracellular domains( PROTEIN2 .,AIMed.d47.s415
766,AIMed.d47,False,The receptor chains bind to the 'wrist' epitopes of the PROTEIN1 dimer and contact both PROTEIN2 monomers.,AIMed.d47.s416
767,AIMed.d48,False, PROTEIN induces chemotaxis and adhesion by interacting with PROTEIN1 and PROTEIN2 ,AIMed.d48.s419
768,AIMed.d48,True, PROTEIN1 induces chemotaxis and adhesion by interacting with PROTEIN2 and PROTEIN ,AIMed.d48.s419
769,AIMed.d48,True, PROTEIN1 induces chemotaxis and adhesion by interacting with PROTEIN and PROTEIN2 ,AIMed.d48.s419
770,AIMed.d48,False," PROTEIN ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN1 PROTEIN PROTEIN and PROTEIN2 ",AIMed.d48.s420
771,AIMed.d48,False," PROTEIN ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN1 PROTEIN2 PROTEIN and PROTEIN ",AIMed.d48.s420
772,AIMed.d48,False," PROTEIN1 ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN2 PROTEIN PROTEIN and PROTEIN ",AIMed.d48.s420
773,AIMed.d48,False," PROTEIN ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN1 PROTEIN PROTEIN2 and PROTEIN ",AIMed.d48.s420
774,AIMed.d48,False," PROTEIN ( PROTEIN1 is an unusually large CC chemokine, which is also known as PROTEIN2 PROTEIN PROTEIN and PROTEIN ",AIMed.d48.s420
775,AIMed.d48,False," PROTEIN ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN1 PROTEIN and PROTEIN2 ",AIMed.d48.s420
776,AIMed.d48,False," PROTEIN1 ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN PROTEIN and PROTEIN2 ",AIMed.d48.s420
777,AIMed.d48,False," PROTEIN ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN PROTEIN1 and PROTEIN2 ",AIMed.d48.s420
778,AIMed.d48,False," PROTEIN ( PROTEIN1 is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN PROTEIN and PROTEIN2 ",AIMed.d48.s420
779,AIMed.d48,False," PROTEIN1 ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN2 PROTEIN and PROTEIN ",AIMed.d48.s420
780,AIMed.d48,False," PROTEIN ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN1 PROTEIN2 and PROTEIN ",AIMed.d48.s420
781,AIMed.d48,False," PROTEIN ( PROTEIN1 is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN2 PROTEIN and PROTEIN ",AIMed.d48.s420
782,AIMed.d48,False," PROTEIN1 ( PROTEIN is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN PROTEIN2 and PROTEIN ",AIMed.d48.s420
783,AIMed.d48,False," PROTEIN1 ( PROTEIN2 is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN PROTEIN and PROTEIN ",AIMed.d48.s420
784,AIMed.d48,False," PROTEIN ( PROTEIN1 is an unusually large CC chemokine, which is also known as PROTEIN PROTEIN PROTEIN2 and PROTEIN ",AIMed.d48.s420
785,AIMed.d48,False,We report chemotaxis and competitive binding studies that show PROTEIN binds to and activates PROTEIN1 and PROTEIN2 transfected HEK-293 cells.,AIMed.d48.s422
786,AIMed.d48,True,We report chemotaxis and competitive binding studies that show PROTEIN1 binds to and activates PROTEIN and PROTEIN2 transfected HEK-293 cells.,AIMed.d48.s422
787,AIMed.d48,True,We report chemotaxis and competitive binding studies that show PROTEIN1 binds to and activates PROTEIN2 and PROTEIN transfected HEK-293 cells.,AIMed.d48.s422
788,AIMed.d48,False, PROTEIN induced maximal migration of PROTEIN1 and PROTEIN2 transfected cells at 89.3 nmol/L and cell adhesion at 5.6 nmol/L.,AIMed.d48.s423
789,AIMed.d48,False, PROTEIN1 induced maximal migration of PROTEIN and PROTEIN2 transfected cells at 89.3 nmol/L and cell adhesion at 5.6 nmol/L.,AIMed.d48.s423
790,AIMed.d48,False, PROTEIN1 induced maximal migration of PROTEIN2 and PROTEIN transfected cells at 89.3 nmol/L and cell adhesion at 5.6 nmol/L.,AIMed.d48.s423
791,AIMed.d48,False,The molar concentration of PROTEIN1 required to induce maximum cell migration is 20- to 200-fold greater than that required for PROTEIN or PROTEIN2 respectively.,AIMed.d48.s424
792,AIMed.d48,False,The molar concentration of PROTEIN required to induce maximum cell migration is 20- to 200-fold greater than that required for PROTEIN1 or PROTEIN2 respectively.,AIMed.d48.s424
793,AIMed.d48,False,The molar concentration of PROTEIN1 required to induce maximum cell migration is 20- to 200-fold greater than that required for PROTEIN2 or PROTEIN respectively.,AIMed.d48.s424
794,AIMed.d48,False,A neutralizing polyclonal antibody to PROTEIN1 was developed to demonstrate that the unusually high concentration of PROTEIN required to induce chemotaxis was a property of PROTEIN2 and not as a result of an irrelevant protein contamination.,AIMed.d48.s426
795,AIMed.d48,False,A neutralizing polyclonal antibody to PROTEIN was developed to demonstrate that the unusually high concentration of PROTEIN1 required to induce chemotaxis was a property of PROTEIN2 and not as a result of an irrelevant protein contamination.,AIMed.d48.s426
796,AIMed.d48,False,A neutralizing polyclonal antibody to PROTEIN1 was developed to demonstrate that the unusually high concentration of PROTEIN2 required to induce chemotaxis was a property of PROTEIN and not as a result of an irrelevant protein contamination.,AIMed.d48.s426
797,AIMed.d49,False," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN ( PROTEIN , whereas PROTEIN2 binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
798,AIMed.d49,False," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN2 but interacts poorly with PROTEIN ",AIMed.d49.s431
799,AIMed.d49,False," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN2 receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
800,AIMed.d49,False," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN2 ",AIMed.d49.s431
801,AIMed.d49,True," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN2 ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
802,AIMed.d49,False," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN2 PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
803,AIMed.d49,False," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN2 and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
804,AIMed.d49,True," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN2 isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
805,AIMed.d49,True," PROTEIN1 recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN2 , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
806,AIMed.d49,True," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN ( PROTEIN , whereas PROTEIN1 binds well to PROTEIN PROTEIN and PROTEIN2 but interacts poorly with PROTEIN ",AIMed.d49.s431
807,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 receptor ( PROTEIN , whereas PROTEIN2 binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
808,AIMed.d49,True," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN ( PROTEIN , whereas PROTEIN1 binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN2 ",AIMed.d49.s431
809,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 ( PROTEIN , whereas PROTEIN2 binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
810,AIMed.d49,True," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN1 binds well to PROTEIN2 PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
811,AIMed.d49,True," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN ( PROTEIN , whereas PROTEIN1 binds well to PROTEIN PROTEIN2 and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
812,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or PROTEIN ( PROTEIN , whereas PROTEIN2 binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
813,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN ( PROTEIN1 , whereas PROTEIN2 binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
814,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN2 but interacts poorly with PROTEIN ",AIMed.d49.s431
815,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN1 but interacts poorly with PROTEIN2 ",AIMed.d49.s431
816,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN2 but interacts poorly with PROTEIN ",AIMed.d49.s431
817,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN1 PROTEIN and PROTEIN2 but interacts poorly with PROTEIN ",AIMed.d49.s431
818,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN1 and PROTEIN2 but interacts poorly with PROTEIN ",AIMed.d49.s431
819,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN2 but interacts poorly with PROTEIN ",AIMed.d49.s431
820,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN1 , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN2 but interacts poorly with PROTEIN ",AIMed.d49.s431
821,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN2 ",AIMed.d49.s431
822,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
823,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN2 PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
824,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN2 and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
825,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or PROTEIN2 receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
826,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 receptor ( PROTEIN2 , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
827,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN2 ",AIMed.d49.s431
828,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN1 PROTEIN and PROTEIN but interacts poorly with PROTEIN2 ",AIMed.d49.s431
829,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN1 and PROTEIN but interacts poorly with PROTEIN2 ",AIMed.d49.s431
830,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN2 ",AIMed.d49.s431
831,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN1 , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN2 ",AIMed.d49.s431
832,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 ( PROTEIN , whereas PROTEIN binds well to PROTEIN2 PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
833,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN2 and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
834,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or PROTEIN2 ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
835,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN1 ( PROTEIN2 , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
836,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN1 PROTEIN2 and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
837,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN2 PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
838,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN1 , whereas PROTEIN binds well to PROTEIN2 PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
839,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or PROTEIN receptor ( PROTEIN , whereas PROTEIN binds well to PROTEIN PROTEIN2 and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
840,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN isoform or PROTEIN receptor ( PROTEIN1 , whereas PROTEIN binds well to PROTEIN PROTEIN2 and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
841,AIMed.d49,False," PROTEIN recognizes one FGFR isoform known as the PROTEIN1 isoform or PROTEIN receptor ( PROTEIN2 , whereas PROTEIN binds well to PROTEIN PROTEIN and PROTEIN but interacts poorly with PROTEIN ",AIMed.d49.s431
842,AIMed.d49,True, PROTEIN1 contains this primary site as well as a region that restricts interaction with PROTEIN2 ,AIMed.d49.s433
843,AIMed.d49,True,The sequences that confer on PROTEIN1 its specific binding to PROTEIN2 have not been identified.,AIMed.d49.s434
844,AIMed.d49,True,By utilizing domain swapping and site-directed mutagenesis we have found that the loop connecting the beta4-beta5 strands of PROTEIN1 contributes to high affinity receptor binding and is critical for PROTEIN2 recognition.,AIMed.d49.s435
845,AIMed.d49,False,Replacement of this loop with the homologous loop from PROTEIN1 dramatically reduced both the affinity of PROTEIN for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN2 ,AIMed.d49.s436
846,AIMed.d49,False,Replacement of this loop with the homologous loop from PROTEIN1 dramatically reduced both the affinity of PROTEIN for PROTEIN2 and its biological potency but did not result in the ability to bind PROTEIN ,AIMed.d49.s436
847,AIMed.d49,False,Replacement of this loop with the homologous loop from PROTEIN1 dramatically reduced both the affinity of PROTEIN2 for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN ,AIMed.d49.s436
848,AIMed.d49,False,Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN for PROTEIN1 and its biological potency but did not result in the ability to bind PROTEIN2 ,AIMed.d49.s436
849,AIMed.d49,False,Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN1 for PROTEIN and its biological potency but did not result in the ability to bind PROTEIN2 ,AIMed.d49.s436
850,AIMed.d49,True,Replacement of this loop with the homologous loop from PROTEIN dramatically reduced both the affinity of PROTEIN1 for PROTEIN2 and its biological potency but did not result in the ability to bind PROTEIN ,AIMed.d49.s436
851,AIMed.d49,False,The reciprocal loop replacement mutant ( PROTEIN1 L4/7) retained PROTEIN like affinity for PROTEIN and for PROTEIN2 ,AIMed.d49.s438
852,AIMed.d49,True,The reciprocal loop replacement mutant ( PROTEIN L4/7) retained PROTEIN1 like affinity for PROTEIN and for PROTEIN2 ,AIMed.d49.s438
853,AIMed.d49,False,The reciprocal loop replacement mutant ( PROTEIN L4/7) retained PROTEIN like affinity for PROTEIN1 and for PROTEIN2 ,AIMed.d49.s438
854,AIMed.d49,False,The reciprocal loop replacement mutant ( PROTEIN1 L4/7) retained PROTEIN2 like affinity for PROTEIN and for PROTEIN ,AIMed.d49.s438
855,AIMed.d49,False,The reciprocal loop replacement mutant ( PROTEIN1 L4/7) retained PROTEIN like affinity for PROTEIN2 and for PROTEIN ,AIMed.d49.s438
856,AIMed.d49,True,The reciprocal loop replacement mutant ( PROTEIN L4/7) retained PROTEIN1 like affinity for PROTEIN2 and for PROTEIN ,AIMed.d49.s438
857,AIMed.d50,False,"Type I interferons bind to two cell surface receptors, PROTEIN1 and PROTEIN2 as the first step in the activation of several signal transduction pathways that elicit an anti-viral state and an anti-proliferative response.",AIMed.d50.s441
858,AIMed.d50,True,"Here, we quantitatively mapped the complete binding region of PROTEIN1 on PROTEIN2 by 35 individual mutations to alanine and isosteric residues.",AIMed.d50.s442
859,AIMed.d50,True,"Interestingly, the PROTEIN1 binding site overlaps the largest continuous hydrophobic patch on PROTEIN2 ",AIMed.d50.s445
860,AIMed.d50,False,"Relating the anti-viral and anti-proliferative activity of the various interferon mutants with their affinity toward PROTEIN1 results in linear function over the whole range of affinities investigated, suggesting that PROTEIN2 binding is the rate-determining step in cellular activation.",AIMed.d50.s447
861,AIMed.d51,True,Here we report the crystal structure of the PROTEIN1 ectodomain in a dimeric form that is induced by simultaneous binding to PROTEIN2 and a heparin decasaccharide.,AIMed.d51.s455
862,AIMed.d51,True,The structure of the PROTEIN1 PROTEIN2 heparin ternary complex provides a structural basis for the essential role of heparan sulphate in FGF signalling.,AIMed.d51.s458
863,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN1 ( PROTEIN to be activated by PROTEIN PROTEIN2 and PROTEIN ,AIMed.d52.s464
864,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN1 and PROTEIN2 ,AIMed.d52.s464
865,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN2 and PROTEIN ,AIMed.d52.s464
866,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN2 and PROTEIN ,AIMed.d52.s464
867,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN2 and PROTEIN ,AIMed.d52.s464
868,AIMed.d52,True,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN1 to be activated by PROTEIN PROTEIN2 and PROTEIN ,AIMed.d52.s464
869,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN2 and PROTEIN ,AIMed.d52.s464
870,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN1 PROTEIN2 and PROTEIN ,AIMed.d52.s464
871,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN1 ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN2 ,AIMed.d52.s464
872,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN2 ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
873,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN2 ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
874,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN2 ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
875,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN1 ( PROTEIN2 to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
876,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN2 ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
877,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN1 ( PROTEIN to be activated by PROTEIN2 PROTEIN and PROTEIN ,AIMed.d52.s464
878,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN2 ,AIMed.d52.s464
879,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN2 ,AIMed.d52.s464
880,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN2 ,AIMed.d52.s464
881,AIMed.d52,True,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN1 to be activated by PROTEIN PROTEIN and PROTEIN2 ,AIMed.d52.s464
882,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN2 ,AIMed.d52.s464
883,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN1 PROTEIN and PROTEIN2 ,AIMed.d52.s464
884,AIMed.d52,True,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN2 and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
885,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN2 to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
886,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN2 to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
887,AIMed.d52,True,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 to bind and to be activated by the mesenchymally expressed ligands PROTEIN2 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
888,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN2 PROTEIN and PROTEIN ,AIMed.d52.s464
889,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN2 and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
890,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN ( PROTEIN2 to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
891,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN2 and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
892,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN2 PROTEIN and PROTEIN ,AIMed.d52.s464
893,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN2 to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
894,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN2 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
895,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN2 PROTEIN and PROTEIN ,AIMed.d52.s464
896,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN2 to be activated by PROTEIN PROTEIN and PROTEIN ,AIMed.d52.s464
897,AIMed.d52,True,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN1 to be activated by PROTEIN2 PROTEIN and PROTEIN ,AIMed.d52.s464
898,AIMed.d52,False,We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN to be activated by PROTEIN2 PROTEIN and PROTEIN ,AIMed.d52.s464
899,AIMed.d53,False,Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human PROTEIN1 ( PROTEIN2 that activates human PROTEIN ,AIMed.d53.s469
900,AIMed.d53,True,Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human PROTEIN ( PROTEIN1 that activates human PROTEIN2 ,AIMed.d53.s469
901,AIMed.d53,True,Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human PROTEIN1 ( PROTEIN that activates human PROTEIN2 ,AIMed.d53.s469
902,AIMed.d53,False,In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral PROTEIN1 and human PROTEIN two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of PROTEIN2 and site III of viral PROTEIN which is necessary for receptor activation.,AIMed.d53.s470
903,AIMed.d53,True,In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral PROTEIN and human PROTEIN two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of PROTEIN1 and site III of viral PROTEIN2 which is necessary for receptor activation.,AIMed.d53.s470
904,AIMed.d53,False,In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral PROTEIN and human PROTEIN1 two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of PROTEIN2 and site III of viral PROTEIN which is necessary for receptor activation.,AIMed.d53.s470
905,AIMed.d53,False,In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral PROTEIN1 and human PROTEIN two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of PROTEIN and site III of viral PROTEIN2 which is necessary for receptor activation.,AIMed.d53.s470
906,AIMed.d53,True,In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral PROTEIN1 and human PROTEIN2 two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of PROTEIN and site III of viral PROTEIN which is necessary for receptor activation.,AIMed.d53.s470
907,AIMed.d53,False,In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral PROTEIN and human PROTEIN1 two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of PROTEIN and site III of viral PROTEIN2 which is necessary for receptor activation.,AIMed.d53.s470
908,AIMed.d53,False,"Unlike human PROTEIN1 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact PROTEIN which enhances the complementarity of the viral PROTEIN2 PROTEIN binding interfaces.",AIMed.d53.s471
909,AIMed.d53,True,"Unlike human PROTEIN1 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact PROTEIN2 which enhances the complementarity of the viral PROTEIN PROTEIN binding interfaces.",AIMed.d53.s471
910,AIMed.d53,False,"Unlike human PROTEIN1 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact PROTEIN which enhances the complementarity of the viral PROTEIN PROTEIN2 binding interfaces.",AIMed.d53.s471
911,AIMed.d53,False,"Unlike human PROTEIN (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact PROTEIN1 which enhances the complementarity of the viral PROTEIN2 PROTEIN binding interfaces.",AIMed.d53.s471
912,AIMed.d53,True,"Unlike human PROTEIN (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact PROTEIN which enhances the complementarity of the viral PROTEIN1 PROTEIN2 binding interfaces.",AIMed.d53.s471
913,AIMed.d53,False,"Unlike human PROTEIN (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact PROTEIN1 which enhances the complementarity of the viral PROTEIN PROTEIN2 binding interfaces.",AIMed.d53.s471
914,AIMed.d53,False,The cross-reactivity of PROTEIN1 is apparently due to a chemical plasticity evident in the amphipathic PROTEIN2 cytokine-binding sites.,AIMed.d53.s472
915,AIMed.d54,False," PROTEIN1 ( PROTEIN2 , a novel growth factor that binds to PROTEIN and beta receptor.",AIMed.d54.s473
916,AIMed.d54,True," PROTEIN1 ( PROTEIN , a novel growth factor that binds to PROTEIN2 and beta receptor.",AIMed.d54.s473
917,AIMed.d54,True," PROTEIN ( PROTEIN1 , a novel growth factor that binds to PROTEIN2 and beta receptor.",AIMed.d54.s473
918,AIMed.d54,False, PROTEIN1 is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of PROTEIN and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular PROTEIN (25%) and PROTEIN2 chain (23%).,AIMed.d54.s475
919,AIMed.d54,False, PROTEIN1 is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of PROTEIN2 and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular PROTEIN (25%) and PROTEIN chain (23%).,AIMed.d54.s475
920,AIMed.d54,False, PROTEIN1 is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of PROTEIN and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular PROTEIN2 (25%) and PROTEIN chain (23%).,AIMed.d54.s475
921,AIMed.d54,False, PROTEIN is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of PROTEIN1 and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular PROTEIN (25%) and PROTEIN2 chain (23%).,AIMed.d54.s475
922,AIMed.d54,False, PROTEIN is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of PROTEIN and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular PROTEIN1 (25%) and PROTEIN2 chain (23%).,AIMed.d54.s475
923,AIMed.d54,False, PROTEIN is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of PROTEIN1 and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular PROTEIN2 (25%) and PROTEIN chain (23%).,AIMed.d54.s475
924,AIMed.d54,True,Competition binding and immunoprecipitation studies on cells bearing both PROTEIN and beta receptors reveal a high affinity binding of recombinant GFD ( PROTEIN1 to PROTEIN homodimers and PROTEIN2 beta heterodimers.,AIMed.d54.s477
925,AIMed.d54,False,Competition binding and immunoprecipitation studies on cells bearing both PROTEIN1 and beta receptors reveal a high affinity binding of recombinant GFD ( PROTEIN to PROTEIN homodimers and PROTEIN2 beta heterodimers.,AIMed.d54.s477
926,AIMed.d54,False,Competition binding and immunoprecipitation studies on cells bearing both PROTEIN and beta receptors reveal a high affinity binding of recombinant GFD ( PROTEIN to PROTEIN1 homodimers and PROTEIN2 beta heterodimers.,AIMed.d54.s477
927,AIMed.d54,False,Competition binding and immunoprecipitation studies on cells bearing both PROTEIN1 and beta receptors reveal a high affinity binding of recombinant GFD ( PROTEIN2 to PROTEIN homodimers and PROTEIN beta heterodimers.,AIMed.d54.s477
928,AIMed.d54,True,Competition binding and immunoprecipitation studies on cells bearing both PROTEIN and beta receptors reveal a high affinity binding of recombinant GFD ( PROTEIN1 to PROTEIN2 homodimers and PROTEIN beta heterodimers.,AIMed.d54.s477
929,AIMed.d54,False,Competition binding and immunoprecipitation studies on cells bearing both PROTEIN1 and beta receptors reveal a high affinity binding of recombinant GFD ( PROTEIN to PROTEIN2 homodimers and PROTEIN beta heterodimers.,AIMed.d54.s477
930,AIMed.d54,False, PROTEIN exhibits greater mitogenic potency than PROTEIN1 and comparable or greater mitogenic activity than PROTEIN and PROTEIN2 on several mesenchymal cell types.,AIMed.d54.s478
931,AIMed.d54,False, PROTEIN1 exhibits greater mitogenic potency than PROTEIN and comparable or greater mitogenic activity than PROTEIN and PROTEIN2 on several mesenchymal cell types.,AIMed.d54.s478
932,AIMed.d54,False, PROTEIN exhibits greater mitogenic potency than PROTEIN and comparable or greater mitogenic activity than PROTEIN1 and PROTEIN2 on several mesenchymal cell types.,AIMed.d54.s478
933,AIMed.d54,False, PROTEIN1 exhibits greater mitogenic potency than PROTEIN2 and comparable or greater mitogenic activity than PROTEIN and PROTEIN on several mesenchymal cell types.,AIMed.d54.s478
934,AIMed.d54,False, PROTEIN exhibits greater mitogenic potency than PROTEIN1 and comparable or greater mitogenic activity than PROTEIN2 and PROTEIN on several mesenchymal cell types.,AIMed.d54.s478
935,AIMed.d54,False, PROTEIN1 exhibits greater mitogenic potency than PROTEIN and comparable or greater mitogenic activity than PROTEIN2 and PROTEIN on several mesenchymal cell types.,AIMed.d54.s478
936,AIMed.d54,False,Analysis of PROTEIN1 in vivo in a diabetic mouse model of delayed wound healing showed that PROTEIN2 significantly enhanced repair of a full-thickness skin excision.,AIMed.d54.s479
937,AIMed.d54,False,"Together, these studies describe a third member of the PDGF family ( PROTEIN1 as a potent mitogen for cells of mesenchymal origin in in vitro and in vivo systems with a binding pattern similar to PROTEIN2 ",AIMed.d54.s480
938,AIMed.d56,True,Cloning of PROTEIN1 a ligand for PROTEIN2 on human T cells.,AIMed.d56.s494
939,AIMed.d56,False,"A cDNA clone, designated PROTEIN1 ( PROTEIN2 was isolated from a collection of T cell activation genes.",AIMed.d56.s495
940,AIMed.d56,False," PROTEIN1 is highly similar to an identified murine PROTEIN both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/ PROTEIN2 ",AIMed.d56.s499
941,AIMed.d56,False," PROTEIN1 is highly similar to an identified murine PROTEIN2 both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/ PROTEIN ",AIMed.d56.s499
942,AIMed.d56,False," PROTEIN is highly similar to an identified murine PROTEIN1 both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/ PROTEIN2 ",AIMed.d56.s499
943,AIMed.d56,True,"Expressed in a murine myeloma, PROTEIN1 was identified as a ligand for PROTEIN by binding to a soluble PROTEIN2 construct.",AIMed.d56.s500
944,AIMed.d56,False,"Expressed in a murine myeloma, PROTEIN was identified as a ligand for PROTEIN1 by binding to a soluble PROTEIN2 construct.",AIMed.d56.s500
945,AIMed.d56,True,"Expressed in a murine myeloma, PROTEIN1 was identified as a ligand for PROTEIN2 by binding to a soluble PROTEIN construct.",AIMed.d56.s500
946,AIMed.d57,True,Reconstitution of the multiprotein complex of PROTEIN1 PROTEIN2 and PROTEIN in a cell-free system.,AIMed.d57.s503
947,AIMed.d57,False,Reconstitution of the multiprotein complex of PROTEIN PROTEIN1 and PROTEIN2 in a cell-free system.,AIMed.d57.s503
948,AIMed.d57,False,Reconstitution of the multiprotein complex of PROTEIN1 PROTEIN and PROTEIN2 in a cell-free system.,AIMed.d57.s503
949,AIMed.d57,False,A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein ( PROTEIN1 has been used here to form complexes between the PROTEIN2 tyrosine kinase and PROTEIN ,AIMed.d57.s504
950,AIMed.d57,True,A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein ( PROTEIN has been used here to form complexes between the PROTEIN1 tyrosine kinase and PROTEIN2 ,AIMed.d57.s504
951,AIMed.d57,False,A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein ( PROTEIN1 has been used here to form complexes between the PROTEIN tyrosine kinase and PROTEIN2 ,AIMed.d57.s504
952,AIMed.d57,True,Reticulocyte lysate forms complexes between PROTEIN1 and a temperature-sensitive mutant of Rous sarcoma virus PROTEIN2 which is normally present in cytosol virtually entirely in the multiprotein complex form.,AIMed.d57.s505
953,AIMed.d57,False,"In addition, PROTEIN in the lysate complexes with wild-type PROTEIN1 of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, PROTEIN which has never been recovered in cytosol in the form of a native multiprotein complex with PROTEIN2 ",AIMed.d57.s506
954,AIMed.d57,False,"In addition, PROTEIN in the lysate complexes with wild-type PROTEIN1 of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, PROTEIN2 which has never been recovered in cytosol in the form of a native multiprotein complex with PROTEIN ",AIMed.d57.s506
955,AIMed.d57,True,"In addition, PROTEIN1 in the lysate complexes with wild-type PROTEIN2 of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, PROTEIN which has never been recovered in cytosol in the form of a native multiprotein complex with PROTEIN ",AIMed.d57.s506
956,AIMed.d57,False,"In addition, PROTEIN in the lysate complexes with wild-type PROTEIN of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, PROTEIN1 which has never been recovered in cytosol in the form of a native multiprotein complex with PROTEIN2 ",AIMed.d57.s506
957,AIMed.d57,False,"In addition, PROTEIN1 in the lysate complexes with wild-type PROTEIN of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, PROTEIN which has never been recovered in cytosol in the form of a native multiprotein complex with PROTEIN2 ",AIMed.d57.s506
958,AIMed.d57,True,"In addition, PROTEIN1 in the lysate complexes with wild-type PROTEIN of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, PROTEIN2 which has never been recovered in cytosol in the form of a native multiprotein complex with PROTEIN ",AIMed.d57.s506
959,AIMed.d57,True,"The native and reconstituted PROTEIN1 PROTEIN2 complexes have similar thermal stability and, like steroid receptor heterocomplexes, they are stabilized by molybdate.",AIMed.d57.s508
960,AIMed.d57,True,"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted PROTEIN1 multiprotein complex contains PROTEIN2 which is a major candidate for providing the protein unfoldase activity required for PROTEIN association.",AIMed.d57.s509
961,AIMed.d57,False,"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted PROTEIN1 multiprotein complex contains PROTEIN which is a major candidate for providing the protein unfoldase activity required for PROTEIN2 association.",AIMed.d57.s509
962,AIMed.d57,False,"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted PROTEIN multiprotein complex contains PROTEIN1 which is a major candidate for providing the protein unfoldase activity required for PROTEIN2 association.",AIMed.d57.s509
963,AIMed.d58,False,"A cDNA clone encoding a novel, widely expressed protein (called PROTEIN1 or PROTEIN2 containing one src homology 2 (SH2) domain and two SH3 domains was isolated.",AIMed.d58.s511
964,AIMed.d58,False,"While injection of PROTEIN or PROTEIN proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of PROTEIN1 together with PROTEIN2 protein stimulated DNA synthesis.",AIMed.d58.s516
965,AIMed.d58,False,"While injection of PROTEIN or PROTEIN1 proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of PROTEIN2 together with PROTEIN protein stimulated DNA synthesis.",AIMed.d58.s516
966,AIMed.d58,False,"While injection of PROTEIN1 or PROTEIN proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of PROTEIN2 together with PROTEIN protein stimulated DNA synthesis.",AIMed.d58.s516
967,AIMed.d58,False,"While injection of PROTEIN or PROTEIN1 proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of PROTEIN together with PROTEIN2 protein stimulated DNA synthesis.",AIMed.d58.s516
968,AIMed.d58,False,"While injection of PROTEIN1 or PROTEIN proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of PROTEIN together with PROTEIN2 protein stimulated DNA synthesis.",AIMed.d58.s516
969,AIMed.d58,False,"While injection of PROTEIN1 or PROTEIN2 proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of PROTEIN together with PROTEIN protein stimulated DNA synthesis.",AIMed.d58.s516
970,AIMed.d58,False,These results suggest that PROTEIN1 PROTEIN2 plays a crucial role in a highly conserved mechanism for growth factor control of ras signaling.,AIMed.d58.s517
971,AIMed.d59,False,Analysis of the oligomerization of PROTEIN1 and PROTEIN2 products in vivo using a two-hybrid assay system.,AIMed.d59.s518
972,AIMed.d59,False," PROTEIN1 is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the PROTEIN2 gene products PROTEIN and PROTEIN ",AIMed.d59.s520
973,AIMed.d59,False," PROTEIN is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the PROTEIN1 gene products PROTEIN and PROTEIN2 ",AIMed.d59.s520
974,AIMed.d59,False," PROTEIN is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the PROTEIN1 gene products PROTEIN2 and PROTEIN ",AIMed.d59.s520
975,AIMed.d59,True," PROTEIN1 is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the PROTEIN gene products PROTEIN and PROTEIN2 ",AIMed.d59.s520
976,AIMed.d59,True," PROTEIN1 is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the PROTEIN gene products PROTEIN2 and PROTEIN ",AIMed.d59.s520
977,AIMed.d59,False," PROTEIN is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the PROTEIN gene products PROTEIN1 and PROTEIN2 ",AIMed.d59.s520
978,AIMed.d59,False,"The results show that PROTEIN heterodimerizes with PROTEIN1 and PROTEIN2 in vivo, but it does not homodimerize to a measurable extent.",AIMed.d59.s523
979,AIMed.d59,True,"The results show that PROTEIN1 heterodimerizes with PROTEIN2 and PROTEIN in vivo, but it does not homodimerize to a measurable extent.",AIMed.d59.s523
980,AIMed.d59,True,"The results show that PROTEIN1 heterodimerizes with PROTEIN and PROTEIN2 in vivo, but it does not homodimerize to a measurable extent.",AIMed.d59.s523
981,AIMed.d59,False,"Peptide growth factors, as well as the immediate early gene products PROTEIN1 PROTEIN2 and PROTEIN inhibit the activity of myogenin through a mechanism independent of its association with PROTEIN products.",AIMed.d59.s524
982,AIMed.d59,False,"Peptide growth factors, as well as the immediate early gene products PROTEIN1 PROTEIN and PROTEIN2 inhibit the activity of myogenin through a mechanism independent of its association with PROTEIN products.",AIMed.d59.s524
983,AIMed.d59,False,"Peptide growth factors, as well as the immediate early gene products PROTEIN1 PROTEIN and PROTEIN inhibit the activity of myogenin through a mechanism independent of its association with PROTEIN2 products.",AIMed.d59.s524
984,AIMed.d59,False,"Peptide growth factors, as well as the immediate early gene products PROTEIN PROTEIN1 and PROTEIN2 inhibit the activity of myogenin through a mechanism independent of its association with PROTEIN products.",AIMed.d59.s524
985,AIMed.d59,False,"Peptide growth factors, as well as the immediate early gene products PROTEIN PROTEIN1 and PROTEIN inhibit the activity of myogenin through a mechanism independent of its association with PROTEIN2 products.",AIMed.d59.s524
986,AIMed.d59,False,"Peptide growth factors, as well as the immediate early gene products PROTEIN PROTEIN and PROTEIN1 inhibit the activity of myogenin through a mechanism independent of its association with PROTEIN2 products.",AIMed.d59.s524
987,AIMed.d60,True,Activation of PROTEIN1 by PROTEIN2 in NIH 3T3 cells and in vitro.,AIMed.d60.s525
988,AIMed.d60,False,Activation of PROTEIN1 kinase by PROTEIN in NIH 3T3 cells and in vitro.,AIMed.d60.s525
989,AIMed.d60,False,Activation of PROTEIN1 kinase by PROTEIN2 in NIH 3T3 cells and in vitro.,AIMed.d60.s525
990,AIMed.d60,True," PROTEIN and the protein kinase that activates it ( PROTEIN1 were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the PROTEIN2 protein kinase.",AIMed.d60.s527
991,AIMed.d60,True," PROTEIN1 and the protein kinase that activates it ( PROTEIN2 were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the PROTEIN protein kinase.",AIMed.d60.s527
992,AIMed.d60,True," PROTEIN1 and the protein kinase that activates it ( PROTEIN were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the PROTEIN2 protein kinase.",AIMed.d60.s527
993,AIMed.d60,True,The PROTEIN1 proteins purified from cells infected with EC12 or 22W viruses activated PROTEIN2 from skeletal muscle in vitro.,AIMed.d60.s528
994,AIMed.d60,False,The PROTEIN1 proteins purified from cells infected with EC12 or 22W viruses activated PROTEIN2 kinase from skeletal muscle in vitro.,AIMed.d60.s528
995,AIMed.d60,False,The PROTEIN proteins purified from cells infected with EC12 or 22W viruses activated PROTEIN1 from skeletal muscle in vitro.,AIMed.d60.s528
996,AIMed.d60,False,"Furthermore, a bacterially expressed PROTEIN1 fusion protein (glutathione S-transferase-p3722W) also activated PROTEIN2 in vitro.",AIMed.d60.s529
997,AIMed.d60,False,"Furthermore, a bacterially expressed PROTEIN fusion protein (glutathione S-transferase-p3722W) also activated PROTEIN1 kinase in vitro.",AIMed.d60.s529
998,AIMed.d60,False,"Furthermore, a bacterially expressed PROTEIN1 fusion protein (glutathione S-transferase-p3722W) also activated PROTEIN2 kinase in vitro.",AIMed.d60.s529
999,AIMed.d60,True,These findings suggest that one function of PROTEIN1 in mitogenic signaling is to phosphorylate and activate PROTEIN2 ,AIMed.d60.s530
1000,AIMed.d60,False,These findings suggest that one function of PROTEIN1 in mitogenic signaling is to phosphorylate and activate PROTEIN2 kinase.,AIMed.d60.s530
1001,AIMed.d60,False,These findings suggest that one function of PROTEIN in mitogenic signaling is to phosphorylate and activate PROTEIN1 kinase.,AIMed.d60.s530
1002,AIMed.d61,False,An expression plasmid encoding the human 75-kDa PROTEIN1 ( PROTEIN2 was constructed and used to generate a stable human cell line (293/ PROTEIN overexpressing PROTEIN ,AIMed.d61.s532
1003,AIMed.d61,False,An expression plasmid encoding the human 75-kDa PROTEIN1 ( PROTEIN was constructed and used to generate a stable human cell line (293/ PROTEIN overexpressing PROTEIN2 ,AIMed.d61.s532
1004,AIMed.d61,False,An expression plasmid encoding the human 75-kDa PROTEIN1 ( PROTEIN was constructed and used to generate a stable human cell line (293/ PROTEIN2 overexpressing PROTEIN ,AIMed.d61.s532
1005,AIMed.d61,False,An expression plasmid encoding the human 75-kDa PROTEIN ( PROTEIN1 was constructed and used to generate a stable human cell line (293/ PROTEIN overexpressing PROTEIN2 ,AIMed.d61.s532
1006,AIMed.d61,False,An expression plasmid encoding the human 75-kDa PROTEIN ( PROTEIN1 was constructed and used to generate a stable human cell line (293/ PROTEIN2 overexpressing PROTEIN ,AIMed.d61.s532
1007,AIMed.d61,False,An expression plasmid encoding the human 75-kDa PROTEIN ( PROTEIN was constructed and used to generate a stable human cell line (293/ PROTEIN1 overexpressing PROTEIN2 ,AIMed.d61.s532
1008,AIMed.d61,False,"Ligand binding analysis revealed high affinity binding (Kd = 0.2 nM) with approximately 94,000 +/- 7,500 sites/cell for 125I- PROTEIN1 and approximately 5-fold lower affinity for PROTEIN2 (Kd = 1.1 nM) with 264,000 +/- 2,000 sites/cell.",AIMed.d61.s533
1009,AIMed.d61,False,"Cross-linking of 125I- PROTEIN1 and 125I- PROTEIN2 to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1010,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN1 to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN2 suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1011,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN1 to 293/ PROTEIN2 cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1012,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN1 to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN2 molecules.",AIMed.d61.s534
1013,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN1 to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN2 and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1014,AIMed.d61,False,"Cross-linking of 125I- PROTEIN1 and 125I- PROTEIN to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN2 suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1015,AIMed.d61,False,"Cross-linking of 125I- PROTEIN1 and 125I- PROTEIN to 293/ PROTEIN2 cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1016,AIMed.d61,False,"Cross-linking of 125I- PROTEIN1 and 125I- PROTEIN to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN2 molecules.",AIMed.d61.s534
1017,AIMed.d61,False,"Cross-linking of 125I- PROTEIN1 and 125I- PROTEIN to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN2 and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1018,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN to 293/ PROTEIN1 cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN2 suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1019,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN1 suggesting these complexes contain two or three PROTEIN2 molecules.",AIMed.d61.s534
1020,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN1 and 205,000 and 244,000 for PROTEIN2 suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1021,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN to 293/ PROTEIN1 cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN2 molecules.",AIMed.d61.s534
1022,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN to 293/ PROTEIN1 cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN2 and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN molecules.",AIMed.d61.s534
1023,AIMed.d61,False,"Cross-linking of 125I- PROTEIN and 125I- PROTEIN to 293/ PROTEIN cells yielded predominant complexes with apparent molecular weights of 211,000 for PROTEIN1 and 205,000 and 244,000 for PROTEIN suggesting these complexes contain two or three PROTEIN2 molecules.",AIMed.d61.s534
1024,AIMed.d61,False,Immunoprecipitation of PROTEIN1 from 32P-labeled 293/ PROTEIN2 cells demonstrated that the receptor is phosphorylated.,AIMed.d61.s535
1025,AIMed.d61,False, PROTEIN1 treatment of 293/ PROTEIN2 cells did not significantly affect the degree or pattern of phosphorylation.,AIMed.d61.s537
1026,AIMed.d61,False,Shedding of the extracellular domain of PROTEIN was induced by 4 beta-phorbol 12-myristate 13-acetate but not by PROTEIN1 or PROTEIN2 ,AIMed.d61.s539
1027,AIMed.d61,False,Shedding of the extracellular domain of PROTEIN1 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by PROTEIN or PROTEIN2 ,AIMed.d61.s539
1028,AIMed.d61,False,Shedding of the extracellular domain of PROTEIN1 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by PROTEIN2 or PROTEIN ,AIMed.d61.s539
1029,AIMed.d63,True,Coassociation of PROTEIN ( PROTEIN1 with PROTEIN2 on the surface of human T lymphocytes.,AIMed.d63.s544
1030,AIMed.d63,True,Coassociation of PROTEIN1 ( PROTEIN with PROTEIN2 on the surface of human T lymphocytes.,AIMed.d63.s544
1031,AIMed.d63,False,Coassociation of PROTEIN1 ( PROTEIN2 with PROTEIN on the surface of human T lymphocytes.,AIMed.d63.s544
1032,AIMed.d63,False,"In the present report, we demonstrated that modulation of PROTEIN from T cell surface induced by anti PROTEIN1 (1F7) led to enhanced phosphorylation of PROTEIN2 zeta tyrosine residues and increased PROTEIN associated p56lck tyrosine kinase activity.",AIMed.d63.s545
1033,AIMed.d63,False,"In the present report, we demonstrated that modulation of PROTEIN1 from T cell surface induced by anti PROTEIN2 (1F7) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN associated p56lck tyrosine kinase activity.",AIMed.d63.s545
1034,AIMed.d63,False,"In the present report, we demonstrated that modulation of PROTEIN from T cell surface induced by anti PROTEIN1 (1F7) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN2 associated p56lck tyrosine kinase activity.",AIMed.d63.s545
1035,AIMed.d63,False,"In the present report, we demonstrated that modulation of PROTEIN1 from T cell surface induced by anti PROTEIN (1F7) led to enhanced phosphorylation of PROTEIN2 zeta tyrosine residues and increased PROTEIN associated p56lck tyrosine kinase activity.",AIMed.d63.s545
1036,AIMed.d63,False,"In the present report, we demonstrated that modulation of PROTEIN from T cell surface induced by anti PROTEIN (1F7) led to enhanced phosphorylation of PROTEIN1 zeta tyrosine residues and increased PROTEIN2 associated p56lck tyrosine kinase activity.",AIMed.d63.s545
1037,AIMed.d63,False,"In the present report, we demonstrated that modulation of PROTEIN1 from T cell surface induced by anti PROTEIN (1F7) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN2 associated p56lck tyrosine kinase activity.",AIMed.d63.s545
1038,AIMed.d63,False,We further showed that PROTEIN was comodulated on the T cell surface with PROTEIN1 a known membrane-linked protein tyrosine phosphatase and that anti- PROTEIN2 was capable of precipitating PROTEIN from T cell lysates.,AIMed.d63.s546
1039,AIMed.d63,False,We further showed that PROTEIN1 was comodulated on the T cell surface with PROTEIN a known membrane-linked protein tyrosine phosphatase and that anti- PROTEIN2 was capable of precipitating PROTEIN from T cell lysates.,AIMed.d63.s546
1040,AIMed.d63,False,We further showed that PROTEIN was comodulated on the T cell surface with PROTEIN a known membrane-linked protein tyrosine phosphatase and that anti- PROTEIN1 was capable of precipitating PROTEIN2 from T cell lysates.,AIMed.d63.s546
1041,AIMed.d63,False,We further showed that PROTEIN1 was comodulated on the T cell surface with PROTEIN2 a known membrane-linked protein tyrosine phosphatase and that anti- PROTEIN was capable of precipitating PROTEIN from T cell lysates.,AIMed.d63.s546
1042,AIMed.d63,False,We further showed that PROTEIN was comodulated on the T cell surface with PROTEIN1 a known membrane-linked protein tyrosine phosphatase and that anti- PROTEIN was capable of precipitating PROTEIN2 from T cell lysates.,AIMed.d63.s546
1043,AIMed.d63,False,We further showed that PROTEIN1 was comodulated on the T cell surface with PROTEIN a known membrane-linked protein tyrosine phosphatase and that anti- PROTEIN was capable of precipitating PROTEIN2 from T cell lysates.,AIMed.d63.s546
1044,AIMed.d63,False,"These findings strongly suggest that PROTEIN1 may be closely associated with the PROTEIN protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN2 with PROTEIN results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.",AIMed.d63.s547
1045,AIMed.d63,True,"These findings strongly suggest that PROTEIN may be closely associated with the PROTEIN protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN1 with PROTEIN2 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.",AIMed.d63.s547
1046,AIMed.d63,False,"These findings strongly suggest that PROTEIN may be closely associated with the PROTEIN1 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN2 with PROTEIN results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.",AIMed.d63.s547
1047,AIMed.d63,False,"These findings strongly suggest that PROTEIN1 may be closely associated with the PROTEIN protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN with PROTEIN2 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.",AIMed.d63.s547
1048,AIMed.d63,False,"These findings strongly suggest that PROTEIN1 may be closely associated with the PROTEIN2 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN with PROTEIN results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.",AIMed.d63.s547
1049,AIMed.d63,False,"These findings strongly suggest that PROTEIN may be closely associated with the PROTEIN1 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN with PROTEIN2 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.",AIMed.d63.s547
1050,AIMed.d64,False,"We have isolated and characterized a cDNA clone, PROTEIN1 encoding a human fibroblast growth factor (FGF) receptor. PROTEIN2 contains an open reading frame which encodes an 820 amino acid polypeptide with three immunoglobulin-like domains in the extracellular part and an intracellular split tyrosine kinase domain.",AIMed.d64.s549
1051,AIMed.d64,False,"Transient expression in COS-1 cells and immunoprecipitation using an antiserum raised against a C-terminal peptide, gave rise to two components, representing mature (130 kDa) and precursor (115 kDa) forms of the PROTEIN1 encoded polypeptide, which was denoted PROTEIN2 ",AIMed.d64.s550
1052,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN2 ",AIMed.d64.s551
1053,AIMed.d64,False,"Crosslinking of iodinated PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN2 ",AIMed.d64.s551
1054,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN2 ",AIMed.d64.s551
1055,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN and PROTEIN ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN1 and PROTEIN2 ",AIMed.d64.s551
1056,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN and PROTEIN ( PROTEIN1 to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN2 ",AIMed.d64.s551
1057,AIMed.d64,False,"Crosslinking of iodinated PROTEIN1 ( PROTEIN2 and PROTEIN ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN ",AIMed.d64.s551
1058,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN1 and PROTEIN2 ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN ",AIMed.d64.s551
1059,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN2 and PROTEIN ",AIMed.d64.s551
1060,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN2 to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN ",AIMed.d64.s551
1061,AIMed.d64,False,"Crosslinking of iodinated PROTEIN1 ( PROTEIN and PROTEIN2 ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN ",AIMed.d64.s551
1062,AIMed.d64,False,"Crosslinking of iodinated PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN2 and PROTEIN ",AIMed.d64.s551
1063,AIMed.d64,False,"Crosslinking of iodinated PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN2 to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN ",AIMed.d64.s551
1064,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN2 and PROTEIN ",AIMed.d64.s551
1065,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN2 to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN and PROTEIN ",AIMed.d64.s551
1066,AIMed.d64,False,"Crosslinking of iodinated PROTEIN ( PROTEIN and PROTEIN ( PROTEIN1 to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both PROTEIN2 and PROTEIN ",AIMed.d64.s551
1067,AIMed.d64,True,"From Scatchard analyses, the Kd:s for binding of PROTEIN and PROTEIN1 to PROTEIN2 were estimated to 25 pM and 41 pM, respectively.",AIMed.d64.s552
1068,AIMed.d64,True,"From Scatchard analyses, the Kd:s for binding of PROTEIN1 and PROTEIN to PROTEIN2 were estimated to 25 pM and 41 pM, respectively.",AIMed.d64.s552
1069,AIMed.d64,False,"From Scatchard analyses, the Kd:s for binding of PROTEIN1 and PROTEIN2 to PROTEIN were estimated to 25 pM and 41 pM, respectively.",AIMed.d64.s552
1070,AIMed.d64,True,"Thus, PROTEIN1 encodes a human FGF receptor with high affinity for both PROTEIN2 and PROTEIN ",AIMed.d64.s553
1071,AIMed.d64,True,"Thus, PROTEIN1 encodes a human FGF receptor with high affinity for both PROTEIN and PROTEIN2 ",AIMed.d64.s553
1072,AIMed.d64,False,"Thus, PROTEIN encodes a human FGF receptor with high affinity for both PROTEIN1 and PROTEIN2 ",AIMed.d64.s553
1073,AIMed.d65,True,Cross-family dimerization of transcription factors PROTEIN1 PROTEIN2 and PROTEIN PROTEIN alters DNA binding specificity.,AIMed.d65.s554
1074,AIMed.d65,False,Cross-family dimerization of transcription factors PROTEIN1 PROTEIN and PROTEIN PROTEIN2 alters DNA binding specificity.,AIMed.d65.s554
1075,AIMed.d65,False,Cross-family dimerization of transcription factors PROTEIN1 PROTEIN and PROTEIN2 PROTEIN alters DNA binding specificity.,AIMed.d65.s554
1076,AIMed.d65,False,Cross-family dimerization of transcription factors PROTEIN PROTEIN1 and PROTEIN PROTEIN2 alters DNA binding specificity.,AIMed.d65.s554
1077,AIMed.d65,False,Cross-family dimerization of transcription factors PROTEIN PROTEIN1 and PROTEIN2 PROTEIN alters DNA binding specificity.,AIMed.d65.s554
1078,AIMed.d65,True,Cross-family dimerization of transcription factors PROTEIN PROTEIN and PROTEIN1 PROTEIN2 alters DNA binding specificity.,AIMed.d65.s554
1079,AIMed.d65,False,The PROTEIN1 PROTEIN and PROTEIN2 PROTEIN families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.,AIMed.d65.s555
1080,AIMed.d65,False,The PROTEIN PROTEIN and PROTEIN1 PROTEIN2 families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.,AIMed.d65.s555
1081,AIMed.d65,False,The PROTEIN PROTEIN1 and PROTEIN2 PROTEIN families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.,AIMed.d65.s555
1082,AIMed.d65,False,The PROTEIN1 PROTEIN and PROTEIN PROTEIN2 families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.,AIMed.d65.s555
1083,AIMed.d65,False,The PROTEIN1 PROTEIN2 and PROTEIN PROTEIN families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.,AIMed.d65.s555
1084,AIMed.d65,False,The PROTEIN PROTEIN1 and PROTEIN PROTEIN2 families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.,AIMed.d65.s555
1085,AIMed.d65,False,"Although PROTEIN1 PROTEIN2 and PROTEIN PROTEIN were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.",AIMed.d65.s558
1086,AIMed.d65,False,"Although PROTEIN PROTEIN1 and PROTEIN PROTEIN2 were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.",AIMed.d65.s558
1087,AIMed.d65,False,"Although PROTEIN PROTEIN1 and PROTEIN2 PROTEIN were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.",AIMed.d65.s558
1088,AIMed.d65,False,"Although PROTEIN1 PROTEIN and PROTEIN PROTEIN2 were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.",AIMed.d65.s558
1089,AIMed.d65,False,"Although PROTEIN1 PROTEIN and PROTEIN2 PROTEIN were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.",AIMed.d65.s558
1090,AIMed.d65,False,"Although PROTEIN PROTEIN and PROTEIN1 PROTEIN2 were previously thought to interact preferentially with different DNA regulatory elements (the AP-1/TRE and ATF/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.",AIMed.d65.s558
1091,AIMed.d65,False,These findings indicate that the PROTEIN1 PROTEIN and PROTEIN2 PROTEIN families of transcription factors are not as distinct as was previously thought.,AIMed.d65.s560
1092,AIMed.d65,False,These findings indicate that the PROTEIN PROTEIN1 and PROTEIN2 PROTEIN families of transcription factors are not as distinct as was previously thought.,AIMed.d65.s560
1093,AIMed.d65,False,These findings indicate that the PROTEIN PROTEIN and PROTEIN1 PROTEIN2 families of transcription factors are not as distinct as was previously thought.,AIMed.d65.s560
1094,AIMed.d65,False,These findings indicate that the PROTEIN1 PROTEIN2 and PROTEIN PROTEIN families of transcription factors are not as distinct as was previously thought.,AIMed.d65.s560
1095,AIMed.d65,False,These findings indicate that the PROTEIN1 PROTEIN and PROTEIN PROTEIN2 families of transcription factors are not as distinct as was previously thought.,AIMed.d65.s560
1096,AIMed.d65,False,These findings indicate that the PROTEIN PROTEIN1 and PROTEIN PROTEIN2 families of transcription factors are not as distinct as was previously thought.,AIMed.d65.s560
1097,AIMed.d68,False,"Two previously unidentified human PROTEIN1 genes have been isolated, PROTEIN and PROTEIN2 ",AIMed.d68.s578
1098,AIMed.d68,False,"Two previously unidentified human PROTEIN1 genes have been isolated, PROTEIN2 and PROTEIN ",AIMed.d68.s578
1099,AIMed.d68,False,"Two previously unidentified human PROTEIN genes have been isolated, PROTEIN1 and PROTEIN2 ",AIMed.d68.s578
1100,AIMed.d68,False,"Microinjection of anti- PROTEIN1 antibodies into HeLa cells causes their arrest in mitosis. PROTEIN2 and PROTEIN display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either PROTEIN or B2 but not A or D1.",AIMed.d68.s580
1101,AIMed.d68,False,"Microinjection of anti- PROTEIN1 antibodies into HeLa cells causes their arrest in mitosis. PROTEIN and PROTEIN2 display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either PROTEIN or B2 but not A or D1.",AIMed.d68.s580
1102,AIMed.d68,False,"Microinjection of anti- PROTEIN1 antibodies into HeLa cells causes their arrest in mitosis. PROTEIN and PROTEIN display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either PROTEIN2 or B2 but not A or D1.",AIMed.d68.s580
1103,AIMed.d68,False,"Microinjection of anti- PROTEIN antibodies into HeLa cells causes their arrest in mitosis. PROTEIN1 and PROTEIN2 display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either PROTEIN or B2 but not A or D1.",AIMed.d68.s580
1104,AIMed.d68,False,"Microinjection of anti- PROTEIN antibodies into HeLa cells causes their arrest in mitosis. PROTEIN1 and PROTEIN display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either PROTEIN2 or B2 but not A or D1.",AIMed.d68.s580
1105,AIMed.d68,False,"Microinjection of anti- PROTEIN antibodies into HeLa cells causes their arrest in mitosis. PROTEIN and PROTEIN1 display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either PROTEIN2 or B2 but not A or D1.",AIMed.d68.s580
1106,AIMed.d68,True,Association between PROTEIN1 and PROTEIN2 PROTEIN was detected in the HeLa cells.,AIMed.d68.s581
1107,AIMed.d68,False,Association between PROTEIN and PROTEIN1 PROTEIN2 was detected in the HeLa cells.,AIMed.d68.s581
1108,AIMed.d68,True,Association between PROTEIN1 and PROTEIN PROTEIN2 was detected in the HeLa cells.,AIMed.d68.s581
1109,AIMed.d68,False,"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the PROTEIN1 protein kinase, but also activate the PROTEIN2 tyrosine phosphatase, of which PROTEIN is the physiological substrate.",AIMed.d68.s582
1110,AIMed.d68,False,"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the PROTEIN protein kinase, but also activate the PROTEIN1 tyrosine phosphatase, of which PROTEIN2 is the physiological substrate.",AIMed.d68.s582
1111,AIMed.d68,False,"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the PROTEIN1 protein kinase, but also activate the PROTEIN tyrosine phosphatase, of which PROTEIN2 is the physiological substrate.",AIMed.d68.s582
1112,AIMed.d68,False,The motif may represent an activating domain that has to be provided to PROTEIN1 by intermolecular interaction with PROTEIN2 ,AIMed.d68.s585
1113,AIMed.d69,True,Activation of PROTEIN1 decreases phosphorylation of PROTEIN2 at sites that negatively regulate its DNA-binding activity.,AIMed.d69.s586
1114,AIMed.d69,True,"In resting human epithelial and fibroblastic cells, PROTEIN1 is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by PROTEIN ( PROTEIN2 .",AIMed.d69.s587
1115,AIMed.d69,False,"In resting human epithelial and fibroblastic cells, PROTEIN is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by PROTEIN1 ( PROTEIN2 .",AIMed.d69.s587
1116,AIMed.d69,True,"In resting human epithelial and fibroblastic cells, PROTEIN1 is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by PROTEIN2 ( PROTEIN .",AIMed.d69.s587
1117,AIMed.d69,True,"Activation of PROTEIN1 results in rapid, site-specific dephosphorylation of PROTEIN2 at one or more of these three sites and is coincident with increased PROTEIN binding activity.",AIMed.d69.s589
1118,AIMed.d69,False,"Activation of PROTEIN1 results in rapid, site-specific dephosphorylation of PROTEIN at one or more of these three sites and is coincident with increased PROTEIN2 binding activity.",AIMed.d69.s589
1119,AIMed.d69,False,"Activation of PROTEIN results in rapid, site-specific dephosphorylation of PROTEIN1 at one or more of these three sites and is coincident with increased PROTEIN2 binding activity.",AIMed.d69.s589
1120,AIMed.d69,True,Phosphorylation of recombinant human PROTEIN1 proteins in vitro by PROTEIN2 decreases their DNA-binding activity.,AIMed.d69.s590
1121,AIMed.d69,True,"We propose that PROTEIN1 is present in resting cells in a latent, phosphorylated form that can be activated by site-specific dephosphorylation in response to PROTEIN2 activation.",AIMed.d69.s592
1122,AIMed.d70,False,Interaction of the regulatory subunit ( PROTEIN of PROTEIN1 with PROTEIN2 anchoring proteins occurs through an amphipathic helix binding motif.,AIMed.d70.s593
1123,AIMed.d70,False,Interaction of the regulatory subunit ( PROTEIN1 of PROTEIN2 with PROTEIN anchoring proteins occurs through an amphipathic helix binding motif.,AIMed.d70.s593
1124,AIMed.d70,False,Interaction of the regulatory subunit ( PROTEIN1 of PROTEIN with PROTEIN2 anchoring proteins occurs through an amphipathic helix binding motif.,AIMed.d70.s593
1125,AIMed.d70,False,The PROTEIN1 is localized to specific subcellular environments through the binding of the regulatory subunit ( PROTEIN2 dimer to PROTEIN anchoring proteins.,AIMed.d70.s594
1126,AIMed.d70,False,The PROTEIN1 is localized to specific subcellular environments through the binding of the regulatory subunit ( PROTEIN dimer to PROTEIN2 anchoring proteins.,AIMed.d70.s594
1127,AIMed.d70,False,The PROTEIN is localized to specific subcellular environments through the binding of the regulatory subunit ( PROTEIN1 dimer to PROTEIN2 anchoring proteins.,AIMed.d70.s594
1128,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN1 anchoring protein sequences (the PROTEIN PROTEIN and two thyroid proteins PROTEIN2 and PROTEIN , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1129,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN anchoring protein sequences (the PROTEIN1 PROTEIN and two thyroid proteins PROTEIN2 and PROTEIN , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1130,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN anchoring protein sequences (the PROTEIN PROTEIN1 and two thyroid proteins PROTEIN2 and PROTEIN , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1131,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN anchoring protein sequences (the PROTEIN PROTEIN and two thyroid proteins PROTEIN1 and PROTEIN2 , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1132,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN1 anchoring protein sequences (the PROTEIN2 PROTEIN and two thyroid proteins PROTEIN and PROTEIN , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1133,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN1 anchoring protein sequences (the PROTEIN PROTEIN2 and two thyroid proteins PROTEIN and PROTEIN , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1134,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN1 anchoring protein sequences (the PROTEIN PROTEIN and two thyroid proteins PROTEIN and PROTEIN2 , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1135,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN anchoring protein sequences (the PROTEIN1 PROTEIN2 and two thyroid proteins PROTEIN and PROTEIN , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1136,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN anchoring protein sequences (the PROTEIN1 PROTEIN and two thyroid proteins PROTEIN and PROTEIN2 , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1137,AIMed.d70,False,"Computer-aided analysis of secondary structure, performed on four PROTEIN anchoring protein sequences (the PROTEIN PROTEIN1 and two thyroid proteins PROTEIN and PROTEIN2 , has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.",AIMed.d70.s595
1138,AIMed.d70,False,"A bacterially expressed 318-amino acid fragment, PROTEIN1 (418-736), containing the amphipathic helix region, was able to bind PROTEIN2 alpha.",AIMed.d70.s597
1139,AIMed.d70,True,"A bacterially expressed 318-amino acid fragment, PROTEIN1 (418-736), containing the amphipathic helix region, was able to bind PROTEIN2 ",AIMed.d70.s597
1140,AIMed.d70,False,"A bacterially expressed 318-amino acid fragment, PROTEIN (418-736), containing the amphipathic helix region, was able to bind PROTEIN1 ",AIMed.d70.s597
1141,AIMed.d70,False,"Specifically, substitution of proline for Ala-498 significantly diminished PROTEIN1 alpha binding, and similar mutation of Ile-502 or Ile-507 abolished interaction.",AIMed.d70.s599
1142,AIMed.d70,False,"Mutation of Ala-522 to proline, which is located outside the predicted amphipathic helix region, had no effect on PROTEIN1 alpha binding.",AIMed.d70.s600
1143,AIMed.d70,False,These data suggest that anchoring proteins interact with PROTEIN1 alpha via an amphipathic helix binding motif.,AIMed.d70.s601
1144,AIMed.d71,False,The proto-oncogene PROTEIN1 is a component of the PROTEIN2 transcription factor family involved in the mediation of nuclear events elicited by extracellular stimuli.,AIMed.d71.s603
1145,AIMed.d71,False,We present evidence that PROTEIN ( PROTEIN1 and PROTEIN2 44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of PROTEIN ,AIMed.d71.s606
1146,AIMed.d71,False,We present evidence that PROTEIN1 ( PROTEIN and PROTEIN2 44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of PROTEIN ,AIMed.d71.s606
1147,AIMed.d71,True,We present evidence that PROTEIN ( PROTEIN and PROTEIN1 44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of PROTEIN2 ,AIMed.d71.s606
1148,AIMed.d71,False,We present evidence that PROTEIN1 ( PROTEIN2 and PROTEIN 44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of PROTEIN ,AIMed.d71.s606
1149,AIMed.d71,True,We present evidence that PROTEIN ( PROTEIN1 and PROTEIN 44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of PROTEIN2 ,AIMed.d71.s606
1150,AIMed.d71,False,We present evidence that PROTEIN1 ( PROTEIN and PROTEIN 44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of PROTEIN2 ,AIMed.d71.s606
1151,AIMed.d71,False,The PROTEIN1 enzymes PROTEIN2 and PROTEIN 44 are regulated by tyrosine as well as serine/threonine phosphorylation.,AIMed.d71.s607
1152,AIMed.d71,False,The PROTEIN1 enzymes PROTEIN and PROTEIN2 44 are regulated by tyrosine as well as serine/threonine phosphorylation.,AIMed.d71.s607
1153,AIMed.d71,False,The PROTEIN enzymes PROTEIN1 and PROTEIN2 44 are regulated by tyrosine as well as serine/threonine phosphorylation.,AIMed.d71.s607
1154,AIMed.d71,False," PROTEIN1 activation of PROTEIN2 may underlie the common stimulation of this transcription factor by mitogens, growth factors and oncogenes.",AIMed.d71.s608
1155,AIMed.d73,False,The extracellular cysteine-rich domain of the TNF-R is homologous to the nerve growth factor receptor and the PROTEIN1 PROTEIN2 ,AIMed.d73.s621
1156,AIMed.d73,False,Unlabeled PROTEIN and PROTEIN1 were equally effective at displacing the binding of labeled PROTEIN2 to TNF-R expressing cells.,AIMed.d73.s623
1157,AIMed.d73,False,Unlabeled PROTEIN1 and PROTEIN2 were equally effective at displacing the binding of labeled PROTEIN to TNF-R expressing cells.,AIMed.d73.s623
1158,AIMed.d73,False,Unlabeled PROTEIN1 and PROTEIN were equally effective at displacing the binding of labeled PROTEIN2 to TNF-R expressing cells.,AIMed.d73.s623
1159,AIMed.d74,True,Two cDNA clones encoding a receptor for human PROTEIN1 ( PROTEIN2 were isolated by expression screening of a library made from human placental mRNA.,AIMed.d74.s627
1160,AIMed.d74,False,"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for PROTEIN1 PROTEIN and PROTEIN2 (beta-chain) and also to the prolactin receptor.",AIMed.d74.s630
1161,AIMed.d74,False,"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for PROTEIN PROTEIN1 and PROTEIN2 (beta-chain) and also to the prolactin receptor.",AIMed.d74.s630
1162,AIMed.d74,False,"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for PROTEIN1 PROTEIN2 and PROTEIN (beta-chain) and also to the prolactin receptor.",AIMed.d74.s630
1163,AIMed.d74,False,When transfected into COS cells the cloned cDNA directed the expression of a PROTEIN1 showing a single class of affinity (KD = 2(-8) nM) and specificity for human PROTEIN but not PROTEIN2 ,AIMed.d74.s631
1164,AIMed.d74,True,When transfected into COS cells the cloned cDNA directed the expression of a PROTEIN1 showing a single class of affinity (KD = 2(-8) nM) and specificity for human PROTEIN2 but not PROTEIN ,AIMed.d74.s631
1165,AIMed.d74,False,When transfected into COS cells the cloned cDNA directed the expression of a PROTEIN showing a single class of affinity (KD = 2(-8) nM) and specificity for human PROTEIN1 but not PROTEIN2 ,AIMed.d74.s631
1166,AIMed.d76,True,The T-cell antigen PROTEIN1 acts as a receptor and substrate for the protein-tyrosine kinase PROTEIN2 ,AIMed.d76.s637
1167,AIMed.d76,True, PROTEIN1 is a T-cell-specific antigen which binds to the B-cell antigen PROTEIN2 and acts as a coreceptor in the stimulation of T-cell growth.,AIMed.d76.s638
1168,AIMed.d76,False, PROTEIN1 associates with the PROTEIN2 ( PROTEIN / PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1169,AIMed.d76,False, PROTEIN1 associates with PROTEIN2 T PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1170,AIMed.d76,False, PROTEIN1 associates with PROTEIN T PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1171,AIMed.d76,True, PROTEIN1 associates with PROTEIN E PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1172,AIMed.d76,False, PROTEIN1 associates with PROTEIN T PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2 PROTEIN ligation.,AIMed.d76.s639
1173,AIMed.d76,False, PROTEIN1 associates with PROTEIN T PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN2 ligation.,AIMed.d76.s639
1174,AIMed.d76,False, PROTEIN associates with the PROTEIN1 ( PROTEIN2 / PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1175,AIMed.d76,True, PROTEIN associates with the PROTEIN1 ( PROTEIN / PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1176,AIMed.d76,False, PROTEIN associates with PROTEIN E PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1177,AIMed.d76,False, PROTEIN associates with the PROTEIN1 ( PROTEIN / PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2 PROTEIN ligation.,AIMed.d76.s639
1178,AIMed.d76,False, PROTEIN associates with the PROTEIN1 ( PROTEIN / PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN2 ligation.,AIMed.d76.s639
1179,AIMed.d76,True, PROTEIN associates with PROTEIN1 T PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1180,AIMed.d76,False, PROTEIN associates with PROTEIN2 E PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1181,AIMed.d76,False, PROTEIN associates with PROTEIN1 T PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2 PROTEIN ligation.,AIMed.d76.s639
1182,AIMed.d76,False, PROTEIN associates with PROTEIN1 T PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN2 ligation.,AIMed.d76.s639
1183,AIMed.d76,False, PROTEIN associates with PROTEIN E PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN ligation.,AIMed.d76.s639
1184,AIMed.d76,False, PROTEIN associates with PROTEIN T PROTEIN1 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2 PROTEIN ligation.,AIMed.d76.s639
1185,AIMed.d76,False, PROTEIN associates with PROTEIN T PROTEIN1 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN2 ligation.,AIMed.d76.s639
1186,AIMed.d76,False, PROTEIN associates with PROTEIN E PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2 PROTEIN ligation.,AIMed.d76.s639
1187,AIMed.d76,False, PROTEIN associates with PROTEIN E PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN PROTEIN2 ligation.,AIMed.d76.s639
1188,AIMed.d76,False, PROTEIN associates with the PROTEIN ( PROTEIN / PROTEIN complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN1 PROTEIN2 ligation.,AIMed.d76.s639
1189,AIMed.d76,False,"In this study, we demonstrate that PROTEIN is coupled to the protein-tyrosine kinase PROTEIN1 and can act as a substrate for PROTEIN2 ",AIMed.d76.s641
1190,AIMed.d76,True,"In this study, we demonstrate that PROTEIN1 is coupled to the protein-tyrosine kinase PROTEIN and can act as a substrate for PROTEIN2 ",AIMed.d76.s641
1191,AIMed.d76,True,"In this study, we demonstrate that PROTEIN1 is coupled to the protein-tyrosine kinase PROTEIN2 and can act as a substrate for PROTEIN ",AIMed.d76.s641
1192,AIMed.d76,False,Coexpression of PROTEIN1 with PROTEIN2 in the baculovirus expression system resulted in the phosphorylation of PROTEIN on tyrosine residues.,AIMed.d76.s642
1193,AIMed.d76,False,Coexpression of PROTEIN1 with PROTEIN in the baculovirus expression system resulted in the phosphorylation of PROTEIN2 on tyrosine residues.,AIMed.d76.s642
1194,AIMed.d76,False,Coexpression of PROTEIN with PROTEIN1 in the baculovirus expression system resulted in the phosphorylation of PROTEIN2 on tyrosine residues.,AIMed.d76.s642
1195,AIMed.d76,False,"Further, anti- PROTEIN1 and anti- PROTEIN2 coprecipitated each other in a variety of detergents, including Nonidet P-40 and Triton X-100.",AIMed.d76.s643
1196,AIMed.d76,False,Anti- PROTEIN also precipitated the kinase from various T cells irrespective of the expression of PROTEIN1 PROTEIN or PROTEIN2 ,AIMed.d76.s644
1197,AIMed.d76,False,Anti- PROTEIN1 also precipitated the kinase from various T cells irrespective of the expression of PROTEIN2 PROTEIN or PROTEIN ,AIMed.d76.s644
1198,AIMed.d76,False,Anti- PROTEIN also precipitated the kinase from various T cells irrespective of the expression of PROTEIN1 PROTEIN2 or PROTEIN ,AIMed.d76.s644
1199,AIMed.d76,False,Anti- PROTEIN1 also precipitated the kinase from various T cells irrespective of the expression of PROTEIN PROTEIN or PROTEIN2 ,AIMed.d76.s644
1200,AIMed.d76,False,Anti- PROTEIN also precipitated the kinase from various T cells irrespective of the expression of PROTEIN PROTEIN1 or PROTEIN2 ,AIMed.d76.s644
1201,AIMed.d76,False,Anti- PROTEIN1 also precipitated the kinase from various T cells irrespective of the expression of PROTEIN PROTEIN2 or PROTEIN ,AIMed.d76.s644
1202,AIMed.d76,False,No binding between PROTEIN1 T) and PROTEIN2 was detected in T cells.,AIMed.d76.s645
1203,AIMed.d76,False,"The binding of PROTEIN1 to PROTEIN induced a 10- to 15-fold increase in PROTEIN2 catalytic activity, as measured by in vitro kinase analysis.",AIMed.d76.s646
1204,AIMed.d76,True,"The binding of PROTEIN1 to PROTEIN2 induced a 10- to 15-fold increase in PROTEIN catalytic activity, as measured by in vitro kinase analysis.",AIMed.d76.s646
1205,AIMed.d76,False,"The binding of PROTEIN to PROTEIN1 induced a 10- to 15-fold increase in PROTEIN2 catalytic activity, as measured by in vitro kinase analysis.",AIMed.d76.s646
1206,AIMed.d76,True,In vivo labelling with 32P(i) also showed a four- to fivefold increase in Y-394 occupancy in PROTEIN1 when associated with PROTEIN2 ,AIMed.d76.s647
1207,AIMed.d76,True,The use of glutathione S-transferase-Lck fusion proteins in precipitation analysis showed that the SH2 domain of PROTEIN1 could recognize PROTEIN2 as expressed in the baculovirus expression system.,AIMed.d76.s648
1208,AIMed.d76,False, PROTEIN interaction w PROTEIN PROTEIN1 represents a novel variant of a receptor-kinas PROTEIN2 x in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS ),AIMed.d76.s649
1209,AIMed.d76,False, PROTEIN interaction w PROTEIN1 PROTEIN represents a novel variant of a receptor-kinas PROTEIN2 x in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS ),AIMed.d76.s649
1210,AIMed.d76,False, PROTEIN1 interaction w PROTEIN PROTEIN represents a novel variant of a receptor-kinas PROTEIN2 x in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS ),AIMed.d76.s649
1211,AIMed.d76,False, PROTEIN interaction w PROTEIN1 PROTEIN2 represents a novel variant of a receptor-kinas PROTEIN x in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS ),AIMed.d76.s649
1212,AIMed.d76,True, PROTEIN1 interaction w PROTEIN PROTEIN2 represents a novel variant of a receptor-kinas PROTEIN x in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS ),AIMed.d76.s649
1213,AIMed.d76,False, PROTEIN1 interaction w PROTEIN2 PROTEIN represents a novel variant of a receptor-kinas PROTEIN x in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS ),AIMed.d76.s649
1214,AIMed.d77,False," PROTEIN1 ( PROTEIN2 , a desmosomal component lacking a transmembrane domain, has been implicated in this interaction, although most studies have been conducted with cells that contain few or no desmosomes, and efforts to demonstrate direct interactions between desmoplakin and intermediate filaments have not been successful.",AIMed.d77.s652
1215,AIMed.d77,True,"We show that the carboxy terminal ""tail"" of PROTEIN1 associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN2 PROTEIN PROTEIN and PROTEIN ",AIMed.d77.s654
1216,AIMed.d77,True,"We show that the carboxy terminal ""tail"" of PROTEIN1 associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN PROTEIN2 PROTEIN and PROTEIN ",AIMed.d77.s654
1217,AIMed.d77,True,"We show that the carboxy terminal ""tail"" of PROTEIN1 associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN PROTEIN PROTEIN and PROTEIN2 ",AIMed.d77.s654
1218,AIMed.d77,True,"We show that the carboxy terminal ""tail"" of PROTEIN1 associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN PROTEIN PROTEIN2 and PROTEIN ",AIMed.d77.s654
1219,AIMed.d77,False,"We show that the carboxy terminal ""tail"" of PROTEIN associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN1 PROTEIN2 PROTEIN and PROTEIN ",AIMed.d77.s654
1220,AIMed.d77,False,"We show that the carboxy terminal ""tail"" of PROTEIN associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN1 PROTEIN PROTEIN and PROTEIN2 ",AIMed.d77.s654
1221,AIMed.d77,False,"We show that the carboxy terminal ""tail"" of PROTEIN associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN1 PROTEIN PROTEIN2 and PROTEIN ",AIMed.d77.s654
1222,AIMed.d77,False,"We show that the carboxy terminal ""tail"" of PROTEIN associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN PROTEIN1 PROTEIN and PROTEIN2 ",AIMed.d77.s654
1223,AIMed.d77,False,"We show that the carboxy terminal ""tail"" of PROTEIN associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN PROTEIN1 PROTEIN2 and PROTEIN ",AIMed.d77.s654
1224,AIMed.d77,False,"We show that the carboxy terminal ""tail"" of PROTEIN associates directly with the amino terminal ""head"" of type II epidermal keratins, including PROTEIN PROTEIN PROTEIN1 and PROTEIN2 ",AIMed.d77.s654
1225,AIMed.d77,True,"We have engineered and purified recombinant PROTEIN1 head and PROTEIN2 tail, and we demonstrate direct interaction in vitro by solution-binding assays and by ligand blot assays.",AIMed.d77.s655
1226,AIMed.d77,True,We have identified an 18-amino acid residue stretch in the PROTEIN1 head that is conserved only among type II epidermal keratins and that appears to play some role in PROTEIN2 tail binding.,AIMed.d77.s657
1227,AIMed.d79,True,The PROTEIN1 protein binds to PROTEIN2 a zinc-finger protein that shares an epitope with the adenovirus PROTEIN protein.,AIMed.d79.s671
1228,AIMed.d79,False,The PROTEIN1 protein binds to PROTEIN a zinc-finger protein that shares an epitope with the adenovirus PROTEIN2 protein.,AIMed.d79.s671
1229,AIMed.d79,False,The PROTEIN protein binds to PROTEIN1 a zinc-finger protein that shares an epitope with the adenovirus PROTEIN2 protein.,AIMed.d79.s671
1230,AIMed.d79,False,The PROTEIN1 ( PROTEIN2 is a target of viral oncoproteins.,AIMed.d79.s672
1231,AIMed.d79,False,It contains an PROTEIN1 binding motif that shares an antigenic epitope with the C terminus of PROTEIN2 ,AIMed.d79.s676
1232,AIMed.d79,False,A domain is conserved between PROTEIN and the PROTEIN1 PROTEIN2 differentiation factor.,AIMed.d79.s677
1233,AIMed.d79,False,A domain is conserved between PROTEIN1 and the PROTEIN2 PROTEIN differentiation factor.,AIMed.d79.s677
1234,AIMed.d79,False,A domain is conserved between PROTEIN1 and the PROTEIN PROTEIN2 differentiation factor.,AIMed.d79.s677
1235,AIMed.d79,False,"While the function of PROTEIN1 is not yet clear, its structure and pattern of expression suggest a role for PROTEIN2 in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.",AIMed.d79.s681
1236,AIMed.d80,True," PROTEIN1 a novel death domain-containing protein, interacts with the death domain of PROTEIN2 and initiates apoptosis.",AIMed.d80.s682
1237,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN1 which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN2 ",AIMed.d80.s683
1238,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN1 PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN2 ",AIMed.d80.s683
1239,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN1 PROTEIN and PROTEIN PROTEIN2 ",AIMed.d80.s683
1240,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN2 ",AIMed.d80.s683
1241,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN1 a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN2 ",AIMed.d80.s683
1242,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN1 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN2 ",AIMed.d80.s683
1243,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN1 and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN2 ",AIMed.d80.s683
1244,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN1 PROTEIN2 ",AIMed.d80.s683
1245,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN1 and PROTEIN PROTEIN2 ",AIMed.d80.s683
1246,AIMed.d80,True,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN1 which binds PROTEIN and PROTEIN2 PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1247,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN1 which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN2 PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1248,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN2 which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1249,AIMed.d80,True,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN1 which binds PROTEIN and PROTEIN PROTEIN2 a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1250,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN1 which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN2 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1251,AIMed.d80,True,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN1 which binds PROTEIN2 and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1252,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN1 which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN2 PROTEIN ",AIMed.d80.s683
1253,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN1 which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN2 and PROTEIN PROTEIN ",AIMed.d80.s683
1254,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN1 PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN2 PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1255,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN2 PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1256,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN1 PROTEIN2 a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1257,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN1 PROTEIN a mutant of PROTEIN2 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1258,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN1 and PROTEIN2 PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1259,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN1 PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN2 PROTEIN ",AIMed.d80.s683
1260,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN1 PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN2 and PROTEIN PROTEIN ",AIMed.d80.s683
1261,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN2 PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1262,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN1 a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN2 PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1263,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN1 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN2 PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1264,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN1 and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN2 PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1265,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN1 PROTEIN and PROTEIN2 PROTEIN ",AIMed.d80.s683
1266,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN1 PROTEIN2 and PROTEIN PROTEIN ",AIMed.d80.s683
1267,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN2 a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1268,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN2 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1269,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN2 and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1270,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN2 PROTEIN ",AIMed.d80.s683
1271,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN2 and PROTEIN PROTEIN ",AIMed.d80.s683
1272,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN1 a mutant of PROTEIN2 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1273,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN1 and PROTEIN PROTEIN2 a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1274,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN1 a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN2 PROTEIN ",AIMed.d80.s683
1275,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN1 a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN2 and PROTEIN PROTEIN ",AIMed.d80.s683
1276,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN1 and PROTEIN PROTEIN a mutant of PROTEIN2 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN PROTEIN ",AIMed.d80.s683
1277,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN1 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN2 PROTEIN ",AIMed.d80.s683
1278,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN1 possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN2 and PROTEIN PROTEIN ",AIMed.d80.s683
1279,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN1 and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN and PROTEIN2 PROTEIN ",AIMed.d80.s683
1280,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN1 and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN2 and PROTEIN PROTEIN ",AIMed.d80.s683
1281,AIMed.d80,False,"Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system, we have identified a novel interacting protein, PROTEIN which binds PROTEIN and PROTEIN PROTEIN a mutant of PROTEIN possessing enhanced killing activity, but not the functionally inactive mutants PROTEIN PROTEIN1 and PROTEIN2 PROTEIN ",AIMed.d80.s683
1282,AIMed.d80,False, PROTEIN1 contains a death domain homologous to the death domains of PROTEIN and PROTEIN2 ,AIMed.d80.s684
1283,AIMed.d80,False, PROTEIN1 contains a death domain homologous to the death domains of PROTEIN2 and PROTEIN ,AIMed.d80.s684
1284,AIMed.d80,False, PROTEIN contains a death domain homologous to the death domains of PROTEIN1 and PROTEIN2 ,AIMed.d80.s684
1285,AIMed.d80,True,A point mutation in PROTEIN1 analogous to the lpr mutation of PROTEIN abolishes its ability to bind PROTEIN2 suggesting a death domain to death domain interaction.,AIMed.d80.s685
1286,AIMed.d80,False,A point mutation in PROTEIN analogous to the lpr mutation of PROTEIN1 abolishes its ability to bind PROTEIN2 suggesting a death domain to death domain interaction.,AIMed.d80.s685
1287,AIMed.d80,False,A point mutation in PROTEIN1 analogous to the lpr mutation of PROTEIN2 abolishes its ability to bind PROTEIN suggesting a death domain to death domain interaction.,AIMed.d80.s685
1288,AIMed.d80,False,"Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN induced apoptosis, is blocked by PROTEIN1 a specific inhibitor of the PROTEIN2 converting enzyme.",AIMed.d80.s686
1289,AIMed.d80,False,"Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN induced apoptosis, is blocked by PROTEIN a specific inhibitor of the PROTEIN1 ",AIMed.d80.s686
1290,AIMed.d80,False,"Overexpression of PROTEIN1 in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN induced apoptosis, is blocked by PROTEIN a specific inhibitor of the PROTEIN2 converting enzyme.",AIMed.d80.s686
1291,AIMed.d80,False,"Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN1 induced apoptosis, is blocked by PROTEIN a specific inhibitor of the PROTEIN2 converting enzyme.",AIMed.d80.s686
1292,AIMed.d80,True,"Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN induced apoptosis, is blocked by PROTEIN1 a specific inhibitor of the PROTEIN2 ",AIMed.d80.s686
1293,AIMed.d80,False,"Overexpression of PROTEIN1 in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN induced apoptosis, is blocked by PROTEIN2 a specific inhibitor of the PROTEIN ",AIMed.d80.s686
1294,AIMed.d80,False,"Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN1 induced apoptosis, is blocked by PROTEIN2 a specific inhibitor of the PROTEIN ",AIMed.d80.s686
1295,AIMed.d80,False,"Overexpression of PROTEIN1 in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN induced apoptosis, is blocked by PROTEIN a specific inhibitor of the PROTEIN2 ",AIMed.d80.s686
1296,AIMed.d80,False,"Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN1 induced apoptosis, is blocked by PROTEIN a specific inhibitor of the PROTEIN2 ",AIMed.d80.s686
1297,AIMed.d80,False,"Overexpression of PROTEIN1 in MCF7 and BJAB cells induces apoptosis, which, like PROTEIN2 induced apoptosis, is blocked by PROTEIN a specific inhibitor of the PROTEIN ",AIMed.d80.s686
1298,AIMed.d80,False,These findings suggest that PROTEIN1 may play an important role in the proximal signal transduction of PROTEIN2 ,AIMed.d80.s687
1299,AIMed.d81,True, PROTEIN1 a novel protein containing a death domain that interacts with PROTEIN PROTEIN ( PROTEIN2 in yeast and causes cell death.,AIMed.d81.s688
1300,AIMed.d81,True, PROTEIN1 a novel protein containing a death domain that interacts with PROTEIN2 PROTEIN ( PROTEIN in yeast and causes cell death.,AIMed.d81.s688
1301,AIMed.d81,True, PROTEIN1 a novel protein containing a death domain that interacts with PROTEIN PROTEIN2 ( PROTEIN in yeast and causes cell death.,AIMed.d81.s688
1302,AIMed.d81,False, PROTEIN a novel protein containing a death domain that interacts with PROTEIN1 PROTEIN ( PROTEIN2 in yeast and causes cell death.,AIMed.d81.s688
1303,AIMed.d81,False, PROTEIN a novel protein containing a death domain that interacts with PROTEIN PROTEIN1 ( PROTEIN2 in yeast and causes cell death.,AIMed.d81.s688
1304,AIMed.d81,False, PROTEIN a novel protein containing a death domain that interacts with PROTEIN1 PROTEIN2 ( PROTEIN in yeast and causes cell death.,AIMed.d81.s688
1305,AIMed.d81,False,Ligation of the extracellular domain of the cell surface receptor PROTEIN1 PROTEIN2 ( PROTEIN elicits a characteristic programmed death response in susceptible cells.,AIMed.d81.s689
1306,AIMed.d81,False,Ligation of the extracellular domain of the cell surface receptor PROTEIN1 PROTEIN ( PROTEIN2 elicits a characteristic programmed death response in susceptible cells.,AIMed.d81.s689
1307,AIMed.d81,False,Ligation of the extracellular domain of the cell surface receptor PROTEIN PROTEIN1 ( PROTEIN2 elicits a characteristic programmed death response in susceptible cells.,AIMed.d81.s689
1308,AIMed.d81,False,"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of PROTEIN PROTEIN1 itself, and a novel 74 kDa protein we have named PROTEIN for PROTEIN2 ",AIMed.d81.s690
1309,AIMed.d81,True,"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of PROTEIN1 PROTEIN2 itself, and a novel 74 kDa protein we have named PROTEIN for PROTEIN ",AIMed.d81.s690
1310,AIMed.d81,False,"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of PROTEIN PROTEIN1 itself, and a novel 74 kDa protein we have named PROTEIN2 for PROTEIN ",AIMed.d81.s690
1311,AIMed.d81,True,"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of PROTEIN1 PROTEIN itself, and a novel 74 kDa protein we have named PROTEIN for PROTEIN2 ",AIMed.d81.s690
1312,AIMed.d81,False,"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of PROTEIN PROTEIN itself, and a novel 74 kDa protein we have named PROTEIN1 for PROTEIN2 ",AIMed.d81.s690
1313,AIMed.d81,True,"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of PROTEIN1 PROTEIN itself, and a novel 74 kDa protein we have named PROTEIN2 for PROTEIN ",AIMed.d81.s690
1314,AIMed.d81,False," PROTEIN1 also interacts weakly with the PROTEIN2 tumor necrosis factor receptor ( PROTEIN intracellular domain, but not with a mutant version of PROTEIN corresponding to the murine lprcg mutation.",AIMed.d81.s691
1315,AIMed.d81,False," PROTEIN also interacts weakly with the PROTEIN1 tumor necrosis factor receptor ( PROTEIN intracellular domain, but not with a mutant version of PROTEIN2 corresponding to the murine lprcg mutation.",AIMed.d81.s691
1316,AIMed.d81,False," PROTEIN also interacts weakly with the PROTEIN1 tumor necrosis factor receptor ( PROTEIN2 intracellular domain, but not with a mutant version of PROTEIN corresponding to the murine lprcg mutation.",AIMed.d81.s691
1317,AIMed.d81,False," PROTEIN1 also interacts weakly with the PROTEIN tumor necrosis factor receptor ( PROTEIN intracellular domain, but not with a mutant version of PROTEIN2 corresponding to the murine lprcg mutation.",AIMed.d81.s691
1318,AIMed.d81,True," PROTEIN1 also interacts weakly with the PROTEIN tumor necrosis factor receptor ( PROTEIN2 intracellular domain, but not with a mutant version of PROTEIN corresponding to the murine lprcg mutation.",AIMed.d81.s691
1319,AIMed.d81,False," PROTEIN also interacts weakly with the PROTEIN tumor necrosis factor receptor ( PROTEIN1 intracellular domain, but not with a mutant version of PROTEIN2 corresponding to the murine lprcg mutation.",AIMed.d81.s691
1320,AIMed.d81,False, PROTEIN1 contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the PROTEIN and PROTEIN2 intracellular domains.,AIMed.d81.s692
1321,AIMed.d81,False, PROTEIN1 contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the PROTEIN2 and PROTEIN intracellular domains.,AIMed.d81.s692
1322,AIMed.d81,False, PROTEIN contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the PROTEIN1 and PROTEIN2 intracellular domains.,AIMed.d81.s692
1323,AIMed.d82,False,Identification of an 11-kDa PROTEIN1 rapamycin-binding domain within the 289-kDa PROTEIN2 and characterization of a critical serine residue.,AIMed.d82.s695
1324,AIMed.d82,False,"Previously, a mammalian protein that directly associates with PROTEIN rapamycin has been identified and its encoding gene has been cloned from both human (designated PROTEIN1 [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated PROTEIN2 [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].",AIMed.d82.s697
1325,AIMed.d82,False,"Previously, a mammalian protein that directly associates with PROTEIN1 rapamycin has been identified and its encoding gene has been cloned from both human (designated PROTEIN [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated PROTEIN2 [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].",AIMed.d82.s697
1326,AIMed.d82,True,"Previously, a mammalian protein that directly associates with PROTEIN1 rapamycin has been identified and its encoding gene has been cloned from both human (designated PROTEIN2 [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated PROTEIN [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].",AIMed.d82.s697
1327,AIMed.d82,True,"Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa PROTEIN1 rapamycin-binding domain within PROTEIN2 ",AIMed.d82.s699
1328,AIMed.d83,False,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN1 ( PROTEIN with PROTEIN and not with the beta-components, PROTEIN and PROTEIN2 ",AIMed.d83.s704
1329,AIMed.d83,False,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN1 ( PROTEIN with PROTEIN and not with the beta-components, PROTEIN2 and PROTEIN ",AIMed.d83.s704
1330,AIMed.d83,True,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN1 ( PROTEIN with PROTEIN2 and not with the beta-components, PROTEIN and PROTEIN ",AIMed.d83.s704
1331,AIMed.d83,False,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN1 ( PROTEIN2 with PROTEIN and not with the beta-components, PROTEIN and PROTEIN ",AIMed.d83.s704
1332,AIMed.d83,False,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN ( PROTEIN with PROTEIN and not with the beta-components, PROTEIN1 and PROTEIN2 ",AIMed.d83.s704
1333,AIMed.d83,False,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN ( PROTEIN with PROTEIN1 and not with the beta-components, PROTEIN and PROTEIN2 ",AIMed.d83.s704
1334,AIMed.d83,False,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN ( PROTEIN1 with PROTEIN and not with the beta-components, PROTEIN and PROTEIN2 ",AIMed.d83.s704
1335,AIMed.d83,False,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN ( PROTEIN with PROTEIN1 and not with the beta-components, PROTEIN2 and PROTEIN ",AIMed.d83.s704
1336,AIMed.d83,False,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN ( PROTEIN1 with PROTEIN and not with the beta-components, PROTEIN2 and PROTEIN ",AIMed.d83.s704
1337,AIMed.d83,True,"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of PROTEIN ( PROTEIN1 with PROTEIN2 and not with the beta-components, PROTEIN and PROTEIN ",AIMed.d83.s704
1338,AIMed.d83,False,Superposition of the PROTEIN1 and growth hormone structures showed that the location of these epitopes on PROTEIN2 is analogous to the location of the first and second receptor epitopes on the surface of growth hormone.,AIMed.d83.s707
1339,AIMed.d85,True, PROTEIN1 physically associates with PROTEIN2 through Src homology 3 domains.,AIMed.d85.s717
1340,AIMed.d85,False,"In the second of a series of experiments designed to identify PROTEIN Src homology 3 (SH3)-binding molecules, we report the cloning of PROTEIN1 ( PROTEIN2 from an HL60 cDNA expression library.",AIMed.d85.s718
1341,AIMed.d85,False,"In the second of a series of experiments designed to identify PROTEIN1 Src homology 3 (SH3)-binding molecules, we report the cloning of PROTEIN2 ( PROTEIN from an HL60 cDNA expression library.",AIMed.d85.s718
1342,AIMed.d85,False,"In the second of a series of experiments designed to identify PROTEIN1 Src homology 3 (SH3)-binding molecules, we report the cloning of PROTEIN ( PROTEIN2 from an HL60 cDNA expression library.",AIMed.d85.s718
1343,AIMed.d85,True,Studies in vivo and in vitro demonstrated a highly specific interaction between the SH3 domains of PROTEIN1 and PROTEIN2 ,AIMed.d85.s720
1344,AIMed.d85,False,"In vitro translation studies identified the 66-kDa protein as the protein product of PROTEIN1 and subcellular fractionation experiments showed that PROTEIN2 is mainly present in the cytosol fraction, although significant amounts are also present in membrane and nuclear fractions.",AIMed.d85.s722
1345,AIMed.d85,True,The main PROTEIN1 region implicated in the association with PROTEIN2 was found to be the carboxy-terminal SH3 domain.,AIMed.d85.s723
1346,AIMed.d87,False,Interaction of PROTEIN1 subunit of PROTEIN with PROTEIN and PROTEIN2 receptors analysed by using the two-hybrid system.,AIMed.d87.s733
1347,AIMed.d87,False,Interaction of PROTEIN subunit of PROTEIN with PROTEIN1 and PROTEIN2 receptors analysed by using the two-hybrid system.,AIMed.d87.s733
1348,AIMed.d87,False,Interaction of PROTEIN subunit of PROTEIN1 with PROTEIN and PROTEIN2 receptors analysed by using the two-hybrid system.,AIMed.d87.s733
1349,AIMed.d87,False,Interaction of PROTEIN1 subunit of PROTEIN with PROTEIN2 and PROTEIN receptors analysed by using the two-hybrid system.,AIMed.d87.s733
1350,AIMed.d87,False,Interaction of PROTEIN1 subunit of PROTEIN2 with PROTEIN and PROTEIN receptors analysed by using the two-hybrid system.,AIMed.d87.s733
1351,AIMed.d87,False,Interaction of PROTEIN subunit of PROTEIN1 with PROTEIN2 and PROTEIN receptors analysed by using the two-hybrid system.,AIMed.d87.s733
1352,AIMed.d87,True,Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN ( PROTEIN2 and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1353,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN ( PROTEIN1 and the PROTEIN2 receptor ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1354,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN ( PROTEIN1 and the PROTEIN ( PROTEIN2 was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1355,AIMed.d87,False,Interaction of the PROTEIN1 subunit of PROTEIN with the PROTEIN ( PROTEIN2 and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1356,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN ( PROTEIN1 and the PROTEIN2 ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1357,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 receptor ( PROTEIN2 and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1358,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 ( PROTEIN2 and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1359,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN ( PROTEIN and the PROTEIN2 receptor ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1360,AIMed.d87,True,Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN2 was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1361,AIMed.d87,False,Interaction of the PROTEIN1 subunit of PROTEIN2 with the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1362,AIMed.d87,True,Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN ( PROTEIN and the PROTEIN2 ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1363,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN2 receptor ( PROTEIN and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1364,AIMed.d87,True,Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN2 ( PROTEIN and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1365,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN ( PROTEIN and the PROTEIN1 receptor ( PROTEIN2 was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1366,AIMed.d87,False,Interaction of the PROTEIN1 subunit of PROTEIN with the PROTEIN ( PROTEIN and the PROTEIN2 receptor ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1367,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN ( PROTEIN and the PROTEIN1 ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1368,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 receptor ( PROTEIN and the PROTEIN2 receptor ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1369,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 ( PROTEIN and the PROTEIN2 receptor ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1370,AIMed.d87,False,Interaction of the PROTEIN1 subunit of PROTEIN with the PROTEIN ( PROTEIN and the PROTEIN ( PROTEIN2 was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1371,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN ( PROTEIN and the PROTEIN1 ( PROTEIN2 was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1372,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 receptor ( PROTEIN and the PROTEIN ( PROTEIN2 was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1373,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 ( PROTEIN and the PROTEIN ( PROTEIN2 was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1374,AIMed.d87,False,Interaction of the PROTEIN1 subunit of PROTEIN with the PROTEIN ( PROTEIN and the PROTEIN2 ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1375,AIMed.d87,False,Interaction of the PROTEIN1 subunit of PROTEIN with the PROTEIN2 receptor ( PROTEIN and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1376,AIMed.d87,False,Interaction of the PROTEIN1 subunit of PROTEIN with the PROTEIN2 ( PROTEIN and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1377,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 receptor ( PROTEIN and the PROTEIN2 ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1378,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 ( PROTEIN and the PROTEIN2 ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1379,AIMed.d87,False,Interaction of the PROTEIN subunit of PROTEIN with the PROTEIN1 ( PROTEIN and the PROTEIN ( PROTEIN was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.,AIMed.d87.s734
1380,AIMed.d87,False,"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of PROTEIN1 and PROTEIN and PROTEIN2 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).",AIMed.d87.s735
1381,AIMed.d87,False,"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of PROTEIN1 and PROTEIN2 and PROTEIN or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).",AIMed.d87.s735
1382,AIMed.d87,False,"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of PROTEIN and PROTEIN1 and PROTEIN2 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).",AIMed.d87.s735
1383,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN1 whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ,AIMed.d87.s736
1384,AIMed.d87,False,"The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 beta and PROTEIN2 beta, whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ",AIMed.d87.s736
1385,AIMed.d87,False,"The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 and PROTEIN2 beta, whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ",AIMed.d87.s736
1386,AIMed.d87,False,"The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN1 beta, whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 beta.",AIMed.d87.s736
1387,AIMed.d87,False,"The results of his3 activation indicated that PROTEIN1 N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN2 beta, whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ",AIMed.d87.s736
1388,AIMed.d87,False,"The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN1 beta, whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 ",AIMed.d87.s736
1389,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 beta and PROTEIN2 whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ,AIMed.d87.s736
1390,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 and PROTEIN2 whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ,AIMed.d87.s736
1391,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN1 whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 beta.,AIMed.d87.s736
1392,AIMed.d87,True,The results of his3 activation indicated that PROTEIN1 N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN2 whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ,AIMed.d87.s736
1393,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN1 whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 ,AIMed.d87.s736
1394,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ,AIMed.d87.s736
1395,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 beta and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 beta.,AIMed.d87.s736
1396,AIMed.d87,False,The results of his3 activation indicated that PROTEIN1 N + C-SH2 and C-SH2 interact with both PROTEIN2 beta and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ,AIMed.d87.s736
1397,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 beta and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 ,AIMed.d87.s736
1398,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 beta.,AIMed.d87.s736
1399,AIMed.d87,True,The results of his3 activation indicated that PROTEIN1 N + C-SH2 and C-SH2 interact with both PROTEIN2 and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN ,AIMed.d87.s736
1400,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN1 and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 ,AIMed.d87.s736
1401,AIMed.d87,False,The results of his3 activation indicated that PROTEIN1 N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 beta.,AIMed.d87.s736
1402,AIMed.d87,False,The results of his3 activation indicated that PROTEIN N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1 ,AIMed.d87.s736
1403,AIMed.d87,False,The results of his3 activation indicated that PROTEIN1 N + C-SH2 and C-SH2 interact with both PROTEIN and PROTEIN whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN2 ,AIMed.d87.s736
1404,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN ( PROTEIN or PROTEIN1 beta( PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1405,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN1 ( PROTEIN or PROTEIN2 beta( PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1406,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN ( PROTEIN1 or PROTEIN2 beta( PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1407,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN ( PROTEIN or PROTEIN1 beta( PROTEIN2 in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1408,AIMed.d87,False,"Interaction of PROTEIN1 and N+C-SH2 with PROTEIN ( PROTEIN or PROTEIN2 beta( PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1409,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN1 ( PROTEIN or PROTEIN2 PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1410,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN ( PROTEIN1 or PROTEIN2 PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1411,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN ( PROTEIN or PROTEIN1 PROTEIN2 in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1412,AIMed.d87,True,"Interaction of PROTEIN1 and N+C-SH2 with PROTEIN ( PROTEIN or PROTEIN2 PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1413,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN1 ( PROTEIN2 or PROTEIN beta( PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1414,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN1 ( PROTEIN or PROTEIN beta( PROTEIN2 in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1415,AIMed.d87,True,"Interaction of PROTEIN1 and N+C-SH2 with PROTEIN2 ( PROTEIN or PROTEIN beta( PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1416,AIMed.d87,False,"Interaction of PROTEIN and N+C-SH2 with PROTEIN ( PROTEIN1 or PROTEIN beta( PROTEIN2 in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1417,AIMed.d87,False,"Interaction of PROTEIN1 and N+C-SH2 with PROTEIN ( PROTEIN2 or PROTEIN beta( PROTEIN in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1418,AIMed.d87,False,"Interaction of PROTEIN1 and N+C-SH2 with PROTEIN ( PROTEIN or PROTEIN beta( PROTEIN2 in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.",AIMed.d87.s737
1419,AIMed.d87,False,The internal binding site thus revealed was not altered by further mutating Y960/F for PROTEIN1 or Y950/F for PROTEIN2 ,AIMed.d87.s738
1420,AIMed.d87,False,Activation of lacZ upon interaction of PROTEIN with PROTEIN1 PROTEIN was 4-fold less as compared to PROTEIN2 ,AIMed.d87.s739
1421,AIMed.d87,True,Activation of lacZ upon interaction of PROTEIN1 with PROTEIN PROTEIN was 4-fold less as compared to PROTEIN2 ,AIMed.d87.s739
1422,AIMed.d87,False,Activation of lacZ upon interaction of PROTEIN with PROTEIN PROTEIN1 was 4-fold less as compared to PROTEIN2 ,AIMed.d87.s739
1423,AIMed.d87,True,Activation of lacZ upon interaction of PROTEIN1 with PROTEIN2 PROTEIN was 4-fold less as compared to PROTEIN ,AIMed.d87.s739
1424,AIMed.d87,False,Activation of lacZ upon interaction of PROTEIN with PROTEIN1 PROTEIN2 was 4-fold less as compared to PROTEIN ,AIMed.d87.s739
1425,AIMed.d87,False,Activation of lacZ upon interaction of PROTEIN1 with PROTEIN PROTEIN2 was 4-fold less as compared to PROTEIN ,AIMed.d87.s739
1426,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 beta was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN2 ( PROTEIN ).,AIMed.d87.s740
1427,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 beta was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN2 ).,AIMed.d87.s740
1428,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 beta was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN2 beta ( PROTEIN ).,AIMed.d87.s740
1429,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 beta was 4-fold less as compared to PROTEIN2 and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN ).,AIMed.d87.s740
1430,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN ).,AIMed.d87.s740
1431,AIMed.d87,False,This activation with PROTEIN1 and PROTEIN2 beta was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN ).,AIMed.d87.s740
1432,AIMed.d87,False,This activation with PROTEIN and PROTEIN was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN1 ( PROTEIN2 ).,AIMed.d87.s740
1433,AIMed.d87,False,This activation with PROTEIN and PROTEIN was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN1 beta ( PROTEIN ).,AIMed.d87.s740
1434,AIMed.d87,False,This activation with PROTEIN and PROTEIN was 4-fold less as compared to PROTEIN1 and was somewhat increased (2-fold) for PROTEIN2 ( PROTEIN ).,AIMed.d87.s740
1435,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN2 ( PROTEIN ).,AIMed.d87.s740
1436,AIMed.d87,True,This activation with PROTEIN1 and PROTEIN was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN2 ( PROTEIN ).,AIMed.d87.s740
1437,AIMed.d87,False,This activation with PROTEIN and PROTEIN was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN1 beta ( PROTEIN2 ).,AIMed.d87.s740
1438,AIMed.d87,False,This activation with PROTEIN and PROTEIN was 4-fold less as compared to PROTEIN1 and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN2 ).,AIMed.d87.s740
1439,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN2 ).,AIMed.d87.s740
1440,AIMed.d87,False,This activation with PROTEIN1 and PROTEIN was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN2 ).,AIMed.d87.s740
1441,AIMed.d87,False,This activation with PROTEIN and PROTEIN was 4-fold less as compared to PROTEIN1 and was somewhat increased (2-fold) for PROTEIN2 beta ( PROTEIN ).,AIMed.d87.s740
1442,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN2 beta ( PROTEIN ).,AIMed.d87.s740
1443,AIMed.d87,False,This activation with PROTEIN1 and PROTEIN was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN2 beta ( PROTEIN ).,AIMed.d87.s740
1444,AIMed.d87,False,This activation with PROTEIN and PROTEIN1 was 4-fold less as compared to PROTEIN2 and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN ).,AIMed.d87.s740
1445,AIMed.d87,True,This activation with PROTEIN1 and PROTEIN was 4-fold less as compared to PROTEIN2 and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN ).,AIMed.d87.s740
1446,AIMed.d87,True,This activation with PROTEIN1 and PROTEIN2 was 4-fold less as compared to PROTEIN and was somewhat increased (2-fold) for PROTEIN beta ( PROTEIN ).,AIMed.d87.s740
1447,AIMed.d87,False,"Thus, the C-terminal domain in PROTEIN1 appears to exert a negative control on binding of PROTEIN thereby providing a possible regulatory mechanism for direct activation of the PROTEIN2 pathway.",AIMed.d87.s741
1448,AIMed.d87,False,"Thus, the C-terminal domain in PROTEIN appears to exert a negative control on binding of PROTEIN1 thereby providing a possible regulatory mechanism for direct activation of the PROTEIN2 pathway.",AIMed.d87.s741
1449,AIMed.d87,True,"Thus, the C-terminal domain in PROTEIN1 appears to exert a negative control on binding of PROTEIN2 thereby providing a possible regulatory mechanism for direct activation of the PROTEIN pathway.",AIMed.d87.s741
1450,AIMed.d89,True,The mitogenic effects of the PROTEIN1 are mediated through cell surface PROTEIN2 ,AIMed.d89.s753
1451,AIMed.d89,False,Immunoprecipitation experiments employing a polyclonal anti- PROTEIN1 antibody provided further evidence that the 60-kDa protein isolated in this study was PROTEIN2 ,AIMed.d89.s761
1452,AIMed.d89,False,"Further, polyclonal antibodies to human PROTEIN1 significantly inhibited the mitogenic activity of PROTEIN2 on human fibroblasts.",AIMed.d89.s762
1453,AIMed.d89,True,The present study has shown that cell surface PROTEIN1 binds to the PROTEIN2 mediating its mitogenic activity.,AIMed.d89.s763
1454,AIMed.d90,False,Multiple proteins physically interact with PROTEIN Transcriptional synergy with PROTEIN (C/ PROTEIN1 PROTEIN2 .,AIMed.d90.s764
1455,AIMed.d90,False,Multiple proteins physically interact with PROTEIN1 Transcriptional synergy with PROTEIN (C/ PROTEIN PROTEIN2 .,AIMed.d90.s764
1456,AIMed.d90,False,Multiple proteins physically interact with PROTEIN Transcriptional synergy with PROTEIN1 (C/ PROTEIN PROTEIN2 .,AIMed.d90.s764
1457,AIMed.d90,False,Multiple proteins physically interact with PROTEIN1 Transcriptional synergy with PROTEIN (C/ PROTEIN2 PROTEIN .,AIMed.d90.s764
1458,AIMed.d90,False,Multiple proteins physically interact with PROTEIN Transcriptional synergy with PROTEIN1 (C/ PROTEIN2 PROTEIN .,AIMed.d90.s764
1459,AIMed.d90,False,Multiple proteins physically interact with PROTEIN1 Transcriptional synergy with PROTEIN2 (C/ PROTEIN PROTEIN .,AIMed.d90.s764
1460,AIMed.d90,False,"Using radiolabeled PROTEIN1 protein as a probe, we screened a B cell cDNA expression library and isolated a number of clones encoding PROTEIN2 interacting proteins.",AIMed.d90.s767
1461,AIMed.d90,False,"Three of these clones encode DNA binding proteins ( PROTEIN1 PROTEIN2 and PROTEIN , one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.",AIMed.d90.s768
1462,AIMed.d90,False,"Three of these clones encode DNA binding proteins ( PROTEIN PROTEIN1 and PROTEIN2 , one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.",AIMed.d90.s768
1463,AIMed.d90,False,"Three of these clones encode DNA binding proteins ( PROTEIN1 PROTEIN and PROTEIN2 , one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.",AIMed.d90.s768
1464,AIMed.d90,True,We have characterized the physical and functional interactions between PROTEIN1 and PROTEIN2 a leucine zipper transcription factor implicated in inflammatory responses.,AIMed.d90.s769
1465,AIMed.d90,False,We found that deletion of the carboxyl-terminal 28 amino acids of PROTEIN1 disrupted PROTEIN2 PROTEIN physical interaction.,AIMed.d90.s770
1466,AIMed.d90,False,We found that deletion of the carboxyl-terminal 28 amino acids of PROTEIN1 disrupted PROTEIN PROTEIN2 physical interaction.,AIMed.d90.s770
1467,AIMed.d90,True,We found that deletion of the carboxyl-terminal 28 amino acids of PROTEIN disrupted PROTEIN1 PROTEIN2 physical interaction.,AIMed.d90.s770
1468,AIMed.d90,False,"In transient expression assays, we found that PROTEIN1 and PROTEIN2 can functionally cooperate to synergistically activate transcription.",AIMed.d90.s773
1469,AIMed.d90,False,"Electrophoretic mobility shift assays showed that PROTEIN1 and PROTEIN2 can simultaneously bind to adjacent DNA binding sites, but apparently do not influence the kinetics or affinity of each other's DNA binding.",AIMed.d90.s774
1470,AIMed.d91,False,Molecular cloning and expression of the 32-kDa subunit of human PROTEIN reveals interactions with PROTEIN1 and PROTEIN2 that mediate transcriptional activation.,AIMed.d91.s776
1471,AIMed.d91,False,Molecular cloning and expression of the 32-kDa subunit of human PROTEIN1 reveals interactions with PROTEIN2 and PROTEIN that mediate transcriptional activation.,AIMed.d91.s776
1472,AIMed.d91,False,Molecular cloning and expression of the 32-kDa subunit of human PROTEIN1 reveals interactions with PROTEIN and PROTEIN2 that mediate transcriptional activation.,AIMed.d91.s776
1473,AIMed.d91,False,Transcription factor PROTEIN consists of PROTEIN1 ( PROTEIN2 and at least eight PROTEIN associated factors (TAFs).,AIMed.d91.s777
1474,AIMed.d91,False,Transcription factor PROTEIN1 consists of PROTEIN2 ( PROTEIN and at least eight PROTEIN associated factors (TAFs).,AIMed.d91.s777
1475,AIMed.d91,False,Transcription factor PROTEIN consists of PROTEIN1 ( PROTEIN and at least eight PROTEIN2 associated factors (TAFs).,AIMed.d91.s777
1476,AIMed.d91,False,Transcription factor PROTEIN1 consists of PROTEIN ( PROTEIN2 and at least eight PROTEIN associated factors (TAFs).,AIMed.d91.s777
1477,AIMed.d91,False,Transcription factor PROTEIN consists of PROTEIN ( PROTEIN1 and at least eight PROTEIN2 associated factors (TAFs).,AIMed.d91.s777
1478,AIMed.d91,False,Transcription factor PROTEIN1 consists of PROTEIN ( PROTEIN and at least eight PROTEIN2 associated factors (TAFs).,AIMed.d91.s777
1479,AIMed.d91,False,"Here we report the cloning, expression, and biochemical characterization of the 32-kDa subunit of human (h) PROTEIN1 termed PROTEIN2 ",AIMed.d91.s779
1480,AIMed.d91,False,We find that PROTEIN1 is the human homologue of Drosophila PROTEIN2 ,AIMed.d91.s780
1481,AIMed.d91,True,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN PROTEIN1 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN ( PROTEIN as well as with the general transcription factor PROTEIN2 ,AIMed.d91.s781
1482,AIMed.d91,False,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN1 PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN ( PROTEIN as well as with the general transcription factor PROTEIN2 ,AIMed.d91.s781
1483,AIMed.d91,False,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN ( PROTEIN1 as well as with the general transcription factor PROTEIN2 ,AIMed.d91.s781
1484,AIMed.d91,False,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN1 ( PROTEIN as well as with the general transcription factor PROTEIN2 ,AIMed.d91.s781
1485,AIMed.d91,False,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN1 PROTEIN2 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN ( PROTEIN as well as with the general transcription factor PROTEIN ,AIMed.d91.s781
1486,AIMed.d91,True,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN PROTEIN1 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN ( PROTEIN2 as well as with the general transcription factor PROTEIN ,AIMed.d91.s781
1487,AIMed.d91,True,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN PROTEIN1 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN2 ( PROTEIN as well as with the general transcription factor PROTEIN ,AIMed.d91.s781
1488,AIMed.d91,False,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN1 PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN ( PROTEIN2 as well as with the general transcription factor PROTEIN ,AIMed.d91.s781
1489,AIMed.d91,False,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN1 PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN2 ( PROTEIN as well as with the general transcription factor PROTEIN ,AIMed.d91.s781
1490,AIMed.d91,False,In vitro protein-protein interaction assays reveal that as observed with Drosophila PROTEIN PROTEIN interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator PROTEIN1 ( PROTEIN2 as well as with the general transcription factor PROTEIN ,AIMed.d91.s781
1491,AIMed.d91,False,"Moreover, a partial recombinant PROTEIN complex containing PROTEIN1 was capable of mediating in vitro transcriptional activation by the PROTEIN2 activation domain.",AIMed.d91.s782
1492,AIMed.d91,False,"Moreover, a partial recombinant PROTEIN1 complex containing PROTEIN was capable of mediating in vitro transcriptional activation by the PROTEIN2 activation domain.",AIMed.d91.s782
1493,AIMed.d91,False,"Moreover, a partial recombinant PROTEIN1 complex containing PROTEIN2 was capable of mediating in vitro transcriptional activation by the PROTEIN activation domain.",AIMed.d91.s782
1494,AIMed.d92,False,A potential interaction of PROTEIN and PROTEIN1 PROTEIN2 receptors revealed by affinity crosslinking and immunoprecipitation.,AIMed.d92.s784
1495,AIMed.d92,False,A potential interaction of PROTEIN1 and PROTEIN PROTEIN2 receptors revealed by affinity crosslinking and immunoprecipitation.,AIMed.d92.s784
1496,AIMed.d92,False,A potential interaction of PROTEIN1 and PROTEIN2 PROTEIN receptors revealed by affinity crosslinking and immunoprecipitation.,AIMed.d92.s784
1497,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN neurotro PROTEIN1 receptor and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 ",AIMed.d92.s785
1498,AIMed.d92,False," PROTEIN1 binds independently to two transmembrane receptors, the PROTEIN neurotrophin receptor and the PROTEIN ( PROTEIN2 tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1499,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, PROTEIN2 PROTEIN1 and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1500,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN1 neurotro PROTEIN2 receptor and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1501,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN neurotrop PROTEIN2 eceptor and the PROTEIN1 which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1502,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN neurotrophin receptor and the PROTEIN1 ( PROTEIN2 tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1503,AIMed.d92,False," PROTEIN1 binds independently to two transmembrane receptors, the PROTEIN neurotro PROTEIN receptor and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 ",AIMed.d92.s785
1504,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, PROTEIN PROTEIN1 and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 ",AIMed.d92.s785
1505,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN1 neurotro PROTEIN receptor and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 ",AIMed.d92.s785
1506,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN neurotrop PROTEIN eceptor and the PROTEIN1 which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 ",AIMed.d92.s785
1507,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN neurotrophin receptor and the PROTEIN1 ( PROTEIN tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 ",AIMed.d92.s785
1508,AIMed.d92,True," PROTEIN1 binds independently to two transmembrane receptors, PROTEIN PROTEIN2 and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1509,AIMed.d92,False," PROTEIN1 binds independently to two transmembrane receptors, the PROTEIN2 neurotro PROTEIN receptor and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1510,AIMed.d92,True," PROTEIN1 binds independently to two transmembrane receptors, the PROTEIN neurotrop PROTEIN eceptor and the PROTEIN2 which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1511,AIMed.d92,False," PROTEIN1 binds independently to two transmembrane receptors, the PROTEIN neurotrophin receptor and the PROTEIN2 ( PROTEIN tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1512,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN1 neurotro PROTEIN receptor and the PROTEIN which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1513,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, t PROTEIN ROTEIN1 and the PROTEIN2 which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1514,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN1 and the PROTEIN2 ( PROTEIN tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1515,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN1 neurotrop PROTEIN eceptor and the PROTEIN2 which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1516,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN1 neurotrophin receptor and the PROTEIN2 ( PROTEIN tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1517,AIMed.d92,False," PROTEIN binds independently to two transmembrane receptors, the PROTEIN neurotrophin receptor and the PROTEIN1 ( PROTEIN tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to PROTEIN ",AIMed.d92.s785
1518,AIMed.d92,False,Here we have utilized affinity crosslinking agents with 125I-NGF to detect an association of PROTEIN1 and PROTEIN2 receptors in embryonic spinal cord and brain tissues enriched in the two receptors.,AIMed.d92.s787
1519,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN1 receptor complexes with PROTEIN2 specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1520,AIMed.d92,False,"Although multimeric complexes of PROTEIN1 and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN complexes with PROTEIN2 specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1521,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN1 complexes with PROTEIN2 specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1522,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN1 were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN complexes with PROTEIN2 specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1523,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN complexes with PROTEIN1 specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 ",AIMed.d92.s788
1524,AIMed.d92,False,"Although multimeric complexes of PROTEIN1 and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN2 receptor complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1525,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN1 complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1526,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN1 were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN2 receptor complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1527,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN1 receptor complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 ",AIMed.d92.s788
1528,AIMed.d92,False,"Although multimeric complexes of PROTEIN1 and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN2 complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1529,AIMed.d92,False,"Although multimeric complexes of PROTEIN1 and PROTEIN2 were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN receptor complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1530,AIMed.d92,False,"Although multimeric complexes of PROTEIN1 and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN receptor complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 ",AIMed.d92.s788
1531,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN1 were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN2 complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN ",AIMed.d92.s788
1532,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN1 complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 ",AIMed.d92.s788
1533,AIMed.d92,False,"Although multimeric complexes of PROTEIN and PROTEIN1 were not detected by affinity crosslinking, immunoprecipitation of cross-linked PROTEIN receptor complexes with PROTEIN specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 ",AIMed.d92.s788
1534,AIMed.d92,False,"Our results indicate that the PROTEIN1 and PROTEIN receptors can potentially interact, and that such an association may be responsible for the generation of high affinity PROTEIN2 binding sites.",AIMed.d92.s789
1535,AIMed.d92,False,"Our results indicate that the PROTEIN and PROTEIN1 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity PROTEIN2 binding sites.",AIMed.d92.s789
1536,AIMed.d92,False,"Our results indicate that the PROTEIN1 and PROTEIN2 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity PROTEIN binding sites.",AIMed.d92.s789
1537,AIMed.d94,False,"Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN1 regulated on activation, normal T expressed and secreted ( PROTEIN2 , and PROTEIN ( PROTEIN , but the receptors involved have not been defined.",AIMed.d94.s796
1538,AIMed.d94,False,"Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN1 regulated on activation, normal T expressed and secreted ( PROTEIN , and PROTEIN ( PROTEIN2 , but the receptors involved have not been defined.",AIMed.d94.s796
1539,AIMed.d94,False,"Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN1 regulated on activation, normal T expressed and secreted ( PROTEIN , and PROTEIN2 ( PROTEIN , but the receptors involved have not been defined.",AIMed.d94.s796
1540,AIMed.d94,False,"Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN regulated on activation, normal T expressed and secreted ( PROTEIN1 , and PROTEIN ( PROTEIN2 , but the receptors involved have not been defined.",AIMed.d94.s796
1541,AIMed.d94,False,"Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN regulated on activation, normal T expressed and secreted ( PROTEIN1 , and PROTEIN2 ( PROTEIN , but the receptors involved have not been defined.",AIMed.d94.s796
1542,AIMed.d94,False,"Eosinophils undergo chemotaxis, degranulate, and exhibit [C2+]i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN regulated on activation, normal T expressed and secreted ( PROTEIN , and PROTEIN1 ( PROTEIN2 , but the receptors involved have not been defined.",AIMed.d94.s796
1543,AIMed.d94,False,"We have isolated a human cDNA encoding the first eosinophil-selective chemokine receptor, designated PROTEIN1 ( PROTEIN2 .",AIMed.d94.s797
1544,AIMed.d94,False, PROTEIN1 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor PROTEIN2 (also known as the PROTEIN PROTEIN receptor).,AIMed.d94.s798
1545,AIMed.d94,False, PROTEIN is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor PROTEIN1 (also known as the PROTEIN PROTEIN2 receptor).,AIMed.d94.s798
1546,AIMed.d94,False, PROTEIN is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor PROTEIN1 (also known as the PROTEIN2 PROTEIN receptor).,AIMed.d94.s798
1547,AIMed.d94,False, PROTEIN1 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor PROTEIN (also known as the PROTEIN PROTEIN2 receptor).,AIMed.d94.s798
1548,AIMed.d94,False, PROTEIN1 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor PROTEIN (also known as the PROTEIN2 PROTEIN receptor).,AIMed.d94.s798
1549,AIMed.d94,False, PROTEIN is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor PROTEIN (also known as the PROTEIN1 PROTEIN2 receptor).,AIMed.d94.s798
1550,AIMed.d94,False,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN1 PROTEIN and PROTEIN2 were both potent agonists for PROTEIN and PROTEIN ",AIMed.d94.s799
1551,AIMed.d94,False,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN1 PROTEIN2 and PROTEIN were both potent agonists for PROTEIN and PROTEIN ",AIMed.d94.s799
1552,AIMed.d94,True,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN1 PROTEIN and PROTEIN were both potent agonists for PROTEIN and PROTEIN2 ",AIMed.d94.s799
1553,AIMed.d94,True,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN1 PROTEIN and PROTEIN were both potent agonists for PROTEIN2 and PROTEIN ",AIMed.d94.s799
1554,AIMed.d94,False,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN PROTEIN1 and PROTEIN2 were both potent agonists for PROTEIN and PROTEIN ",AIMed.d94.s799
1555,AIMed.d94,True,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN PROTEIN and PROTEIN1 were both potent agonists for PROTEIN and PROTEIN2 ",AIMed.d94.s799
1556,AIMed.d94,True,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN PROTEIN and PROTEIN1 were both potent agonists for PROTEIN2 and PROTEIN ",AIMed.d94.s799
1557,AIMed.d94,False,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN PROTEIN1 and PROTEIN were both potent agonists for PROTEIN and PROTEIN2 ",AIMed.d94.s799
1558,AIMed.d94,False,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN PROTEIN1 and PROTEIN were both potent agonists for PROTEIN2 and PROTEIN ",AIMed.d94.s799
1559,AIMed.d94,False,"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, PROTEIN PROTEIN and PROTEIN were both potent agonists for PROTEIN1 and PROTEIN2 ",AIMed.d94.s799
1560,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN1 but not PROTEIN2 PROTEIN was an agonist for PROTEIN but not PROTEIN ",AIMed.d94.s800
1561,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN but not PROTEIN1 PROTEIN was an agonist for PROTEIN2 but not PROTEIN ",AIMed.d94.s800
1562,AIMed.d94,False,"However, PROTEIN1 was also an agonist for PROTEIN but not PROTEIN2 PROTEIN was an agonist for PROTEIN but not PROTEIN ",AIMed.d94.s800
1563,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN but not PROTEIN1 PROTEIN2 was an agonist for PROTEIN but not PROTEIN ",AIMed.d94.s800
1564,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN but not PROTEIN1 PROTEIN was an agonist for PROTEIN but not PROTEIN2 ",AIMed.d94.s800
1565,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN1 but not PROTEIN PROTEIN was an agonist for PROTEIN2 but not PROTEIN ",AIMed.d94.s800
1566,AIMed.d94,True,"However, PROTEIN1 was also an agonist for PROTEIN2 but not PROTEIN PROTEIN was an agonist for PROTEIN but not PROTEIN ",AIMed.d94.s800
1567,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN1 but not PROTEIN PROTEIN2 was an agonist for PROTEIN but not PROTEIN ",AIMed.d94.s800
1568,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN1 but not PROTEIN PROTEIN was an agonist for PROTEIN but not PROTEIN2 ",AIMed.d94.s800
1569,AIMed.d94,False,"However, PROTEIN1 was also an agonist for PROTEIN but not PROTEIN PROTEIN was an agonist for PROTEIN2 but not PROTEIN ",AIMed.d94.s800
1570,AIMed.d94,True,"However, PROTEIN was also an agonist for PROTEIN but not PROTEIN PROTEIN1 was an agonist for PROTEIN2 but not PROTEIN ",AIMed.d94.s800
1571,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN but not PROTEIN PROTEIN was an agonist for PROTEIN1 but not PROTEIN2 ",AIMed.d94.s800
1572,AIMed.d94,False,"However, PROTEIN1 was also an agonist for PROTEIN but not PROTEIN PROTEIN2 was an agonist for PROTEIN but not PROTEIN ",AIMed.d94.s800
1573,AIMed.d94,False,"However, PROTEIN1 was also an agonist for PROTEIN but not PROTEIN PROTEIN was an agonist for PROTEIN but not PROTEIN2 ",AIMed.d94.s800
1574,AIMed.d94,False,"However, PROTEIN was also an agonist for PROTEIN but not PROTEIN PROTEIN1 was an agonist for PROTEIN but not PROTEIN2 ",AIMed.d94.s800
1575,AIMed.d95,True,Mechanism of CDK activation revealed by the structure of a PROTEIN1 PROTEIN2 complex.,AIMed.d95.s802
1576,AIMed.d95,True,The crystal structure of the human PROTEIN1 PROTEIN2 ( PROTEIN -ATP complex has been determined at 2.3 A resolution.,AIMed.d95.s803
1577,AIMed.d95,False,The crystal structure of the human PROTEIN PROTEIN1 ( PROTEIN2 -ATP complex has been determined at 2.3 A resolution.,AIMed.d95.s803
1578,AIMed.d95,True,The crystal structure of the human PROTEIN1 PROTEIN ( PROTEIN2 -ATP complex has been determined at 2.3 A resolution.,AIMed.d95.s803
1579,AIMed.d96,True,"It binds homophilically, i.e., PROTEIN1 on the surface of one cell binds to PROTEIN2 on an apposing cell, and the binding site lies within the immunoglobulin domain.",AIMed.d96.s808
1580,AIMed.d96,False,"In this article, we demonstrate that PROTEIN1 associates with a complex containing PROTEIN2 and PROTEIN in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.",AIMed.d96.s811
1581,AIMed.d96,False,"In this article, we demonstrate that PROTEIN associates with a complex containing PROTEIN1 and PROTEIN2 in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.",AIMed.d96.s811
1582,AIMed.d96,True,"In this article, we demonstrate that PROTEIN1 associates with a complex containing PROTEIN and PROTEIN2 in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.",AIMed.d96.s811
1583,AIMed.d96,True,In vitro binding studies demonstrated that the intracellular segment of PROTEIN1 binds directly to the intracellular domain of PROTEIN2 but not to alpha- or PROTEIN ,AIMed.d96.s813
1584,AIMed.d96,False,In vitro binding studies demonstrated that the intracellular segment of PROTEIN binds directly to the intracellular domain of PROTEIN1 but not to alpha- or PROTEIN2 ,AIMed.d96.s813
1585,AIMed.d96,False,In vitro binding studies demonstrated that the intracellular segment of PROTEIN1 binds directly to the intracellular domain of PROTEIN but not to alpha- or PROTEIN2 ,AIMed.d96.s813
1586,AIMed.d96,False,"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including PROTEIN1 the cadherins associated with PROTEIN2 are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for PROTEIN ",AIMed.d96.s815
1587,AIMed.d96,False,"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including PROTEIN the cadherins associated with PROTEIN1 are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for PROTEIN2 ",AIMed.d96.s815
1588,AIMed.d96,False,"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including PROTEIN1 the cadherins associated with PROTEIN are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for PROTEIN2 ",AIMed.d96.s815
1589,AIMed.d97,False,"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs ( PROTEIN1 , which is distantly related to PROTEIN a PROTEIN2 from Caenorhabditis elegans.",AIMed.d97.s820
1590,AIMed.d97,False,"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs ( PROTEIN1 , which is distantly related to PROTEIN2 a PROTEIN from Caenorhabditis elegans.",AIMed.d97.s820
1591,AIMed.d97,False,"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs ( PROTEIN , which is distantly related to PROTEIN1 a PROTEIN2 from Caenorhabditis elegans.",AIMed.d97.s820
1592,AIMed.d97,False,"In transfected COS-1 cells, PROTEIN1 PROTEIN and less efficiently PROTEIN2 bound to PROTEIN ",AIMed.d97.s821
1593,AIMed.d97,True,"In transfected COS-1 cells, PROTEIN PROTEIN and less efficiently PROTEIN1 bound to PROTEIN2 ",AIMed.d97.s821
1594,AIMed.d97,False,"In transfected COS-1 cells, PROTEIN PROTEIN1 and less efficiently PROTEIN2 bound to PROTEIN ",AIMed.d97.s821
1595,AIMed.d97,True,"In transfected COS-1 cells, PROTEIN1 PROTEIN and less efficiently PROTEIN bound to PROTEIN2 ",AIMed.d97.s821
1596,AIMed.d97,False,"In transfected COS-1 cells, PROTEIN1 PROTEIN2 and less efficiently PROTEIN bound to PROTEIN ",AIMed.d97.s821
1597,AIMed.d97,True,"In transfected COS-1 cells, PROTEIN PROTEIN1 and less efficiently PROTEIN bound to PROTEIN2 ",AIMed.d97.s821
1598,AIMed.d97,False,Binding of PROTEIN1 PROTEIN2 to PROTEIN was also observed in nontransfected cell lines.,AIMed.d97.s823
1599,AIMed.d97,True,Binding of PROTEIN1 PROTEIN to PROTEIN2 was also observed in nontransfected cell lines.,AIMed.d97.s823
1600,AIMed.d97,True,Binding of PROTEIN PROTEIN1 to PROTEIN2 was also observed in nontransfected cell lines.,AIMed.d97.s823
1601,AIMed.d97,True,"Moreover, a transcriptional activation signal was transduced by PROTEIN1 in the presence of type I receptors after stimulation by PROTEIN PROTEIN2 ",AIMed.d97.s824
1602,AIMed.d97,False,"Moreover, a transcriptional activation signal was transduced by PROTEIN in the presence of type I receptors after stimulation by PROTEIN1 PROTEIN2 ",AIMed.d97.s824
1603,AIMed.d97,True,"Moreover, a transcriptional activation signal was transduced by PROTEIN1 in the presence of type I receptors after stimulation by PROTEIN2 PROTEIN ",AIMed.d97.s824
1604,AIMed.d98,True," PROTEIN1 which is known to bind 14-3-3 proteins, has recently been shown to associate with PROTEIN2 and to stimulate its phosphatase activity.",AIMed.d98.s832
1605,AIMed.d98,False,"14-3-3 protein, however, has no effect on the PROTEIN1 kinase activity of PROTEIN2 ",AIMed.d98.s833
1606,AIMed.d98,True,"Instead, 14-3-3 may facilitate the association of PROTEIN1 with PROTEIN2 in vivo, participating in the linkage between mitogenic signaling and the cell cycle machinery.",AIMed.d98.s834
1607,AIMed.d99,False,"The cloned PROTEIN1 gene encodes a member of a protein family that includes the yeast PROTEIN protein, a component of the transcriptional regulator PROTEIN2 PROTEIN ",AIMed.d99.s838
1608,AIMed.d99,False,"The cloned PROTEIN1 gene encodes a member of a protein family that includes the yeast PROTEIN2 protein, a component of the transcriptional regulator PROTEIN PROTEIN ",AIMed.d99.s838
1609,AIMed.d99,False,"The cloned PROTEIN1 gene encodes a member of a protein family that includes the yeast PROTEIN protein, a component of the transcriptional regulator PROTEIN PROTEIN2 ",AIMed.d99.s838
1610,AIMed.d99,False,"The cloned PROTEIN gene encodes a member of a protein family that includes the yeast PROTEIN1 protein, a component of the transcriptional regulator PROTEIN2 PROTEIN ",AIMed.d99.s838
1611,AIMed.d99,False,"The cloned PROTEIN gene encodes a member of a protein family that includes the yeast PROTEIN protein, a component of the transcriptional regulator PROTEIN1 PROTEIN2 ",AIMed.d99.s838
1612,AIMed.d99,False,"The cloned PROTEIN gene encodes a member of a protein family that includes the yeast PROTEIN1 protein, a component of the transcriptional regulator PROTEIN PROTEIN2 ",AIMed.d99.s838
1613,AIMed.d99,False," PROTEIN protein interacts with PROTEIN1 protein and with PROTEIN2 protein, a subunit of the human RNA polymerase II transcription factor IIH.",AIMed.d99.s841
1614,AIMed.d99,True," PROTEIN1 protein interacts with PROTEIN2 protein and with PROTEIN protein, a subunit of the human RNA polymerase II transcription factor IIH.",AIMed.d99.s841
1615,AIMed.d99,True," PROTEIN1 protein interacts with PROTEIN protein and with PROTEIN2 protein, a subunit of the human RNA polymerase II transcription factor IIH.",AIMed.d99.s841
1616,AIMed.d99,False,These observations suggest that the products of the PROTEIN1 and PROTEIN2 genes are involved in transcription.,AIMed.d99.s842
1617,AIMed.d100,False,Biochemical studies established that some coactivators are associated with the PROTEIN1 ( PROTEIN2 to form the PROTEIN complex.,AIMed.d100.s846
1618,AIMed.d100,False,Biochemical studies established that some coactivators are associated with the PROTEIN1 ( PROTEIN to form the PROTEIN2 complex.,AIMed.d100.s846
1619,AIMed.d100,False,Biochemical studies established that some coactivators are associated with the PROTEIN ( PROTEIN1 to form the PROTEIN2 complex.,AIMed.d100.s846
1620,AIMed.d100,False,"The PROTEIN1 gene is identical to a gene, PROTEIN2 (ref 7,8), implicated in cell-cycle progression.",AIMed.d100.s849
1621,AIMed.d100,False,"Recombinant PROTEIN binds directly to PROTEIN1 both in vitro and in yeast, and participates in the formation of the PROTEIN2 complex.",AIMed.d100.s850
1622,AIMed.d100,True,"Recombinant PROTEIN1 binds directly to PROTEIN2 both in vitro and in yeast, and participates in the formation of the PROTEIN complex.",AIMed.d100.s850
1623,AIMed.d100,False,"Recombinant PROTEIN1 binds directly to PROTEIN both in vitro and in yeast, and participates in the formation of the PROTEIN2 complex.",AIMed.d100.s850
1624,AIMed.d100,False,"This largest TAF may therefore play a central role in PROTEIN1 assembly by interacting with both PROTEIN2 and other TAFs, as well as serving to link the control of transcription to the cell cycle.",AIMed.d100.s851
1625,AIMed.d101,True,The bZIP domains of PROTEIN1 and PROTEIN mediate a physical association with the PROTEIN2 ,AIMed.d101.s852
1626,AIMed.d101,True,The bZIP domains of PROTEIN and PROTEIN1 mediate a physical association with the PROTEIN2 ,AIMed.d101.s852
1627,AIMed.d101,False,The bZIP domains of PROTEIN1 and PROTEIN2 mediate a physical association with the PROTEIN ,AIMed.d101.s852
1628,AIMed.d101,True, PROTEIN1 and PROTEIN2 oncoproteins form a complex that regulates transcription from promoters containing AP-1 binding sites.,AIMed.d101.s853
1629,AIMed.d101,False,"The ability of PROTEIN1 and PROTEIN2 proteins to interact directly with the PROTEIN ( PROTEIN , the general transcription factor required for initiating the assembly of transcription complexes, was investigated.",AIMed.d101.s855
1630,AIMed.d101,True,"The ability of PROTEIN1 and PROTEIN proteins to interact directly with the PROTEIN2 ( PROTEIN , the general transcription factor required for initiating the assembly of transcription complexes, was investigated.",AIMed.d101.s855
1631,AIMed.d101,True,"The ability of PROTEIN1 and PROTEIN proteins to interact directly with the PROTEIN ( PROTEIN2 , the general transcription factor required for initiating the assembly of transcription complexes, was investigated.",AIMed.d101.s855
1632,AIMed.d101,True,"The ability of PROTEIN and PROTEIN1 proteins to interact directly with the PROTEIN2 ( PROTEIN , the general transcription factor required for initiating the assembly of transcription complexes, was investigated.",AIMed.d101.s855
1633,AIMed.d101,True,"The ability of PROTEIN and PROTEIN1 proteins to interact directly with the PROTEIN ( PROTEIN2 , the general transcription factor required for initiating the assembly of transcription complexes, was investigated.",AIMed.d101.s855
1634,AIMed.d101,False,"The ability of PROTEIN and PROTEIN proteins to interact directly with the PROTEIN1 ( PROTEIN2 , the general transcription factor required for initiating the assembly of transcription complexes, was investigated.",AIMed.d101.s855
1635,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN1 and PROTEIN bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN2 are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1636,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN bind specifically and stably to PROTEIN1 Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN2 are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1637,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN1 bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN2 are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1638,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN1 and PROTEIN2 are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1639,AIMed.d101,True,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN1 are necessary and sufficient for stable association with PROTEIN2 ",AIMed.d101.s856
1640,AIMed.d101,True,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN1 and PROTEIN bind specifically and stably to PROTEIN2 Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1641,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN1 and PROTEIN2 bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1642,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN1 and PROTEIN bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN2 and PROTEIN are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1643,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN1 and PROTEIN bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN are necessary and sufficient for stable association with PROTEIN2 ",AIMed.d101.s856
1644,AIMed.d101,True,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN1 bind specifically and stably to PROTEIN2 Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1645,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN bind specifically and stably to PROTEIN1 Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN2 and PROTEIN are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1646,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN bind specifically and stably to PROTEIN1 Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN are necessary and sufficient for stable association with PROTEIN2 ",AIMed.d101.s856
1647,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN1 bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN2 and PROTEIN are necessary and sufficient for stable association with PROTEIN ",AIMed.d101.s856
1648,AIMed.d101,False,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN1 bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN and PROTEIN are necessary and sufficient for stable association with PROTEIN2 ",AIMed.d101.s856
1649,AIMed.d101,True,"Using co-immunoprecipitation and protein-protein association assays, we show that both PROTEIN and PROTEIN bind specifically and stably to PROTEIN Mutational analysis demonstrates that both the basic region and leucine zipper domains of PROTEIN1 and PROTEIN are necessary and sufficient for stable association with PROTEIN2 ",AIMed.d101.s856
1650,AIMed.d101,True,A 51-residue region from the conserved C-terminal region of PROTEIN1 previously shown to be the binding site for the viral activator protein PROTEIN2 interacts with PROTEIN and PROTEIN proteins.,AIMed.d101.s857
1651,AIMed.d101,False,A 51-residue region from the conserved C-terminal region of PROTEIN previously shown to be the binding site for the viral activator protein PROTEIN1 interacts with PROTEIN2 and PROTEIN proteins.,AIMed.d101.s857
1652,AIMed.d101,False,A 51-residue region from the conserved C-terminal region of PROTEIN previously shown to be the binding site for the viral activator protein PROTEIN1 interacts with PROTEIN and PROTEIN2 proteins.,AIMed.d101.s857
1653,AIMed.d101,True,A 51-residue region from the conserved C-terminal region of PROTEIN1 previously shown to be the binding site for the viral activator protein PROTEIN interacts with PROTEIN2 and PROTEIN proteins.,AIMed.d101.s857
1654,AIMed.d101,True,A 51-residue region from the conserved C-terminal region of PROTEIN1 previously shown to be the binding site for the viral activator protein PROTEIN interacts with PROTEIN and PROTEIN2 proteins.,AIMed.d101.s857
1655,AIMed.d101,False,A 51-residue region from the conserved C-terminal region of PROTEIN previously shown to be the binding site for the viral activator protein PROTEIN interacts with PROTEIN1 and PROTEIN2 proteins.,AIMed.d101.s857
1656,AIMed.d101,False,"We propose that PROTEIN1 and PROTEIN2 proteins function as transcriptional activators, in part by recruiting PROTEIN to form complexes to initiate RNA synthesis.",AIMed.d101.s858
1657,AIMed.d101,True,"We propose that PROTEIN1 and PROTEIN proteins function as transcriptional activators, in part by recruiting PROTEIN2 to form complexes to initiate RNA synthesis.",AIMed.d101.s858
1658,AIMed.d101,True,"We propose that PROTEIN and PROTEIN1 proteins function as transcriptional activators, in part by recruiting PROTEIN2 to form complexes to initiate RNA synthesis.",AIMed.d101.s858
1659,AIMed.d102,True,The PROTEIN1 susceptibility gene product binds directly to the human PROTEIN PROTEIN2 ,AIMed.d102.s859
1660,AIMed.d102,False,The PROTEIN1 susceptibility gene product binds directly to the human PROTEIN2 PROTEIN ,AIMed.d102.s859
1661,AIMed.d102,False,The PROTEIN1 susceptibility gene product binds directly to the human PROTEIN2 associated factor PROTEIN ,AIMed.d102.s859
1662,AIMed.d102,False,The PROTEIN susceptibility gene product binds directly to the human PROTEIN1 PROTEIN2 ,AIMed.d102.s859
1663,AIMed.d102,False,The PROTEIN susceptibility gene product binds directly to the human PROTEIN1 associated factor PROTEIN2 ,AIMed.d102.s859
1664,AIMed.d102,False,The PROTEIN susceptibility gene product binds directly to the human PROTEIN1 PROTEIN ,AIMed.d102.s859
1665,AIMed.d102,False," PROTEIN1 the protein product of the PROTEIN2 tumor-suppressor gene, regulates the activity of specific transcription factors.",AIMed.d102.s860
1666,AIMed.d102,False,Here we report that stimulation of PROTEIN1 mediated transcription by PROTEIN2 is partially abrogated at the nonpermissive temperature in ts13 cells.,AIMed.d102.s862
1667,AIMed.d102,False,These cells contain a temperature-sensitive mutation in the PROTEIN associated factor PROTEIN1 first identified as the cell cycle regulatory protein PROTEIN2 ,AIMed.d102.s863
1668,AIMed.d102,False,These cells contain a temperature-sensitive mutation in the PROTEIN1 PROTEIN first identified as the cell cycle regulatory protein PROTEIN2 ,AIMed.d102.s863
1669,AIMed.d102,False,These cells contain a temperature-sensitive mutation in the PROTEIN1 associated factor PROTEIN first identified as the cell cycle regulatory protein PROTEIN2 ,AIMed.d102.s863
1670,AIMed.d102,False,These cells contain a temperature-sensitive mutation in the PROTEIN1 PROTEIN2 first identified as the cell cycle regulatory protein PROTEIN ,AIMed.d102.s863
1671,AIMed.d102,False,These cells contain a temperature-sensitive mutation in the PROTEIN1 associated factor PROTEIN2 first identified as the cell cycle regulatory protein PROTEIN ,AIMed.d102.s863
1672,AIMed.d102,False,These cells contain a temperature-sensitive mutation in the PROTEIN1 associated factor PROTEIN first identified as the cell cycle regulatory protein PROTEIN ,AIMed.d102.s863
1673,AIMed.d102,False,The stimulation of PROTEIN mediated transcription by PROTEIN1 in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human PROTEIN2 ,AIMed.d102.s864
1674,AIMed.d102,False,The stimulation of PROTEIN1 mediated transcription by PROTEIN in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human PROTEIN2 ,AIMed.d102.s864
1675,AIMed.d102,False,The stimulation of PROTEIN1 mediated transcription by PROTEIN2 in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human PROTEIN ,AIMed.d102.s864
1676,AIMed.d102,True,"Furthermore, we demonstrate that PROTEIN1 binds directly to PROTEIN2 in vitro and in vivo.",AIMed.d102.s865
1677,AIMed.d102,True,These results suggest that PROTEIN1 can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with PROTEIN in particular with PROTEIN2 ,AIMed.d102.s866
1678,AIMed.d102,False,These results suggest that PROTEIN can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with PROTEIN1 in particular with PROTEIN2 ,AIMed.d102.s866
1679,AIMed.d102,False,These results suggest that PROTEIN1 can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with PROTEIN2 in particular with PROTEIN ,AIMed.d102.s866
1680,AIMed.d103,True,Cloning and characterization of PROTEIN PROTEIN1 and PROTEIN2 three subunits of the human transcription factor PROTEIN ,AIMed.d103.s867
1681,AIMed.d103,False,Cloning and characterization of PROTEIN PROTEIN1 and PROTEIN three subunits of the human transcription factor PROTEIN2 ,AIMed.d103.s867
1682,AIMed.d103,True,Cloning and characterization of PROTEIN1 PROTEIN2 and PROTEIN three subunits of the human transcription factor PROTEIN ,AIMed.d103.s867
1683,AIMed.d103,False,Cloning and characterization of PROTEIN PROTEIN and PROTEIN1 three subunits of the human transcription factor PROTEIN2 ,AIMed.d103.s867
1684,AIMed.d103,True,Cloning and characterization of PROTEIN1 PROTEIN and PROTEIN2 three subunits of the human transcription factor PROTEIN ,AIMed.d103.s867
1685,AIMed.d103,False,Cloning and characterization of PROTEIN1 PROTEIN and PROTEIN three subunits of the human transcription factor PROTEIN2 ,AIMed.d103.s867
1686,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1687,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN2 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1688,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN2 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1689,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1690,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1691,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN2 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1692,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN2 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1693,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN2 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1694,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN2 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1695,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1696,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1697,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1698,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1699,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1700,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1701,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN2 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1702,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN1 ( PROTEIN2 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1703,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1704,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1705,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1706,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN1 ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1707,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1708,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1709,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1710,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1711,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 alpha and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1712,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1713,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1714,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 alpha and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1715,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1716,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1717,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1718,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 alpha and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1719,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN2 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1720,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1721,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1722,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN2 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1723,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN2 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1724,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN2 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1725,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN2 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1726,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1727,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1728,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1729,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1730,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1731,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1732,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN1 and PROTEIN PROTEIN is a core PROTEIN2 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1733,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN2 and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1734,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1735,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1736,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN2 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1737,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN2 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1738,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN2 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1739,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN2 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1740,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1741,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1742,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1743,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1744,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1745,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1746,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN1 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN2 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1747,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN2 complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1748,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN1 ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1749,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1750,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1751,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1752,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1753,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1754,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1755,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1756,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1757,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1758,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN1 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1759,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1760,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN2 and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1761,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1762,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1763,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1764,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1765,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN1 ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1766,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN1 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1767,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN1 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1768,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN1 ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1769,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN1 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1770,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN1 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1771,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1772,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN2 ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1773,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN2 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1774,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN2 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1775,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN2 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1776,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1777,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1778,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1779,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1780,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1781,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1782,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN1 is a core PROTEIN2 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1783,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN2 is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1784,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN2 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1785,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN2 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1786,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1787,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1788,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1789,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1790,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1791,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1792,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN1 PROTEIN is a core PROTEIN2 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1793,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN2 PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1794,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN2 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1795,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1796,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1797,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1798,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1799,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1800,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN1 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1801,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN2 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1802,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN2 species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1803,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1804,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1805,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1806,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1807,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1808,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1809,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN1 PROTEIN and PROTEIN PROTEIN is a core PROTEIN2 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1810,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN2 PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1811,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1812,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1813,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1814,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1815,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1816,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1817,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1818,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN1 which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1819,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1820,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN1 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1821,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN1 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1822,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1823,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN2 but has no known Drosophila counterpart.",AIMed.d103.s868
1824,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1825,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN1 is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1826,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN1 PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1827,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1828,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN2 which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1829,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1830,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN1 beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1831,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1832,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN2 beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1833,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN1 PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1834,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1835,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN2 is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1836,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN1 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1837,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN2 PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1838,AIMed.d103,False,"We have cloned cDNAs encoding three novel TAFIIs [ PROTEIN ( PROTEIN1 -associated factors] from the human (h) HeLa cell PROTEIN complexes PROTEIN PROTEIN and PROTEIN PROTEIN is a core PROTEIN2 present in both of the previously described PROTEIN species which either lack or contain PROTEIN ( PROTEIN and PROTEIN beta respectively), and is the homologue of Drosophila (d) PROTEIN PROTEIN is a novel PROTEIN which shows homology to the N-terminal region of the yeast PROTEIN but has no known Drosophila counterpart.",AIMed.d103.s868
1839,AIMed.d103,False,In contrast to PROTEIN1 PROTEIN is a PROTEIN2 specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1840,AIMed.d103,False,In contrast to PROTEIN1 PROTEIN is a PROTEIN2 beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1841,AIMed.d103,False,In contrast to PROTEIN1 PROTEIN2 is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1842,AIMed.d103,False,In contrast to PROTEIN1 PROTEIN is a PROTEIN beta-specific PROTEIN2 PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1843,AIMed.d103,False,In contrast to PROTEIN1 PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN2 is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1844,AIMed.d103,False,In contrast to PROTEIN1 PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN2 an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1845,AIMed.d103,False,In contrast to PROTEIN1 PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN2 .,AIMed.d103.s869
1846,AIMed.d103,False,In contrast to PROTEIN1 PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN2 ( PROTEIN .,AIMed.d103.s869
1847,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1848,AIMed.d103,False,In contrast to PROTEIN PROTEIN1 is a PROTEIN2 specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1849,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 specific PROTEIN2 PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1850,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 specific PROTEIN PROTEIN2 is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1851,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 specific PROTEIN PROTEIN is the homologue of PROTEIN2 an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1852,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN2 .,AIMed.d103.s869
1853,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN2 ( PROTEIN .,AIMed.d103.s869
1854,AIMed.d103,False,In contrast to PROTEIN PROTEIN1 is a PROTEIN2 beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1855,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 beta-specific PROTEIN2 PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1856,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 beta-specific PROTEIN PROTEIN2 is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1857,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 beta-specific PROTEIN PROTEIN is the homologue of PROTEIN2 an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1858,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN2 .,AIMed.d103.s869
1859,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN1 beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN2 ( PROTEIN .,AIMed.d103.s869
1860,AIMed.d103,False,In contrast to PROTEIN PROTEIN1 is a PROTEIN beta-specific PROTEIN2 PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1861,AIMed.d103,False,In contrast to PROTEIN PROTEIN1 is a PROTEIN beta-specific PROTEIN PROTEIN2 is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1862,AIMed.d103,False,In contrast to PROTEIN PROTEIN1 is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN2 an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1863,AIMed.d103,False,In contrast to PROTEIN PROTEIN1 is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN2 .,AIMed.d103.s869
1864,AIMed.d103,False,In contrast to PROTEIN PROTEIN1 is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN2 ( PROTEIN .,AIMed.d103.s869
1865,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN1 PROTEIN2 is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1866,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN1 PROTEIN is the homologue of PROTEIN2 an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1867,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN1 PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN2 .,AIMed.d103.s869
1868,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN1 PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN2 ( PROTEIN .,AIMed.d103.s869
1869,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN1 is the homologue of PROTEIN2 an alternatively spliced form of d PROTEIN ( PROTEIN .,AIMed.d103.s869
1870,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN1 is the homologue of PROTEIN an alternatively spliced form of d PROTEIN ( PROTEIN2 .,AIMed.d103.s869
1871,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN1 is the homologue of PROTEIN an alternatively spliced form of d PROTEIN2 ( PROTEIN .,AIMed.d103.s869
1872,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN1 an alternatively spliced form of d PROTEIN ( PROTEIN2 .,AIMed.d103.s869
1873,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN1 an alternatively spliced form of d PROTEIN2 ( PROTEIN .,AIMed.d103.s869
1874,AIMed.d103,False,In contrast to PROTEIN PROTEIN is a PROTEIN beta-specific PROTEIN PROTEIN is the homologue of PROTEIN an alternatively spliced form of d PROTEIN1 ( PROTEIN2 .,AIMed.d103.s869
1875,AIMed.d103,False,"We show that PROTEIN1 interacts with PROTEIN both in vitro and intracellularly; in contrast to its Drosophila homologue, PROTEIN2 also interacts directly with PROTEIN ",AIMed.d103.s871
1876,AIMed.d103,True,"We show that PROTEIN interacts with PROTEIN both in vitro and intracellularly; in contrast to its Drosophila homologue, PROTEIN1 also interacts directly with PROTEIN2 ",AIMed.d103.s871
1877,AIMed.d103,False,"We show that PROTEIN interacts with PROTEIN1 both in vitro and intracellularly; in contrast to its Drosophila homologue, PROTEIN2 also interacts directly with PROTEIN ",AIMed.d103.s871
1878,AIMed.d103,False,"We show that PROTEIN1 interacts with PROTEIN both in vitro and intracellularly; in contrast to its Drosophila homologue, PROTEIN also interacts directly with PROTEIN2 ",AIMed.d103.s871
1879,AIMed.d103,True,"We show that PROTEIN1 interacts with PROTEIN2 both in vitro and intracellularly; in contrast to its Drosophila homologue, PROTEIN also interacts directly with PROTEIN ",AIMed.d103.s871
1880,AIMed.d103,False,"We show that PROTEIN interacts with PROTEIN1 both in vitro and intracellularly; in contrast to its Drosophila homologue, PROTEIN also interacts directly with PROTEIN2 ",AIMed.d103.s871
1881,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN1 bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN2 ,AIMed.d103.s872
1882,AIMed.d103,False,Deletion analysis indicates that PROTEIN1 and PROTEIN bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN2 ,AIMed.d103.s872
1883,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN1 but it interacts more strongly with PROTEIN and PROTEIN2 ,AIMed.d103.s872
1884,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN1 PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN2 ,AIMed.d103.s872
1885,AIMed.d103,True,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN PROTEIN1 also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN2 ,AIMed.d103.s872
1886,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN1 and PROTEIN2 ,AIMed.d103.s872
1887,AIMed.d103,False,Deletion analysis indicates that PROTEIN1 and PROTEIN2 bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1888,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN1 bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN2 but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1889,AIMed.d103,True,Deletion analysis indicates that PROTEIN and PROTEIN1 bind to distinct domains of PROTEIN2 PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1890,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN1 bind to distinct domains of PROTEIN PROTEIN2 also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1891,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN1 bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN2 and PROTEIN ,AIMed.d103.s872
1892,AIMed.d103,False,Deletion analysis indicates that PROTEIN1 and PROTEIN bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN2 but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1893,AIMed.d103,True,Deletion analysis indicates that PROTEIN1 and PROTEIN bind to distinct domains of PROTEIN2 PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1894,AIMed.d103,False,Deletion analysis indicates that PROTEIN1 and PROTEIN bind to distinct domains of PROTEIN PROTEIN2 also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1895,AIMed.d103,False,Deletion analysis indicates that PROTEIN1 and PROTEIN bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN2 and PROTEIN ,AIMed.d103.s872
1896,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN1 PROTEIN also interacts with PROTEIN2 but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1897,AIMed.d103,True,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN PROTEIN1 also interacts with PROTEIN2 but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1898,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN PROTEIN also interacts with PROTEIN1 but it interacts more strongly with PROTEIN2 and PROTEIN ,AIMed.d103.s872
1899,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN1 PROTEIN2 also interacts with PROTEIN but it interacts more strongly with PROTEIN and PROTEIN ,AIMed.d103.s872
1900,AIMed.d103,False,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN1 PROTEIN also interacts with PROTEIN but it interacts more strongly with PROTEIN2 and PROTEIN ,AIMed.d103.s872
1901,AIMed.d103,True,Deletion analysis indicates that PROTEIN and PROTEIN bind to distinct domains of PROTEIN PROTEIN1 also interacts with PROTEIN but it interacts more strongly with PROTEIN2 and PROTEIN ,AIMed.d103.s872
1902,AIMed.d103,False,The binding of PROTEIN1 and PROTEIN2 requires distinct domains of PROTEIN ,AIMed.d103.s873
1903,AIMed.d103,True,The binding of PROTEIN and PROTEIN1 requires distinct domains of PROTEIN2 ,AIMed.d103.s873
1904,AIMed.d103,True,The binding of PROTEIN1 and PROTEIN requires distinct domains of PROTEIN2 ,AIMed.d103.s873
1905,AIMed.d103,False,"As observed with the homologous Drosophila proteins, PROTEIN1 interacts directly with PROTEIN however, additional interactions between PROTEIN and PROTEIN2 or PROTEIN were detected.",AIMed.d103.s874
1906,AIMed.d103,False,"As observed with the homologous Drosophila proteins, PROTEIN1 interacts directly with PROTEIN however, additional interactions between PROTEIN2 and PROTEIN or PROTEIN were detected.",AIMed.d103.s874
1907,AIMed.d103,False,"As observed with the homologous Drosophila proteins, PROTEIN1 interacts directly with PROTEIN however, additional interactions between PROTEIN and PROTEIN or PROTEIN2 were detected.",AIMed.d103.s874
1908,AIMed.d103,True,"As observed with the homologous Drosophila proteins, PROTEIN1 interacts directly with PROTEIN2 however, additional interactions between PROTEIN and PROTEIN or PROTEIN were detected.",AIMed.d103.s874
1909,AIMed.d103,True,"As observed with the homologous Drosophila proteins, PROTEIN interacts directly with PROTEIN however, additional interactions between PROTEIN1 and PROTEIN2 or PROTEIN were detected.",AIMed.d103.s874
1910,AIMed.d103,False,"As observed with the homologous Drosophila proteins, PROTEIN interacts directly with PROTEIN however, additional interactions between PROTEIN and PROTEIN1 or PROTEIN2 were detected.",AIMed.d103.s874
1911,AIMed.d103,False,"As observed with the homologous Drosophila proteins, PROTEIN interacts directly with PROTEIN1 however, additional interactions between PROTEIN and PROTEIN2 or PROTEIN were detected.",AIMed.d103.s874
1912,AIMed.d103,True,"As observed with the homologous Drosophila proteins, PROTEIN interacts directly with PROTEIN however, additional interactions between PROTEIN1 and PROTEIN or PROTEIN2 were detected.",AIMed.d103.s874
1913,AIMed.d103,False,"As observed with the homologous Drosophila proteins, PROTEIN interacts directly with PROTEIN1 however, additional interactions between PROTEIN2 and PROTEIN or PROTEIN were detected.",AIMed.d103.s874
1914,AIMed.d103,False,"As observed with the homologous Drosophila proteins, PROTEIN interacts directly with PROTEIN1 however, additional interactions between PROTEIN and PROTEIN or PROTEIN2 were detected.",AIMed.d103.s874
1915,AIMed.d103,False,"These results reveal differences not only in subunit composition, but also in the organization of PROTEIN1 and PROTEIN2 complexes.",AIMed.d103.s875
1916,AIMed.d104,False,This transcriptional activity is inhibited by association with the PROTEIN ( PROTEIN or its relatives PROTEIN1 and PROTEIN2 ,AIMed.d104.s878
1917,AIMed.d104,False,This transcriptional activity is inhibited by association with the PROTEIN ( PROTEIN1 or its relatives PROTEIN2 and PROTEIN ,AIMed.d104.s878
1918,AIMed.d104,False,This transcriptional activity is inhibited by association with the PROTEIN1 ( PROTEIN or its relatives PROTEIN2 and PROTEIN ,AIMed.d104.s878
1919,AIMed.d104,False,This transcriptional activity is inhibited by association with the PROTEIN ( PROTEIN1 or its relatives PROTEIN and PROTEIN2 ,AIMed.d104.s878
1920,AIMed.d104,False,This transcriptional activity is inhibited by association with the PROTEIN1 ( PROTEIN or its relatives PROTEIN and PROTEIN2 ,AIMed.d104.s878
1921,AIMed.d104,False,This transcriptional activity is inhibited by association with the PROTEIN1 ( PROTEIN2 or its relatives PROTEIN and PROTEIN ,AIMed.d104.s878
1922,AIMed.d104,False,The first cDNA from the PROTEIN1 family to be cloned was designated PROTEIN2 and multiple PROTEIN family members have now been identified.,AIMed.d104.s879
1923,AIMed.d104,False,The first cDNA from the PROTEIN family to be cloned was designated PROTEIN1 and multiple PROTEIN2 family members have now been identified.,AIMed.d104.s879
1924,AIMed.d104,False,The first cDNA from the PROTEIN1 family to be cloned was designated PROTEIN and multiple PROTEIN2 family members have now been identified.,AIMed.d104.s879
1925,AIMed.d104,False,Here we demonstrate that DP is also a family of polypeptides with at least two members ( PROTEIN1 and PROTEIN2 .,AIMed.d104.s881
1926,AIMed.d104,False,"Both PROTEIN1 and PROTEIN2 bind to all PROTEIN family members in vivo, and each complex is capable of activating transcription.",AIMed.d104.s882
1927,AIMed.d104,False,"Both PROTEIN and PROTEIN1 bind to all PROTEIN2 family members in vivo, and each complex is capable of activating transcription.",AIMed.d104.s882
1928,AIMed.d104,False,"Both PROTEIN1 and PROTEIN bind to all PROTEIN2 family members in vivo, and each complex is capable of activating transcription.",AIMed.d104.s882
1929,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN1 in vivo, and the specificity of PROTEIN or PROTEIN binding is mediated by the PROTEIN2 subunit.",AIMed.d104.s883
1930,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN1 in vivo, and the specificity of PROTEIN2 or PROTEIN binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1931,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN1 or PROTEIN2 in vivo, and the specificity of PROTEIN or PROTEIN binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1932,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN1 in vivo, and the specificity of PROTEIN or PROTEIN2 binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1933,AIMed.d104,False,"However, the various PROTEIN1 DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN2 in vivo, and the specificity of PROTEIN or PROTEIN binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1934,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN in vivo, and the specificity of PROTEIN1 or PROTEIN binding is mediated by the PROTEIN2 subunit.",AIMed.d104.s883
1935,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN1 or PROTEIN in vivo, and the specificity of PROTEIN or PROTEIN binding is mediated by the PROTEIN2 subunit.",AIMed.d104.s883
1936,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN in vivo, and the specificity of PROTEIN or PROTEIN1 binding is mediated by the PROTEIN2 subunit.",AIMed.d104.s883
1937,AIMed.d104,False,"However, the various PROTEIN1 DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN in vivo, and the specificity of PROTEIN or PROTEIN binding is mediated by the PROTEIN2 subunit.",AIMed.d104.s883
1938,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN1 or PROTEIN in vivo, and the specificity of PROTEIN2 or PROTEIN binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1939,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN in vivo, and the specificity of PROTEIN1 or PROTEIN2 binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1940,AIMed.d104,False,"However, the various PROTEIN1 DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN in vivo, and the specificity of PROTEIN2 or PROTEIN binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1941,AIMed.d104,False,"However, the various PROTEIN DP complexes display strong differences in the ability to bind to either PROTEIN1 or PROTEIN in vivo, and the specificity of PROTEIN or PROTEIN2 binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1942,AIMed.d104,False,"However, the various PROTEIN1 DP complexes display strong differences in the ability to bind to either PROTEIN2 or PROTEIN in vivo, and the specificity of PROTEIN or PROTEIN binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1943,AIMed.d104,False,"However, the various PROTEIN1 DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN in vivo, and the specificity of PROTEIN or PROTEIN2 binding is mediated by the PROTEIN subunit.",AIMed.d104.s883
1944,AIMed.d105,True,Two distinct and independent sites on PROTEIN1 trigger PROTEIN2 dimer formation and signalling.,AIMed.d105.s884
1945,AIMed.d105,False,"The helical cytokine PROTEIN1 and its specific binding subunit PROTEIN form a 1:1 complex which, by promoting homodimerization of the signalling subunit PROTEIN2 on the surface of target cells, triggers intracellular responses.",AIMed.d105.s885
1946,AIMed.d105,False,"The helical cytokine PROTEIN and its specific binding subunit PROTEIN1 form a 1:1 complex which, by promoting homodimerization of the signalling subunit PROTEIN2 on the surface of target cells, triggers intracellular responses.",AIMed.d105.s885
1947,AIMed.d105,True,"The helical cytokine PROTEIN1 and its specific binding subunit PROTEIN2 form a 1:1 complex which, by promoting homodimerization of the signalling subunit PROTEIN on the surface of target cells, triggers intracellular responses.",AIMed.d105.s885
1948,AIMed.d105,False,We expressed differently tagged forms of PROTEIN1 and used them in solution-phase binding assays to show that the soluble extracellular domains of PROTEIN2 undergo dimerization in the absence of membranes.,AIMed.d105.s886
1949,AIMed.d105,False,"We demonstrate here that both the site 2 and site 3 PROTEIN1 variants complexed with PROTEIN bind a single PROTEIN molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with PROTEIN2 ",AIMed.d105.s889
1950,AIMed.d105,False,"We demonstrate here that both the site 2 and site 3 PROTEIN variants complexed with PROTEIN bind a single PROTEIN1 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with PROTEIN2 ",AIMed.d105.s889
1951,AIMed.d105,False,"We demonstrate here that both the site 2 and site 3 PROTEIN variants complexed with PROTEIN1 bind a single PROTEIN molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with PROTEIN2 ",AIMed.d105.s889
1952,AIMed.d105,True,"We demonstrate here that both the site 2 and site 3 PROTEIN1 variants complexed with PROTEIN bind a single PROTEIN2 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with PROTEIN ",AIMed.d105.s889
1953,AIMed.d105,True,"We demonstrate here that both the site 2 and site 3 PROTEIN1 variants complexed with PROTEIN2 bind a single PROTEIN molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with PROTEIN ",AIMed.d105.s889
1954,AIMed.d105,True,"We demonstrate here that both the site 2 and site 3 PROTEIN variants complexed with PROTEIN1 bind a single PROTEIN2 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with PROTEIN ",AIMed.d105.s889
1955,AIMed.d105,False,"The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that PROTEIN1 dimer is formed through direct binding at two independent and differently oriented sites on PROTEIN2 ",AIMed.d105.s890
1956,AIMed.d105,True,Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two PROTEIN1 two PROTEIN2 and two PROTEIN molecules.,AIMed.d105.s891
1957,AIMed.d105,True,Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two PROTEIN two PROTEIN1 and two PROTEIN2 molecules.,AIMed.d105.s891
1958,AIMed.d105,True,Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two PROTEIN1 two PROTEIN and two PROTEIN2 molecules.,AIMed.d105.s891
1959,AIMed.d108,False, PROTEIN transcriptional activation mediated by coactivators PROTEIN1 and PROTEIN2 ,AIMed.d108.s909
1960,AIMed.d108,True, PROTEIN1 transcriptional activation mediated by coactivators PROTEIN2 and PROTEIN ,AIMed.d108.s909
1961,AIMed.d108,True, PROTEIN1 transcriptional activation mediated by coactivators PROTEIN and PROTEIN2 ,AIMed.d108.s909
1962,AIMed.d108,False,The multisubunit PROTEIN1 ( PROTEIN2 is thought to be a primary target for site-specific activators of transcription.,AIMed.d108.s911
1963,AIMed.d108,False,"Here, a direct interaction between the activation domain of PROTEIN and two subunits of the PROTEIN1 complex, PROTEIN and PROTEIN2 is reported.",AIMed.d108.s912
1964,AIMed.d108,False,"Here, a direct interaction between the activation domain of PROTEIN1 and two subunits of the PROTEIN2 complex, PROTEIN and PROTEIN is reported.",AIMed.d108.s912
1965,AIMed.d108,False,"Here, a direct interaction between the activation domain of PROTEIN and two subunits of the PROTEIN1 complex, PROTEIN2 and PROTEIN is reported.",AIMed.d108.s912
1966,AIMed.d108,True,"Here, a direct interaction between the activation domain of PROTEIN1 and two subunits of the PROTEIN complex, PROTEIN and PROTEIN2 is reported.",AIMed.d108.s912
1967,AIMed.d108,False,"Here, a direct interaction between the activation domain of PROTEIN and two subunits of the PROTEIN complex, PROTEIN1 and PROTEIN2 is reported.",AIMed.d108.s912
1968,AIMed.d108,True,"Here, a direct interaction between the activation domain of PROTEIN1 and two subunits of the PROTEIN complex, PROTEIN2 and PROTEIN is reported.",AIMed.d108.s912
1969,AIMed.d108,True,"A double point mutation in the activation domain of PROTEIN1 impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both PROTEIN and PROTEIN2 ",AIMed.d108.s913
1970,AIMed.d108,False,"A double point mutation in the activation domain of PROTEIN impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both PROTEIN1 and PROTEIN2 ",AIMed.d108.s913
1971,AIMed.d108,True,"A double point mutation in the activation domain of PROTEIN1 impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both PROTEIN2 and PROTEIN ",AIMed.d108.s913
1972,AIMed.d108,False,"Furthermore, a partial PROTEIN1 complex containing Drosophila PROTEIN2 ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1973,AIMed.d108,False,"Furthermore, a partial PROTEIN1 complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN2 and PROTEIN did not.",AIMed.d108.s914
1974,AIMed.d108,False,"Furthermore, a partial PROTEIN1 complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN2 PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1975,AIMed.d108,False,"Furthermore, a partial PROTEIN1 complex containing Drosophila PROTEIN ( PROTEIN2 , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1976,AIMed.d108,False,"Furthermore, a partial PROTEIN1 complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN2 or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1977,AIMed.d108,False,"Furthermore, a partial PROTEIN1 complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN2 and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1978,AIMed.d108,False,"Furthermore, a partial PROTEIN1 complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN2 did not.",AIMed.d108.s914
1979,AIMed.d108,False,"Furthermore, a partial PROTEIN1 complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN2 supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1980,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN1 ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN2 and PROTEIN did not.",AIMed.d108.s914
1981,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN1 ( PROTEIN , human PROTEIN2 PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1982,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN1 ( PROTEIN2 , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1983,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN1 ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN2 or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1984,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN1 ( PROTEIN , human PROTEIN PROTEIN2 and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1985,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN1 ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN2 did not.",AIMed.d108.s914
1986,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN1 ( PROTEIN , human PROTEIN PROTEIN and PROTEIN2 supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1987,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN1 PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN2 and PROTEIN did not.",AIMed.d108.s914
1988,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN1 , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN2 and PROTEIN did not.",AIMed.d108.s914
1989,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN1 or a subcomplex lacking PROTEIN2 and PROTEIN did not.",AIMed.d108.s914
1990,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN1 and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN2 and PROTEIN did not.",AIMed.d108.s914
1991,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN1 and PROTEIN2 did not.",AIMed.d108.s914
1992,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN1 supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN2 and PROTEIN did not.",AIMed.d108.s914
1993,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN1 , human PROTEIN2 PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1994,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN1 PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN2 or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1995,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN1 PROTEIN2 and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1996,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN1 PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN2 did not.",AIMed.d108.s914
1997,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN1 PROTEIN and PROTEIN2 supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1998,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN1 , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN2 or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
1999,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN1 , human PROTEIN PROTEIN2 and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
2000,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN1 , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN2 did not.",AIMed.d108.s914
2001,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN1 , human PROTEIN PROTEIN and PROTEIN2 supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
2002,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN1 and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN2 or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
2003,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN1 or a subcomplex lacking PROTEIN and PROTEIN2 did not.",AIMed.d108.s914
2004,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN1 supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN2 or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
2005,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN1 and PROTEIN supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN2 did not.",AIMed.d108.s914
2006,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN1 and PROTEIN2 supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN did not.",AIMed.d108.s914
2007,AIMed.d108,False,"Furthermore, a partial PROTEIN complex containing Drosophila PROTEIN ( PROTEIN , human PROTEIN PROTEIN and PROTEIN1 supported activation by a Gal4-p53 fusion protein in vitro, whereas PROTEIN or a subcomplex lacking PROTEIN and PROTEIN2 did not.",AIMed.d108.s914
2008,AIMed.d108,True,"Together, these results suggest that PROTEIN1 and PROTEIN are important targets for transmitting activation signals between PROTEIN2 and the initiation complex.",AIMed.d108.s915
2009,AIMed.d108,True,"Together, these results suggest that PROTEIN and PROTEIN1 are important targets for transmitting activation signals between PROTEIN2 and the initiation complex.",AIMed.d108.s915
2010,AIMed.d108,False,"Together, these results suggest that PROTEIN1 and PROTEIN2 are important targets for transmitting activation signals between PROTEIN and the initiation complex.",AIMed.d108.s915
2011,AIMed.d109,True,Crystal structure of the heterodimeric bZIP transcription factor PROTEIN1 PROTEIN2 bound to DNA.,AIMed.d109.s916
2012,AIMed.d109,True,The PROTEIN1 and PROTEIN2 families of eukaryotic transcription factors heterodimerize to form complexes capable of binding 5'-TGAGTCA-3' DNA elements.,AIMed.d109.s917
2013,AIMed.d109,True,We have determined the X-ray crystal structure of a heterodimer of the bZIP regions of PROTEIN1 and PROTEIN2 bound to DNA.,AIMed.d109.s918
2014,AIMed.d109,True,Comparison of the two crystallographically distinct protein-DNA complexes show that the coiled-coil is flexibly joined to the basic regions and that the PROTEIN1 PROTEIN2 heterodimer does not recognize the asymmetric 5'-TGAGTCA-3' recognition element in a unique orientation.,AIMed.d109.s921
2015,AIMed.d110,False, PROTEIN1 is a multisubunit protein complex comprised of the PROTEIN2 ( PROTEIN and multiple TBP-associated factors (TAFs).,AIMed.d110.s924
2016,AIMed.d110,False, PROTEIN1 is a multisubunit protein complex comprised of the PROTEIN ( PROTEIN2 and multiple TBP-associated factors (TAFs).,AIMed.d110.s924
2017,AIMed.d110,False, PROTEIN is a multisubunit protein complex comprised of the PROTEIN1 ( PROTEIN2 and multiple TBP-associated factors (TAFs).,AIMed.d110.s924
2018,AIMed.d110,False,"The cloning of a complementary DNA encoding a human PROTEIN1 TAF, PROTEIN2 that has no known homolog in Drosophila PROTEIN is now described.",AIMed.d110.s926
2019,AIMed.d110,False,"The cloning of a complementary DNA encoding a human PROTEIN TAF, PROTEIN1 that has no known homolog in Drosophila PROTEIN2 is now described.",AIMed.d110.s926
2020,AIMed.d110,False,"The cloning of a complementary DNA encoding a human PROTEIN1 TAF, PROTEIN that has no known homolog in Drosophila PROTEIN2 is now described.",AIMed.d110.s926
2021,AIMed.d110,True, PROTEIN1 is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN2 and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2022,AIMed.d110,False, PROTEIN1 is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN2 proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2023,AIMed.d110,True, PROTEIN1 is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN2 PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2024,AIMed.d110,True, PROTEIN1 is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN2 adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2025,AIMed.d110,True, PROTEIN1 is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN2 PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2026,AIMed.d110,True, PROTEIN1 is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN2 PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2027,AIMed.d110,True, PROTEIN1 is shown to interact with the largest subunit ( PROTEIN2 of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2028,AIMed.d110,False, PROTEIN1 is shown to interact with the largest subunit ( PROTEIN of human PROTEIN2 through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2029,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN1 and human immunodeficiency virus-type 1 PROTEIN2 proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2030,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN1 PROTEIN adenoviral PROTEIN2 and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2031,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN1 adenoviral PROTEIN2 and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2032,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN1 PROTEIN PROTEIN adenoviral PROTEIN2 and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2033,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN1 PROTEIN PROTEIN PROTEIN adenoviral PROTEIN2 and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2034,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN1 of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN2 and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2035,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN1 through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN2 and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2036,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN1 PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN2 proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2037,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN1 adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN2 proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2038,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN1 PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN2 proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2039,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN1 PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN2 proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2040,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN1 of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN2 proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2041,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN1 through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN2 proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2042,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN1 PROTEIN2 adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2043,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN1 PROTEIN2 PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2044,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN1 PROTEIN PROTEIN2 PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2045,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN1 of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN2 PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2046,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN1 through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN2 PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2047,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN1 PROTEIN PROTEIN2 adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2048,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN1 PROTEIN PROTEIN PROTEIN2 adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2049,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN1 of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN2 adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2050,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN1 through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN2 adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2051,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN through its central region and with multiple activators--including PROTEIN1 PROTEIN2 PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2052,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN1 of human PROTEIN through its central region and with multiple activators--including PROTEIN PROTEIN2 PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2053,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN1 through its central region and with multiple activators--including PROTEIN PROTEIN2 PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2054,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN1 of human PROTEIN through its central region and with multiple activators--including PROTEIN2 PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2055,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN of human PROTEIN1 through its central region and with multiple activators--including PROTEIN2 PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2056,AIMed.d110,False, PROTEIN is shown to interact with the largest subunit ( PROTEIN1 of human PROTEIN2 through its central region and with multiple activators--including PROTEIN PROTEIN PROTEIN PROTEIN adenoviral PROTEIN and human immunodeficiency virus-type 1 PROTEIN proteins--through a distinct amino-terminal domain.,AIMed.d110.s927
2057,AIMed.d110,False,"The PROTEIN1 interacting region of PROTEIN was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila PROTEIN2 ",AIMed.d110.s928
2058,AIMed.d110,True,"The PROTEIN interacting region of PROTEIN1 was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila PROTEIN2 ",AIMed.d110.s928
2059,AIMed.d110,True,"The PROTEIN1 interacting region of PROTEIN2 was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila PROTEIN ",AIMed.d110.s928
2060,AIMed.d112,True,Human spleen tyrosine kinase PROTEIN1 associates with the Src-family kinase PROTEIN PROTEIN2 and a PROTEIN ,AIMed.d112.s944
2061,AIMed.d112,True,Human spleen tyrosine kinase PROTEIN1 associates with the Src-family kinase PROTEIN2 PROTEIN and a PROTEIN ,AIMed.d112.s944
2062,AIMed.d112,True,Human spleen tyrosine kinase PROTEIN1 associates with the Src-family kinase PROTEIN PROTEIN and a PROTEIN2 ,AIMed.d112.s944
2063,AIMed.d112,False,Human spleen tyrosine kinase PROTEIN associates with the Src-family kinase PROTEIN1 PROTEIN2 and a PROTEIN ,AIMed.d112.s944
2064,AIMed.d112,False,Human spleen tyrosine kinase PROTEIN associates with the Src-family kinase PROTEIN PROTEIN1 and a PROTEIN2 ,AIMed.d112.s944
2065,AIMed.d112,False,Human spleen tyrosine kinase PROTEIN associates with the Src-family kinase PROTEIN1 PROTEIN and a PROTEIN2 ,AIMed.d112.s944
2066,AIMed.d112,False,The 72-kDa spleen tyrosine kinase ( PROTEIN and Src-family kinase PROTEIN1 PROTEIN2 ( PROTEIN contribute to signaling via the B-cell antigen receptor complex.,AIMed.d112.s945
2067,AIMed.d112,False,The 72-kDa spleen tyrosine kinase ( PROTEIN1 and Src-family kinase PROTEIN PROTEIN2 ( PROTEIN contribute to signaling via the B-cell antigen receptor complex.,AIMed.d112.s945
2068,AIMed.d112,False,The 72-kDa spleen tyrosine kinase ( PROTEIN and Src-family kinase PROTEIN PROTEIN1 ( PROTEIN2 contribute to signaling via the B-cell antigen receptor complex.,AIMed.d112.s945
2069,AIMed.d112,False,The 72-kDa spleen tyrosine kinase ( PROTEIN1 and Src-family kinase PROTEIN2 PROTEIN ( PROTEIN contribute to signaling via the B-cell antigen receptor complex.,AIMed.d112.s945
2070,AIMed.d112,False,The 72-kDa spleen tyrosine kinase ( PROTEIN and Src-family kinase PROTEIN1 PROTEIN ( PROTEIN2 contribute to signaling via the B-cell antigen receptor complex.,AIMed.d112.s945
2071,AIMed.d112,False,The 72-kDa spleen tyrosine kinase ( PROTEIN1 and Src-family kinase PROTEIN PROTEIN ( PROTEIN2 contribute to signaling via the B-cell antigen receptor complex.,AIMed.d112.s945
2072,AIMed.d112,True,Here we show that PROTEIN1 and PROTEIN2 from human B lymphocytes can interact directly.,AIMed.d112.s946
2073,AIMed.d112,True," PROTEIN and PROTEIN coimmunoprecipitated from mature and activated B-cell lines, and gel-purified PROTEIN1 and PROTEIN2 reassociated in vitro, demonstrating their direct interaction.",AIMed.d112.s947
2074,AIMed.d112,False," PROTEIN1 and PROTEIN coimmunoprecipitated from mature and activated B-cell lines, and gel-purified PROTEIN2 and PROTEIN reassociated in vitro, demonstrating their direct interaction.",AIMed.d112.s947
2075,AIMed.d112,False," PROTEIN and PROTEIN1 coimmunoprecipitated from mature and activated B-cell lines, and gel-purified PROTEIN2 and PROTEIN reassociated in vitro, demonstrating their direct interaction.",AIMed.d112.s947
2076,AIMed.d112,False," PROTEIN1 and PROTEIN coimmunoprecipitated from mature and activated B-cell lines, and gel-purified PROTEIN and PROTEIN2 reassociated in vitro, demonstrating their direct interaction.",AIMed.d112.s947
2077,AIMed.d112,False," PROTEIN and PROTEIN1 coimmunoprecipitated from mature and activated B-cell lines, and gel-purified PROTEIN and PROTEIN2 reassociated in vitro, demonstrating their direct interaction.",AIMed.d112.s947
2078,AIMed.d112,True," PROTEIN1 and PROTEIN2 coimmunoprecipitated from mature and activated B-cell lines, and gel-purified PROTEIN and PROTEIN reassociated in vitro, demonstrating their direct interaction.",AIMed.d112.s947
2079,AIMed.d112,False,"This PROTEIN1 PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN2 in vitro.",AIMed.d112.s948
2080,AIMed.d112,False,"This PROTEIN PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN1 associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN2 in vitro.",AIMed.d112.s948
2081,AIMed.d112,False,"This PROTEIN PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN1 from an immature B-cell line did not reassociate with PROTEIN2 in vitro.",AIMed.d112.s948
2082,AIMed.d112,False,"This PROTEIN PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN1 PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN2 in vitro.",AIMed.d112.s948
2083,AIMed.d112,False,"This PROTEIN PROTEIN1 interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN2 in vitro.",AIMed.d112.s948
2084,AIMed.d112,False,"This PROTEIN1 PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN2 associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2085,AIMed.d112,False,"This PROTEIN1 PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN2 from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2086,AIMed.d112,False,"This PROTEIN1 PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN2 PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2087,AIMed.d112,True,"This PROTEIN1 PROTEIN2 interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2088,AIMed.d112,False,"This PROTEIN PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN1 associations were not detected in pre-B and myeloma cell lines and PROTEIN2 from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2089,AIMed.d112,True,"This PROTEIN PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN1 PROTEIN2 associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2090,AIMed.d112,False,"This PROTEIN PROTEIN1 interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN2 associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2091,AIMed.d112,False,"This PROTEIN PROTEIN interaction may be dependent on the stage of B-cell differentiation, since PROTEIN1 PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN2 from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2092,AIMed.d112,False,"This PROTEIN PROTEIN1 interaction may be dependent on the stage of B-cell differentiation, since PROTEIN PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN2 from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2093,AIMed.d112,False,"This PROTEIN PROTEIN1 interaction may be dependent on the stage of B-cell differentiation, since PROTEIN2 PROTEIN associations were not detected in pre-B and myeloma cell lines and PROTEIN from an immature B-cell line did not reassociate with PROTEIN in vitro.",AIMed.d112.s948
2094,AIMed.d112,False,"Crosslinking of cell surface IgM led to rapid activation of both tyrosine and serine/threonine protein kinase activities that resulted in phosphorylation in vitro of proteins coprecipitating with PROTEIN1 -in particular, a serine/threonine phosphorylated protein 120 kDa in size ( PROTEIN2 .",AIMed.d112.s950
2095,AIMed.d112,False,"Several phosphoproteins, including one of 72 kDa and one of 120 kDa, coprecipitated with PROTEIN1 ( PROTEIN2 .",AIMed.d112.s951
2096,AIMed.d112,True,Sequential immunoprecipitation identified the 72-kDa protein associated with PROTEIN1 as PROTEIN2 ,AIMed.d112.s952
2097,AIMed.d112,False,The 120-kDa serine/threonine phosphorylated protein that coprecipitated with PROTEIN1 resembled the PROTEIN2 associated PROTEIN by several criteria.,AIMed.d112.s953
2098,AIMed.d112,True,The 120-kDa serine/threonine phosphorylated protein that coprecipitated with PROTEIN resembled the PROTEIN1 associated PROTEIN2 by several criteria.,AIMed.d112.s953
2099,AIMed.d112,False,The 120-kDa serine/threonine phosphorylated protein that coprecipitated with PROTEIN1 resembled the PROTEIN associated PROTEIN2 by several criteria.,AIMed.d112.s953
2100,AIMed.d112,True,"Thus, PROTEIN1 may serve as a link between PROTEIN2 and PROTEIN coupling the B-cell antigen receptor to the phosphatidylinositol pathway.",AIMed.d112.s954
2101,AIMed.d112,True,"Thus, PROTEIN1 may serve as a link between PROTEIN and PROTEIN2 coupling the B-cell antigen receptor to the phosphatidylinositol pathway.",AIMed.d112.s954
2102,AIMed.d112,True,"Thus, PROTEIN may serve as a link between PROTEIN1 and PROTEIN2 coupling the B-cell antigen receptor to the phosphatidylinositol pathway.",AIMed.d112.s954
2103,AIMed.d113,False,Cloning and functional analysis of PROTEIN1 a novel PROTEIN2 with anti-cell death activity.,AIMed.d113.s955
2104,AIMed.d113,True,Cloning and functional analysis of PROTEIN1 a novel PROTEIN2 binding protein with anti-cell death activity.,AIMed.d113.s955
2105,AIMed.d113,False,Cloning and functional analysis of PROTEIN a novel PROTEIN1 binding protein with anti-cell death activity.,AIMed.d113.s955
2106,AIMed.d113,True,"Using a protein interaction cloning technique, we identified cDNAs that encode a novel PROTEIN1 binding protein, termed PROTEIN2 ",AIMed.d113.s956
2107,AIMed.d113,False,"Using a protein interaction cloning technique, we identified cDNAs that encode a novel PROTEIN1 termed PROTEIN ",AIMed.d113.s956
2108,AIMed.d113,False,"Using a protein interaction cloning technique, we identified cDNAs that encode a novel PROTEIN1 termed PROTEIN2 ",AIMed.d113.s956
2109,AIMed.d113,False,"The PROTEIN1 protein shares no significant homology with PROTEIN or other PROTEIN2 family proteins, which can form homo- and heterodimers.",AIMed.d113.s957
2110,AIMed.d113,False,"The PROTEIN protein shares no significant homology with PROTEIN1 or other PROTEIN2 family proteins, which can form homo- and heterodimers.",AIMed.d113.s957
2111,AIMed.d113,False,"The PROTEIN1 protein shares no significant homology with PROTEIN2 or other PROTEIN family proteins, which can form homo- and heterodimers.",AIMed.d113.s957
2112,AIMed.d113,False,"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of PROTEIN1 and PROTEIN provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either PROTEIN2 or PROTEIN protein alone.",AIMed.d113.s958
2113,AIMed.d113,False,"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of PROTEIN and PROTEIN provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either PROTEIN1 or PROTEIN2 protein alone.",AIMed.d113.s958
2114,AIMed.d113,False,"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of PROTEIN and PROTEIN1 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either PROTEIN2 or PROTEIN protein alone.",AIMed.d113.s958
2115,AIMed.d113,False,"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of PROTEIN1 and PROTEIN provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either PROTEIN or PROTEIN2 protein alone.",AIMed.d113.s958
2116,AIMed.d113,False,"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of PROTEIN1 and PROTEIN2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either PROTEIN or PROTEIN protein alone.",AIMed.d113.s958
2117,AIMed.d113,False,"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of PROTEIN and PROTEIN1 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either PROTEIN or PROTEIN2 protein alone.",AIMed.d113.s958
2118,AIMed.d113,False,The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to PROTEIN1 independent pathways may instead reflect a need for the combination of PROTEIN2 and PROTEIN ,AIMed.d113.s960
2119,AIMed.d113,False,The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to PROTEIN independent pathways may instead reflect a need for the combination of PROTEIN1 and PROTEIN2 ,AIMed.d113.s960
2120,AIMed.d113,False,The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to PROTEIN1 independent pathways may instead reflect a need for the combination of PROTEIN and PROTEIN2 ,AIMed.d113.s960
2121,AIMed.d114,False, PROTEIN1 binds to an alternatively spliced exon of PROTEIN2 ,AIMed.d114.s961
2122,AIMed.d114,False,We expressed the cDNA of human PROTEIN1 and the COOH terminus of human PROTEIN2 in reticulocyte lysates using an in vitro transcription/translation system.,AIMed.d114.s964
2123,AIMed.d114,True,"We demonstrate that the 53 amino acids encoded on exon 74 of PROTEIN1 an alternatively spliced exon, are necessary and sufficient for interaction with translated PROTEIN2 in our assay.",AIMed.d114.s966
2124,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN related protein ( PROTEIN1 or PROTEIN2 and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2125,AIMed.d114,False,"In this recombinant expression system, the PROTEIN1 relatives, human PROTEIN related protein ( PROTEIN2 or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2126,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 ( PROTEIN2 or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2127,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN ( PROTEIN1 or PROTEIN and the PROTEIN2 from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2128,AIMed.d114,True,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN related protein ( PROTEIN1 or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN2 ",AIMed.d114.s968
2129,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 related protein ( PROTEIN2 or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2130,AIMed.d114,False,"In this recombinant expression system, the PROTEIN1 relatives, human PROTEIN related protein ( PROTEIN or PROTEIN2 and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2131,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 ( PROTEIN or PROTEIN2 and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2132,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN related protein ( PROTEIN or PROTEIN1 and the PROTEIN2 from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2133,AIMed.d114,True,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN related protein ( PROTEIN or PROTEIN1 and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN2 ",AIMed.d114.s968
2134,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 related protein ( PROTEIN or PROTEIN2 and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2135,AIMed.d114,False,"In this recombinant expression system, the PROTEIN1 relatives, human PROTEIN2 ( PROTEIN or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2136,AIMed.d114,False,"In this recombinant expression system, the PROTEIN1 relatives, human PROTEIN related protein ( PROTEIN or PROTEIN and the PROTEIN2 from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2137,AIMed.d114,False,"In this recombinant expression system, the PROTEIN1 relatives, human PROTEIN related protein ( PROTEIN or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN2 ",AIMed.d114.s968
2138,AIMed.d114,False,"In this recombinant expression system, the PROTEIN1 relatives, human PROTEIN2 related protein ( PROTEIN or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2139,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 ( PROTEIN or PROTEIN and the PROTEIN2 from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2140,AIMed.d114,True,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 ( PROTEIN or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN2 ",AIMed.d114.s968
2141,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 related protein ( PROTEIN or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2142,AIMed.d114,True,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN related protein ( PROTEIN or PROTEIN and the PROTEIN1 from Torpedo electric organ, also bind to translated PROTEIN2 ",AIMed.d114.s968
2143,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 related protein ( PROTEIN or PROTEIN and the PROTEIN2 from Torpedo electric organ, also bind to translated PROTEIN ",AIMed.d114.s968
2144,AIMed.d114,False,"In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 related protein ( PROTEIN or PROTEIN and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN2 ",AIMed.d114.s968
2145,AIMed.d114,False,"We have found a COOH-terminal 37-kD fragment of PROTEIN1 sufficient to interact with translated PROTEIN and its homologues, suggesting that the PROTEIN2 binding site on PROTEIN occurs on a region that is conserved among the three syntrophin homologues.",AIMed.d114.s969
2146,AIMed.d114,True,"We have found a COOH-terminal 37-kD fragment of PROTEIN sufficient to interact with translated PROTEIN and its homologues, suggesting that the PROTEIN1 binding site on PROTEIN2 occurs on a region that is conserved among the three syntrophin homologues.",AIMed.d114.s969
2147,AIMed.d114,False,"We have found a COOH-terminal 37-kD fragment of PROTEIN sufficient to interact with translated PROTEIN1 and its homologues, suggesting that the PROTEIN2 binding site on PROTEIN occurs on a region that is conserved among the three syntrophin homologues.",AIMed.d114.s969
2148,AIMed.d114,False,"We have found a COOH-terminal 37-kD fragment of PROTEIN1 sufficient to interact with translated PROTEIN and its homologues, suggesting that the PROTEIN binding site on PROTEIN2 occurs on a region that is conserved among the three syntrophin homologues.",AIMed.d114.s969
2149,AIMed.d114,True,"We have found a COOH-terminal 37-kD fragment of PROTEIN1 sufficient to interact with translated PROTEIN2 and its homologues, suggesting that the PROTEIN binding site on PROTEIN occurs on a region that is conserved among the three syntrophin homologues.",AIMed.d114.s969
2150,AIMed.d114,False,"We have found a COOH-terminal 37-kD fragment of PROTEIN sufficient to interact with translated PROTEIN1 and its homologues, suggesting that the PROTEIN binding site on PROTEIN2 occurs on a region that is conserved among the three syntrophin homologues.",AIMed.d114.s969
2151,AIMed.d115,False,Interaction with PROTEIN1 subunit of PROTEIN2 is required for transcriptional activation by PROTEIN ,AIMed.d115.s970
2152,AIMed.d115,False,Interaction with PROTEIN subunit of PROTEIN1 is required for transcriptional activation by PROTEIN2 ,AIMed.d115.s970
2153,AIMed.d115,True,Interaction with PROTEIN1 subunit of PROTEIN is required for transcriptional activation by PROTEIN2 ,AIMed.d115.s970
2154,AIMed.d115,False,"A few general transcription factors, in particular PROTEIN1 and PROTEIN2 have been found to bind transcriptional activators.",AIMed.d115.s971
2155,AIMed.d115,False,"Here we show that the general transcription factor PROTEIN is also a target for a transcriptional activator, namely PROTEIN ( PROTEIN1 , which binds to the PROTEIN2 promoter.",AIMed.d115.s972
2156,AIMed.d115,False,"Here we show that the general transcription factor PROTEIN1 is also a target for a transcriptional activator, namely PROTEIN ( PROTEIN , which binds to the PROTEIN2 promoter.",AIMed.d115.s972
2157,AIMed.d115,False,"Here we show that the general transcription factor PROTEIN is also a target for a transcriptional activator, namely PROTEIN1 ( PROTEIN , which binds to the PROTEIN2 promoter.",AIMed.d115.s972
2158,AIMed.d115,False,"Here we show that the general transcription factor PROTEIN1 is also a target for a transcriptional activator, namely PROTEIN ( PROTEIN2 , which binds to the PROTEIN promoter.",AIMed.d115.s972
2159,AIMed.d115,False,"Here we show that the general transcription factor PROTEIN is also a target for a transcriptional activator, namely PROTEIN1 ( PROTEIN2 , which binds to the PROTEIN promoter.",AIMed.d115.s972
2160,AIMed.d115,False,"Here we show that the general transcription factor PROTEIN1 is also a target for a transcriptional activator, namely PROTEIN2 ( PROTEIN , which binds to the PROTEIN promoter.",AIMed.d115.s972
2161,AIMed.d115,False,"Using a yeast interaction assay, we find that PROTEIN1 binds the PROTEIN subunit of PROTEIN and that PROTEIN2 s transcriptional activation domain is the region involved in this binding.",AIMed.d115.s973
2162,AIMed.d115,False,"Using a yeast interaction assay, we find that PROTEIN binds the PROTEIN subunit of PROTEIN1 and that PROTEIN2 s transcriptional activation domain is the region involved in this binding.",AIMed.d115.s973
2163,AIMed.d115,False,"Using a yeast interaction assay, we find that PROTEIN binds the PROTEIN1 subunit of PROTEIN and that PROTEIN2 s transcriptional activation domain is the region involved in this binding.",AIMed.d115.s973
2164,AIMed.d115,False,"Using a yeast interaction assay, we find that PROTEIN1 binds the PROTEIN subunit of PROTEIN2 and that PROTEIN s transcriptional activation domain is the region involved in this binding.",AIMed.d115.s973
2165,AIMed.d115,True,"Using a yeast interaction assay, we find that PROTEIN1 binds the PROTEIN2 subunit of PROTEIN and that PROTEIN s transcriptional activation domain is the region involved in this binding.",AIMed.d115.s973
2166,AIMed.d115,False,"Using a yeast interaction assay, we find that PROTEIN binds the PROTEIN1 subunit of PROTEIN2 and that PROTEIN s transcriptional activation domain is the region involved in this binding.",AIMed.d115.s973
2167,AIMed.d115,False,"Further, PROTEIN1 s central charged cluster domain is required for binding to PROTEIN2 s activation domain.",AIMed.d115.s974
2168,AIMed.d115,False,Deletion of this domain impairs PROTEIN s ability to support PROTEIN1 activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support PROTEIN2 activated transcription.,AIMed.d115.s975
2169,AIMed.d115,False,Deletion of this domain impairs PROTEIN1 s ability to support PROTEIN activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support PROTEIN2 activated transcription.,AIMed.d115.s975
2170,AIMed.d115,False,Deletion of this domain impairs PROTEIN1 s ability to support PROTEIN2 activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support PROTEIN activated transcription.,AIMed.d115.s975
2171,AIMed.d115,False,The correlation of PROTEIN PROTEIN1 binding with transcriptional activation suggests that PROTEIN is a critical target for PROTEIN2 activated transcription.,AIMed.d115.s976
2172,AIMed.d115,True,The correlation of PROTEIN1 PROTEIN2 binding with transcriptional activation suggests that PROTEIN is a critical target for PROTEIN activated transcription.,AIMed.d115.s976
2173,AIMed.d115,False,The correlation of PROTEIN PROTEIN1 binding with transcriptional activation suggests that PROTEIN2 is a critical target for PROTEIN activated transcription.,AIMed.d115.s976
2174,AIMed.d115,False,The correlation of PROTEIN1 PROTEIN binding with transcriptional activation suggests that PROTEIN is a critical target for PROTEIN2 activated transcription.,AIMed.d115.s976
2175,AIMed.d115,True,The correlation of PROTEIN PROTEIN binding with transcriptional activation suggests that PROTEIN1 is a critical target for PROTEIN2 activated transcription.,AIMed.d115.s976
2176,AIMed.d115,False,The correlation of PROTEIN1 PROTEIN binding with transcriptional activation suggests that PROTEIN2 is a critical target for PROTEIN activated transcription.,AIMed.d115.s976
2177,AIMed.d116,True,Activity of RNA polymerase I transcription factor PROTEIN1 blocked by PROTEIN2 gene product.,AIMed.d116.s977
2178,AIMed.d116,False,The protein encoded by the PROTEIN1 ( PROTEIN2 functions as a tumour suppressor and negative growth regulator.,AIMed.d116.s978
2179,AIMed.d116,True,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN1 specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN2 ( PROTEIN in vitro.,AIMed.d116.s980
2180,AIMed.d116,True,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN1 specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN2 in vitro.,AIMed.d116.s980
2181,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN1 protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN2 specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN in vitro.,AIMed.d116.s980
2182,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN1 pocket; and (4) PROTEIN2 specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN in vitro.,AIMed.d116.s980
2183,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN1 to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN2 specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN in vitro.,AIMed.d116.s980
2184,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN1 ( PROTEIN2 in vitro.,AIMed.d116.s980
2185,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN1 protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN2 ( PROTEIN in vitro.,AIMed.d116.s980
2186,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN1 pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN2 ( PROTEIN in vitro.,AIMed.d116.s980
2187,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN1 to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN2 ( PROTEIN in vitro.,AIMed.d116.s980
2188,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN1 protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN2 in vitro.,AIMed.d116.s980
2189,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN1 pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN2 in vitro.,AIMed.d116.s980
2190,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN1 to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN2 in vitro.,AIMed.d116.s980
2191,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN1 protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN2 pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN in vitro.,AIMed.d116.s980
2192,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN1 protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN2 to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN in vitro.,AIMed.d116.s980
2193,AIMed.d116,False,Here we report that (1) there is an accumulation of PROTEIN protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of PROTEIN1 to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional PROTEIN2 pocket; and (4) PROTEIN specifically inhibits the activity of the RNA polymerase I transcription factor PROTEIN ( PROTEIN in vitro.,AIMed.d116.s980
2194,AIMed.d116,True,"This last observation was confirmed by affinity chromatography and immunoprecipitation, which demonstrated an interaction between PROTEIN1 and PROTEIN2 ",AIMed.d116.s981
2195,AIMed.d116,False,"These results indicate that there is an additional mechanism by which PROTEIN1 suppresses cell growth, namely that PROTEIN2 directly represses transcription of the rRNA genes.",AIMed.d116.s982
2196,AIMed.d117,False,The beta: PROTEIN1 homodimer and alpha: PROTEIN2 heterodimer are mutual antagonists which share a common beta subunit.,AIMed.d117.s984
2197,AIMed.d117,False,"Activin type I receptors, PROTEIN1 and PROTEIN2 were first cloned from well differentiated human hepatoma cells (HepG2).",AIMed.d117.s987
2198,AIMed.d117,False,Here we show that beta: PROTEIN1 binds to the PROTEIN ( PROTEIN which induces activin binding to the type I receptor kinase PROTEIN2 to form PROTEIN beta:beta.,AIMed.d117.s989
2199,AIMed.d117,True,Here we show that beta: PROTEIN1 binds to the PROTEIN ( PROTEIN2 which induces activin binding to the type I receptor kinase PROTEIN to form PROTEIN beta:beta.,AIMed.d117.s989
2200,AIMed.d117,False,Here we show that beta: PROTEIN1 binds to the PROTEIN ( PROTEIN which induces activin binding to the type I receptor kinase PROTEIN to form PROTEIN2 beta:beta.,AIMed.d117.s989
2201,AIMed.d117,True,Here we show that beta: PROTEIN1 binds to the PROTEIN2 ( PROTEIN which induces activin binding to the type I receptor kinase PROTEIN to form PROTEIN beta:beta.,AIMed.d117.s989
2202,AIMed.d117,False,Here we show that beta: PROTEIN binds to the PROTEIN ( PROTEIN1 which induces activin binding to the type I receptor kinase PROTEIN2 to form PROTEIN beta:beta.,AIMed.d117.s989
2203,AIMed.d117,False,Here we show that beta: PROTEIN binds to the PROTEIN ( PROTEIN which induces activin binding to the type I receptor kinase PROTEIN1 to form PROTEIN2 beta:beta.,AIMed.d117.s989
2204,AIMed.d117,False,Here we show that beta: PROTEIN binds to the PROTEIN1 ( PROTEIN which induces activin binding to the type I receptor kinase PROTEIN2 to form PROTEIN beta:beta.,AIMed.d117.s989
2205,AIMed.d117,False,Here we show that beta: PROTEIN binds to the PROTEIN ( PROTEIN1 which induces activin binding to the type I receptor kinase PROTEIN to form PROTEIN2 beta:beta.,AIMed.d117.s989
2206,AIMed.d117,False,Here we show that beta: PROTEIN binds to the PROTEIN1 ( PROTEIN2 which induces activin binding to the type I receptor kinase PROTEIN to form PROTEIN beta:beta.,AIMed.d117.s989
2207,AIMed.d117,False,Here we show that beta: PROTEIN binds to the PROTEIN1 ( PROTEIN which induces activin binding to the type I receptor kinase PROTEIN to form PROTEIN2 beta:beta.,AIMed.d117.s989
2208,AIMed.d117,False, PROTEIN1 complexes in which an PROTEIN2 chain occupies each receptor subunit.,AIMed.d117.s990
2209,AIMed.d117,False," PROTEIN1 also binds to PROTEIN through its beta subunit, competes with the binding of activin to PROTEIN but fails to form the PROTEIN2 ",AIMed.d117.s991
2210,AIMed.d117,True," PROTEIN1 also binds to PROTEIN2 through its beta subunit, competes with the binding of activin to PROTEIN but fails to form the PROTEIN ",AIMed.d117.s991
2211,AIMed.d117,False," PROTEIN1 also binds to PROTEIN through its beta subunit, competes with the binding of activin to PROTEIN2 but fails to form the PROTEIN ",AIMed.d117.s991
2212,AIMed.d117,False," PROTEIN also binds to PROTEIN1 through its beta subunit, competes with the binding of activin to PROTEIN but fails to form the PROTEIN2 ",AIMed.d117.s991
2213,AIMed.d117,False," PROTEIN also binds to PROTEIN through its beta subunit, competes with the binding of activin to PROTEIN1 but fails to form the PROTEIN2 ",AIMed.d117.s991
2214,AIMed.d117,False," PROTEIN also binds to PROTEIN1 through its beta subunit, competes with the binding of activin to PROTEIN2 but fails to form the PROTEIN ",AIMed.d117.s991
2215,AIMed.d118,True,The PROTEIN1 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PROTEIN2 ,AIMed.d118.s996
2216,AIMed.d118,False,The PROTEIN1 tumour-suppressor protein controls the expression of a gene encoding the PROTEIN2 cyclin-dependent protein kinase (CDK) regulator.,AIMed.d118.s997
2217,AIMed.d118,False,Levels of PROTEIN1 protein are increased in senescent cells and PROTEIN2 overexpression blocks the growth of tumour cells.,AIMed.d118.s998
2218,AIMed.d118,True,"In normal human cells, but not in many tumour cells, PROTEIN1 exists in a quaternary complex with a cyclin, a CDK, and the PROTEIN ( PROTEIN2 .",AIMed.d118.s999
2219,AIMed.d118,True,"In normal human cells, but not in many tumour cells, PROTEIN1 exists in a quaternary complex with a cyclin, a CDK, and the PROTEIN2 ( PROTEIN .",AIMed.d118.s999
2220,AIMed.d118,False,"In normal human cells, but not in many tumour cells, PROTEIN exists in a quaternary complex with a cyclin, a CDK, and the PROTEIN1 ( PROTEIN2 .",AIMed.d118.s999
2221,AIMed.d118,False," PROTEIN1 controls CDK activity, thereby affecting cell-cycle control, whereas PROTEIN2 functions in both DNA replication and repair.",AIMed.d118.s1000
2222,AIMed.d118,True,Here we use simian virus 40 DNA replication in vitro to show than PROTEIN1 directly inhibits PROTEIN2 dependent DNA replication in the absence of a cyclin/CDK.,AIMed.d118.s1001
2223,AIMed.d118,False,"Furthermore, PROTEIN1 blocks the ability of PROTEIN to activate PROTEIN2 the principal replicative DNA polymerase.",AIMed.d118.s1002
2224,AIMed.d118,True,"Furthermore, PROTEIN1 blocks the ability of PROTEIN2 to activate PROTEIN the principal replicative DNA polymerase.",AIMed.d118.s1002
2225,AIMed.d118,True,"Furthermore, PROTEIN blocks the ability of PROTEIN1 to activate PROTEIN2 the principal replicative DNA polymerase.",AIMed.d118.s1002
2226,AIMed.d118,True,This regulation results from a direct interaction between PROTEIN1 and PROTEIN2 ,AIMed.d118.s1003
2227,AIMed.d118,False,"Thus, during PROTEIN1 mediated suppression of cell proliferation, PROTEIN2 and PROTEIN may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.",AIMed.d118.s1004
2228,AIMed.d118,False,"Thus, during PROTEIN1 mediated suppression of cell proliferation, PROTEIN and PROTEIN2 may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.",AIMed.d118.s1004
2229,AIMed.d118,False,"Thus, during PROTEIN mediated suppression of cell proliferation, PROTEIN1 and PROTEIN2 may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.",AIMed.d118.s1004
2230,AIMed.d119,True,Nuclear protein PROTEIN1 is a coactivator for the transcription factor PROTEIN2 ,AIMed.d119.s1005
2231,AIMed.d119,True," PROTEIN1 is activated through phosphorylation by PROTEIN2 ( PROTEIN , but precisely how phosphorylation stimulates PROTEIN function is unknown.",AIMed.d119.s1007
2232,AIMed.d119,False," PROTEIN1 is activated through phosphorylation by PROTEIN ( PROTEIN , but precisely how phosphorylation stimulates PROTEIN2 function is unknown.",AIMed.d119.s1007
2233,AIMed.d119,True," PROTEIN1 is activated through phosphorylation by PROTEIN ( PROTEIN2 , but precisely how phosphorylation stimulates PROTEIN function is unknown.",AIMed.d119.s1007
2234,AIMed.d119,False," PROTEIN is activated through phosphorylation by PROTEIN1 ( PROTEIN , but precisely how phosphorylation stimulates PROTEIN2 function is unknown.",AIMed.d119.s1007
2235,AIMed.d119,False," PROTEIN is activated through phosphorylation by PROTEIN1 ( PROTEIN2 , but precisely how phosphorylation stimulates PROTEIN function is unknown.",AIMed.d119.s1007
2236,AIMed.d119,False," PROTEIN is activated through phosphorylation by PROTEIN ( PROTEIN1 , but precisely how phosphorylation stimulates PROTEIN2 function is unknown.",AIMed.d119.s1007
2237,AIMed.d119,True,"We have previously identified a nuclear protein of M(r)265K, PROTEIN that binds specifically to the PROTEIN1 phosphorylated form of PROTEIN2 ",AIMed.d119.s1009
2238,AIMed.d119,False,"We have previously identified a nuclear protein of M(r)265K, PROTEIN1 that binds specifically to the PROTEIN2 phosphorylated form of PROTEIN ",AIMed.d119.s1009
2239,AIMed.d119,True,"We have previously identified a nuclear protein of M(r)265K, PROTEIN1 that binds specifically to the PROTEIN phosphorylated form of PROTEIN2 ",AIMed.d119.s1009
2240,AIMed.d119,False,We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the PROTEIN PROTEIN1 interaction and report here that PROTEIN2 can activate transcription through a region in its carboxy terminus.,AIMed.d119.s1010
2241,AIMed.d119,True,We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the PROTEIN1 PROTEIN2 interaction and report here that PROTEIN can activate transcription through a region in its carboxy terminus.,AIMed.d119.s1010
2242,AIMed.d119,False,We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the PROTEIN1 PROTEIN interaction and report here that PROTEIN2 can activate transcription through a region in its carboxy terminus.,AIMed.d119.s1010
2243,AIMed.d119,False,The activation domain of PROTEIN1 interacts with the basal transcription factor PROTEIN2 through a domain that is conserved in the yeast coactivator PROTEIN (ref. 8).,AIMed.d119.s1011
2244,AIMed.d119,False,The activation domain of PROTEIN interacts with the basal transcription factor PROTEIN1 through a domain that is conserved in the yeast coactivator PROTEIN2 (ref. 8).,AIMed.d119.s1011
2245,AIMed.d119,True,The activation domain of PROTEIN1 interacts with the basal transcription factor PROTEIN through a domain that is conserved in the yeast coactivator PROTEIN2 (ref. 8).,AIMed.d119.s1011
2246,AIMed.d119,True,"Consistent with its role as a coactivator, PROTEIN1 augments the activity of phosphorylated PROTEIN2 to activate transcription of cAMP-responsive genes.",AIMed.d119.s1012
2247,AIMed.d120,True,"Specific binding of the transglutaminase, PROTEIN1 to PROTEIN2 ",AIMed.d120.s1013
2248,AIMed.d120,False,"However, the function of PROTEIN1 and the identity of proteins that interact with PROTEIN2 remain unknown.",AIMed.d120.s1016
2249,AIMed.d120,False,"To identify specific PROTEIN1 protein interactions, a recombinant fusion protein affinity reagent was constructed and used to identify proteins associating with PROTEIN2 from human platelet lysates and erythroleukemia cells.",AIMed.d120.s1017
2250,AIMed.d120,True,Immunoblotting studies were used to confirm the binding of PROTEIN1 from fresh platelet lysates to the PROTEIN2 fusion protein.,AIMed.d120.s1020
2251,AIMed.d120,True, PROTEIN1 also was shown to coprecipitate with PROTEIN2 in immunoprecipitation studies and to colocalize with PROTEIN in immunofluorescence studies of intact glass-activated platelets.,AIMed.d120.s1021
2252,AIMed.d120,False, PROTEIN also was shown to coprecipitate with PROTEIN1 in immunoprecipitation studies and to colocalize with PROTEIN2 in immunofluorescence studies of intact glass-activated platelets.,AIMed.d120.s1021
2253,AIMed.d120,False, PROTEIN1 also was shown to coprecipitate with PROTEIN in immunoprecipitation studies and to colocalize with PROTEIN2 in immunofluorescence studies of intact glass-activated platelets.,AIMed.d120.s1021
2254,AIMed.d120,False,The data thus demonstrate specific binding of platelet PROTEIN1 to PROTEIN and suggest that PROTEIN2 may participate in the cellular localization and/or enzymatic regulation of platelet PROTEIN ,AIMed.d120.s1022
2255,AIMed.d120,True,The data thus demonstrate specific binding of platelet PROTEIN1 to PROTEIN2 and suggest that PROTEIN may participate in the cellular localization and/or enzymatic regulation of platelet PROTEIN ,AIMed.d120.s1022
2256,AIMed.d120,False,The data thus demonstrate specific binding of platelet PROTEIN1 to PROTEIN and suggest that PROTEIN may participate in the cellular localization and/or enzymatic regulation of platelet PROTEIN2 ,AIMed.d120.s1022
2257,AIMed.d120,False,The data thus demonstrate specific binding of platelet PROTEIN to PROTEIN1 and suggest that PROTEIN2 may participate in the cellular localization and/or enzymatic regulation of platelet PROTEIN ,AIMed.d120.s1022
2258,AIMed.d120,True,The data thus demonstrate specific binding of platelet PROTEIN to PROTEIN and suggest that PROTEIN1 may participate in the cellular localization and/or enzymatic regulation of platelet PROTEIN2 ,AIMed.d120.s1022
2259,AIMed.d120,False,The data thus demonstrate specific binding of platelet PROTEIN to PROTEIN1 and suggest that PROTEIN may participate in the cellular localization and/or enzymatic regulation of platelet PROTEIN2 ,AIMed.d120.s1022
2260,AIMed.d121,True,"Several hydrophobic amino acids in the PROTEIN1 amino-terminal domain are required for transcriptional activation, binding to PROTEIN and the adenovirus PROTE PROTEIN 55-kD protein.",AIMed.d121.s1023
2261,AIMed.d121,False,"Several hydrophobic amino acids in the PROTEIN amino-terminal domain are required for transcriptional activation, binding to PROTEIN and the adenovirus PROTE PROTEIN2 55-kD protein.",AIMed.d121.s1023
2262,AIMed.d121,False,"Several hydrophobic amino acids in the PROTEIN amino-terminal domain are required for transcriptional activation, binding to PROTEIN1 and the adenovirus PROTE PROTEIN 55-kD protein.",AIMed.d121.s1023
2263,AIMed.d121,False,"Several hydrophobic amino acids in the PROTEIN1 amino-terminal domain are required for transcriptional activation, binding to PROTEIN and the adenovirus PROT PROTEIN2 55-kD protein.",AIMed.d121.s1023
2264,AIMed.d121,True,"Several hydrophobic amino acids in the PROTEIN1 amino-terminal domain are required for transcriptional activation, binding to PROTEIN2 and the adenovirus PROT PROTEIN 55-kD protein.",AIMed.d121.s1023
2265,AIMed.d121,False,"Several hydrophobic amino acids in the PROTEIN amino-terminal domain are required for transcriptional activation, binding to PROTEIN1 and the adenovirus PROT PROTEIN2 55-kD protein.",AIMed.d121.s1023
2266,AIMed.d121,False,The acidic amino terminus of the PROTEIN protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN1 and adenovirus PROT PROTEIN2 55-kD protein binding.,AIMed.d121.s1025
2267,AIMed.d121,True,The acidic amino terminus of the PROTEIN1 protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN2 and adenovirus PROT PROTEIN 55-kD protein binding.,AIMed.d121.s1025
2268,AIMed.d121,False,The acidic amino terminus of the PROTEIN protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN1 and adenovirus PROTE PROTEIN 55-kD protein binding.,AIMed.d121.s1025
2269,AIMed.d121,False,The acidic amino terminus of the PROTEIN1 protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN and adenovirus PROT PROTEIN2 55-kD protein binding.,AIMed.d121.s1025
2270,AIMed.d121,False,The acidic amino terminus of the PROTEIN protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN and adenovirus PROTE PROTEIN2 55-kD protein binding.,AIMed.d121.s1025
2271,AIMed.d121,True,The acidic amino terminus of the PROTEIN1 protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN and adenovirus PROTE PROTEIN 55-kD protein binding.,AIMed.d121.s1025
2272,AIMed.d121,True,"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN1 are both required for trans-activation activity, binding to the adenovirus PROTEIN2 55-kD protein and the human PROTEIN PROTEIN protein in vitro.",AIMed.d121.s1028
2273,AIMed.d121,False,"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN are both required for trans-activation activity, binding to the adenovirus PROTEIN1 55-kD protein and the human PROTEIN PROTEIN2 protein in vitro.",AIMed.d121.s1028
2274,AIMed.d121,False,"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN are both required for trans-activation activity, binding to the adenovirus PROTEIN1 55-kD protein and the human PROTEIN2 PROTEIN protein in vitro.",AIMed.d121.s1028
2275,AIMed.d121,False,"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN1 are both required for trans-activation activity, binding to the adenovirus PROTEIN 55-kD protein and the human PROTEIN PROTEIN2 protein in vitro.",AIMed.d121.s1028
2276,AIMed.d121,False,"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN1 are both required for trans-activation activity, binding to the adenovirus PROTEIN 55-kD protein and the human PROTEIN2 PROTEIN protein in vitro.",AIMed.d121.s1028
2277,AIMed.d121,True,"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN are both required for trans-activation activity, binding to the adenovirus PROTEIN 55-kD protein and the human PROTEIN1 PROTEIN2 protein in vitro.",AIMed.d121.s1028
2278,AIMed.d121,True,"In addition, hydrophobic residues Leu-14 and Phe-19 are crucial for the interactions between PROTEIN1 and human PROTEIN2 ( PROTEIN .",AIMed.d121.s1029
2279,AIMed.d121,True,"In addition, hydrophobic residues Leu-14 and Phe-19 are crucial for the interactions between PROTEIN1 and human PROTEIN ( PROTEIN2 .",AIMed.d121.s1029
2280,AIMed.d121,False,"In addition, hydrophobic residues Leu-14 and Phe-19 are crucial for the interactions between PROTEIN and human PROTEIN1 ( PROTEIN2 .",AIMed.d121.s1029
2281,AIMed.d121,False,These mutations have no impact on the ability of the PROTEIN1 protein to bind to a PROTEIN2 specific DNA element.,AIMed.d121.s1031
2282,AIMed.d121,False,These very same hydrophobic residues contact the PROTEIN1 and Ad5 PROTEIN2 55-kD oncogene products.,AIMed.d121.s1033
2283,AIMed.d122,True,"In previous studies (Scott, J. D., Stofko, R. E., McDonald, J. R., Comer, J. D., Vitalis, E. A., and Mangili J. (1990) J. Biol. Chem. 265, 21561-21566) we have shown that dimerization of PROTEIN1 was required for interaction with the cytoskeletal component PROTEIN2 ",AIMed.d122.s1036
2284,AIMed.d122,True,"Measurement of PROTEIN1 I3A,I5A interaction with the human PROTEIN PROTEIN2 by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.",AIMed.d122.s1041
2285,AIMed.d122,False,"Measurement of PROTEIN I3A,I5A interaction with the human PROTEIN1 PROTEIN2 by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.",AIMed.d122.s1041
2286,AIMed.d122,True,"Measurement of PROTEIN1 I3A,I5A interaction with the human PROTEIN2 PROTEIN by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.",AIMed.d122.s1041
2287,AIMed.d123,True,Characterization of an interaction between PROTEIN1 and the PROTEIN2 by using the two-hybrid system.,AIMed.d123.s1043
2288,AIMed.d123,False, PROTEIN1 ( PROTEIN is a major substrate of the PROTEIN and has been implicated in PROTEIN2 signaling.,AIMed.d123.s1044
2289,AIMed.d123,False, PROTEIN ( PROTEIN is a major substrate of the PROTEIN1 and has been implicated in PROTEIN2 signaling.,AIMed.d123.s1044
2290,AIMed.d123,False, PROTEIN ( PROTEIN1 is a major substrate of the PROTEIN and has been implicated in PROTEIN2 signaling.,AIMed.d123.s1044
2291,AIMed.d123,True, PROTEIN1 ( PROTEIN is a major substrate of the PROTEIN2 and has been implicated in PROTEIN signaling.,AIMed.d123.s1044
2292,AIMed.d123,False, PROTEIN1 ( PROTEIN2 is a major substrate of the PROTEIN and has been implicated in PROTEIN signaling.,AIMed.d123.s1044
2293,AIMed.d123,True, PROTEIN ( PROTEIN1 is a major substrate of the PROTEIN2 and has been implicated in PROTEIN signaling.,AIMed.d123.s1044
2294,AIMed.d123,True,Although PROTEIN1 is thought to interact with the PROTEIN2 the nature of the interaction has not been defined.,AIMed.d123.s1045
2295,AIMed.d123,False,"Although PROTEIN is thought to interact with the PROTEIN1 receptor, the nature of the interaction has not been defined.",AIMed.d123.s1045
2296,AIMed.d123,False,"Although PROTEIN1 is thought to interact with the PROTEIN2 receptor, the nature of the interaction has not been defined.",AIMed.d123.s1045
2297,AIMed.d123,False,"In this study, we used the two-hybrid assay of protein-protein interaction in the yeast Saccharomyces cerevisiae to study the interaction between human PROTEIN1 and the PROTEIN2 receptor.",AIMed.d123.s1046
2298,AIMed.d123,True,"In this study, we used the two-hybrid assay of protein-protein interaction in the yeast Saccharomyces cerevisiae to study the interaction between human PROTEIN1 and the PROTEIN2 ",AIMed.d123.s1046
2299,AIMed.d123,False,"In this study, we used the two-hybrid assay of protein-protein interaction in the yeast Saccharomyces cerevisiae to study the interaction between human PROTEIN and the PROTEIN1 receptor.",AIMed.d123.s1046
2300,AIMed.d123,True,We demonstrate that PROTEIN1 forms a specific complex with the cytoplasmic domain of the PROTEIN2 when both are expressed as hybrid proteins in yeast cells.,AIMed.d123.s1047
2301,AIMed.d123,False,"Lastly, in agreement with our findings for yeast cells, we show that the PROTEIN1 is unable to phosphorylate an PROTEIN2 protein containing a deletion of amino acids 45 to 516 when expressed in COS cells.",AIMed.d123.s1052
2302,AIMed.d124,True,"The protein PROTEIN1 a key mediator of mitogenesis and differentiation, associates with PROTEIN2 (refs 1-3).",AIMed.d124.s1055
2303,AIMed.d124,False,"These proteins, PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN2 , are members of the 14-3-3 family of proteins.",AIMed.d124.s1058
2304,AIMed.d124,False,"These proteins, PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN2 , are members of the 14-3-3 family of proteins.",AIMed.d124.s1058
2305,AIMed.d124,False,"These proteins, PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN2 , are members of the 14-3-3 family of proteins.",AIMed.d124.s1058
2306,AIMed.d124,False,"These proteins, PROTEIN1 ( PROTEIN and PROTEIN2 ( PROTEIN , are members of the 14-3-3 family of proteins.",AIMed.d124.s1058
2307,AIMed.d124,False,"These proteins, PROTEIN ( PROTEIN1 and PROTEIN2 ( PROTEIN , are members of the 14-3-3 family of proteins.",AIMed.d124.s1058
2308,AIMed.d124,False,"These proteins, PROTEIN1 ( PROTEIN2 and PROTEIN ( PROTEIN , are members of the 14-3-3 family of proteins.",AIMed.d124.s1058
2309,AIMed.d124,False,Expression of 14-3-3 proteins in Xenopus oocytes enhanced PROTEIN1 activity and promoted PROTEIN2 dependent oocyte maturation.,AIMed.d124.s1059
2310,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN family, including PROTEIN1 PROTEIN PROTEIN and PROTEIN2 were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2311,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN family, including PROTEIN PROTEIN1 PROTEIN and PROTEIN2 were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2312,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN family, including PROTEIN PROTEIN PROTEIN1 and PROTEIN2 were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2313,AIMed.d125,True,"Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN family, including PROTEIN PROTEIN PROTEIN and PROTEIN2 were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2314,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN1 family, including PROTEIN PROTEIN PROTEIN and PROTEIN2 were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2315,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN family, including PROTEIN1 PROTEIN2 PROTEIN and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2316,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN family, including PROTEIN1 PROTEIN PROTEIN2 and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2317,AIMed.d125,True,"Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN family, including PROTEIN2 PROTEIN PROTEIN and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2318,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN1 family, including PROTEIN2 PROTEIN PROTEIN and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2319,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN family, including PROTEIN PROTEIN1 PROTEIN2 and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2320,AIMed.d125,True,"Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN family, including PROTEIN PROTEIN2 PROTEIN and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2321,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN1 family, including PROTEIN PROTEIN2 PROTEIN and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2322,AIMed.d125,True,"Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN family, including PROTEIN PROTEIN PROTEIN2 and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2323,AIMed.d125,False,"Interactions of the PROTEIN protein with itself and other members of the PROTEIN1 family, including PROTEIN PROTEIN PROTEIN2 and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2324,AIMed.d125,False,"Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN2 family, including PROTEIN PROTEIN PROTEIN and PROTEIN were explored with a yeast two-hybrid system.",AIMed.d125.s1062
2325,AIMed.d125,True, PROTEIN1 also interacted with PROTEIN and PROTEIN2 and with the dominant inhibitors PROTEIN and PROTEIN ,AIMed.d125.s1066
2326,AIMed.d125,False, PROTEIN also interacted with PROTEIN1 and PROTEIN2 and with the dominant inhibitors PROTEIN and PROTEIN ,AIMed.d125.s1066
2327,AIMed.d125,False, PROTEIN also interacted with PROTEIN and PROTEIN1 and with the dominant inhibitors PROTEIN and PROTEIN2 ,AIMed.d125.s1066
2328,AIMed.d125,False, PROTEIN also interacted with PROTEIN and PROTEIN1 and with the dominant inhibitors PROTEIN2 and PROTEIN ,AIMed.d125.s1066
2329,AIMed.d125,True, PROTEIN1 also interacted with PROTEIN2 and PROTEIN and with the dominant inhibitors PROTEIN and PROTEIN ,AIMed.d125.s1066
2330,AIMed.d125,True, PROTEIN1 also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN and PROTEIN2 ,AIMed.d125.s1066
2331,AIMed.d125,True, PROTEIN1 also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN2 and PROTEIN ,AIMed.d125.s1066
2332,AIMed.d125,False, PROTEIN also interacted with PROTEIN1 and PROTEIN and with the dominant inhibitors PROTEIN and PROTEIN2 ,AIMed.d125.s1066
2333,AIMed.d125,False, PROTEIN also interacted with PROTEIN1 and PROTEIN and with the dominant inhibitors PROTEIN2 and PROTEIN ,AIMed.d125.s1066
2334,AIMed.d125,False, PROTEIN also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN1 and PROTEIN2 ,AIMed.d125.s1066
2335,AIMed.d125,False, PROTEIN1 displayed the same pattern of combinatorial interactions with PROTEIN2 family proteins as PROTEIN ,AIMed.d125.s1067
2336,AIMed.d125,False, PROTEIN1 displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN2 ,AIMed.d125.s1067
2337,AIMed.d125,False, PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN1 family proteins as PROTEIN2 ,AIMed.d125.s1067
2338,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN1 protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN2 amino acids 83-218.",AIMed.d125.s1068
2339,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN1 homodimerization involves interactions between two distinct regions within the PROTEIN2 protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2340,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN1 protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN2 amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2341,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN1 protein, since a LexA protein containing PROTEIN2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2342,AIMed.d125,False,"Use of deletion mutants of PROTEIN1 suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN2 protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2343,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN1 homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN2 amino acids 83-218.",AIMed.d125.s1068
2344,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN1 amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN2 amino acids 83-218.",AIMed.d125.s1068
2345,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN1 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN2 amino acids 83-218.",AIMed.d125.s1068
2346,AIMed.d125,False,"Use of deletion mutants of PROTEIN1 suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN2 amino acids 83-218.",AIMed.d125.s1068
2347,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN1 homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN2 amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2348,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN1 homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2349,AIMed.d125,False,"Use of deletion mutants of PROTEIN1 suggested that PROTEIN2 homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2350,AIMed.d125,False,"Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN1 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN2 amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2351,AIMed.d125,False,"Use of deletion mutants of PROTEIN1 suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN2 amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2352,AIMed.d125,False,"Use of deletion mutants of PROTEIN1 suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein, since a LexA protein containing PROTEIN2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218.",AIMed.d125.s1068
2353,AIMed.d125,False,"In contrast to LexA/ PROTEIN1 fusion proteins, expression of a LexA/ PROTEIN2 protein was lethal to yeast.",AIMed.d125.s1069
2354,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN PROTEIN1 or PROTEIN but not those containing PROTEIN2 (an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2355,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN PROTEIN or PROTEIN but not those containing PROTEIN1 (an alternatively spliced form of PROTEIN2 that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2356,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN1 PROTEIN or PROTEIN but not those containing PROTEIN2 (an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2357,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN PROTEIN or PROTEIN1 but not those containing PROTEIN2 (an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2358,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN PROTEIN1 or PROTEIN but not those containing PROTEIN (an alternatively spliced form of PROTEIN2 that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2359,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN1 PROTEIN2 or PROTEIN but not those containing PROTEIN (an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2360,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN PROTEIN1 or PROTEIN2 but not those containing PROTEIN (an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2361,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN1 PROTEIN or PROTEIN but not those containing PROTEIN (an alternatively spliced form of PROTEIN2 that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2362,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN PROTEIN or PROTEIN1 but not those containing PROTEIN (an alternatively spliced form of PROTEIN2 that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2363,AIMed.d125,False,This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN1 PROTEIN or PROTEIN2 but not those containing PROTEIN (an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region).,AIMed.d125.s1070
2364,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN1 PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN2 homodimerization.",AIMed.d125.s1071
2365,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN1 function, and indicate that requirements for PROTEIN2 PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2366,AIMed.d125,True,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN1 PROTEIN2 heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2367,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN1 differentially regulate PROTEIN function, and indicate that requirements for PROTEIN2 PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2368,AIMed.d125,False,"The findings suggest a model whereby PROTEIN1 and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN2 PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2369,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN1 PROTEIN heterodimerization may be different from those for PROTEIN2 PROTEIN homodimerization.",AIMed.d125.s1071
2370,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN1 function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN2 homodimerization.",AIMed.d125.s1071
2371,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN1 heterodimerization may be different from those for PROTEIN PROTEIN2 homodimerization.",AIMed.d125.s1071
2372,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN1 differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN2 homodimerization.",AIMed.d125.s1071
2373,AIMed.d125,False,"The findings suggest a model whereby PROTEIN1 and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN2 homodimerization.",AIMed.d125.s1071
2374,AIMed.d125,True,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN1 PROTEIN2 homodimerization.",AIMed.d125.s1071
2375,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN1 function, and indicate that requirements for PROTEIN PROTEIN2 heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2376,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN1 differentially regulate PROTEIN2 function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2377,AIMed.d125,False,"The findings suggest a model whereby PROTEIN1 and PROTEIN differentially regulate PROTEIN2 function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2378,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN1 function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN2 PROTEIN homodimerization.",AIMed.d125.s1071
2379,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN1 differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN2 heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2380,AIMed.d125,False,"The findings suggest a model whereby PROTEIN1 and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN2 heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2381,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN1 heterodimerization may be different from those for PROTEIN2 PROTEIN homodimerization.",AIMed.d125.s1071
2382,AIMed.d125,False,"The findings suggest a model whereby PROTEIN1 and PROTEIN2 differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN PROTEIN homodimerization.",AIMed.d125.s1071
2383,AIMed.d125,False,"The findings suggest a model whereby PROTEIN and PROTEIN1 differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN2 PROTEIN homodimerization.",AIMed.d125.s1071
2384,AIMed.d125,False,"The findings suggest a model whereby PROTEIN1 and PROTEIN differentially regulate PROTEIN function, and indicate that requirements for PROTEIN PROTEIN heterodimerization may be different from those for PROTEIN2 PROTEIN homodimerization.",AIMed.d125.s1071
2385,AIMed.d126,False,The rates of commitment to renaturation of PROTEIN1 and PROTEIN2 in the presence of the groE chaperonins.,AIMed.d126.s1072
2386,AIMed.d126,False,"Using immunoprecipitation techniques, we have determined the rates at which PROTEIN1 and PROTEIN2 ( PROTEIN are released from PROTEIN in a form committed to refold to active enzyme.",AIMed.d126.s1074
2387,AIMed.d126,False,"Using immunoprecipitation techniques, we have determined the rates at which PROTEIN1 and PROTEIN ( PROTEIN2 are released from PROTEIN in a form committed to refold to active enzyme.",AIMed.d126.s1074
2388,AIMed.d126,True,"Using immunoprecipitation techniques, we have determined the rates at which PROTEIN1 and PROTEIN ( PROTEIN are released from PROTEIN2 in a form committed to refold to active enzyme.",AIMed.d126.s1074
2389,AIMed.d126,False,"Using immunoprecipitation techniques, we have determined the rates at which PROTEIN and PROTEIN1 ( PROTEIN2 are released from PROTEIN in a form committed to refold to active enzyme.",AIMed.d126.s1074
2390,AIMed.d126,True,"Using immunoprecipitation techniques, we have determined the rates at which PROTEIN and PROTEIN1 ( PROTEIN are released from PROTEIN2 in a form committed to refold to active enzyme.",AIMed.d126.s1074
2391,AIMed.d126,True,"Using immunoprecipitation techniques, we have determined the rates at which PROTEIN and PROTEIN ( PROTEIN1 are released from PROTEIN2 in a form committed to refold to active enzyme.",AIMed.d126.s1074
2392,AIMed.d126,True," PROTEIN and PROTEIN1 were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable ""folding arrested"" complexes with PROTEIN2 ",AIMed.d126.s1075
2393,AIMed.d126,False," PROTEIN1 and PROTEIN2 were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable ""folding arrested"" complexes with PROTEIN ",AIMed.d126.s1075
2394,AIMed.d126,True," PROTEIN1 and PROTEIN were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable ""folding arrested"" complexes with PROTEIN2 ",AIMed.d126.s1075
2395,AIMed.d126,False,"At 25 degrees C, the rate profiles indicate the release and commitment to folding of PROTEIN1 to its native state occurs far earlier (t1/2 < 1 min) than for PROTEIN2 (t1/2 = 5 min).",AIMed.d126.s1078
2396,AIMed.d126,False,"In contrast, the renaturation rate for PROTEIN1 with the groE chaperonins mirrored the committed renaturation rates following PROTEIN2 depletion.",AIMed.d126.s1080
2397,AIMed.d126,True,This suggests that PROTEIN1 must interact with PROTEIN2 throughout most of its folding reaction before it acquires a folding competent (groE independent) state.,AIMed.d126.s1081
2398,AIMed.d126,False,"If current models of chaperonin mechanism are correct, PROTEIN1 undergoes more rebinding and release cycles than does PROTEIN2 ",AIMed.d126.s1082
2399,AIMed.d127,True,Interaction of PROTEIN1 and gamma c chains with PROTEIN2 and PROTEIN implications for XSCID and XCID.,AIMed.d127.s1084
2400,AIMed.d127,True,Interaction of PROTEIN1 and gamma c chains with PROTEIN and PROTEIN2 implications for XSCID and XCID.,AIMed.d127.s1084
2401,AIMed.d127,False,Interaction of PROTEIN and gamma c chains with PROTEIN1 and PROTEIN2 implications for XSCID and XCID.,AIMed.d127.s1084
2402,AIMed.d127,False, PROTEIN ( PROTEIN1 signaling requires the dimerization of the PROTEIN2 ( PROTEIN and common gamma (gamma c) chains.,AIMed.d127.s1085
2403,AIMed.d127,False, PROTEIN ( PROTEIN1 signaling requires the dimerization of the PROTEIN2 receptor beta.( PROTEIN and common gamma (gamma c) chains.,AIMed.d127.s1085
2404,AIMed.d127,False, PROTEIN1 ( PROTEIN2 signaling requires the dimerization of the PROTEIN receptor beta.( PROTEIN and common gamma (gamma c) chains.,AIMed.d127.s1085
2405,AIMed.d127,False, PROTEIN ( PROTEIN1 signaling requires the dimerization of the PROTEIN receptor beta.( PROTEIN2 and common gamma (gamma c) chains.,AIMed.d127.s1085
2406,AIMed.d127,False, PROTEIN ( PROTEIN signaling requires the dimerization of the PROTEIN1 receptor beta.( PROTEIN and common gamma (gamma c) chains.,AIMed.d127.s1085
2407,AIMed.d127,False, PROTEIN1 ( PROTEIN signaling requires the dimerization of the PROTEIN2 ( PROTEIN and common gamma (gamma c) chains.,AIMed.d127.s1085
2408,AIMed.d127,False, PROTEIN ( PROTEIN signaling requires the dimerization of the PROTEIN1 ( PROTEIN2 and common gamma (gamma c) chains.,AIMed.d127.s1085
2409,AIMed.d127,False, PROTEIN1 ( PROTEIN signaling requires the dimerization of the PROTEIN2 receptor beta.( PROTEIN and common gamma (gamma c) chains.,AIMed.d127.s1085
2410,AIMed.d127,False, PROTEIN ( PROTEIN signaling requires the dimerization of the PROTEIN1 receptor beta.( PROTEIN2 and common gamma (gamma c) chains.,AIMed.d127.s1085
2411,AIMed.d127,False, PROTEIN1 ( PROTEIN signaling requires the dimerization of the PROTEIN receptor beta.( PROTEIN2 and common gamma (gamma c) chains.,AIMed.d127.s1085
2412,AIMed.d127,False," PROTEIN1 PROTEIN2 PROTEIN (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN ",AIMed.d127.s1087
2413,AIMed.d127,False," PROTEIN1 PROTEIN PROTEIN2 (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN ",AIMed.d127.s1087
2414,AIMed.d127,False," PROTEIN1 PROTEIN PROTEIN (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN2 and PROTEIN ",AIMed.d127.s1087
2415,AIMed.d127,False," PROTEIN1 PROTEIN PROTEIN (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN2 ",AIMed.d127.s1087
2416,AIMed.d127,False," PROTEIN1 PROTEIN PROTEIN (whose receptors are known to contain gamma c), and PROTEIN2 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN ",AIMed.d127.s1087
2417,AIMed.d127,False," PROTEIN PROTEIN1 PROTEIN2 (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN ",AIMed.d127.s1087
2418,AIMed.d127,False," PROTEIN PROTEIN1 PROTEIN (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN2 and PROTEIN ",AIMed.d127.s1087
2419,AIMed.d127,False," PROTEIN PROTEIN1 PROTEIN (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN2 ",AIMed.d127.s1087
2420,AIMed.d127,False," PROTEIN PROTEIN1 PROTEIN (whose receptors are known to contain gamma c), and PROTEIN2 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN ",AIMed.d127.s1087
2421,AIMed.d127,False," PROTEIN PROTEIN PROTEIN1 (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN2 and PROTEIN ",AIMed.d127.s1087
2422,AIMed.d127,False," PROTEIN PROTEIN PROTEIN1 (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN2 ",AIMed.d127.s1087
2423,AIMed.d127,False," PROTEIN PROTEIN PROTEIN1 (whose receptors are known to contain gamma c), and PROTEIN2 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN ",AIMed.d127.s1087
2424,AIMed.d127,False," PROTEIN PROTEIN PROTEIN (whose receptors are known to contain gamma c), and PROTEIN (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN1 and PROTEIN2 ",AIMed.d127.s1087
2425,AIMed.d127,False," PROTEIN PROTEIN PROTEIN (whose receptors are known to contain gamma c), and PROTEIN1 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN2 and PROTEIN ",AIMed.d127.s1087
2426,AIMed.d127,False," PROTEIN PROTEIN PROTEIN (whose receptors are known to contain gamma c), and PROTEIN1 (whose receptor is shown here to contain gamma c) induced the tyrosine phosphorylation and activation of the Janus family tyrosine kinases PROTEIN and PROTEIN2 ",AIMed.d127.s1087
2427,AIMed.d127,False," PROTEIN1 and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN2 and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2428,AIMed.d127,False," PROTEIN1 and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN and increased PROTEIN2 gamma c associations.",AIMed.d127.s1088
2429,AIMed.d127,False," PROTEIN1 and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN2 induced PROTEIN PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2430,AIMed.d127,False," PROTEIN1 and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN2 PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2431,AIMed.d127,True," PROTEIN1 and PROTEIN associated with PROTEIN2 and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2432,AIMed.d127,False," PROTEIN1 and PROTEIN2 associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2433,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN1 and increased PROTEIN2 gamma c associations.",AIMed.d127.s1088
2434,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN1 induced PROTEIN PROTEIN2 and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2435,AIMed.d127,True," PROTEIN and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN1 PROTEIN2 and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2436,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN1 and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN2 and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2437,AIMed.d127,False," PROTEIN and PROTEIN1 associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN2 and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2438,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN1 induced PROTEIN PROTEIN and increased PROTEIN2 gamma c associations.",AIMed.d127.s1088
2439,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN1 PROTEIN and increased PROTEIN2 gamma c associations.",AIMed.d127.s1088
2440,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN1 and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN and increased PROTEIN2 gamma c associations.",AIMed.d127.s1088
2441,AIMed.d127,False," PROTEIN and PROTEIN1 associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN and increased PROTEIN2 gamma c associations.",AIMed.d127.s1088
2442,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN and gamma c, respectively; PROTEIN1 induced PROTEIN2 PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2443,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN1 and gamma c, respectively; PROTEIN2 induced PROTEIN PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2444,AIMed.d127,False," PROTEIN and PROTEIN1 associated with PROTEIN and gamma c, respectively; PROTEIN2 induced PROTEIN PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2445,AIMed.d127,False," PROTEIN and PROTEIN associated with PROTEIN1 and gamma c, respectively; PROTEIN induced PROTEIN2 PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2446,AIMed.d127,False," PROTEIN and PROTEIN1 associated with PROTEIN and gamma c, respectively; PROTEIN induced PROTEIN2 PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2447,AIMed.d127,True," PROTEIN and PROTEIN1 associated with PROTEIN2 and gamma c, respectively; PROTEIN induced PROTEIN PROTEIN and increased PROTEIN gamma c associations.",AIMed.d127.s1088
2448,AIMed.d127,False,"Thus, gamma c mutations in at least some XSCID and XCID patients prevent normal PROTEIN1 activation, suggesting that mutations of PROTEIN2 may result in an XSCID-like phenotype.",AIMed.d127.s1090
2449,AIMed.d128,False,The X-ray structure of a PROTEIN1 PROTEIN2 receptor complex.,AIMed.d128.s1091
2450,AIMed.d128,False,"The human pituitary hormones, PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN2 , regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.",AIMed.d128.s1092
2451,AIMed.d128,False,"The human pituitary hormones, PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN2 , regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.",AIMed.d128.s1092
2452,AIMed.d128,False,"The human pituitary hormones, PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN2 , regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.",AIMed.d128.s1092
2453,AIMed.d128,False,"The human pituitary hormones, PROTEIN1 ( PROTEIN and PROTEIN2 ( PROTEIN , regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.",AIMed.d128.s1092
2454,AIMed.d128,False,"The human pituitary hormones, PROTEIN1 ( PROTEIN2 and PROTEIN ( PROTEIN , regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.",AIMed.d128.s1092
2455,AIMed.d128,False,"The human pituitary hormones, PROTEIN ( PROTEIN1 and PROTEIN2 ( PROTEIN , regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.",AIMed.d128.s1092
2456,AIMed.d128,True,The PROTEIN and PROTEIN1 receptors ( PROTEIN and PROTEIN2 respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.,AIMed.d128.s1094
2457,AIMed.d128,False,The PROTEIN and PROTEIN1 receptors ( PROTEIN2 and PROTEIN respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.,AIMed.d128.s1094
2458,AIMed.d128,False,The PROTEIN1 and PROTEIN2 receptors ( PROTEIN and PROTEIN respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.,AIMed.d128.s1094
2459,AIMed.d128,False,The PROTEIN and PROTEIN receptors ( PROTEIN1 and PROTEIN2 respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.,AIMed.d128.s1094
2460,AIMed.d128,False,The PROTEIN1 and PROTEIN receptors ( PROTEIN and PROTEIN2 respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.,AIMed.d128.s1094
2461,AIMed.d128,True,The PROTEIN1 and PROTEIN receptors ( PROTEIN2 and PROTEIN respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.,AIMed.d128.s1094
2462,AIMed.d128,True,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN1 binds to both the PROTEIN2 and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2463,AIMed.d128,True,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN1 binds to both the PROTEIN and PROTEIN2 and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2464,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN1 does not bind to the PROTEIN receptor, but PROTEIN2 binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2465,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN1 binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap.",AIMed.d128.s1097
2466,AIMed.d128,False,"In the case of PROTEIN1 activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN2 binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2467,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN1 receptor, but PROTEIN2 binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2468,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN1 and PROTEIN2 and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2469,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN1 does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN2 and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2470,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN1 and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap.",AIMed.d128.s1097
2471,AIMed.d128,False,"In the case of PROTEIN1 activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN2 and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2472,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN1 receptor, but PROTEIN binds to both the PROTEIN2 and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2473,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN1 does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN and PROTEIN2 and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2474,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN and PROTEIN1 and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap.",AIMed.d128.s1097
2475,AIMed.d128,False,"In the case of PROTEIN1 activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN and PROTEIN2 and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2476,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN1 receptor, but PROTEIN binds to both the PROTEIN and PROTEIN2 and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2477,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN1 does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap.",AIMed.d128.s1097
2478,AIMed.d128,False,"In the case of PROTEIN1 activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN2 does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2479,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN1 does not bind to the PROTEIN2 receptor, but PROTEIN binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2480,AIMed.d128,False,"In the case of PROTEIN1 activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN receptor, but PROTEIN binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap.",AIMed.d128.s1097
2481,AIMed.d128,False,"In the case of PROTEIN activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN1 receptor, but PROTEIN binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap.",AIMed.d128.s1097
2482,AIMed.d128,False,"In the case of PROTEIN1 activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. PROTEIN does not bind to the PROTEIN2 receptor, but PROTEIN binds to both the PROTEIN and PROTEIN and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap.",AIMed.d128.s1097
2483,AIMed.d128,True,We present here the crystal structure of the 1:1 complex of PROTEIN1 bound to the extracellular domain of the PROTEIN2 ,AIMed.d128.s1098
2484,AIMed.d128,False,Comparisons with the PROTEIN PROTEIN1 complex reveal how PROTEIN2 can bind to the two distinctly different receptor binding surfaces.,AIMed.d128.s1099
2485,AIMed.d128,True,Comparisons with the PROTEIN1 PROTEIN2 complex reveal how PROTEIN can bind to the two distinctly different receptor binding surfaces.,AIMed.d128.s1099
2486,AIMed.d128,False,Comparisons with the PROTEIN1 PROTEIN complex reveal how PROTEIN2 can bind to the two distinctly different receptor binding surfaces.,AIMed.d128.s1099
2487,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN1 PROTEIN2 and three additional proteins, PROTEIN PROTEIN and PROTEIN ",AIMed.d129.s1101
2488,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN1 PROTEIN and three additional proteins, PROTEIN2 PROTEIN and PROTEIN ",AIMed.d129.s1101
2489,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN1 PROTEIN and three additional proteins, PROTEIN PROTEIN and PROTEIN2 ",AIMed.d129.s1101
2490,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN1 PROTEIN and three additional proteins, PROTEIN PROTEIN2 and PROTEIN ",AIMed.d129.s1101
2491,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN PROTEIN1 and three additional proteins, PROTEIN2 PROTEIN and PROTEIN ",AIMed.d129.s1101
2492,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN PROTEIN1 and three additional proteins, PROTEIN PROTEIN and PROTEIN2 ",AIMed.d129.s1101
2493,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN PROTEIN1 and three additional proteins, PROTEIN PROTEIN2 and PROTEIN ",AIMed.d129.s1101
2494,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN PROTEIN and three additional proteins, PROTEIN1 PROTEIN and PROTEIN2 ",AIMed.d129.s1101
2495,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN PROTEIN and three additional proteins, PROTEIN1 PROTEIN2 and PROTEIN ",AIMed.d129.s1101
2496,AIMed.d129,False,"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of PROTEIN PROTEIN and three additional proteins, PROTEIN PROTEIN1 and PROTEIN2 ",AIMed.d129.s1101
2497,AIMed.d129,False," PROTEIN is also present in immunoaffinity-purified PROTEIN1 complexes along with PROTEIN2 and another protein, PROTEIN ",AIMed.d129.s1102
2498,AIMed.d129,False," PROTEIN is also present in immunoaffinity-purified PROTEIN complexes along with PROTEIN1 and another protein, PROTEIN2 ",AIMed.d129.s1102
2499,AIMed.d129,False," PROTEIN1 is also present in immunoaffinity-purified PROTEIN complexes along with PROTEIN2 and another protein, PROTEIN ",AIMed.d129.s1102
2500,AIMed.d129,False," PROTEIN is also present in immunoaffinity-purified PROTEIN1 complexes along with PROTEIN and another protein, PROTEIN2 ",AIMed.d129.s1102
2501,AIMed.d129,False," PROTEIN1 is also present in immunoaffinity-purified PROTEIN2 complexes along with PROTEIN and another protein, PROTEIN ",AIMed.d129.s1102
2502,AIMed.d129,False," PROTEIN1 is also present in immunoaffinity-purified PROTEIN complexes along with PROTEIN and another protein, PROTEIN2 ",AIMed.d129.s1102
2503,AIMed.d129,False,"Antibodies to PROTEIN1 detect similar levels of PROTEIN2 in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that PROTEIN is a conserved protein of broad tissue distribution.",AIMed.d129.s1104
2504,AIMed.d129,False,"Antibodies to PROTEIN1 detect similar levels of PROTEIN in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that PROTEIN2 is a conserved protein of broad tissue distribution.",AIMed.d129.s1104
2505,AIMed.d129,False,"Antibodies to PROTEIN detect similar levels of PROTEIN1 in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that PROTEIN2 is a conserved protein of broad tissue distribution.",AIMed.d129.s1104
2506,AIMed.d129,False,Bacterially overexpressed human PROTEIN1 was used to raise several monoclonal antibodies to PROTEIN2 ,AIMed.d129.s1110
2507,AIMed.d129,True,These antibodies specifically immunoprecipitate PROTEIN1 in complex with PROTEIN2 in all tissues tested and can be used to immunoaffinity isolate progesterone receptor complexes from chicken oviduct cytosol.,AIMed.d129.s1111
2508,AIMed.d130,False,Cloning of the complete coding region for human PROTEIN1 using the two hybrid system and expression of PROTEIN2 in E. coli.,AIMed.d130.s1112
2509,AIMed.d131,False,Expression cloning and characterization of a human PROTEIN1 receptor.,AIMed.d131.s1119
2510,AIMed.d131,False,"cDNA clones encoding a human PROTEIN1 ( PROTEIN2 from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds PROTEIN specifically.",AIMed.d131.s1120
2511,AIMed.d131,True,"cDNA clones encoding a human PROTEIN1 ( PROTEIN from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds PROTEIN2 specifically.",AIMed.d131.s1120
2512,AIMed.d131,True,"cDNA clones encoding a human PROTEIN ( PROTEIN1 from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds PROTEIN2 specifically.",AIMed.d131.s1120
2513,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN1 expressed in an PROTEIN2 dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2514,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN expressed in an PROTEIN1 dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN2 ",AIMed.d131.s1121
2515,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN1 ( PROTEIN . PROTEIN expressed in an PROTEIN2 dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2516,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN1 . PROTEIN expressed in an PROTEIN2 dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2517,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN1 is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN expressed in an PROTEIN2 dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2518,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN expressed in an PROTEIN1 dependent mouse pro-B cell line (Ba/F3) binds PROTEIN2 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2519,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN1 expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN2 ",AIMed.d131.s1121
2520,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN1 ( PROTEIN . PROTEIN2 expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2521,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN1 . PROTEIN2 expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2522,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN1 is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN2 expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2523,AIMed.d131,True,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN1 expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN2 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2524,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN1 ( PROTEIN . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN2 ",AIMed.d131.s1121
2525,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN1 . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN2 ",AIMed.d131.s1121
2526,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN1 is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN2 ",AIMed.d131.s1121
2527,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN1 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN2 ",AIMed.d131.s1121
2528,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN1 ( PROTEIN2 . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2529,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN1 is 60% identical and 73% similar to mouse PROTEIN2 ( PROTEIN . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2530,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN1 ( PROTEIN . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN2 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2531,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN1 is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN2 . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2532,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN1 . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN2 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2533,AIMed.d131,False,"The predicted amino acid sequence of PROTEIN1 is 60% identical and 73% similar to mouse PROTEIN ( PROTEIN . PROTEIN expressed in an PROTEIN dependent mouse pro-B cell line (Ba/F3) binds PROTEIN2 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to PROTEIN ",AIMed.d131.s1121
2534,AIMed.d131,False,"Mouse PROTEIN1 does not bind to PROTEIN2 and PROTEIN expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of PROTEIN ",AIMed.d131.s1122
2535,AIMed.d131,False,"Mouse PROTEIN1 does not bind to PROTEIN and PROTEIN expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of PROTEIN2 ",AIMed.d131.s1122
2536,AIMed.d131,False,"Mouse PROTEIN1 does not bind to PROTEIN and PROTEIN2 expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of PROTEIN ",AIMed.d131.s1122
2537,AIMed.d131,False,"Mouse PROTEIN does not bind to PROTEIN1 and PROTEIN expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of PROTEIN2 ",AIMed.d131.s1122
2538,AIMed.d131,False,"Mouse PROTEIN does not bind to PROTEIN1 and PROTEIN2 expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of PROTEIN ",AIMed.d131.s1122
2539,AIMed.d131,False,"Mouse PROTEIN does not bind to PROTEIN and PROTEIN1 expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of PROTEIN2 ",AIMed.d131.s1122
2540,AIMed.d131,False,"In a number of human T cell clones, expression of PROTEIN1 mRNA is down-regulated after activation of the cells with anti- PROTEIN2 Ab and phorbol ester.",AIMed.d131.s1124
2541,AIMed.d131,False,Like PROTEIN1 PROTEIN2 is structurally related to PROTEIN ,AIMed.d131.s1126
2542,AIMed.d131,False,Like PROTEIN PROTEIN1 is structurally related to PROTEIN2 ,AIMed.d131.s1126
2543,AIMed.d131,False,Like PROTEIN1 PROTEIN is structurally related to PROTEIN2 ,AIMed.d131.s1126
2544,AIMed.d131,False,Because PROTEIN1 inhibits macrophage activation by PROTEIN2 this relationship suggests possible shared receptor or signal transduction pathway components.,AIMed.d131.s1127
2545,AIMed.d132,False,Functional participation of the PROTEIN1 receptor gamma chain in PROTEIN2 complexes.,AIMed.d132.s1128
2546,AIMed.d132,False,Functional participation of the PROTEIN chain in PROTEIN1 receptor complexes.,AIMed.d132.s1128
2547,AIMed.d132,False,Functional participation of the PROTEIN1 chain in PROTEIN2 complexes.,AIMed.d132.s1128
2548,AIMed.d132,False,Functional participation of the PROTEIN1 receptor gamma chain in PROTEIN2 receptor complexes.,AIMed.d132.s1128
2549,AIMed.d132,False,Functional participation of the PROTEIN1 chain in PROTEIN receptor complexes.,AIMed.d132.s1128
2550,AIMed.d132,False,Functional participation of the PROTEIN1 chain in PROTEIN2 receptor complexes.,AIMed.d132.s1128
2551,AIMed.d132,False,"The gamma chain of the PROTEIN1 ( PROTEIN receptor is shared with the functional PROTEIN2 and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2552,AIMed.d132,False,"The gamma chain of the PROTEIN1 ( PROTEIN2 receptor is shared with the functional PROTEIN receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2553,AIMed.d132,False,"The gamma chain of the PROTEIN1 ( PROTEIN receptor is shared with the functional PROTEIN2 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2554,AIMed.d132,False,"The gamma chain of PROTEIN PROTEIN1 is shared with the functional PROTEIN receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2555,AIMed.d132,False,"The gamma chain o PROTEIN1 PROTEIN is shared with the functional PROTEIN2 and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2556,AIMed.d132,False,"The gamma chain o PROTEIN PROTEIN is shared with the functional PROTEIN1 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2557,AIMed.d132,False,"The gamma chain of PROTEIN PROTEIN1 is shared with the functional PROTEIN2 and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2558,AIMed.d132,False,"The gamma chain o PROTEIN1 PROTEIN is shared with the functional PROTEIN2 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2559,AIMed.d132,False,"The gamma chain of PROTEIN2 PROTEIN1 is shared with the functional PROTEIN receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2560,AIMed.d132,False,"The gamma chain of PROTEIN PROTEIN1 is shared with the functional PROTEIN2 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.",AIMed.d132.s1129
2561,AIMed.d132,False,Studies with monoclonal antibodies specific for the PROTEIN1 receptor gamma chain showed that the gamma chain participates in the functional high-affinity receptor complexes for PROTEIN2 that are involved in the differentiation of T and B cells.,AIMed.d132.s1130
2562,AIMed.d135,False,Tumor necrosis factor (TNF) and PROTEIN1 ( PROTEIN2 are members of a family of secreted and cell surface cytokines that participate in the regulation of immune and inflammatory responses.,AIMed.d135.s1147
2563,AIMed.d135,False,"The cell surface form of PROTEIN is assembled during biosynthesis as a heteromeric complex with PROTEIN1 ( PROTEIN2 , a type II transmembrane protein that is another member of the TNF ligand family.",AIMed.d135.s1148
2564,AIMed.d135,True,"The cell surface form of PROTEIN1 is assembled during biosynthesis as a heteromeric complex with PROTEIN2 ( PROTEIN , a type II transmembrane protein that is another member of the TNF ligand family.",AIMed.d135.s1148
2565,AIMed.d135,True,"The cell surface form of PROTEIN1 is assembled during biosynthesis as a heteromeric complex with PROTEIN ( PROTEIN2 , a type II transmembrane protein that is another member of the TNF ligand family.",AIMed.d135.s1148
2566,AIMed.d135,False,"Secreted PROTEIN1 is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface PROTEIN2 PROTEIN complex.",AIMed.d135.s1149
2567,AIMed.d135,True,"Secreted PROTEIN is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface PROTEIN1 PROTEIN2 complex.",AIMed.d135.s1149
2568,AIMed.d135,False,"Secreted PROTEIN1 is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface PROTEIN PROTEIN2 complex.",AIMed.d135.s1149
2569,AIMed.d135,False,"A receptor specific for human PROTEIN1 was identified, which suggests that cell surface LT may have functions that are distinct from those of secreted PROTEIN2 ",AIMed.d135.s1150
2570,AIMed.d136,False,"The cytokine, designated PROTEIN1 ( PROTEIN , is produced by a wide variety of cells and tissues and shares many biological properties with PROTEIN2 ",AIMed.d136.s1153
2571,AIMed.d136,False,"The cytokine, designated PROTEIN ( PROTEIN1 , is produced by a wide variety of cells and tissues and shares many biological properties with PROTEIN2 ",AIMed.d136.s1153
2572,AIMed.d136,False,"The cytokine, designated PROTEIN1 ( PROTEIN2 , is produced by a wide variety of cells and tissues and shares many biological properties with PROTEIN ",AIMed.d136.s1153
2573,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN2 receptor.,AIMed.d136.s1154
2574,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 and PROTEIN competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN2 receptor.,AIMed.d136.s1154
2575,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN1 receptor.,AIMed.d136.s1154
2576,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN1 indicating that PROTEIN uses components of the PROTEIN2 receptor.,AIMed.d136.s1154
2577,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN indicating that PROTEIN1 uses components of the PROTEIN2 receptor.,AIMed.d136.s1154
2578,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN1 competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN2 receptor.,AIMed.d136.s1154
2579,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN2 and PROTEIN competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN receptor.,AIMed.d136.s1154
2580,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN2 ,AIMed.d136.s1154
2581,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN2 indicating that PROTEIN uses components of the PROTEIN receptor.,AIMed.d136.s1154
2582,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN indicating that PROTEIN2 uses components of the PROTEIN receptor.,AIMed.d136.s1154
2583,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN and PROTEIN2 competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN receptor.,AIMed.d136.s1154
2584,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 and PROTEIN competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN2 ,AIMed.d136.s1154
2585,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 and PROTEIN competed for binding with PROTEIN2 indicating that PROTEIN uses components of the PROTEIN receptor.,AIMed.d136.s1154
2586,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 and PROTEIN competed for binding with PROTEIN indicating that PROTEIN2 uses components of the PROTEIN receptor.,AIMed.d136.s1154
2587,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 and PROTEIN2 competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN receptor.,AIMed.d136.s1154
2588,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN1 indicating that PROTEIN uses components of the PROTEIN2 ,AIMed.d136.s1154
2589,AIMed.d136,True,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN indicating that PROTEIN1 uses components of the PROTEIN2 ,AIMed.d136.s1154
2590,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN1 competed for binding with PROTEIN indicating that PROTEIN uses components of the PROTEIN2 ,AIMed.d136.s1154
2591,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN competed for binding with PROTEIN1 indicating that PROTEIN2 uses components of the PROTEIN receptor.,AIMed.d136.s1154
2592,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN1 competed for binding with PROTEIN2 indicating that PROTEIN uses components of the PROTEIN receptor.,AIMed.d136.s1154
2593,AIMed.d136,False,Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN and PROTEIN1 competed for binding with PROTEIN indicating that PROTEIN2 uses components of the PROTEIN receptor.,AIMed.d136.s1154
2594,AIMed.d137,True,The POU domains of the PROTEIN1 and PROTEIN transcription factors mediate specific interaction with PROTEIN2 ,AIMed.d137.s1155
2595,AIMed.d137,True,The POU domains of the PROTEIN and PROTEIN1 transcription factors mediate specific interaction with PROTEIN2 ,AIMed.d137.s1155
2596,AIMed.d137,False,The POU domains of the PROTEIN1 and PROTEIN2 transcription factors mediate specific interaction with PROTEIN ,AIMed.d137.s1155
2597,AIMed.d137,False,We had previously shown that the ubiquitous PROTEIN1 and the lymphoid-specific PROTEIN2 transcription factors stimulate transcription at the level of stable preinitiation complex formation.,AIMed.d137.s1156
2598,AIMed.d137,False,We have therefore investigated whether the octamer binding proteins might physically interact with PROTEIN1 the PROTEIN2 component of the PROTEIN factor.,AIMed.d137.s1157
2599,AIMed.d137,False,We have therefore investigated whether the octamer binding proteins might physically interact with PROTEIN the PROTEIN1 component of the PROTEIN2 factor.,AIMed.d137.s1157
2600,AIMed.d137,False,We have therefore investigated whether the octamer binding proteins might physically interact with PROTEIN1 the PROTEIN component of the PROTEIN2 factor.,AIMed.d137.s1157
2601,AIMed.d137,False,By using several different experimental systems we show that PROTEIN efficiently associates with PROTEIN1 and PROTEIN2 ,AIMed.d137.s1158
2602,AIMed.d137,True,By using several different experimental systems we show that PROTEIN1 efficiently associates with PROTEIN2 and PROTEIN ,AIMed.d137.s1158
2603,AIMed.d137,True,By using several different experimental systems we show that PROTEIN1 efficiently associates with PROTEIN and PROTEIN2 ,AIMed.d137.s1158
2604,AIMed.d137,True,We show that the POU homeodomain of PROTEIN1 and the evolutionarily conserved C-terminal core domain of PROTEIN2 are both required and sufficient for the interaction.,AIMed.d137.s1161
2605,AIMed.d137,False,"The PROTEIN1 POU domain, which is highly homologous to the PROTEIN2 POU domain, likewise mediates interaction with PROTEIN ",AIMed.d137.s1162
2606,AIMed.d137,True,"The PROTEIN1 POU domain, which is highly homologous to the PROTEIN POU domain, likewise mediates interaction with PROTEIN2 ",AIMed.d137.s1162
2607,AIMed.d137,False,"The PROTEIN POU domain, which is highly homologous to the PROTEIN1 POU domain, likewise mediates interaction with PROTEIN2 ",AIMed.d137.s1162
2608,AIMed.d137,False,"The interaction can also be observed in vivo, as PROTEIN1 can be co-precipitated with PROTEIN from co-transfected Cos1 cells and PROTEIN co-immunoprecipitates with the endogenous PROTEIN2 from HeLa cells.",AIMed.d137.s1163
2609,AIMed.d137,False,"The interaction can also be observed in vivo, as PROTEIN can be co-precipitated with PROTEIN1 from co-transfected Cos1 cells and PROTEIN co-immunoprecipitates with the endogenous PROTEIN2 from HeLa cells.",AIMed.d137.s1163
2610,AIMed.d137,True,"The interaction can also be observed in vivo, as PROTEIN can be co-precipitated with PROTEIN from co-transfected Cos1 cells and PROTEIN1 co-immunoprecipitates with the endogenous PROTEIN2 from HeLa cells.",AIMed.d137.s1163
2611,AIMed.d137,True,"The interaction can also be observed in vivo, as PROTEIN1 can be co-precipitated with PROTEIN2 from co-transfected Cos1 cells and PROTEIN co-immunoprecipitates with the endogenous PROTEIN from HeLa cells.",AIMed.d137.s1163
2612,AIMed.d137,False,"The interaction can also be observed in vivo, as PROTEIN1 can be co-precipitated with PROTEIN from co-transfected Cos1 cells and PROTEIN2 co-immunoprecipitates with the endogenous PROTEIN from HeLa cells.",AIMed.d137.s1163
2613,AIMed.d137,False,"The interaction can also be observed in vivo, as PROTEIN can be co-precipitated with PROTEIN1 from co-transfected Cos1 cells and PROTEIN2 co-immunoprecipitates with the endogenous PROTEIN from HeLa cells.",AIMed.d137.s1163
2614,AIMed.d137,False,Co-transfection of human PROTEIN1 and PROTEIN2 expression vectors into B cells resulted in a synergistic activation of an octamer motif containing promoter.,AIMed.d137.s1164
2615,AIMed.d138,False,Interaction of mammalian splicing factor PROTEIN with PROTEIN1 and relation of its 60-kD subunit to yeast PROTEIN2 ,AIMed.d138.s1165
2616,AIMed.d138,False,Interaction of mammalian splicing factor PROTEIN1 with PROTEIN and relation of its 60-kD subunit to yeast PROTEIN2 ,AIMed.d138.s1165
2617,AIMed.d138,True,Interaction of mammalian splicing factor PROTEIN1 with PROTEIN2 and relation of its 60-kD subunit to yeast PROTEIN ,AIMed.d138.s1165
2618,AIMed.d138,False,"In the assembly of a prespliceosome, PROTEIN1 (snRNP) functions in pre-messenger RNA (mRNA) splicing together with splicing factors (SFs) 3a, PROTEIN2 and several other proteins.",AIMed.d138.s1166
2619,AIMed.d138,False,Here it is shown that the PROTEIN1 subunits correspond to three of the 17S PROTEIN2 specific polypeptides.,AIMed.d138.s1168
2620,AIMed.d138,False, PROTEIN1 interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN2 and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2621,AIMed.d138,True, PROTEIN1 interacts with PROTEIN2 in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2622,AIMed.d138,False, PROTEIN1 interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN2 into the spliceosome.,AIMed.d138.s1169
2623,AIMed.d138,False, PROTEIN1 interacts with PROTEIN in the presence of PROTEIN2 to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2624,AIMed.d138,False, PROTEIN1 interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN2 in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2625,AIMed.d138,False, PROTEIN1 interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN2 which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2626,AIMed.d138,False, PROTEIN interacts with PROTEIN1 in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN2 and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2627,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN1 and PROTEIN in the incorporation of PROTEIN2 into the spliceosome.,AIMed.d138.s1169
2628,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN1 to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN2 and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2629,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN1 and PROTEIN2 in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2630,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN1 which suggests a function for PROTEIN2 and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2631,AIMed.d138,False, PROTEIN interacts with PROTEIN1 in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN2 into the spliceosome.,AIMed.d138.s1169
2632,AIMed.d138,False, PROTEIN interacts with PROTEIN1 in the presence of PROTEIN2 to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2633,AIMed.d138,False, PROTEIN interacts with PROTEIN1 in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN2 in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2634,AIMed.d138,False, PROTEIN interacts with PROTEIN1 in the presence of PROTEIN to generate a structure similar to 17S PROTEIN2 which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2635,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN1 to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN2 into the spliceosome.,AIMed.d138.s1169
2636,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN1 in the incorporation of PROTEIN2 into the spliceosome.,AIMed.d138.s1169
2637,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN1 which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN2 into the spliceosome.,AIMed.d138.s1169
2638,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN1 to generate a structure similar to 17S PROTEIN which suggests a function for PROTEIN and PROTEIN2 in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2639,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN1 to generate a structure similar to 17S PROTEIN2 which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2640,AIMed.d138,False, PROTEIN interacts with PROTEIN in the presence of PROTEIN to generate a structure similar to 17S PROTEIN1 which suggests a function for PROTEIN and PROTEIN2 in the incorporation of PROTEIN into the spliceosome.,AIMed.d138.s1169
2641,AIMed.d138,False,"Furthermore, the 60-kilodalton subunit of PROTEIN1 is related to the yeast splicing protein PROTEIN2 ",AIMed.d138.s1170
2642,AIMed.d139,False, PROTEIN1 an Ala-->Gly substitution in helix 1 of PROTEIN2 repeat 17 that severely disrupts the structure and self-association of the erythrocyte spectrin heterodimer.,AIMed.d139.s1171
2643,AIMed.d139,True,The self-association site appears to be formed by interactions between helices 1 and 2 of PROTEIN1 repeat 17 of one dimer with helix 3 of PROTEIN2 repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.,AIMed.d139.s1173
2644,AIMed.d139,False,"Following linkage studies which were most consistent with a PROTEIN1 gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of PROTEIN2 repeat 17.",AIMed.d139.s1177
2645,AIMed.d141,False,The PROTEIN1 Cdk-interacting protein PROTEIN2 is a potent inhibitor of G1 cyclin-dependent kinases.,AIMed.d141.s1188
2646,AIMed.d141,False,"The cyclin-dependent kinase PROTEIN1 associates with PROTEIN2 D, and E and has been implicated in the control of the G1 to S phase transition in mammals.",AIMed.d141.s1189
2647,AIMed.d141,False, PROTEIN1 encodes a novel 21 kd protein that is found in PROTEIN PROTEIN PROTEIN2 and PROTEIN immunoprecipitates.,AIMed.d141.s1191
2648,AIMed.d141,False, PROTEIN1 encodes a novel 21 kd protein that is found in PROTEIN PROTEIN2 PROTEIN and PROTEIN immunoprecipitates.,AIMed.d141.s1191
2649,AIMed.d141,False, PROTEIN1 encodes a novel 21 kd protein that is found in PROTEIN2 PROTEIN PROTEIN and PROTEIN immunoprecipitates.,AIMed.d141.s1191
2650,AIMed.d141,False, PROTEIN1 encodes a novel 21 kd protein that is found in PROTEIN PROTEIN PROTEIN and PROTEIN2 immunoprecipitates.,AIMed.d141.s1191
2651,AIMed.d141,False, PROTEIN encodes a novel 21 kd protein that is found in PROTEIN PROTEIN1 PROTEIN2 and PROTEIN immunoprecipitates.,AIMed.d141.s1191
2652,AIMed.d141,False, PROTEIN encodes a novel 21 kd protein that is found in PROTEIN1 PROTEIN PROTEIN2 and PROTEIN immunoprecipitates.,AIMed.d141.s1191
2653,AIMed.d141,False, PROTEIN encodes a novel 21 kd protein that is found in PROTEIN PROTEIN PROTEIN1 and PROTEIN2 immunoprecipitates.,AIMed.d141.s1191
2654,AIMed.d141,False, PROTEIN encodes a novel 21 kd protein that is found in PROTEIN1 PROTEIN2 PROTEIN and PROTEIN immunoprecipitates.,AIMed.d141.s1191
2655,AIMed.d141,False, PROTEIN encodes a novel 21 kd protein that is found in PROTEIN PROTEIN1 PROTEIN and PROTEIN2 immunoprecipitates.,AIMed.d141.s1191
2656,AIMed.d141,False, PROTEIN encodes a novel 21 kd protein that is found in PROTEIN1 PROTEIN PROTEIN and PROTEIN2 immunoprecipitates.,AIMed.d141.s1191
2657,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2658,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2659,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN2 by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2660,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2661,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2662,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2663,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 PROTEIN complexes.",AIMed.d141.s1192
2664,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2665,AIMed.d141,False," PROTEIN1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN2 complexes.",AIMed.d141.s1192
2666,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2667,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2668,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2669,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2670,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2671,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN2 PROTEIN complexes.",AIMed.d141.s1192
2672,AIMed.d141,True," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2673,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN PROTEIN2 complexes.",AIMed.d141.s1192
2674,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2675,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2676,AIMed.d141,True," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2677,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2678,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN2 PROTEIN complexes.",AIMed.d141.s1192
2679,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2680,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN PROTEIN2 complexes.",AIMed.d141.s1192
2681,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2682,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2683,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2684,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 PROTEIN complexes.",AIMed.d141.s1192
2685,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2686,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN1 by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN2 complexes.",AIMed.d141.s1192
2687,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2688,AIMed.d141,True," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2689,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 PROTEIN complexes.",AIMed.d141.s1192
2690,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2691,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN2 complexes.",AIMed.d141.s1192
2692,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2693,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN2 PROTEIN complexes.",AIMed.d141.s1192
2694,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2695,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN2 complexes.",AIMed.d141.s1192
2696,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN2 PROTEIN complexes.",AIMed.d141.s1192
2697,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and PROTEIN PROTEIN complexes.",AIMed.d141.s1192
2698,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN PROTEIN2 complexes.",AIMed.d141.s1192
2699,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN2 PROTEIN complexes.",AIMed.d141.s1192
2700,AIMed.d141,True," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 PROTEIN2 complexes.",AIMed.d141.s1192
2701,AIMed.d141,False," PROTEIN is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of PROTEIN by PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN PROTEIN2 complexes.",AIMed.d141.s1192
2702,AIMed.d141,False,Cotransfection experiments indicate that PROTEIN1 and PROTEIN2 function in a mutually antagonistic manner to control cell cycle progression.,AIMed.d141.s1193
2703,AIMed.d142,True,Evidence for physical interaction between the zinc-finger transcription factors PROTEIN1 and PROTEIN2 ,AIMed.d142.s1194
2704,AIMed.d142,False,The recently cloned PROTEIN1 is such an PROTEIN2 ,AIMed.d142.s1197
2705,AIMed.d142,False,The ability of PROTEIN1 to initiate transcription is augmented by the presence of a TATA motif or binding sites for transcription factor PROTEIN2 ,AIMed.d142.s1199
2706,AIMed.d142,False,To study the mechanism underlying the apparent functional cooperation between PROTEIN1 and PROTEIN2 we explored the possibility of protein-protein interactions between these two transcription factors.,AIMed.d142.s1200
2707,AIMed.d142,True,We found that PROTEIN1 and PROTEIN2 can form a physical complex.,AIMed.d142.s1201
2708,AIMed.d142,True,"In addition, we identified domains within PROTEIN1 and PROTEIN2 that mediate their interactions with each other.",AIMed.d142.s1202
2709,AIMed.d142,True,The physical interaction between PROTEIN1 and PROTEIN2 may thus form the basis for the functional interplay observed previously.,AIMed.d142.s1203
2710,AIMed.d143,False,Involvement of PROTEIN1 signal transducer PROTEIN2 in PROTEIN mediated signal transduction.,AIMed.d143.s1204
2711,AIMed.d143,False,Involvement of PROTEIN1 signal transducer PROTEIN in PROTEIN2 mediated signal transduction.,AIMed.d143.s1204
2712,AIMed.d143,False,Involvement of PROTEIN signal transducer PROTEIN1 in PROTEIN2 mediated signal transduction.,AIMed.d143.s1204
2713,AIMed.d143,False, PROTEIN1 is a novel cytokine with a variety of biofunctions which overlap with those of PROTEIN2 ,AIMed.d143.s1205
2714,AIMed.d143,False,We have previously identified PROTEIN1 specific binding protein which is distinct from that of PROTEIN2 in a number of cell lines.,AIMed.d143.s1206
2715,AIMed.d143,False,The similarities in biofunctions and differences in ligand binding proteins between PROTEIN and PROTEIN prompted us to investigate whether PROTEIN1 shares common signal transduction mechanisms with PROTEIN2 ,AIMed.d143.s1207
2716,AIMed.d143,False,The similarities in biofunctions and differences in ligand binding proteins between PROTEIN1 and PROTEIN prompted us to investigate whether PROTEIN2 shares common signal transduction mechanisms with PROTEIN ,AIMed.d143.s1207
2717,AIMed.d143,False,The similarities in biofunctions and differences in ligand binding proteins between PROTEIN and PROTEIN1 prompted us to investigate whether PROTEIN2 shares common signal transduction mechanisms with PROTEIN ,AIMed.d143.s1207
2718,AIMed.d143,False,The similarities in biofunctions and differences in ligand binding proteins between PROTEIN1 and PROTEIN prompted us to investigate whether PROTEIN shares common signal transduction mechanisms with PROTEIN2 ,AIMed.d143.s1207
2719,AIMed.d143,False,The similarities in biofunctions and differences in ligand binding proteins between PROTEIN and PROTEIN1 prompted us to investigate whether PROTEIN shares common signal transduction mechanisms with PROTEIN2 ,AIMed.d143.s1207
2720,AIMed.d143,False,The similarities in biofunctions and differences in ligand binding proteins between PROTEIN1 and PROTEIN2 prompted us to investigate whether PROTEIN shares common signal transduction mechanisms with PROTEIN ,AIMed.d143.s1207
2721,AIMed.d143,False,"We have examined early signals triggered by PROTEIN1 or PROTEIN2 in a multifactor-dependent human erythroleukemic cell line, TF-1.",AIMed.d143.s1208
2722,AIMed.d143,False,"The results showed that PROTEIN1 and PROTEIN2 can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene ( PROTEIN expression in TF-1 cells.",AIMed.d143.s1209
2723,AIMed.d143,True,"The results showed that PROTEIN and PROTEIN1 can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene ( PROTEIN2 expression in TF-1 cells.",AIMed.d143.s1209
2724,AIMed.d143,True,"The results showed that PROTEIN1 and PROTEIN can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene ( PROTEIN2 expression in TF-1 cells.",AIMed.d143.s1209
2725,AIMed.d143,False,"These findings imply that PROTEIN1 and PROTEIN2 share similar early signaling events with the possibility of using the same signal transducer, PROTEIN ",AIMed.d143.s1210
2726,AIMed.d143,False,"These findings imply that PROTEIN1 and PROTEIN share similar early signaling events with the possibility of using the same signal transducer, PROTEIN2 ",AIMed.d143.s1210
2727,AIMed.d143,False,"These findings imply that PROTEIN and PROTEIN1 share similar early signaling events with the possibility of using the same signal transducer, PROTEIN2 ",AIMed.d143.s1210
2728,AIMed.d143,False,We next tested whether PROTEIN1 induced signaling can be inhibited by anti- PROTEIN antibodies which blocked PROTEIN2 mediated functions.,AIMed.d143.s1211
2729,AIMed.d143,False,We next tested whether PROTEIN induced signaling can be inhibited by anti- PROTEIN1 antibodies which blocked PROTEIN2 mediated functions.,AIMed.d143.s1211
2730,AIMed.d143,False,We next tested whether PROTEIN1 induced signaling can be inhibited by anti- PROTEIN2 antibodies which blocked PROTEIN mediated functions.,AIMed.d143.s1211
2731,AIMed.d143,False,"It was observed that anti- PROTEIN1 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and PROTEIN gene expression elicited by PROTEIN2 or PROTEIN in TF-1 cells.",AIMed.d143.s1212
2732,AIMed.d143,False,"It was observed that anti- PROTEIN1 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and PROTEIN2 gene expression elicited by PROTEIN or PROTEIN in TF-1 cells.",AIMed.d143.s1212
2733,AIMed.d143,False,"It was observed that anti- PROTEIN1 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and PROTEIN gene expression elicited by PROTEIN or PROTEIN2 in TF-1 cells.",AIMed.d143.s1212
2734,AIMed.d143,False,"It was observed that anti- PROTEIN antibodies abolished cell proliferation, protein tyrosine phosphorylation, and PROTEIN1 gene expression elicited by PROTEIN2 or PROTEIN in TF-1 cells.",AIMed.d143.s1212
2735,AIMed.d143,False,"It was observed that anti- PROTEIN antibodies abolished cell proliferation, protein tyrosine phosphorylation, and PROTEIN gene expression elicited by PROTEIN1 or PROTEIN2 in TF-1 cells.",AIMed.d143.s1212
2736,AIMed.d143,False,"It was observed that anti- PROTEIN antibodies abolished cell proliferation, protein tyrosine phosphorylation, and PROTEIN1 gene expression elicited by PROTEIN or PROTEIN2 in TF-1 cells.",AIMed.d143.s1212
2737,AIMed.d143,False,"Finally, anti- PROTEIN antibody inhibited the ability of PROTEIN1 but not PROTEIN2 to transduce early signals in TF-1 cells.",AIMed.d143.s1214
2738,AIMed.d143,False,"Finally, anti- PROTEIN1 antibody inhibited the ability of PROTEIN but not PROTEIN2 to transduce early signals in TF-1 cells.",AIMed.d143.s1214
2739,AIMed.d143,False,"Finally, anti- PROTEIN1 antibody inhibited the ability of PROTEIN2 but not PROTEIN to transduce early signals in TF-1 cells.",AIMed.d143.s1214
2740,AIMed.d143,False,"These results demonstrate that PROTEIN and PROTEIN1 utilize different ligand binding proteins, but share common signal transducer, PROTEIN2 in TF-1 cells.",AIMed.d143.s1215
2741,AIMed.d143,False,"These results demonstrate that PROTEIN1 and PROTEIN utilize different ligand binding proteins, but share common signal transducer, PROTEIN2 in TF-1 cells.",AIMed.d143.s1215
2742,AIMed.d143,False,"These results demonstrate that PROTEIN1 and PROTEIN2 utilize different ligand binding proteins, but share common signal transducer, PROTEIN in TF-1 cells.",AIMed.d143.s1215
2743,AIMed.d144,True,The PROTEIN1 associates with the PROTEIN2 catalytic subunit.,AIMed.d144.s1216
2744,AIMed.d144,False,The PROTEIN1 ( PROTEIN2 interacts with many cellular proteins in complexes potentially important for its growth-suppressing function.,AIMed.d144.s1217
2745,AIMed.d144,False,"One clone encodes a novel PROTEIN1 catalytic subunit ( PROTEIN2 , which differs from the originally defined PROTEIN by an amino-terminal 11-amino-acid insert.",AIMed.d144.s1219
2746,AIMed.d144,False,"One clone encodes a novel PROTEIN1 catalytic subunit ( PROTEIN , which differs from the originally defined PROTEIN2 by an amino-terminal 11-amino-acid insert.",AIMed.d144.s1219
2747,AIMed.d144,False,"One clone encodes a novel PROTEIN catalytic subunit ( PROTEIN1 , which differs from the originally defined PROTEIN2 by an amino-terminal 11-amino-acid insert.",AIMed.d144.s1219
2748,AIMed.d144,True,In vitro-binding assays demonstrated that PROTEIN1 isoforms preferentially bind the hypophosphorylated form of PROTEIN2 ,AIMed.d144.s1220
2749,AIMed.d144,True,"Moreover, similar PROTEIN1 sequences are required for binding PROTEIN and PROTEIN2 ",AIMed.d144.s1221
2750,AIMed.d144,False,"Moreover, similar PROTEIN sequences are required for binding PROTEIN1 and PROTEIN2 ",AIMed.d144.s1221
2751,AIMed.d144,True,"Moreover, similar PROTEIN1 sequences are required for binding PROTEIN2 and PROTEIN ",AIMed.d144.s1221
2752,AIMed.d145,False,The novel fold of the TNF receptor structure is likely to be representative of the PROTEIN1 ( PROTEIN2 /TNF receptor family as a whole.,AIMed.d145.s1229
2753,AIMed.d146,False,Characterization of a novel high affinity human PROTEIN1 Expression on T cells and association with PROTEIN2 driven proliferation.,AIMed.d146.s1230
2754,AIMed.d146,False,Characterization of a novel high affinity human PROTEIN1 receptor. Expression on T cells and association with PROTEIN2 driven proliferation.,AIMed.d146.s1230
2755,AIMed.d146,False,Characterization of a novel high affinity human PROTEIN1 receptor. Expression on T cells and association with PROTEIN driven proliferation.,AIMed.d146.s1230
2756,AIMed.d146,False,"We have previously demonstrated such changes by affinity cross-linking studies, and have shown that unstimulated human T cells express a single PROTEIN1 of 90 kDa, whereas activated T cells express an additional 76-kDa PROTEIN2 binding protein.",AIMed.d146.s1233
2757,AIMed.d146,False,In this study the origin and function of the PROTEIN1 and PROTEIN2 molecules have been investigated.,AIMed.d146.s1234
2758,AIMed.d146,False,"To determine the role of each of these receptors in PROTEIN1 driven proliferation, PROTEIN2 expression and proliferative capacity were monitored during mitogenic stimulation.",AIMed.d146.s1235
2759,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN correlated with expression of the PROTEIN1 PROTEIN2 and not with expression of the PROTEIN PROTEIN ,AIMed.d146.s1236
2760,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN correlated with expression of the PROTEIN1 PROTEIN and not with expression of the PROTEIN PROTEIN2 ,AIMed.d146.s1236
2761,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN1 correlated with expression of the PROTEIN2 PROTEIN and not with expression of the PROTEIN PROTEIN ,AIMed.d146.s1236
2762,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN correlated with expression of the PROTEIN1 PROTEIN and not with expression of the PROTEIN2 PROTEIN ,AIMed.d146.s1236
2763,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN correlated with expression of the PROTEIN PROTEIN1 and not with expression of the PROTEIN PROTEIN2 ,AIMed.d146.s1236
2764,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN1 correlated with expression of the PROTEIN PROTEIN2 and not with expression of the PROTEIN PROTEIN ,AIMed.d146.s1236
2765,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN correlated with expression of the PROTEIN PROTEIN1 and not with expression of the PROTEIN2 PROTEIN ,AIMed.d146.s1236
2766,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN1 correlated with expression of the PROTEIN PROTEIN and not with expression of the PROTEIN PROTEIN2 ,AIMed.d146.s1236
2767,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN correlated with expression of the PROTEIN PROTEIN and not with expression of the PROTEIN1 PROTEIN2 ,AIMed.d146.s1236
2768,AIMed.d146,False,These analyses showed that the ability of PBMC to proliferate to PROTEIN1 correlated with expression of the PROTEIN PROTEIN and not with expression of the PROTEIN2 PROTEIN ,AIMed.d146.s1236
2769,AIMed.d146,False," PROTEIN1 driven proliferation is mediated via high affinity PROTEIN2 and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2770,AIMed.d146,False," PROTEIN1 driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN2 the PROTEIN PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2771,AIMed.d146,False," PROTEIN1 driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN PROTEIN bound PROTEIN2 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2772,AIMed.d146,False," PROTEIN1 driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN PROTEIN2 bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2773,AIMed.d146,False," PROTEIN1 driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN2 PROTEIN the PROTEIN PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2774,AIMed.d146,False," PROTEIN1 driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN2 PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2775,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN1 and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN2 the PROTEIN PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2776,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN1 and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN PROTEIN bound PROTEIN2 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2777,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN1 and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN PROTEIN2 bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2778,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN1 and accordingly, Scatchard analysis revealed that, like the PROTEIN2 PROTEIN the PROTEIN PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2779,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN1 and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN2 PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2780,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN1 the PROTEIN PROTEIN bound PROTEIN2 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2781,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN1 the PROTEIN PROTEIN2 bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2782,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN1 PROTEIN2 the PROTEIN PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2783,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN1 the PROTEIN2 PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2784,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN PROTEIN1 bound PROTEIN2 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2785,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN1 PROTEIN the PROTEIN PROTEIN bound PROTEIN2 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2786,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN1 PROTEIN bound PROTEIN2 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2787,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN1 PROTEIN the PROTEIN PROTEIN2 bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2788,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN PROTEIN the PROTEIN1 PROTEIN2 bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2789,AIMed.d146,False," PROTEIN driven proliferation is mediated via high affinity PROTEIN and accordingly, Scatchard analysis revealed that, like the PROTEIN1 PROTEIN the PROTEIN2 PROTEIN bound PROTEIN with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.",AIMed.d146.s1237
2790,AIMed.d146,False,Deglycosylation studies showed that the PROTEIN1 and PROTEIN PROTEIN2 are not simply differently glycosylated isoforms of a single receptor.,AIMed.d146.s1238
2791,AIMed.d146,False,Deglycosylation studies showed that the PROTEIN1 and PROTEIN2 PROTEIN are not simply differently glycosylated isoforms of a single receptor.,AIMed.d146.s1238
2792,AIMed.d146,False,Deglycosylation studies showed that the PROTEIN and PROTEIN1 PROTEIN2 are not simply differently glycosylated isoforms of a single receptor.,AIMed.d146.s1238
2793,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN1 were found to stain unstimulated T cells that express only the PROTEIN PROTEIN but not T-cell clones that express predominantly the PROTEIN PROTEIN2 ",AIMed.d146.s1239
2794,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN1 were found to stain unstimulated T cells that express only the PROTEIN PROTEIN but not T-cell clones that express predominantly the PROTEIN2 PROTEIN ",AIMed.d146.s1239
2795,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN1 were found to stain unstimulated T cells that express only the PROTEIN PROTEIN2 but not T-cell clones that express predominantly the PROTEIN PROTEIN ",AIMed.d146.s1239
2796,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN1 were found to stain unstimulated T cells that express only the PROTEIN2 PROTEIN but not T-cell clones that express predominantly the PROTEIN PROTEIN ",AIMed.d146.s1239
2797,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN PROTEIN but not T-cell clones that express predominantly the PROTEIN1 PROTEIN2 ",AIMed.d146.s1239
2798,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN PROTEIN1 but not T-cell clones that express predominantly the PROTEIN PROTEIN2 ",AIMed.d146.s1239
2799,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN1 PROTEIN but not T-cell clones that express predominantly the PROTEIN PROTEIN2 ",AIMed.d146.s1239
2800,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN PROTEIN1 but not T-cell clones that express predominantly the PROTEIN2 PROTEIN ",AIMed.d146.s1239
2801,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN1 PROTEIN but not T-cell clones that express predominantly the PROTEIN2 PROTEIN ",AIMed.d146.s1239
2802,AIMed.d146,False,"In agreement, mAb to the previously cloned PROTEIN were found to stain unstimulated T cells that express only the PROTEIN1 PROTEIN2 but not T-cell clones that express predominantly the PROTEIN PROTEIN ",AIMed.d146.s1239
2803,AIMed.d146,False,"These antibodies also immunoprecipitated the cloned PROTEIN1 as a 90-kDa species from both 125-I-surface-labeled resting and activated T cells, but were unable to precipitate the 76-kDa PROTEIN2 ",AIMed.d146.s1240
2804,AIMed.d146,False,"In addition, PCR analysis of PROTEIN expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN thereby excluding the possibility that the PROTEIN PROTEIN1 is a previously undescribed splice variant of the cloned PROTEIN2 ",AIMed.d146.s1241
2805,AIMed.d146,False,"In addition, PCR analysis of PROTEIN expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN thereby excluding the possibility that the PROTEIN1 PROTEIN is a previously undescribed splice variant of the cloned PROTEIN2 ",AIMed.d146.s1241
2806,AIMed.d146,False,"In addition, PCR analysis of PROTEIN1 expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN thereby excluding the possibility that the PROTEIN PROTEIN is a previously undescribed splice variant of the cloned PROTEIN2 ",AIMed.d146.s1241
2807,AIMed.d146,False,"In addition, PCR analysis of PROTEIN expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN1 thereby excluding the possibility that the PROTEIN PROTEIN is a previously undescribed splice variant of the cloned PROTEIN2 ",AIMed.d146.s1241
2808,AIMed.d146,False,"In addition, PCR analysis of PROTEIN expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN thereby excluding the possibility that the PROTEIN1 PROTEIN2 is a previously undescribed splice variant of the cloned PROTEIN ",AIMed.d146.s1241
2809,AIMed.d146,False,"In addition, PCR analysis of PROTEIN1 expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN thereby excluding the possibility that the PROTEIN PROTEIN2 is a previously undescribed splice variant of the cloned PROTEIN ",AIMed.d146.s1241
2810,AIMed.d146,False,"In addition, PCR analysis of PROTEIN expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN1 thereby excluding the possibility that the PROTEIN PROTEIN2 is a previously undescribed splice variant of the cloned PROTEIN ",AIMed.d146.s1241
2811,AIMed.d146,False,"In addition, PCR analysis of PROTEIN1 expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN thereby excluding the possibility that the PROTEIN2 PROTEIN is a previously undescribed splice variant of the cloned PROTEIN ",AIMed.d146.s1241
2812,AIMed.d146,False,"In addition, PCR analysis of PROTEIN expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN1 thereby excluding the possibility that the PROTEIN2 PROTEIN is a previously undescribed splice variant of the cloned PROTEIN ",AIMed.d146.s1241
2813,AIMed.d146,False,"In addition, PCR analysis of PROTEIN1 expressing cells could not detect splicing of the extracellular domain of the cloned PROTEIN2 thereby excluding the possibility that the PROTEIN PROTEIN is a previously undescribed splice variant of the cloned PROTEIN ",AIMed.d146.s1241
2814,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN1 and PROTEIN2 PROTEIN have different extracellular domains.,AIMed.d146.s1242
2815,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN1 is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN and PROTEIN2 PROTEIN have different extracellular domains.,AIMed.d146.s1242
2816,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN1 and imply that the PROTEIN and PROTEIN2 PROTEIN have different extracellular domains.,AIMed.d146.s1242
2817,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN and PROTEIN1 PROTEIN2 have different extracellular domains.,AIMed.d146.s1242
2818,AIMed.d146,False,These data demonstrate that the PROTEIN1 PROTEIN is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN and PROTEIN2 PROTEIN have different extracellular domains.,AIMed.d146.s1242
2819,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN1 is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN2 and PROTEIN PROTEIN have different extracellular domains.,AIMed.d146.s1242
2820,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN1 and imply that the PROTEIN2 and PROTEIN PROTEIN have different extracellular domains.,AIMed.d146.s1242
2821,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN1 and PROTEIN PROTEIN2 have different extracellular domains.,AIMed.d146.s1242
2822,AIMed.d146,False,These data demonstrate that the PROTEIN1 PROTEIN is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN2 and PROTEIN PROTEIN have different extracellular domains.,AIMed.d146.s1242
2823,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN1 is the T-cell homologue of the cloned PROTEIN2 and imply that the PROTEIN and PROTEIN PROTEIN have different extracellular domains.,AIMed.d146.s1242
2824,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN1 is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN and PROTEIN PROTEIN2 have different extracellular domains.,AIMed.d146.s1242
2825,AIMed.d146,False,These data demonstrate that the PROTEIN1 PROTEIN2 is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN and PROTEIN PROTEIN have different extracellular domains.,AIMed.d146.s1242
2826,AIMed.d146,False,These data demonstrate that the PROTEIN PROTEIN is the T-cell homologue of the cloned PROTEIN1 and imply that the PROTEIN and PROTEIN PROTEIN2 have different extracellular domains.,AIMed.d146.s1242
2827,AIMed.d146,False,These data demonstrate that the PROTEIN1 PROTEIN is the T-cell homologue of the cloned PROTEIN2 and imply that the PROTEIN and PROTEIN PROTEIN have different extracellular domains.,AIMed.d146.s1242
2828,AIMed.d146,False,These data demonstrate that the PROTEIN1 PROTEIN is the T-cell homologue of the cloned PROTEIN and imply that the PROTEIN and PROTEIN PROTEIN2 have different extracellular domains.,AIMed.d146.s1242
2829,AIMed.d146,False,Taken together these data suggest that the 76-kDa receptor is a novel high affinity PROTEIN1 that may be necessary for PROTEIN2 driven proliferation in human T cells.,AIMed.d146.s1243
2830,AIMed.d147,True,Characterization of the PROTEIN1 binding proteins PROTEIN2 and PROTEIN ,AIMed.d147.s1244
2831,AIMed.d147,False,Characterization of the PROTEIN binding proteins PROTEIN1 and PROTEIN2 ,AIMed.d147.s1244
2832,AIMed.d147,True,Characterization of the PROTEIN1 binding proteins PROTEIN and PROTEIN2 ,AIMed.d147.s1244
2833,AIMed.d147,False,"The PROTEIN1 gene product, PROTEIN2 regulates cell proliferation by binding to and inhibiting the activity of key growth promoting proteins.",AIMed.d147.s1245
2834,AIMed.d147,True,"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, PROTEIN1 and PROTEIN cloned originally by their interaction with PROTEIN2 ",AIMed.d147.s1248
2835,AIMed.d147,False,"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, PROTEIN1 and PROTEIN2 cloned originally by their interaction with PROTEIN ",AIMed.d147.s1248
2836,AIMed.d147,True,"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, PROTEIN and PROTEIN1 cloned originally by their interaction with PROTEIN2 ",AIMed.d147.s1248
2837,AIMed.d147,False,"The products of the PROTEIN1 and PROTEIN2 genes are ubiquitously expressed, large (200 kDa for PROTEIN and 195 kDa for PROTEIN nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.",AIMed.d147.s1249
2838,AIMed.d147,False,"The products of the PROTEIN and PROTEIN1 genes are ubiquitously expressed, large (200 kDa for PROTEIN and 195 kDa for PROTEIN2 nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.",AIMed.d147.s1249
2839,AIMed.d147,False,"The products of the PROTEIN and PROTEIN1 genes are ubiquitously expressed, large (200 kDa for PROTEIN2 and 195 kDa for PROTEIN nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.",AIMed.d147.s1249
2840,AIMed.d147,False,"The products of the PROTEIN1 and PROTEIN genes are ubiquitously expressed, large (200 kDa for PROTEIN and 195 kDa for PROTEIN2 nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.",AIMed.d147.s1249
2841,AIMed.d147,False,"The products of the PROTEIN1 and PROTEIN genes are ubiquitously expressed, large (200 kDa for PROTEIN2 and 195 kDa for PROTEIN nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.",AIMed.d147.s1249
2842,AIMed.d147,False,"The products of the PROTEIN and PROTEIN genes are ubiquitously expressed, large (200 kDa for PROTEIN1 and 195 kDa for PROTEIN2 nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.",AIMed.d147.s1249
2843,AIMed.d147,True,In addition we have been able to identify complexes of PROTEIN1 and PROTEIN2 in vivo that are dissociated in the presence of purified human papillomavirus PROTEIN protein.,AIMed.d147.s1250
2844,AIMed.d147,False,In addition we have been able to identify complexes of PROTEIN1 and PROTEIN in vivo that are dissociated in the presence of purified human papillomavirus PROTEIN2 protein.,AIMed.d147.s1250
2845,AIMed.d147,False,In addition we have been able to identify complexes of PROTEIN and PROTEIN1 in vivo that are dissociated in the presence of purified human papillomavirus PROTEIN2 protein.,AIMed.d147.s1250
2846,AIMed.d148,False,"Two potentially oncogenic cyclins, PROTEIN1 and PROTEIN2 share common properties of subunit configuration, tyrosine phosphorylation and physical association with the PROTEIN protein",AIMed.d148.s1251
2847,AIMed.d148,True,"Two potentially oncogenic cyclins, PROTEIN and PROTEIN1 share common properties of subunit configuration, tyrosine phosphorylation and physical association with the PROTEIN2 protein",AIMed.d148.s1251
2848,AIMed.d148,True,"Two potentially oncogenic cyclins, PROTEIN1 and PROTEIN share common properties of subunit configuration, tyrosine phosphorylation and physical association with the PROTEIN2 protein",AIMed.d148.s1251
2849,AIMed.d148,False,".Originally identified as a 'mitotic cyclin', PROTEIN1 exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an PROTEIN2 ( PROTEIN as well as a candidate proto-oncogene.",AIMed.d148.s1252
2850,AIMed.d148,False,".Originally identified as a 'mitotic cyclin', PROTEIN exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an PROTEIN1 ( PROTEIN2 as well as a candidate proto-oncogene.",AIMed.d148.s1252
2851,AIMed.d148,False,".Originally identified as a 'mitotic cyclin', PROTEIN1 exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an PROTEIN ( PROTEIN2 as well as a candidate proto-oncogene.",AIMed.d148.s1252
2852,AIMed.d148,False,Other recent studies have identified human PROTEIN1 ( PROTEIN2 as a putative G1 cyclin and candidate proto-oncogene.,AIMed.d148.s1253
2853,AIMed.d148,False,"Moreover, PROTEIN1 was found to be phosphorylated on tyrosine residues in vivo and, like PROTEIN2 was readily phosphorylated by PROTEIN in vitro.",AIMed.d148.s1257
2854,AIMed.d148,True,"Moreover, PROTEIN was found to be phosphorylated on tyrosine residues in vivo and, like PROTEIN1 was readily phosphorylated by PROTEIN2 in vitro.",AIMed.d148.s1257
2855,AIMed.d148,True,"Moreover, PROTEIN1 was found to be phosphorylated on tyrosine residues in vivo and, like PROTEIN was readily phosphorylated by PROTEIN2 in vitro.",AIMed.d148.s1257
2856,AIMed.d148,True,"In synchronized human osteosarcoma cells, PROTEIN1 is induced in early G1 and becomes associated with PROTEIN2 a Cdk-binding subunit.",AIMed.d148.s1258
2857,AIMed.d148,True,Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that PROTEIN1 is associated with both PROTEIN2 and PROTEIN and that PROTEIN immune complexes exhibit appreciable histone H1 kinase activity.,AIMed.d148.s1259
2858,AIMed.d148,False,Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that PROTEIN is associated with both PROTEIN1 and PROTEIN2 and that PROTEIN immune complexes exhibit appreciable histone H1 kinase activity.,AIMed.d148.s1259
2859,AIMed.d148,False,Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that PROTEIN is associated with both PROTEIN1 and PROTEIN and that PROTEIN2 immune complexes exhibit appreciable histone H1 kinase activity.,AIMed.d148.s1259
2860,AIMed.d148,True,Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that PROTEIN1 is associated with both PROTEIN and PROTEIN2 and that PROTEIN immune complexes exhibit appreciable histone H1 kinase activity.,AIMed.d148.s1259
2861,AIMed.d148,False,Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that PROTEIN1 is associated with both PROTEIN and PROTEIN and that PROTEIN2 immune complexes exhibit appreciable histone H1 kinase activity.,AIMed.d148.s1259
2862,AIMed.d148,False,Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that PROTEIN is associated with both PROTEIN and PROTEIN1 and that PROTEIN2 immune complexes exhibit appreciable histone H1 kinase activity.,AIMed.d148.s1259
2863,AIMed.d150,True,Regulation of the PROTEIN related transcription factor PROTEIN1 by binding to the PROTEIN2 protein.,AIMed.d150.s1273
2864,AIMed.d150,False,Regulation of the PROTEIN1 related transcription factor PROTEIN by binding to the PROTEIN2 protein.,AIMed.d150.s1273
2865,AIMed.d150,False,Regulation of the PROTEIN1 related transcription factor PROTEIN2 by binding to the PROTEIN protein.,AIMed.d150.s1273
2866,AIMed.d150,False,The PROTEIN1 gene product ( PROTEIN2 is a nuclear phosphoprotein that regulates cell cycle progression.,AIMed.d150.s1274
2867,AIMed.d150,False, PROTEIN1 is a lymphoid-specific PROTEIN2 transcription factor that regulates inducible gene expression during T cell activation.,AIMed.d150.s1275
2868,AIMed.d150,True,"In this report, it is demonstrated that PROTEIN1 contains a sequence motif that is highly related to the PROTEIN binding sites of several viral oncoproteins and binds to the pocket region of PROTEIN2 both in vitro and in vivo.",AIMed.d150.s1276
2869,AIMed.d150,False,"In this report, it is demonstrated that PROTEIN contains a sequence motif that is highly related to the PROTEIN1 binding sites of several viral oncoproteins and binds to the pocket region of PROTEIN2 both in vitro and in vivo.",AIMed.d150.s1276
2870,AIMed.d150,False,"In this report, it is demonstrated that PROTEIN1 contains a sequence motif that is highly related to the PROTEIN2 binding sites of several viral oncoproteins and binds to the pocket region of PROTEIN both in vitro and in vivo.",AIMed.d150.s1276
2871,AIMed.d150,False, PROTEIN1 binds exclusively to the underphosphorylated form of PROTEIN and fails to bind to PROTEIN2 mutants derived from patients with retinoblastoma.,AIMed.d150.s1277
2872,AIMed.d150,False, PROTEIN1 binds exclusively to the underphosphorylated form of PROTEIN2 and fails to bind to PROTEIN mutants derived from patients with retinoblastoma.,AIMed.d150.s1277
2873,AIMed.d150,False, PROTEIN binds exclusively to the underphosphorylated form of PROTEIN1 and fails to bind to PROTEIN2 mutants derived from patients with retinoblastoma.,AIMed.d150.s1277
2874,AIMed.d150,True,Co-immunoprecipitation experiments demonstrated an association between PROTEIN1 and PROTEIN2 in resting normal human T cells.,AIMed.d150.s1278
2875,AIMed.d150,False,"After T cell activation, the phosphorylation of PROTEIN results in the release of PROTEIN1 which is correlated temporally with the activation of PROTEIN2 mediated transcription.",AIMed.d150.s1279
2876,AIMed.d150,False,"After T cell activation, the phosphorylation of PROTEIN1 results in the release of PROTEIN2 which is correlated temporally with the activation of PROTEIN mediated transcription.",AIMed.d150.s1279
2877,AIMed.d150,False,"After T cell activation, the phosphorylation of PROTEIN1 results in the release of PROTEIN which is correlated temporally with the activation of PROTEIN2 mediated transcription.",AIMed.d150.s1279
2878,AIMed.d150,False,Overexpression of a phosphorylation-defective form of PROTEIN1 inhibited PROTEIN2 dependent transcription during T cell activation.,AIMed.d150.s1280
2879,AIMed.d150,False,These results demonstrate that PROTEIN1 interacts specifically with a lineage-restricted PROTEIN2 transcription factor.,AIMed.d150.s1281
2880,AIMed.d151,False,The PROTEIN1 ( PROTEIN2 specifically recognizes the PSEs of both RNA polymerase II- and RNA polymerase III-transcribed small nuclear RNA (snRNA) genes.,AIMed.d151.s1284
2881,AIMed.d151,False,"We previously have shown that PROTEIN1 purified from human HeLa cells is a multisubunit complex of four polypeptides designated PROTEIN2 alpha, -beta, -gamma, and -delta.",AIMed.d151.s1285
2882,AIMed.d151,False,"We previously have shown that PROTEIN purified from human HeLa cells is a multisubunit complex of four polypeptides designated PROTEIN1 -beta, -gamma, and -delta.",AIMed.d151.s1285
2883,AIMed.d151,False,"We previously have shown that PROTEIN1 purified from human HeLa cells is a multisubunit complex of four polypeptides designated PROTEIN2 -beta, -gamma, and -delta.",AIMed.d151.s1285
2884,AIMed.d151,False,"We now report the isolation and expression of cDNAs encoding PROTEIN gamma and PROTEIN1 delta, as well as functional studies with cognate antibodies that recognize the native PROTEIN2 complex in HeLa extracts.",AIMed.d151.s1286
2885,AIMed.d151,False,"We now report the isolation and expression of cDNAs encoding PROTEIN1 gamma and PROTEIN delta, as well as functional studies with cognate antibodies that recognize the native PROTEIN2 complex in HeLa extracts.",AIMed.d151.s1286
2886,AIMed.d151,False,"We now report the isolation and expression of cDNAs encoding PROTEIN1 gamma and PROTEIN2 delta, as well as functional studies with cognate antibodies that recognize the native PROTEIN complex in HeLa extracts.",AIMed.d151.s1286
2887,AIMed.d151,False,"Immunoprecipitation studies confirm that the four PROTEIN1 subunits originally found to copurify during conventional chromatography indeed form a tightly associated complex; they further show that the PROTEIN2 so defined, including the gamma and delta subunits specifically, is essential for transcription of both class II and class III snRNA genes.",AIMed.d151.s1287
2888,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN1 and a component ( PROTEIN identical in sequence to the PROTEIN2 gamma reported here.,AIMed.d151.s1288
2889,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN1 related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN2 gamma reported here.,AIMed.d151.s1288
2890,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN1 identical in sequence to the PROTEIN2 gamma reported here.,AIMed.d151.s1288
2891,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN1 with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN2 gamma reported here.,AIMed.d151.s1288
2892,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN1 containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN2 gamma reported here.,AIMed.d151.s1288
2893,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN1 ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN2 gamma reported here.,AIMed.d151.s1288
2894,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN1 consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN2 gamma reported here.,AIMed.d151.s1288
2895,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN1 related complex ( PROTEIN containing substoichiometric levels of PROTEIN2 and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2896,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN1 and a component ( PROTEIN2 identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2897,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN1 with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN2 and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2898,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN1 containing substoichiometric levels of PROTEIN2 and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2899,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN1 ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN2 and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2900,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN1 consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN2 and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2901,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN1 related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN2 identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2902,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN1 with PROTEIN consistent with the previous report of a PROTEIN2 related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2903,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN1 related complex ( PROTEIN2 containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2904,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN1 ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN2 related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2905,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN1 consistent with the previous report of a PROTEIN2 related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2906,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN1 with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN2 identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2907,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN1 containing substoichiometric levels of PROTEIN and a component ( PROTEIN2 identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2908,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN1 ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN2 identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2909,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN1 consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN2 identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2910,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN1 with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN2 containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2911,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN1 ( PROTEIN2 with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2912,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN1 with PROTEIN2 consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2913,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN1 ( PROTEIN with PROTEIN consistent with the previous report of a PROTEIN related complex ( PROTEIN2 containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2914,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN ( PROTEIN with PROTEIN1 consistent with the previous report of a PROTEIN related complex ( PROTEIN2 containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2915,AIMed.d151,False,Immunoprecipitation assays also show a weak substoichiometric association of the PROTEIN1 ( PROTEIN with PROTEIN2 consistent with the previous report of a PROTEIN related complex ( PROTEIN containing substoichiometric levels of PROTEIN and a component ( PROTEIN identical in sequence to the PROTEIN gamma reported here.,AIMed.d151.s1288
2916,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN1 delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN2 during promoter activation.,AIMed.d151.s1289
2917,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN1 PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN2 during promoter activation.,AIMed.d151.s1289
2918,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN1 and TATA-bound PROTEIN2 during promoter activation.,AIMed.d151.s1289
2919,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN1 gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN2 during promoter activation.,AIMed.d151.s1289
2920,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN1 with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN2 during promoter activation.,AIMed.d151.s1289
2921,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN1 in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN2 during promoter activation.,AIMed.d151.s1289
2922,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN1 consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN2 during promoter activation.,AIMed.d151.s1289
2923,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN1 associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN2 during promoter activation.,AIMed.d151.s1289
2924,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN1 delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN2 PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2925,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN1 delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN2 and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2926,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN1 gamma and PROTEIN2 delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2927,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN1 delta with PROTEIN consistent either with the natural association of PROTEIN2 with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2928,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN1 delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN2 in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2929,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN1 delta with PROTEIN2 consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2930,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN1 delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN2 associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2931,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN1 PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN2 and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2932,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN1 gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN2 PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2933,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN1 with PROTEIN in a semistable PROTEIN2 PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2934,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN1 in a semistable PROTEIN2 PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2935,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN1 consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN2 PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2936,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN1 PROTEIN2 associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2937,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN1 gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN2 and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2938,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN1 with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN2 and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2939,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN1 in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN2 and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2940,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN1 consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN2 and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2941,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN1 associated factor complex or with possible functional interactions between PSE-bound PROTEIN2 and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2942,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN1 gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN2 with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2943,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN1 gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN2 in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2944,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN1 gamma and PROTEIN delta with PROTEIN2 consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2945,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN1 gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN2 associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2946,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN1 with PROTEIN2 in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2947,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN1 consistent either with the natural association of PROTEIN2 with PROTEIN in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2948,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN1 with PROTEIN in a semistable PROTEIN PROTEIN2 associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2949,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN1 consistent either with the natural association of PROTEIN with PROTEIN2 in a semistable PROTEIN PROTEIN associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2950,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN consistent either with the natural association of PROTEIN with PROTEIN1 in a semistable PROTEIN PROTEIN2 associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2951,AIMed.d151,False,Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PROTEIN gamma and PROTEIN delta with PROTEIN1 consistent either with the natural association of PROTEIN with PROTEIN in a semistable PROTEIN PROTEIN2 associated factor complex or with possible functional interactions between PSE-bound PROTEIN and TATA-bound PROTEIN during promoter activation.,AIMed.d151.s1289
2952,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN1 and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN2 or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2953,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN1 or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN2 complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2954,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN1 associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN2 or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2955,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN1 or PROTEIN2 indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2956,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN1 but not by PROTEIN2 or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2957,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN1 and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN2 complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2958,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN1 and PROTEIN2 associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2959,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN1 and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN or PROTEIN2 indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2960,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN1 and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN2 but not by PROTEIN or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2961,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN1 associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN2 complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2962,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN or PROTEIN1 indicating that transcription of class II snRNA genes requires a PROTEIN2 complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2963,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN1 but not by PROTEIN or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN2 complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2964,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN1 associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN but not by PROTEIN or PROTEIN2 indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2965,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN1 associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN2 but not by PROTEIN or PROTEIN indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2966,AIMed.d151,False,"In addition, we show that in extracts depleted of PROTEIN and PROTEIN associated factors, transcription from the U1 promoter is restored by recombinant PROTEIN1 but not by PROTEIN or PROTEIN2 indicating that transcription of class II snRNA genes requires a PROTEIN complex different from the one used for mRNA-encoding genes.",AIMed.d151.s1290
2967,AIMed.d152,False, PROTEIN1 PROTEIN and PROTEIN2 PROTEIN interactions define two distinct PROTEIN signal transduction pathways.,AIMed.d152.s1291
2968,AIMed.d152,False, PROTEIN PROTEIN and PROTEIN1 PROTEIN interactions define two distinct PROTEIN2 signal transduction pathways.,AIMed.d152.s1291
2969,AIMed.d152,True, PROTEIN PROTEIN and PROTEIN1 PROTEIN2 interactions define two distinct PROTEIN signal transduction pathways.,AIMed.d152.s1291
2970,AIMed.d152,False, PROTEIN PROTEIN1 and PROTEIN2 PROTEIN interactions define two distinct PROTEIN signal transduction pathways.,AIMed.d152.s1291
2971,AIMed.d152,False, PROTEIN1 PROTEIN and PROTEIN PROTEIN interactions define two distinct PROTEIN2 signal transduction pathways.,AIMed.d152.s1291
2972,AIMed.d152,False, PROTEIN1 PROTEIN and PROTEIN PROTEIN2 interactions define two distinct PROTEIN signal transduction pathways.,AIMed.d152.s1291
2973,AIMed.d152,True, PROTEIN1 PROTEIN2 and PROTEIN PROTEIN interactions define two distinct PROTEIN signal transduction pathways.,AIMed.d152.s1291
2974,AIMed.d152,False, PROTEIN PROTEIN and PROTEIN PROTEIN1 interactions define two distinct PROTEIN2 signal transduction pathways.,AIMed.d152.s1291
2975,AIMed.d152,False, PROTEIN PROTEIN1 and PROTEIN PROTEIN interactions define two distinct PROTEIN2 signal transduction pathways.,AIMed.d152.s1291
2976,AIMed.d152,False, PROTEIN PROTEIN1 and PROTEIN PROTEIN2 interactions define two distinct PROTEIN signal transduction pathways.,AIMed.d152.s1291
2977,AIMed.d152,False,Tumor necrosis factor (TNF) can induce apoptosis and activate PROTEIN1 through signaling cascades emanating from PROTEIN2 ( PROTEIN .,AIMed.d152.s1292
2978,AIMed.d152,False,Tumor necrosis factor (TNF) can induce apoptosis and activate PROTEIN through signaling cascades emanating from PROTEIN1 ( PROTEIN2 .,AIMed.d152.s1292
2979,AIMed.d152,False,Tumor necrosis factor (TNF) can induce apoptosis and activate PROTEIN1 through signaling cascades emanating from PROTEIN ( PROTEIN2 .,AIMed.d152.s1292
2980,AIMed.d152,False, PROTEIN1 is a PROTEIN2 associated signal transducer that is involved in activating both pathways.,AIMed.d152.s1293
2981,AIMed.d152,False,"Here we show that PROTEIN1 directly interacts with PROTEIN and PROTEIN signal transducers that activate PROTEIN2 and induce apoptosis, respectively.",AIMed.d152.s1294
2982,AIMed.d152,True,"Here we show that PROTEIN1 directly interacts with PROTEIN2 and PROTEIN signal transducers that activate PROTEIN and induce apoptosis, respectively.",AIMed.d152.s1294
2983,AIMed.d152,True,"Here we show that PROTEIN1 directly interacts with PROTEIN and PROTEIN2 signal transducers that activate PROTEIN and induce apoptosis, respectively.",AIMed.d152.s1294
2984,AIMed.d152,True,"Here we show that PROTEIN directly interacts with PROTEIN1 and PROTEIN signal transducers that activate PROTEIN2 and induce apoptosis, respectively.",AIMed.d152.s1294
2985,AIMed.d152,True,"Here we show that PROTEIN directly interacts with PROTEIN and PROTEIN1 signal transducers that activate PROTEIN2 and induce apoptosis, respectively.",AIMed.d152.s1294
2986,AIMed.d152,False,"Here we show that PROTEIN directly interacts with PROTEIN1 and PROTEIN2 signal transducers that activate PROTEIN and induce apoptosis, respectively.",AIMed.d152.s1294
2987,AIMed.d152,False,"A PROTEIN1 mutant lacking its N-terminal RING finger domain is a dominant-negative inhibitor of TNF-mediated PROTEIN2 activation, but does not affect TNF-induced apoptosis.",AIMed.d152.s1295
2988,AIMed.d152,False,"Conversely, a PROTEIN1 mutant lacking its N-terminal 79 amino acids is a dominant-negative inhibitor of TNF-induced apoptosis, but does not inhibit PROTEIN2 activation.",AIMed.d152.s1296
2989,AIMed.d152,False,"Thus, these two PROTEIN1 PROTEIN2 signaling cascades appear to bifurcate at PROTEIN ",AIMed.d152.s1297
2990,AIMed.d152,False,"Thus, these two PROTEIN1 PROTEIN signaling cascades appear to bifurcate at PROTEIN2 ",AIMed.d152.s1297
2991,AIMed.d152,False,"Thus, these two PROTEIN PROTEIN1 signaling cascades appear to bifurcate at PROTEIN2 ",AIMed.d152.s1297
2992,AIMed.d153,True,Characterization of PROTEIN1 binding to human PROTEIN2 on T cells and its biologic role in immune response.,AIMed.d153.s1298
2993,AIMed.d153,False," PROTEIN1 a T cell activation Ag, also known as PROTEIN2 is directly associated with PROTEIN ( PROTEIN on the surface of T cells and T cell lines.",AIMed.d153.s1299
2994,AIMed.d153,True," PROTEIN1 a T cell activation Ag, also known as PROTEIN is directly associated with PROTEIN ( PROTEIN2 on the surface of T cells and T cell lines.",AIMed.d153.s1299
2995,AIMed.d153,True," PROTEIN1 a T cell activation Ag, also known as PROTEIN is directly associated with PROTEIN2 ( PROTEIN on the surface of T cells and T cell lines.",AIMed.d153.s1299
2996,AIMed.d153,True," PROTEIN a T cell activation Ag, also known as PROTEIN1 is directly associated with PROTEIN ( PROTEIN2 on the surface of T cells and T cell lines.",AIMed.d153.s1299
2997,AIMed.d153,True," PROTEIN a T cell activation Ag, also known as PROTEIN1 is directly associated with PROTEIN2 ( PROTEIN on the surface of T cells and T cell lines.",AIMed.d153.s1299
2998,AIMed.d153,False," PROTEIN a T cell activation Ag, also known as PROTEIN is directly associated with PROTEIN1 ( PROTEIN2 on the surface of T cells and T cell lines.",AIMed.d153.s1299
2999,AIMed.d153,True,"In the present study, we examined both the binding of PROTEIN1 and PROTEIN2 and the functional consequences of this interaction.",AIMed.d153.s1300
3000,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN1 on T cell lines lacking either PROTEIN or PROTEIN enzymatic activity, indicating that the association between PROTEIN and PROTEIN2 did not require enzymatic activity.",AIMed.d153.s1301
3001,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN1 on T cell lines lacking either PROTEIN2 or PROTEIN enzymatic activity, indicating that the association between PROTEIN and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3002,AIMed.d153,True,"We found that PROTEIN1 was associated with PROTEIN2 on T cell lines lacking either PROTEIN or PROTEIN enzymatic activity, indicating that the association between PROTEIN and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3003,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN1 on T cell lines lacking either PROTEIN or PROTEIN2 enzymatic activity, indicating that the association between PROTEIN and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3004,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN1 on T cell lines lacking either PROTEIN or PROTEIN enzymatic activity, indicating that the association between PROTEIN2 and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3005,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN1 or PROTEIN enzymatic activity, indicating that the association between PROTEIN and PROTEIN2 did not require enzymatic activity.",AIMed.d153.s1301
3006,AIMed.d153,False,"We found that PROTEIN1 was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN enzymatic activity, indicating that the association between PROTEIN and PROTEIN2 did not require enzymatic activity.",AIMed.d153.s1301
3007,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN1 enzymatic activity, indicating that the association between PROTEIN and PROTEIN2 did not require enzymatic activity.",AIMed.d153.s1301
3008,AIMed.d153,True,"We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN enzymatic activity, indicating that the association between PROTEIN1 and PROTEIN2 did not require enzymatic activity.",AIMed.d153.s1301
3009,AIMed.d153,False,"We found that PROTEIN1 was associated with PROTEIN on T cell lines lacking either PROTEIN2 or PROTEIN enzymatic activity, indicating that the association between PROTEIN and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3010,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN1 or PROTEIN2 enzymatic activity, indicating that the association between PROTEIN and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3011,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN1 or PROTEIN enzymatic activity, indicating that the association between PROTEIN2 and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3012,AIMed.d153,False,"We found that PROTEIN1 was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN2 enzymatic activity, indicating that the association between PROTEIN and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3013,AIMed.d153,False,"We found that PROTEIN1 was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN enzymatic activity, indicating that the association between PROTEIN2 and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3014,AIMed.d153,False,"We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN1 enzymatic activity, indicating that the association between PROTEIN2 and PROTEIN did not require enzymatic activity.",AIMed.d153.s1301
3015,AIMed.d153,False,"Moreover, using immunoelectron microscopy, we demonstrated that PROTEIN1 and PROTEIN co-localized on the cell surface, but not inside cells, suggesting that PROTEIN did not transport PROTEIN2 to the surface.",AIMed.d153.s1302
3016,AIMed.d153,False,"Moreover, using immunoelectron microscopy, we demonstrated that PROTEIN and PROTEIN1 co-localized on the cell surface, but not inside cells, suggesting that PROTEIN did not transport PROTEIN2 to the surface.",AIMed.d153.s1302
3017,AIMed.d153,False,"Moreover, using immunoelectron microscopy, we demonstrated that PROTEIN and PROTEIN co-localized on the cell surface, but not inside cells, suggesting that PROTEIN1 did not transport PROTEIN2 to the surface.",AIMed.d153.s1302
3018,AIMed.d153,False,"Moreover, using immunoelectron microscopy, we demonstrated that PROTEIN1 and PROTEIN2 co-localized on the cell surface, but not inside cells, suggesting that PROTEIN did not transport PROTEIN to the surface.",AIMed.d153.s1302
3019,AIMed.d153,False,"Moreover, using immunoelectron microscopy, we demonstrated that PROTEIN1 and PROTEIN co-localized on the cell surface, but not inside cells, suggesting that PROTEIN2 did not transport PROTEIN to the surface.",AIMed.d153.s1302
3020,AIMed.d153,False,"Moreover, using immunoelectron microscopy, we demonstrated that PROTEIN and PROTEIN1 co-localized on the cell surface, but not inside cells, suggesting that PROTEIN2 did not transport PROTEIN to the surface.",AIMed.d153.s1302
3021,AIMed.d153,False,"In keeping with this observation, we showed that human PROTEIN1 transfected murine pre-B cell lines lacking human PROTEIN acquired PROTEIN2 from an extracellular source.",AIMed.d153.s1303
3022,AIMed.d153,False,"In keeping with this observation, we showed that human PROTEIN1 transfected murine pre-B cell lines lacking human PROTEIN2 acquired PROTEIN from an extracellular source.",AIMed.d153.s1303
3023,AIMed.d153,False,"In keeping with this observation, we showed that human PROTEIN transfected murine pre-B cell lines lacking human PROTEIN1 acquired PROTEIN2 from an extracellular source.",AIMed.d153.s1303
3024,AIMed.d153,False,"More importantly, adenosine in the absence of cell surface PROTEIN1 inhibited T cell proliferation and PROTEIN2 production induced by various stimuli.",AIMed.d153.s1304
3025,AIMed.d153,False,"On the other hand, cells expressing PROTEIN1 and PROTEIN2 on the surface were much more resistant to the inhibitory effect of adenosine.",AIMed.d153.s1305
3026,AIMed.d153,False,These data suggest that PROTEIN1 on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN binds to cell surface PROTEIN2 and this complex is capable of reducing the local concentration of adenosine.,AIMed.d153.s1306
3027,AIMed.d153,True,These data suggest that PROTEIN on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN1 binds to cell surface PROTEIN2 and this complex is capable of reducing the local concentration of adenosine.,AIMed.d153.s1306
3028,AIMed.d153,False,These data suggest that PROTEIN1 on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN2 binds to cell surface PROTEIN and this complex is capable of reducing the local concentration of adenosine.,AIMed.d153.s1306
3029,AIMed.d154,False,We have cloned and characterized human PROTEIN1 and a second isoform of human PROTEIN2 ,AIMed.d154.s1309
3030,AIMed.d154,False,"The deduced amino acid sequences of human alpha 1- and PROTEIN are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like PROTEIN1 human PROTEIN2 has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.",AIMed.d154.s1311
3031,AIMed.d154,False,"The deduced amino acid sequences of human alpha 1- and PROTEIN1 are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like PROTEIN2 human PROTEIN has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.",AIMed.d154.s1311
3032,AIMed.d154,False,"The deduced amino acid sequences of human alpha 1- and PROTEIN1 are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like PROTEIN human PROTEIN2 has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.",AIMed.d154.s1311
3033,AIMed.d154,False,Somatic cell hybrids and fluorescent in situ hybridization were both used to determine their chromosomal locations: PROTEIN1 to chromosome 16q22-23 and PROTEIN2 to chromosome 20q11.2.,AIMed.d154.s1313
3034,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN2 related protein, and the PROTEIN ",AIMed.d154.s1314
3035,AIMed.d154,True,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN and the PROTEIN2 ",AIMed.d154.s1314
3036,AIMed.d154,True,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN2 and the PROTEIN ",AIMed.d154.s1314
3037,AIMed.d154,True,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN2 PROTEIN and the PROTEIN ",AIMed.d154.s1314
3038,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN2 interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN and the PROTEIN ",AIMed.d154.s1314
3039,AIMed.d154,True,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN2 PROTEIN PROTEIN and the PROTEIN ",AIMed.d154.s1314
3040,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN1 related protein, and the PROTEIN2 ",AIMed.d154.s1314
3041,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN1 and the PROTEIN ",AIMed.d154.s1314
3042,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN1 PROTEIN2 related protein, and the PROTEIN ",AIMed.d154.s1314
3043,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN2 related protein, and the PROTEIN ",AIMed.d154.s1314
3044,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN1 PROTEIN PROTEIN2 related protein, and the PROTEIN ",AIMed.d154.s1314
3045,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN1 and the PROTEIN2 ",AIMed.d154.s1314
3046,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN1 PROTEIN and the PROTEIN2 ",AIMed.d154.s1314
3047,AIMed.d154,True,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN and the PROTEIN2 ",AIMed.d154.s1314
3048,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN1 PROTEIN PROTEIN and the PROTEIN2 ",AIMed.d154.s1314
3049,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN1 PROTEIN2 and the PROTEIN ",AIMed.d154.s1314
3050,AIMed.d154,True,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN PROTEIN2 and the PROTEIN ",AIMed.d154.s1314
3051,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN1 PROTEIN PROTEIN2 and the PROTEIN ",AIMed.d154.s1314
3052,AIMed.d154,True,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN PROTEIN2 PROTEIN and the PROTEIN ",AIMed.d154.s1314
3053,AIMed.d154,False,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN1 PROTEIN2 PROTEIN and the PROTEIN ",AIMed.d154.s1314
3054,AIMed.d154,True,"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 both beta 2- and PROTEIN interact with peptides encoding the syntrophin-binding region of PROTEIN2 PROTEIN PROTEIN and the PROTEIN ",AIMed.d154.s1314
3055,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN1 [ PROTEIN2 ( PROTEIN ] are complexed by an PROTEIN PROTEIN ",AIMed.d157.s1328
3056,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 and PROTEIN [ PROTEIN2 ( PROTEIN ] are complexed by an PROTEIN PROTEIN ",AIMed.d157.s1328
3057,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN [ PROTEIN1 ( PROTEIN2 ] are complexed by an PROTEIN PROTEIN ",AIMed.d157.s1328
3058,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN [ PROTEIN1 ( PROTEIN ] are complexed by an PROTEIN PROTEIN2 ",AIMed.d157.s1328
3059,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN [ PROTEIN1 ( PROTEIN ] are complexed by an PROTEIN2 PROTEIN ",AIMed.d157.s1328
3060,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 and PROTEIN2 [ PROTEIN ( PROTEIN ] are complexed by an PROTEIN PROTEIN ",AIMed.d157.s1328
3061,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN1 [ PROTEIN ( PROTEIN2 ] are complexed by an PROTEIN PROTEIN ",AIMed.d157.s1328
3062,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN1 [ PROTEIN ( PROTEIN ] are complexed by an PROTEIN PROTEIN2 ",AIMed.d157.s1328
3063,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN1 [ PROTEIN ( PROTEIN ] are complexed by an PROTEIN2 PROTEIN ",AIMed.d157.s1328
3064,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 and PROTEIN [ PROTEIN ( PROTEIN2 ] are complexed by an PROTEIN PROTEIN ",AIMed.d157.s1328
3065,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 and PROTEIN [ PROTEIN ( PROTEIN ] are complexed by an PROTEIN PROTEIN2 ",AIMed.d157.s1328
3066,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 and PROTEIN [ PROTEIN ( PROTEIN ] are complexed by an PROTEIN2 PROTEIN ",AIMed.d157.s1328
3067,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN [ PROTEIN ( PROTEIN1 ] are complexed by an PROTEIN PROTEIN2 ",AIMed.d157.s1328
3068,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN [ PROTEIN ( PROTEIN1 ] are complexed by an PROTEIN2 PROTEIN ",AIMed.d157.s1328
3069,AIMed.d157,False,"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN and PROTEIN [ PROTEIN ( PROTEIN ] are complexed by an PROTEIN1 PROTEIN2 ",AIMed.d157.s1328
3070,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN1 ( PROTEIN , binds PROTEIN at a site distinct from those bound by PROTEIN2 or PROTEIN ",AIMed.d157.s1329
3071,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN ( PROTEIN , binds PROTEIN at a site distinct from those bound by PROTEIN1 or PROTEIN2 ",AIMed.d157.s1329
3072,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN ( PROTEIN1 , binds PROTEIN at a site distinct from those bound by PROTEIN2 or PROTEIN ",AIMed.d157.s1329
3073,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN ( PROTEIN , binds PROTEIN1 at a site distinct from those bound by PROTEIN2 or PROTEIN ",AIMed.d157.s1329
3074,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN1 ( PROTEIN , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN2 ",AIMed.d157.s1329
3075,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN1 ( PROTEIN2 , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN ",AIMed.d157.s1329
3076,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN1 ( PROTEIN , binds PROTEIN2 at a site distinct from those bound by PROTEIN or PROTEIN ",AIMed.d157.s1329
3077,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN ( PROTEIN1 , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN2 ",AIMed.d157.s1329
3078,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN ( PROTEIN , binds PROTEIN1 at a site distinct from those bound by PROTEIN or PROTEIN2 ",AIMed.d157.s1329
3079,AIMed.d157,False,"Deletion analysis and binding studies demonstrate that a third enzyme, PROTEIN ( PROTEIN1 , binds PROTEIN2 at a site distinct from those bound by PROTEIN or PROTEIN ",AIMed.d157.s1329
3080,AIMed.d157,False,The subcellular distributions of PROTEIN1 and PROTEIN2 were similar in neurons.,AIMed.d157.s1330
3081,AIMed.d158,False,TNF-dependent recruitment of the protein kinase PROTEIN1 to the PROTEIN2 signaling complex.,AIMed.d158.s1332
3082,AIMed.d158,True,The death domain of PROTEIN ( PROTEIN1 triggers distinct signaling pathways leading to apoptosis and PROTEIN activation through its interaction with the death domain protein PROTEIN2 ,AIMed.d158.s1333
3083,AIMed.d158,False,The death domain of PROTEIN1 ( PROTEIN2 triggers distinct signaling pathways leading to apoptosis and PROTEIN activation through its interaction with the death domain protein PROTEIN ,AIMed.d158.s1333
3084,AIMed.d158,False,The death domain of PROTEIN ( PROTEIN1 triggers distinct signaling pathways leading to apoptosis and PROTEIN2 activation through its interaction with the death domain protein PROTEIN ,AIMed.d158.s1333
3085,AIMed.d158,True,The death domain of PROTEIN1 ( PROTEIN triggers distinct signaling pathways leading to apoptosis and PROTEIN activation through its interaction with the death domain protein PROTEIN2 ,AIMed.d158.s1333
3086,AIMed.d158,False,The death domain of PROTEIN ( PROTEIN triggers distinct signaling pathways leading to apoptosis and PROTEIN1 activation through its interaction with the death domain protein PROTEIN2 ,AIMed.d158.s1333
3087,AIMed.d158,False,The death domain of PROTEIN1 ( PROTEIN triggers distinct signaling pathways leading to apoptosis and PROTEIN2 activation through its interaction with the death domain protein PROTEIN ,AIMed.d158.s1333
3088,AIMed.d158,False,"Here, we show that PROTEIN1 interacts strongly with PROTEIN another death domain protein that was shown previously to associate with PROTEIN2 antigen.",AIMed.d158.s1334
3089,AIMed.d158,True,"Here, we show that PROTEIN1 interacts strongly with PROTEIN2 another death domain protein that was shown previously to associate with PROTEIN antigen.",AIMed.d158.s1334
3090,AIMed.d158,True,"Here, we show that PROTEIN interacts strongly with PROTEIN1 another death domain protein that was shown previously to associate with PROTEIN2 antigen.",AIMed.d158.s1334
3091,AIMed.d158,False,We also show that PROTEIN1 is a serine-threonine kinase that is recruited by PROTEIN to PROTEIN2 in a TNF-dependent process.,AIMed.d158.s1335
3092,AIMed.d158,False,We also show that PROTEIN is a serine-threonine kinase that is recruited by PROTEIN1 to PROTEIN2 in a TNF-dependent process.,AIMed.d158.s1335
3093,AIMed.d158,False,We also show that PROTEIN1 is a serine-threonine kinase that is recruited by PROTEIN2 to PROTEIN in a TNF-dependent process.,AIMed.d158.s1335
3094,AIMed.d158,False,Overexpression of the intact PROTEIN1 protein induces both PROTEIN2 activation and apoptosis.,AIMed.d158.s1336
3095,AIMed.d158,False,"However, expression of the death domain of PROTEIN1 Induces apoptosis, but potently inhibits PROTEIN2 activation by TNF.",AIMed.d158.s1337
3096,AIMed.d158,False,These results suggest that distinct domains of PROTEIN1 participate in the TNF signaling cascades leading to apoptosis and PROTEIN2 activation.,AIMed.d158.s1338
3097,AIMed.d159,True,"The carboxy-terminal region of PROTEIN1 has previously been shown to interact directly with PROTEIN2 a cytoplasmic component of the PROTEIN glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.",AIMed.d159.s1340
3098,AIMed.d159,False,"The carboxy-terminal region of PROTEIN has previously been shown to interact directly with PROTEIN1 a cytoplasmic component of the PROTEIN2 glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.",AIMed.d159.s1340
3099,AIMed.d159,False,"The carboxy-terminal region of PROTEIN1 has previously been shown to interact directly with PROTEIN a cytoplasmic component of the PROTEIN2 glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.",AIMed.d159.s1340
3100,AIMed.d160,False,Identification of vascular endothelial growth factor determinants for binding PROTEIN1 and PROTEIN2 receptors. Generation of receptor-selective PROTEIN variants by site-directed mutagenesis.,AIMed.d160.s1343
3101,AIMed.d160,False,Identification of vascular endothelial growth factor determinants for binding PROTEIN and PROTEIN1 receptors. Generation of receptor-selective PROTEIN2 variants by site-directed mutagenesis.,AIMed.d160.s1343
3102,AIMed.d160,False,Identification of vascular endothelial growth factor determinants for binding PROTEIN1 and PROTEIN receptors. Generation of receptor-selective PROTEIN2 variants by site-directed mutagenesis.,AIMed.d160.s1343
3103,AIMed.d160,False, PROTEIN1 ( PROTEIN2 expression in various cell types is induced by hypoxia and other stimuli.,AIMed.d160.s1344
3104,AIMed.d160,False," PROTEIN1 mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN2 ( PROTEIN / PROTEIN ( PROTEIN and PROTEIN ",AIMed.d160.s1345
3105,AIMed.d160,False," PROTEIN1 mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN / PROTEIN ( PROTEIN and PROTEIN2 ",AIMed.d160.s1345
3106,AIMed.d160,False," PROTEIN1 mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN2 / PROTEIN ( PROTEIN and PROTEIN ",AIMed.d160.s1345
3107,AIMed.d160,False," PROTEIN1 mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN / PROTEIN ( PROTEIN2 and PROTEIN ",AIMed.d160.s1345
3108,AIMed.d160,False," PROTEIN1 mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN / PROTEIN2 ( PROTEIN and PROTEIN ",AIMed.d160.s1345
3109,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN1 ( PROTEIN / PROTEIN ( PROTEIN and PROTEIN2 ",AIMed.d160.s1345
3110,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN1 ( PROTEIN2 / PROTEIN ( PROTEIN and PROTEIN ",AIMed.d160.s1345
3111,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN1 ( PROTEIN / PROTEIN ( PROTEIN2 and PROTEIN ",AIMed.d160.s1345
3112,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN1 ( PROTEIN / PROTEIN2 ( PROTEIN and PROTEIN ",AIMed.d160.s1345
3113,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN1 / PROTEIN ( PROTEIN and PROTEIN2 ",AIMed.d160.s1345
3114,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN / PROTEIN ( PROTEIN1 and PROTEIN2 ",AIMed.d160.s1345
3115,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN / PROTEIN1 ( PROTEIN and PROTEIN2 ",AIMed.d160.s1345
3116,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN1 / PROTEIN ( PROTEIN2 and PROTEIN ",AIMed.d160.s1345
3117,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN1 / PROTEIN2 ( PROTEIN and PROTEIN ",AIMed.d160.s1345
3118,AIMed.d160,False," PROTEIN mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, PROTEIN ( PROTEIN / PROTEIN1 ( PROTEIN2 and PROTEIN ",AIMed.d160.s1345
3119,AIMed.d160,False,Alanine-scanning mutagenesis was used to identify a positively charged surface in PROTEIN1 that mediates binding to PROTEIN PROTEIN2 ,AIMed.d160.s1346
3120,AIMed.d160,False,Alanine-scanning mutagenesis was used to identify a positively charged surface in PROTEIN1 that mediates binding to PROTEIN2 PROTEIN ,AIMed.d160.s1346
3121,AIMed.d160,False,Alanine-scanning mutagenesis was used to identify a positively charged surface in PROTEIN that mediates binding to PROTEIN1 PROTEIN2 ,AIMed.d160.s1346
3122,AIMed.d160,False,"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding PROTEIN1 PROTEIN2 while negatively charged residues, Asp63, Glu64, and Glu67, were associated with PROTEIN binding.",AIMed.d160.s1347
3123,AIMed.d160,False,"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding PROTEIN PROTEIN1 while negatively charged residues, Asp63, Glu64, and Glu67, were associated with PROTEIN2 binding.",AIMed.d160.s1347
3124,AIMed.d160,False,"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding PROTEIN1 PROTEIN while negatively charged residues, Asp63, Glu64, and Glu67, were associated with PROTEIN2 binding.",AIMed.d160.s1347
3125,AIMed.d160,False,A PROTEIN1 model based on PROTEIN2 indicated these positively and negatively charged regions are distal in the monomer but are spatially close in the dimer.,AIMed.d160.s1348
3126,AIMed.d160,False,"Mutations within the PROTEIN site had minimal effect on PROTEIN1 binding, and mutants deficient in PROTEIN2 binding did not affect PROTEIN binding.",AIMed.d160.s1349
3127,AIMed.d160,False,"Mutations within the PROTEIN site had minimal effect on PROTEIN binding, and mutants deficient in PROTEIN1 binding did not affect PROTEIN2 binding.",AIMed.d160.s1349
3128,AIMed.d160,False,"Mutations within the PROTEIN1 site had minimal effect on PROTEIN binding, and mutants deficient in PROTEIN2 binding did not affect PROTEIN binding.",AIMed.d160.s1349
3129,AIMed.d160,False,"Mutations within the PROTEIN site had minimal effect on PROTEIN1 binding, and mutants deficient in PROTEIN binding did not affect PROTEIN2 binding.",AIMed.d160.s1349
3130,AIMed.d160,False,"Mutations within the PROTEIN1 site had minimal effect on PROTEIN2 binding, and mutants deficient in PROTEIN binding did not affect PROTEIN binding.",AIMed.d160.s1349
3131,AIMed.d160,False,"Mutations within the PROTEIN1 site had minimal effect on PROTEIN binding, and mutants deficient in PROTEIN binding did not affect PROTEIN2 binding.",AIMed.d160.s1349
3132,AIMed.d160,False,"Endothelial cell mitogenesis was abolished in mutants lacking PROTEIN1 affinity; however, PROTEIN2 deficient mutants induced normal proliferation.",AIMed.d160.s1350
3133,AIMed.d160,False,"Furthermore, this mutational analysis implicates PROTEIN1 but not PROTEIN2 in PROTEIN induction of endothelial cell proliferation.",AIMed.d160.s1352
3134,AIMed.d160,False,"Furthermore, this mutational analysis implicates PROTEIN but not PROTEIN1 in PROTEIN2 induction of endothelial cell proliferation.",AIMed.d160.s1352
3135,AIMed.d160,False,"Furthermore, this mutational analysis implicates PROTEIN1 but not PROTEIN in PROTEIN2 induction of endothelial cell proliferation.",AIMed.d160.s1352
3136,AIMed.d161,True,"Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, PROTEIN1 with another SH2-containing protein, PROTEIN2 ",AIMed.d161.s1353
3137,AIMed.d161,True," PROTEIN1 associates with PROTEIN PROTEIN2 after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3138,AIMed.d161,False," PROTEIN associates with PROTEIN PROTEIN1 after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN2 ",AIMed.d161.s1355
3139,AIMed.d161,False," PROTEIN associates with PROTEIN PROTEIN1 after ligand stimulation, and binding of PROTEIN2 to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3140,AIMed.d161,False," PROTEIN associates with the PROTEIN1 ( PROTEIN receptor after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3141,AIMed.d161,False," PROTEIN associates with PROTEIN2 PROTEIN1 after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3142,AIMed.d161,False," PROTEIN1 associates with the PROTEIN ( PROTEIN receptor after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN2 ",AIMed.d161.s1355
3143,AIMed.d161,False," PROTEIN1 associates with the PROTEIN ( PROTEIN receptor after ligand stimulation, and binding of PROTEIN2 to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3144,AIMed.d161,False," PROTEIN1 associates with the PROTEIN2 ( PROTEIN receptor after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3145,AIMed.d161,False," PROTEIN1 associates with the PROTEIN ( PROTEIN2 receptor after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3146,AIMed.d161,False," PROTEIN associates with the PROTEIN ( PROTEIN receptor after ligand stimulation, and binding of PROTEIN1 to this receptor promotes tyrosine phosphorylation of PROTEIN2 ",AIMed.d161.s1355
3147,AIMed.d161,False," PROTEIN associates with the PROTEIN1 ( PROTEIN receptor after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN2 ",AIMed.d161.s1355
3148,AIMed.d161,False," PROTEIN associates with the PROTEIN ( PROTEIN1 receptor after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN2 ",AIMed.d161.s1355
3149,AIMed.d161,False," PROTEIN associates with the PROTEIN1 ( PROTEIN receptor after ligand stimulation, and binding of PROTEIN2 to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3150,AIMed.d161,False," PROTEIN associates with the PROTEIN ( PROTEIN1 receptor after ligand stimulation, and binding of PROTEIN2 to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3151,AIMed.d161,False," PROTEIN associates with the PROTEIN1 ( PROTEIN2 receptor after ligand stimulation, and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN ",AIMed.d161.s1355
3152,AIMed.d161,False,"Using PROTEIN1 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that PROTEIN2 interacts with another signaling protein, PROTEIN ",AIMed.d161.s1357
3153,AIMed.d161,False,"Using PROTEIN1 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that PROTEIN interacts with another signaling protein, PROTEIN2 ",AIMed.d161.s1357
3154,AIMed.d161,True,"Using PROTEIN as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that PROTEIN1 interacts with another signaling protein, PROTEIN2 ",AIMed.d161.s1357
3155,AIMed.d161,False,We have localized the region of interaction to tyrosine 580 in the carboxyl end of PROTEIN1 and to the SH2 domain in the carboxy-terminus of PROTEIN2 ,AIMed.d161.s1358
3156,AIMed.d161,True,We demonstrate that PROTEIN1 binds to PROTEIN2 in vitro under conditions where the latter is tyrosine-phosphorylated.,AIMed.d161.s1359
3157,AIMed.d162,False,We found that the human PROTEIN1 ( PROTEIN2 physically interacted with PROTEIN via its DNA binding domain.,AIMed.d162.s1367
3158,AIMed.d162,True,We found that the human PROTEIN1 ( PROTEIN physically interacted with PROTEIN2 via its DNA binding domain.,AIMed.d162.s1367
3159,AIMed.d162,True,We found that the human PROTEIN ( PROTEIN1 physically interacted with PROTEIN2 via its DNA binding domain.,AIMed.d162.s1367
3160,AIMed.d162,True,"As a result of this physical interaction, binding of PROTEIN1 to its hormone response elements either as homodimer or as a heterodimer with the PROTEIN2 was inhibited by PROTEIN in a concentration-dependent manner.",AIMed.d162.s1368
3161,AIMed.d162,False,"As a result of this physical interaction, binding of PROTEIN to its hormone response elements either as homodimer or as a heterodimer with the PROTEIN1 was inhibited by PROTEIN2 in a concentration-dependent manner.",AIMed.d162.s1368
3162,AIMed.d162,False,"As a result of this physical interaction, binding of PROTEIN1 to its hormone response elements either as homodimer or as a heterodimer with the PROTEIN was inhibited by PROTEIN2 in a concentration-dependent manner.",AIMed.d162.s1368
3163,AIMed.d162,True,"In transfected cells, wild-type PROTEIN1 repressed the hormone-dependent transcriptional activation of PROTEIN2 ",AIMed.d162.s1369
3164,AIMed.d162,False,"In contrast, mutant PROTEIN1 either had no effect or activated the transcriptional activity of PROTEIN2 depending on the type of hormone response elements.",AIMed.d162.s1370
3165,AIMed.d163,False,Enhanced degradation of PROTEIN1 receptors by a sorting PROTEIN PROTEIN2 ,AIMed.d163.s1372
3166,AIMed.d163,False,Enhanced degradation of PROTEIN1 receptors by a sorting PROTEIN2 PROTEIN ,AIMed.d163.s1372
3167,AIMed.d163,False,Enhanced degradation of PROTEIN receptors by a sorting PROTEIN1 PROTEIN2 ,AIMed.d163.s1372
3168,AIMed.d163,True,"A protein, PROTEIN1 ( PROTEIN , was identified in a human cell line that bound to a region of the PROTEIN ( PROTEIN2 containing the lysosomal targeting code.",AIMed.d163.s1374
3169,AIMed.d163,False,"A protein, PROTEIN1 ( PROTEIN2 , was identified in a human cell line that bound to a region of the PROTEIN ( PROTEIN containing the lysosomal targeting code.",AIMed.d163.s1374
3170,AIMed.d163,True,"A protein, PROTEIN1 ( PROTEIN , was identified in a human cell line that bound to a region of the PROTEIN2 ( PROTEIN containing the lysosomal targeting code.",AIMed.d163.s1374
3171,AIMed.d163,True,"A protein, PROTEIN ( PROTEIN1 , was identified in a human cell line that bound to a region of the PROTEIN ( PROTEIN2 containing the lysosomal targeting code.",AIMed.d163.s1374
3172,AIMed.d163,False,"A protein, PROTEIN ( PROTEIN , was identified in a human cell line that bound to a region of the PROTEIN1 ( PROTEIN2 containing the lysosomal targeting code.",AIMed.d163.s1374
3173,AIMed.d163,True,"A protein, PROTEIN ( PROTEIN1 , was identified in a human cell line that bound to a region of the PROTEIN2 ( PROTEIN containing the lysosomal targeting code.",AIMed.d163.s1374
3174,AIMed.d163,False," PROTEIN1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of PROTEIN decreased the amount of PROTEIN2 on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.",AIMed.d163.s1375
3175,AIMed.d163,False," PROTEIN1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of PROTEIN2 decreased the amount of PROTEIN on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.",AIMed.d163.s1375
3176,AIMed.d163,False," PROTEIN contains a region of homology to a yeast vacuolar sorting protein, and overexpression of PROTEIN1 decreased the amount of PROTEIN2 on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.",AIMed.d163.s1375
3177,AIMed.d163,False,"Thus, PROTEIN1 is likely to play a role in sorting PROTEIN2 to lysosomes.",AIMed.d163.s1376
3178,AIMed.d164,True,The splicing factor U2AF (U2 snRNP auxiliary factor) is a heterodimer with subunits of 65 and 35 kD ( PROTEIN1 and PROTEIN2 .,AIMed.d164.s1378
3179,AIMed.d164,False," PROTEIN1 binds specifically to 3' splice sites, but previous studies failed to demonstrate a function for PROTEIN2 ",AIMed.d164.s1379
3180,AIMed.d164,False,"Nuclear extracts deficient in PROTEIN1 were inactive; however, both constitutive and enhancer-dependent splicing could be restored by the addition of purified recombinant PROTEIN2 ",AIMed.d164.s1381
3181,AIMed.d164,False,In vitro protein-RNA interaction studies with pre-mRNAs containing either a constitutive or regulated splicing enhancer revealed that PROTEIN1 directly mediates interactions between PROTEIN2 and proteins bound to the enhancers.,AIMed.d164.s1382
3182,AIMed.d164,False,"Thus, PROTEIN1 functions as a bridge between PROTEIN2 and the enhancer complex to recruit PROTEIN to the adjacent intron.",AIMed.d164.s1383
3183,AIMed.d164,False,"Thus, PROTEIN functions as a bridge between PROTEIN1 and the enhancer complex to recruit PROTEIN2 to the adjacent intron.",AIMed.d164.s1383
3184,AIMed.d164,False,"Thus, PROTEIN1 functions as a bridge between PROTEIN and the enhancer complex to recruit PROTEIN2 to the adjacent intron.",AIMed.d164.s1383
3185,AIMed.d165,False,Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex PROTEIN1 the nucleotide excision repair protein PROTEIN2 PROTEIN PROTEIN ,AIMed.d165.s1384
3186,AIMed.d165,False,Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex PROTEIN1 the nucleotide excision repair protein PROTEIN a PROTEIN PROTEIN2 ,AIMed.d165.s1384
3187,AIMed.d165,False,Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex PROTEIN1 the nucleotide excision repair protein PROTEIN PROTEIN2 PROTEIN ,AIMed.d165.s1384
3188,AIMed.d165,False,Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex PROTEIN the nucleotide excision repair protein PROTEIN1 a PROTEIN PROTEIN2 ,AIMed.d165.s1384
3189,AIMed.d165,True,Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex PROTEIN the nucleotide excision repair protein PROTEIN1 PROTEIN2 PROTEIN ,AIMed.d165.s1384
3190,AIMed.d165,False,Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex PROTEIN the nucleotide excision repair protein PROTEIN a PROTEIN2 PROTEIN1 ,AIMed.d165.s1384
3191,AIMed.d165,False,At least two of the subunits of PROTEIN ( PROTEIN1 and PROTEIN2 proteins) are implicated in the disease xeroderma pigmentosum (XP).,AIMed.d165.s1388
3192,AIMed.d165,False,At least two of the subunits of PROTEIN1 ( PROTEIN2 and PROTEIN proteins) are implicated in the disease xeroderma pigmentosum (XP).,AIMed.d165.s1388
3193,AIMed.d165,False,At least two of the subunits of PROTEIN1 ( PROTEIN and PROTEIN2 proteins) are implicated in the disease xeroderma pigmentosum (XP).,AIMed.d165.s1388
3194,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN2 to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3195,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN2 to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3196,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN2 to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3197,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN2 to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3198,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN PROTEIN PROTEIN and PROTEIN1 genes (all of which encode polypeptide subunits of PROTEIN2 to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3199,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN1 PROTEIN PROTEIN2 and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3200,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN1 PROTEIN2 PROTEIN PROTEIN and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3201,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN1 PROTEIN2 PROTEIN and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3202,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN1 PROTEIN PROTEIN and PROTEIN2 genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3203,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN1 PROTEIN PROTEIN PROTEIN2 and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3204,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN PROTEIN1 PROTEIN2 and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3205,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN PROTEIN PROTEIN1 and PROTEIN2 genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3206,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN1 PROTEIN PROTEIN2 PROTEIN and PROTEIN genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3207,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN1 PROTEIN PROTEIN PROTEIN and PROTEIN2 genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3208,AIMed.d165,False,We have exploited the availability of the cloned PROTEIN PROTEIN PROTEIN1 PROTEIN and PROTEIN2 genes (all of which encode polypeptide subunits of PROTEIN to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.,AIMed.d165.s1389
3209,AIMed.d165,False,"Additionally we have examined interactions between PROTEIN1 components, the human NER protein PROTEIN2 and the PROTEIN protein which is implicated in Cockayne syndrome (CS).",AIMed.d165.s1390
3210,AIMed.d165,False,"Additionally we have examined interactions between PROTEIN components, the human NER protein PROTEIN1 and the PROTEIN2 protein which is implicated in Cockayne syndrome (CS).",AIMed.d165.s1390
3211,AIMed.d165,False,"Additionally we have examined interactions between PROTEIN1 components, the human NER protein PROTEIN and the PROTEIN2 protein which is implicated in Cockayne syndrome (CS).",AIMed.d165.s1390
3212,AIMed.d165,False,Our analyses demonstrate that the PROTEIN PROTEIN PROTEIN1 and PROTEIN2 proteins interact with each other.,AIMed.d165.s1391
3213,AIMed.d165,False,Our analyses demonstrate that the PROTEIN1 PROTEIN PROTEIN and PROTEIN2 proteins interact with each other.,AIMed.d165.s1391
3214,AIMed.d165,False,Our analyses demonstrate that the PROTEIN PROTEIN1 PROTEIN and PROTEIN2 proteins interact with each other.,AIMed.d165.s1391
3215,AIMed.d165,False,Our analyses demonstrate that the PROTEIN1 PROTEIN PROTEIN2 and PROTEIN proteins interact with each other.,AIMed.d165.s1391
3216,AIMed.d165,False,Our analyses demonstrate that the PROTEIN PROTEIN1 PROTEIN2 and PROTEIN proteins interact with each other.,AIMed.d165.s1391
3217,AIMed.d165,True,Our analyses demonstrate that the PROTEIN1 PROTEIN2 PROTEIN and PROTEIN proteins interact with each other.,AIMed.d165.s1391
3218,AIMed.d165,False, PROTEIN1 protein interacts with multiple subunits of PROTEIN2 and with PROTEIN protein.,AIMed.d165.s1392
3219,AIMed.d165,True, PROTEIN1 protein interacts with multiple subunits of PROTEIN and with PROTEIN2 protein.,AIMed.d165.s1392
3220,AIMed.d165,False, PROTEIN protein interacts with multiple subunits of PROTEIN1 and with PROTEIN2 protein.,AIMed.d165.s1392
3221,AIMed.d166,False,Residues in human PROTEIN1 ( PROTEIN2 crucial for binding to both the human PROTEIN (R) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3222,AIMed.d166,True,Residues in human PROTEIN ( PROTEIN1 crucial for binding to both the human PROTEIN (R) and PROTEIN2 were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3223,AIMed.d166,False,Residues in human PROTEIN ( PROTEIN1 crucial for binding to both the human PROTEIN (R) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN2 in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3224,AIMed.d166,True,Residues in human PROTEIN ( PROTEIN1 crucial for binding to both the human PROTEIN2 (R) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3225,AIMed.d166,True,Residues in human PROTEIN1 ( PROTEIN crucial for binding to both the human PROTEIN (R) and PROTEIN2 were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3226,AIMed.d166,False,Residues in human PROTEIN1 ( PROTEIN crucial for binding to both the human PROTEIN (R) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN2 in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3227,AIMed.d166,True,Residues in human PROTEIN1 ( PROTEIN crucial for binding to both the human PROTEIN2 (R) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3228,AIMed.d166,False,Residues in human PROTEIN ( PROTEIN crucial for binding to both the human PROTEIN (R) and PROTEIN1 were identified by analysis of alanine scanning mutants of PROTEIN2 in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3229,AIMed.d166,False,Residues in human PROTEIN ( PROTEIN crucial for binding to both the human PROTEIN1 (R) and PROTEIN2 were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3230,AIMed.d166,False,Residues in human PROTEIN ( PROTEIN crucial for binding to both the human PROTEIN1 (R) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN2 in assays for both receptor binding and bioactivity.,AIMed.d166.s1394
3231,AIMed.d166,True,"The region of PROTEIN1 most important for binding to the PROTEIN2 is composed of residues from the amino terminus of the D-helix, carboxyl terminus of the B-helix, and C-D loop.",AIMed.d166.s1395
3232,AIMed.d166,True,"The two residues of PROTEIN1 that contribute the majority of free energy for PROTEIN2 binding, Phe-156 and Lys-159 are surrounded by other residues which have only a moderate impact.",AIMed.d166.s1397
3233,AIMed.d166,True,A second region of PROTEIN1 that includes residues from the carboxyl terminus of the D-helix and A-B loop also had a weak influence on PROTEIN2 binding.,AIMed.d166.s1399
3234,AIMed.d166,True,Residues in PROTEIN1 from both the A- and C-helices are involved in binding the PROTEIN2 co-receptor.,AIMed.d166.s1400
3235,AIMed.d166,False,Abolition of the PROTEIN1 binding site in PROTEIN created antagonists of PROTEIN2 action.,AIMed.d166.s1401
3236,AIMed.d166,True,Abolition of the PROTEIN1 binding site in PROTEIN2 created antagonists of PROTEIN action.,AIMed.d166.s1401
3237,AIMed.d166,False,Abolition of the PROTEIN binding site in PROTEIN1 created antagonists of PROTEIN2 action.,AIMed.d166.s1401
3238,AIMed.d167,True,The PROTEIN1 glucose transporter interacts with PROTEIN and PROTEIN2 ,AIMed.d167.s1402
3239,AIMed.d167,True,The PROTEIN1 glucose transporter interacts with PROTEIN2 and PROTEIN ,AIMed.d167.s1402
3240,AIMed.d167,False,The PROTEIN glucose transporter interacts with PROTEIN1 and PROTEIN2 ,AIMed.d167.s1402
3241,AIMed.d167,False,A truncated version of the integral membrane glycoprotein PROTEIN1 ( PROTEIN2 was synthesized in a rabbit reticulocyte translation system in the presence of canine pancreatic microsomes.,AIMed.d167.s1405
3242,AIMed.d167,True,"Following immunoprecipitation with an anticalnexin antiserum, a cross-linker-independent association was observed between PROTEIN1 and PROTEIN2 ",AIMed.d167.s1406
3243,AIMed.d167,True,"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of PROTEIN1 and a protein of approximately 60 kDa designated PROTEIN ( PROTEIN2 of 60 kDa).",AIMed.d167.s1407
3244,AIMed.d167,True,"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of PROTEIN1 and a protein of approximately 60 kDa designated PROTEIN2 ( PROTEIN of 60 kDa).",AIMed.d167.s1407
3245,AIMed.d167,False,"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of PROTEIN and a protein of approximately 60 kDa designated PROTEIN1 ( PROTEIN2 of 60 kDa).",AIMed.d167.s1407
3246,AIMed.d167,False,Both the PROTEIN PROTEIN and the PROTEIN PROTEIN1 interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN2 interactions.,AIMed.d167.s1408
3247,AIMed.d167,True,Both the PROTEIN PROTEIN and the PROTEIN1 PROTEIN2 interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3248,AIMed.d167,False,Both the PROTEIN1 PROTEIN and the PROTEIN PROTEIN2 interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3249,AIMed.d167,False,Both the PROTEIN PROTEIN1 and the PROTEIN PROTEIN2 interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3250,AIMed.d167,False,Both the PROTEIN PROTEIN and the PROTEIN PROTEIN1 interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN2 a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3251,AIMed.d167,False,Both the PROTEIN PROTEIN and the PROTEIN1 PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN2 interactions.,AIMed.d167.s1408
3252,AIMed.d167,False,Both the PROTEIN1 PROTEIN and the PROTEIN PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN2 interactions.,AIMed.d167.s1408
3253,AIMed.d167,False,Both the PROTEIN PROTEIN1 and the PROTEIN PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN2 interactions.,AIMed.d167.s1408
3254,AIMed.d167,False,Both the PROTEIN PROTEIN and the PROTEIN PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN1 a characteristic of many PROTEIN2 interactions.,AIMed.d167.s1408
3255,AIMed.d167,False,Both the PROTEIN1 PROTEIN and the PROTEIN2 PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3256,AIMed.d167,False,Both the PROTEIN PROTEIN1 and the PROTEIN2 PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3257,AIMed.d167,False,Both the PROTEIN PROTEIN and the PROTEIN1 PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN2 a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3258,AIMed.d167,True,Both the PROTEIN1 PROTEIN2 and the PROTEIN PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3259,AIMed.d167,False,Both the PROTEIN1 PROTEIN and the PROTEIN PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN2 a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3260,AIMed.d167,False,Both the PROTEIN PROTEIN1 and the PROTEIN PROTEIN interactions were dependent on the presence of a correctly modified oligosaccharide group on PROTEIN2 a characteristic of many PROTEIN interactions.,AIMed.d167.s1408
3261,AIMed.d167,False,A PROTEIN mutant that was not glycosylated (AGGT155) did not associate with PROTEIN1 or PROTEIN2 ,AIMed.d167.s1409
3262,AIMed.d167,False,A PROTEIN1 mutant that was not glycosylated (AGGT155) did not associate with PROTEIN2 or PROTEIN ,AIMed.d167.s1409
3263,AIMed.d167,False,A PROTEIN1 mutant that was not glycosylated (AGGT155) did not associate with PROTEIN or PROTEIN2 ,AIMed.d167.s1409
3264,AIMed.d167,False, PROTEIN1 the soluble homologue of PROTEIN2 was also shown to interact with PROTEIN only when the protein bore a correctly modified oligosaccharide group.,AIMed.d167.s1410
3265,AIMed.d167,False, PROTEIN the soluble homologue of PROTEIN1 was also shown to interact with PROTEIN2 only when the protein bore a correctly modified oligosaccharide group.,AIMed.d167.s1410
3266,AIMed.d167,True, PROTEIN1 the soluble homologue of PROTEIN was also shown to interact with PROTEIN2 only when the protein bore a correctly modified oligosaccharide group.,AIMed.d167.s1410
3267,AIMed.d167,True,"Thus, our data show that both PROTEIN1 and PROTEIN interact with PROTEIN2 in a glycosylation-dependent manner.",AIMed.d167.s1411
3268,AIMed.d167,True,"Thus, our data show that both PROTEIN and PROTEIN1 interact with PROTEIN2 in a glycosylation-dependent manner.",AIMed.d167.s1411
3269,AIMed.d167,False,"Thus, our data show that both PROTEIN1 and PROTEIN2 interact with PROTEIN in a glycosylation-dependent manner.",AIMed.d167.s1411
3270,AIMed.d168,False,Identification of a critical ligand binding determinant of the human PROTEIN1 receptor. Evidence for common ligand binding motifs in the cytokine receptor family.,AIMed.d168.s1412
3271,AIMed.d168,False,The PROTEIN1 receptor ( PROTEIN is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.,AIMed.d168.s1413
3272,AIMed.d168,False,The PROTEIN1 ( PROTEIN2 is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.,AIMed.d168.s1413
3273,AIMed.d168,True,The PROTEIN1 receptor ( PROTEIN2 is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.,AIMed.d168.s1413
3274,AIMed.d168,True,We have used site-specific mutagenesis within the extracellular domain of the PROTEIN1 to search for amino acid residues involved in PROTEIN2 ( PROTEIN binding.,AIMed.d168.s1414
3275,AIMed.d168,False,We have used site-specific mutagenesis within the extracellular domain of the PROTEIN to search for amino acid residues involved in PROTEIN1 ( PROTEIN2 binding.,AIMed.d168.s1414
3276,AIMed.d168,True,We have used site-specific mutagenesis within the extracellular domain of the PROTEIN1 to search for amino acid residues involved in PROTEIN ( PROTEIN2 binding.,AIMed.d168.s1414
3277,AIMed.d168,True,Mutant proteins were expressed in bacteria as soluble PROTEIN1 binding proteins ( PROTEIN2 and characterized for PROTEIN binding activity in a number of different assays.,AIMed.d168.s1415
3278,AIMed.d168,False,Mutant proteins were expressed in bacteria as soluble PROTEIN1 binding proteins ( PROTEIN and characterized for PROTEIN2 binding activity in a number of different assays.,AIMed.d168.s1415
3279,AIMed.d168,False,Mutant proteins were expressed in bacteria as soluble PROTEIN binding proteins ( PROTEIN1 and characterized for PROTEIN2 binding activity in a number of different assays.,AIMed.d168.s1415
3280,AIMed.d168,True,Substitution of phenylalanine at position 93 (Phe93) with alanine (F93A mutation) resulted in a drastic reduction in PROTEIN1 binding in the PROTEIN2 ,AIMed.d168.s1416
3281,AIMed.d168,True,"Furthermore, the F93A mutation in full-length PROTEIN1 expressed in COS cells abolished detectable PROTEIN2 binding.",AIMed.d168.s1419
3282,AIMed.d168,True,These data indicate that Phe93 is a critical PROTEIN1 binding determinant of the PROTEIN2 ,AIMed.d168.s1422
3283,AIMed.d169,False,Cloning and characterization of a specific PROTEIN1 binding protein structurally related to the PROTEIN2 receptor alpha chain.,AIMed.d169.s1424
3284,AIMed.d169,False,Cloning and characterization of a specific PROTEIN binding protein structurally related to the PROTEIN1 alpha chain.,AIMed.d169.s1424
3285,AIMed.d169,False,Cloning and characterization of a specific PROTEIN1 binding protein structurally related to the PROTEIN2 alpha chain.,AIMed.d169.s1424
3286,AIMed.d169,False," PROTEIN1 ( PROTEIN2 is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with PROTEIN ",AIMed.d169.s1425
3287,AIMed.d169,False," PROTEIN ( PROTEIN1 is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with PROTEIN2 ",AIMed.d169.s1425
3288,AIMed.d169,False," PROTEIN1 ( PROTEIN is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with PROTEIN2 ",AIMed.d169.s1425
3289,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN1 receptor, a approximately 140-kDa glycoprotein ( PROTEIN2 and the gamma chain (gammac) of the PROTEIN but neither of these proteins binds PROTEIN ",AIMed.d169.s1427
3290,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN1 receptor, a approximately 140-kDa glycoprotein ( PROTEIN and the gamma chain (gammac) of the PROTEIN2 receptor, but neither of these proteins binds PROTEIN ",AIMed.d169.s1427
3291,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN1 receptor, a approximately 140-kDa glycoprotein ( PROTEIN and the gamma chain (gammac) of the PROTEIN2 but neither of these proteins binds PROTEIN ",AIMed.d169.s1427
3292,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN1 receptor, a approximately 140-kDa glycoprotein ( PROTEIN and the gamma chain (gammac) of the PROTEIN but neither of these proteins binds PROTEIN2 ",AIMed.d169.s1427
3293,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN receptor, a approximately 140-kDa glycoprotein ( PROTEIN1 and the gamma chain (gammac) of the PROTEIN2 receptor, but neither of these proteins binds PROTEIN ",AIMed.d169.s1427
3294,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN receptor, a approximately 140-kDa glycoprotein ( PROTEIN1 and the gamma chain (gammac) of the PROTEIN2 but neither of these proteins binds PROTEIN ",AIMed.d169.s1427
3295,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN receptor, a approximately 140-kDa glycoprotein ( PROTEIN1 and the gamma chain (gammac) of the PROTEIN but neither of these proteins binds PROTEIN2 ",AIMed.d169.s1427
3296,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN receptor, a approximately 140-kDa glycoprotein ( PROTEIN and the gamma chain (gammac) of the PROTEIN1 but neither of these proteins binds PROTEIN ",AIMed.d169.s1427
3297,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN receptor, a approximately 140-kDa glycoprotein ( PROTEIN and the gamma chain (gammac) of the PROTEIN1 receptor, but neither of these proteins binds PROTEIN2 ",AIMed.d169.s1427
3298,AIMed.d169,False,"Two proteins have been described as constituents of the PROTEIN receptor, a approximately 140-kDa glycoprotein ( PROTEIN and the gamma chain (gammac) of the PROTEIN1 but neither of these proteins binds PROTEIN2 ",AIMed.d169.s1427
3299,AIMed.d169,True,We have cloned a cDNA encoding an PROTEIN1 binding protein ( PROTEIN2 from the Caki-1 human renal carcinoma cell line.,AIMed.d169.s1428
3300,AIMed.d169,False,"The PROTEIN1 shows homology with the PROTEIN2 receptor, and to a lesser extent, with the prolactin receptor.",AIMed.d169.s1430
3301,AIMed.d169,False,COS-7 cells transfected with the PROTEIN1 cDNA bind PROTEIN with high affinity but do not bind PROTEIN2 ,AIMed.d169.s1431
3302,AIMed.d169,False,COS-7 cells transfected with the PROTEIN cDNA bind PROTEIN1 with high affinity but do not bind PROTEIN2 ,AIMed.d169.s1431
3303,AIMed.d169,True,COS-7 cells transfected with the PROTEIN1 cDNA bind PROTEIN2 with high affinity but do not bind PROTEIN ,AIMed.d169.s1431
3304,AIMed.d169,False,COS-7 cells co-transfected with the cloned PROTEIN1 cDNA and PROTEIN2 cDNA resulted in the reconstitution of a small number of receptors that recognized both PROTEIN and PROTEIN ,AIMed.d169.s1432
3305,AIMed.d169,False,COS-7 cells co-transfected with the cloned PROTEIN1 cDNA and PROTEIN cDNA resulted in the reconstitution of a small number of receptors that recognized both PROTEIN2 and PROTEIN ,AIMed.d169.s1432
3306,AIMed.d169,False,COS-7 cells co-transfected with the cloned PROTEIN1 cDNA and PROTEIN cDNA resulted in the reconstitution of a small number of receptors that recognized both PROTEIN and PROTEIN2 ,AIMed.d169.s1432
3307,AIMed.d169,False,COS-7 cells co-transfected with the cloned PROTEIN cDNA and PROTEIN1 cDNA resulted in the reconstitution of a small number of receptors that recognized both PROTEIN2 and PROTEIN ,AIMed.d169.s1432
3308,AIMed.d169,False,COS-7 cells co-transfected with the cloned PROTEIN cDNA and PROTEIN1 cDNA resulted in the reconstitution of a small number of receptors that recognized both PROTEIN and PROTEIN2 ,AIMed.d169.s1432
3309,AIMed.d169,False,COS-7 cells co-transfected with the cloned PROTEIN cDNA and PROTEIN cDNA resulted in the reconstitution of a small number of receptors that recognized both PROTEIN1 and PROTEIN2 ,AIMed.d169.s1432
3310,AIMed.d171,True,Crystal structure of the PROTEIN1 cyclin-dependent-kinase inhibitor bound to the PROTEIN2 PROTEIN complex.,AIMed.d171.s1441
3311,AIMed.d171,True,Crystal structure of the PROTEIN cyclin-dependent-kinase inhibitor bound to the PROTEIN1 PROTEIN2 complex.,AIMed.d171.s1441
3312,AIMed.d171,True,Crystal structure of the PROTEIN1 cyclin-dependent-kinase inhibitor bound to the PROTEIN PROTEIN2 complex.,AIMed.d171.s1441
3313,AIMed.d171,False,The crystal structure of the human PROTEIN1 inhibitory domain bound to the phosphorylated PROTEIN PROTEIN2 ( PROTEIN complex has been determined at 2.3 angstrom.,AIMed.d171.s1442
3314,AIMed.d171,False,The crystal structure of the human PROTEIN inhibitory domain bound to the phosphorylated PROTEIN1 PROTEIN2 ( PROTEIN complex has been determined at 2.3 angstrom.,AIMed.d171.s1442
3315,AIMed.d171,False,The crystal structure of the human PROTEIN inhibitory domain bound to the phosphorylated PROTEIN PROTEIN1 ( PROTEIN2 complex has been determined at 2.3 angstrom.,AIMed.d171.s1442
3316,AIMed.d171,True,The crystal structure of the human PROTEIN1 inhibitory domain bound to the phosphorylated PROTEIN2 PROTEIN ( PROTEIN complex has been determined at 2.3 angstrom.,AIMed.d171.s1442
3317,AIMed.d171,True,The crystal structure of the human PROTEIN1 inhibitory domain bound to the phosphorylated PROTEIN PROTEIN ( PROTEIN2 complex has been determined at 2.3 angstrom.,AIMed.d171.s1442
3318,AIMed.d171,True,The crystal structure of the human PROTEIN inhibitory domain bound to the phosphorylated PROTEIN1 PROTEIN ( PROTEIN2 complex has been determined at 2.3 angstrom.,AIMed.d171.s1442
3319,AIMed.d171,True, PROTEIN1 binds the complex as an extended structure interacting with both PROTEIN and PROTEIN2 ,AIMed.d171.s1443
3320,AIMed.d171,False, PROTEIN binds the complex as an extended structure interacting with both PROTEIN1 and PROTEIN2 ,AIMed.d171.s1443
3321,AIMed.d171,True, PROTEIN1 binds the complex as an extended structure interacting with both PROTEIN2 and PROTEIN ,AIMed.d171.s1443
3322,AIMed.d172,False, PROTEIN1 related protein: a ligand and specific activator of the tyrosine kinase receptor PROTEIN ,AIMed.d172.s1446
3323,AIMed.d172,True, PROTEIN1 a ligand and specific activator of the tyrosine kinase receptor PROTEIN2 ,AIMed.d172.s1446
3324,AIMed.d172,False, PROTEIN1 related protein: a ligand and specific activator of the tyrosine kinase receptor PROTEIN2 ,AIMed.d172.s1446
3325,AIMed.d172,False,The tyrosine kinases PROTEIN PROTEIN1 and PROTEIN (or PROTEIN2 constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.,AIMed.d172.s1447
3326,AIMed.d172,False,The tyrosine kinases PROTEIN1 PROTEIN and PROTEIN (or PROTEIN2 constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.,AIMed.d172.s1447
3327,AIMed.d172,False,The tyrosine kinases PROTEIN PROTEIN and PROTEIN1 (or PROTEIN2 constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.,AIMed.d172.s1447
3328,AIMed.d172,False,The tyrosine kinases PROTEIN1 PROTEIN2 and PROTEIN (or PROTEIN constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.,AIMed.d172.s1447
3329,AIMed.d172,False,The tyrosine kinases PROTEIN PROTEIN1 and PROTEIN2 (or PROTEIN constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.,AIMed.d172.s1447
3330,AIMed.d172,False,The tyrosine kinases PROTEIN1 PROTEIN and PROTEIN2 (or PROTEIN constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.,AIMed.d172.s1447
3331,AIMed.d172,True, PROTEIN1 and PROTEIN have been shown to play key roles in vascular development; these two receptors bind and are activated by PROTEIN ( PROTEIN2 .,AIMed.d172.s1448
3332,AIMed.d172,False, PROTEIN1 and PROTEIN2 have been shown to play key roles in vascular development; these two receptors bind and are activated by PROTEIN ( PROTEIN .,AIMed.d172.s1448
3333,AIMed.d172,True, PROTEIN1 and PROTEIN have been shown to play key roles in vascular development; these two receptors bind and are activated by PROTEIN2 ( PROTEIN .,AIMed.d172.s1448
3334,AIMed.d172,True, PROTEIN and PROTEIN1 have been shown to play key roles in vascular development; these two receptors bind and are activated by PROTEIN ( PROTEIN2 .,AIMed.d172.s1448
3335,AIMed.d172,False, PROTEIN and PROTEIN have been shown to play key roles in vascular development; these two receptors bind and are activated by PROTEIN1 ( PROTEIN2 .,AIMed.d172.s1448
3336,AIMed.d172,True, PROTEIN and PROTEIN1 have been shown to play key roles in vascular development; these two receptors bind and are activated by PROTEIN2 ( PROTEIN .,AIMed.d172.s1448
3337,AIMed.d172,True,"This protein, designated PROTEIN1 ( PROTEIN , specifically binds to the extracellular domain of PROTEIN2 stimulates the tyrosine phosphorylation of PROTEIN expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3338,AIMed.d172,False,"This protein, designated PROTEIN1 ( PROTEIN , specifically binds to the extracellular domain of PROTEIN stimulates the tyrosine phosphorylation of PROTEIN2 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3339,AIMed.d172,False,"This protein, designated PROTEIN1 related protein ( PROTEIN , specifically binds to the extracellular domain of PROTEIN stimulates the tyrosine phosphorylation of PROTEIN expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3340,AIMed.d172,False,"This protein, designated PROTEIN1 ( PROTEIN2 , specifically binds to the extracellular domain of PROTEIN stimulates the tyrosine phosphorylation of PROTEIN expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3341,AIMed.d172,False,"This protein, designated PROTEIN related protein ( PROTEIN , specifically binds to the extracellular domain of PROTEIN1 stimulates the tyrosine phosphorylation of PROTEIN2 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3342,AIMed.d172,False,"This protein, designated PROTEIN1 related protein ( PROTEIN , specifically binds to the extracellular domain of PROTEIN2 stimulates the tyrosine phosphorylation of PROTEIN expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3343,AIMed.d172,True,"This protein, designated PROTEIN related protein ( PROTEIN1 , specifically binds to the extracellular domain of PROTEIN2 stimulates the tyrosine phosphorylation of PROTEIN expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3344,AIMed.d172,False,"This protein, designated PROTEIN1 related protein ( PROTEIN , specifically binds to the extracellular domain of PROTEIN stimulates the tyrosine phosphorylation of PROTEIN2 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3345,AIMed.d172,False,"This protein, designated PROTEIN related protein ( PROTEIN1 , specifically binds to the extracellular domain of PROTEIN stimulates the tyrosine phosphorylation of PROTEIN2 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3346,AIMed.d172,False,"This protein, designated PROTEIN1 related protein ( PROTEIN2 , specifically binds to the extracellular domain of PROTEIN stimulates the tyrosine phosphorylation of PROTEIN expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.",AIMed.d172.s1451
3347,AIMed.d172,False, PROTEIN1 fails to bind appreciably to the extracellular domain of PROTEIN2 or PROTEIN ,AIMed.d172.s1452
3348,AIMed.d172,False, PROTEIN1 fails to bind appreciably to the extracellular domain of PROTEIN or PROTEIN2 ,AIMed.d172.s1452
3349,AIMed.d172,False, PROTEIN fails to bind appreciably to the extracellular domain of PROTEIN1 or PROTEIN2 ,AIMed.d172.s1452
3350,AIMed.d173,False,The kinetics of amyloid fibril formation by PROTEIN1 ( PROTEIN2 are typical of a nucleation-dependent polymerization mechanism.,AIMed.d173.s1456
3351,AIMed.d173,False,Fusion proteins were created by linking the PROTEIN fragment to a PROTEIN1 DNA-binding domain (bait) and also to a PROTEIN2 transactivation domain (prey).,AIMed.d173.s1459
3352,AIMed.d173,False,Fusion proteins were created by linking the PROTEIN1 fragment to a PROTEIN2 DNA-binding domain (bait) and also to a PROTEIN transactivation domain (prey).,AIMed.d173.s1459
3353,AIMed.d173,False,Fusion proteins were created by linking the PROTEIN1 fragment to a PROTEIN DNA-binding domain (bait) and also to a PROTEIN2 transactivation domain (prey).,AIMed.d173.s1459
3354,AIMed.d173,False,Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring PROTEIN1 ( PROTEIN2 and PROTEIN ( PROTEIN genes under the control of LexA-dependent operators.,AIMed.d173.s1460
3355,AIMed.d173,False,Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring PROTEIN ( PROTEIN1 and PROTEIN2 ( PROTEIN genes under the control of LexA-dependent operators.,AIMed.d173.s1460
3356,AIMed.d173,False,Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN2 genes under the control of LexA-dependent operators.,AIMed.d173.s1460
3357,AIMed.d173,False,Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring PROTEIN1 ( PROTEIN and PROTEIN2 ( PROTEIN genes under the control of LexA-dependent operators.,AIMed.d173.s1460
3358,AIMed.d173,False,Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN2 genes under the control of LexA-dependent operators.,AIMed.d173.s1460
3359,AIMed.d173,False,Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN2 genes under the control of LexA-dependent operators.,AIMed.d173.s1460
3360,AIMed.d173,False, PROTEIN1 protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN2 fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3361,AIMed.d173,False, PROTEIN1 protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN2 failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3362,AIMed.d173,False, PROTEIN1 protein fused to the Drosophila protein PROTEIN2 ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3363,AIMed.d173,False, PROTEIN1 protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN2 PROTEIN interaction was specific.,AIMed.d173.s1462
3364,AIMed.d173,False, PROTEIN1 protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN2 indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3365,AIMed.d173,False, PROTEIN1 protein fused to the Drosophila protein PROTEIN ( PROTEIN2 PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3366,AIMed.d173,False, PROTEIN1 protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN2 interaction was specific.,AIMed.d173.s1462
3367,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN1 failed to interact with the PROTEIN2 fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3368,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN1 ( PROTEIN PROTEIN failed to interact with the PROTEIN2 fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3369,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN1 fragment fused to PROTEIN indicating that the observed PROTEIN2 PROTEIN interaction was specific.,AIMed.d173.s1462
3370,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN1 fragment fused to PROTEIN2 indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3371,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN1 PROTEIN failed to interact with the PROTEIN2 fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3372,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN1 fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN2 interaction was specific.,AIMed.d173.s1462
3373,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN1 ( PROTEIN PROTEIN2 failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3374,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN1 failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN2 PROTEIN interaction was specific.,AIMed.d173.s1462
3375,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN1 failed to interact with the PROTEIN fragment fused to PROTEIN2 indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3376,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN1 PROTEIN2 failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3377,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN1 failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN2 interaction was specific.,AIMed.d173.s1462
3378,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN1 ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN2 PROTEIN interaction was specific.,AIMed.d173.s1462
3379,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN1 ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN2 indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3380,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN1 ( PROTEIN2 PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3381,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN1 ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN2 interaction was specific.,AIMed.d173.s1462
3382,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN1 indicating that the observed PROTEIN2 PROTEIN interaction was specific.,AIMed.d173.s1462
3383,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN1 PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN2 PROTEIN interaction was specific.,AIMed.d173.s1462
3384,AIMed.d173,True, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN1 PROTEIN2 interaction was specific.,AIMed.d173.s1462
3385,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN1 PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN2 indicating that the observed PROTEIN PROTEIN interaction was specific.,AIMed.d173.s1462
3386,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN1 indicating that the observed PROTEIN PROTEIN2 interaction was specific.,AIMed.d173.s1462
3387,AIMed.d173,False, PROTEIN protein fused to the Drosophila protein PROTEIN ( PROTEIN1 PROTEIN failed to interact with the PROTEIN fragment fused to PROTEIN indicating that the observed PROTEIN PROTEIN2 interaction was specific.,AIMed.d173.s1462
3388,AIMed.d173,False,"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing PROTEIN1 PROTEIN2 bait when the PROTEIN transactivation domain was fused to an PROTEIN fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.",AIMed.d173.s1463
3389,AIMed.d173,False,"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing PROTEIN PROTEIN1 bait when the PROTEIN2 transactivation domain was fused to an PROTEIN fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.",AIMed.d173.s1463
3390,AIMed.d173,False,"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing PROTEIN PROTEIN1 bait when the PROTEIN transactivation domain was fused to an PROTEIN2 fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.",AIMed.d173.s1463
3391,AIMed.d173,False,"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing PROTEIN1 PROTEIN bait when the PROTEIN2 transactivation domain was fused to an PROTEIN fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.",AIMed.d173.s1463
3392,AIMed.d173,False,"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing PROTEIN1 PROTEIN bait when the PROTEIN transactivation domain was fused to an PROTEIN2 fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.",AIMed.d173.s1463
3393,AIMed.d173,False,"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing PROTEIN PROTEIN bait when the PROTEIN1 transactivation domain was fused to an PROTEIN2 fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.",AIMed.d173.s1463
3394,AIMed.d174,False,Influence of PROTEIN ( PROTEIN dimerization on formation of the high affinity hexameric PROTEIN1 complex.,AIMed.d174.s1466
3395,AIMed.d174,False,Influence of PROTEIN1 ( PROTEIN dimerization on formation of the high affinity hexameric PROTEIN2 receptor complex.,AIMed.d174.s1466
3396,AIMed.d174,False,Influence of PROTEIN ( PROTEIN1 dimerization on formation of the high affinity hexameric PROTEIN2 receptor complex.,AIMed.d174.s1466
3397,AIMed.d174,False,Influence of PROTEIN1 ( PROTEIN dimerization on formation of the high affinity hexameric PROTEIN2 complex.,AIMed.d174.s1466
3398,AIMed.d174,False,Influence of PROTEIN ( PROTEIN1 dimerization on formation of the high affinity hexameric PROTEIN2 complex.,AIMed.d174.s1466
3399,AIMed.d174,False,Influence of PROTEIN1 ( PROTEIN2 dimerization on formation of the high affinity hexameric PROTEIN complex.,AIMed.d174.s1466
3400,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN1 signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN receptor and the affinity converter/signal transducing protein PROTEIN2 ,AIMed.d174.s1467
3401,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN1 and the affinity converter/signal transducing protein PROTEIN2 ,AIMed.d174.s1467
3402,AIMed.d174,False,The high affinity PROTEIN1 ( PROTEIN signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN receptor and the affinity converter/signal transducing protein PROTEIN2 ,AIMed.d174.s1467
3403,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN1 receptor and the affinity converter/signal transducing protein PROTEIN2 ,AIMed.d174.s1467
3404,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN signaling complex consists of PROTEIN1 and two membrane-associated receptor components: a low affinity but specific PROTEIN receptor and the affinity converter/signal transducing protein PROTEIN2 ,AIMed.d174.s1467
3405,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN1 signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN2 and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3406,AIMed.d174,False,The high affinity PROTEIN1 ( PROTEIN2 signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN receptor and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3407,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN1 signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN2 receptor and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3408,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN1 signaling complex consists of PROTEIN2 and two membrane-associated receptor components: a low affinity but specific PROTEIN receptor and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3409,AIMed.d174,False,The high affinity PROTEIN1 ( PROTEIN signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN2 and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3410,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN1 receptor and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3411,AIMed.d174,True,The high affinity PROTEIN ( PROTEIN signaling complex consists of PROTEIN1 and two membrane-associated receptor components: a low affinity but specific PROTEIN2 and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3412,AIMed.d174,False,The high affinity PROTEIN1 ( PROTEIN signaling complex consists of PROTEIN and two membrane-associated receptor components: a low affinity but specific PROTEIN2 receptor and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3413,AIMed.d174,False,The high affinity PROTEIN1 ( PROTEIN signaling complex consists of PROTEIN2 and two membrane-associated receptor components: a low affinity but specific PROTEIN receptor and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3414,AIMed.d174,False,The high affinity PROTEIN ( PROTEIN signaling complex consists of PROTEIN1 and two membrane-associated receptor components: a low affinity but specific PROTEIN2 receptor and the affinity converter/signal transducing protein PROTEIN ,AIMed.d174.s1467
3415,AIMed.d174,False,"Monomeric ( PROTEIN1 and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN2 ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3416,AIMed.d174,False,"Monomeric ( PROTEIN1 and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN2 dimerization on binding to the receptor complex.",AIMed.d174.s1468
3417,AIMed.d174,False,"Monomeric ( PROTEIN1 and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN2 receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3418,AIMed.d174,False,"Monomeric ( PROTEIN1 and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN2 have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3419,AIMed.d174,False,"Monomeric ( PROTEIN1 and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN2 and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3420,AIMed.d174,False,"Monomeric ( PROTEIN1 and dimeric ( PROTEIN2 forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3421,AIMed.d174,False,"Monomeric ( PROTEIN1 and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN2 and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3422,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN1 ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN2 dimerization on binding to the receptor complex.",AIMed.d174.s1468
3423,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN1 receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3424,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN1 ( PROTEIN and PROTEIN2 have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3425,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN1 and the extracellular (""soluble"") portions of the PROTEIN2 ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3426,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN1 forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN2 ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3427,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN1 ( PROTEIN2 and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3428,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN1 receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN2 dimerization on binding to the receptor complex.",AIMed.d174.s1468
3429,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN1 have been purified in order to investigate the effect of PROTEIN2 dimerization on binding to the receptor complex.",AIMed.d174.s1468
3430,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN1 and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN2 dimerization on binding to the receptor complex.",AIMed.d174.s1468
3431,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN1 forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN2 dimerization on binding to the receptor complex.",AIMed.d174.s1468
3432,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN1 and PROTEIN have been purified in order to investigate the effect of PROTEIN2 dimerization on binding to the receptor complex.",AIMed.d174.s1468
3433,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN1 receptor ( PROTEIN and PROTEIN2 have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3434,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN1 and the extracellular (""soluble"") portions of the PROTEIN2 receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3435,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN1 forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN2 receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3436,AIMed.d174,True,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN1 receptor ( PROTEIN2 and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3437,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN1 and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN2 have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3438,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN1 forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN2 have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3439,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN1 and PROTEIN2 have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3440,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN1 forms of Escherichia coli-derived human PROTEIN2 and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3441,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN forms of Escherichia coli-derived human PROTEIN1 and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN2 and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3442,AIMed.d174,False,"Monomeric ( PROTEIN and dimeric ( PROTEIN1 forms of Escherichia coli-derived human PROTEIN and the extracellular (""soluble"") portions of the PROTEIN receptor ( PROTEIN2 and PROTEIN have been purified in order to investigate the effect of PROTEIN dimerization on binding to the receptor complex.",AIMed.d174.s1468
3443,AIMed.d174,True,"Although PROTEIN1 has a higher binding affinity for immobilized PROTEIN2 as determined by biosensor analysis employing surface plasmon resonance detection, PROTEIN is more potent than PROTEIN in a STAT3 phosphorylation assay.",AIMed.d174.s1469
3444,AIMed.d174,False,"Although PROTEIN1 has a higher binding affinity for immobilized PROTEIN as determined by biosensor analysis employing surface plasmon resonance detection, PROTEIN2 is more potent than PROTEIN in a STAT3 phosphorylation assay.",AIMed.d174.s1469
3445,AIMed.d174,False,"Although PROTEIN1 has a higher binding affinity for immobilized PROTEIN as determined by biosensor analysis employing surface plasmon resonance detection, PROTEIN is more potent than PROTEIN2 in a STAT3 phosphorylation assay.",AIMed.d174.s1469
3446,AIMed.d174,False,"Although PROTEIN has a higher binding affinity for immobilized PROTEIN1 as determined by biosensor analysis employing surface plasmon resonance detection, PROTEIN2 is more potent than PROTEIN in a STAT3 phosphorylation assay.",AIMed.d174.s1469
3447,AIMed.d174,False,"Although PROTEIN has a higher binding affinity for immobilized PROTEIN1 as determined by biosensor analysis employing surface plasmon resonance detection, PROTEIN is more potent than PROTEIN2 in a STAT3 phosphorylation assay.",AIMed.d174.s1469
3448,AIMed.d174,False,"Although PROTEIN has a higher binding affinity for immobilized PROTEIN as determined by biosensor analysis employing surface plasmon resonance detection, PROTEIN1 is more potent than PROTEIN2 in a STAT3 phosphorylation assay.",AIMed.d174.s1469
3449,AIMed.d174,True,The increased binding affinity of PROTEIN1 appears to be due to its ability to cross-link two PROTEIN2 molecules on the biosensor surface.,AIMed.d174.s1471
3450,AIMed.d174,False,Studies of the PROTEIN1 ternary complex formation demonstrated that the reduced biological potency of PROTEIN2 resulted from a decreased ability of the PROTEIN ( PROTEIN 2 complex to couple with the soluble portion of PROTEIN ,AIMed.d174.s1472
3451,AIMed.d174,False,Studies of the PROTEIN1 ternary complex formation demonstrated that the reduced biological potency of PROTEIN resulted from a decreased ability of the PROTEIN2 ( PROTEIN 2 complex to couple with the soluble portion of PROTEIN ,AIMed.d174.s1472
3452,AIMed.d174,False,Studies of the PROTEIN1 ternary complex formation demonstrated that the reduced biological potency of PROTEIN resulted from a decreased ability of the PROTEIN ( PROTEIN2 2 complex to couple with the soluble portion of PROTEIN ,AIMed.d174.s1472
3453,AIMed.d174,False,Studies of the PROTEIN1 ternary complex formation demonstrated that the reduced biological potency of PROTEIN resulted from a decreased ability of the PROTEIN ( PROTEIN 2 complex to couple with the soluble portion of PROTEIN2 ,AIMed.d174.s1472
3454,AIMed.d174,False,Studies of the PROTEIN ternary complex formation demonstrated that the reduced biological potency of PROTEIN1 resulted from a decreased ability of the PROTEIN2 ( PROTEIN 2 complex to couple with the soluble portion of PROTEIN ,AIMed.d174.s1472
3455,AIMed.d174,False,Studies of the PROTEIN ternary complex formation demonstrated that the reduced biological potency of PROTEIN1 resulted from a decreased ability of the PROTEIN ( PROTEIN2 2 complex to couple with the soluble portion of PROTEIN ,AIMed.d174.s1472
3456,AIMed.d174,False,Studies of the PROTEIN ternary complex formation demonstrated that the reduced biological potency of PROTEIN1 resulted from a decreased ability of the PROTEIN ( PROTEIN 2 complex to couple with the soluble portion of PROTEIN2 ,AIMed.d174.s1472
3457,AIMed.d174,True,Studies of the PROTEIN ternary complex formation demonstrated that the reduced biological potency of PROTEIN resulted from a decreased ability of the PROTEIN1 ( PROTEIN2 2 complex to couple with the soluble portion of PROTEIN ,AIMed.d174.s1472
3458,AIMed.d174,False,Studies of the PROTEIN ternary complex formation demonstrated that the reduced biological potency of PROTEIN resulted from a decreased ability of the PROTEIN1 ( PROTEIN 2 complex to couple with the soluble portion of PROTEIN2 ,AIMed.d174.s1472
3459,AIMed.d174,False,Studies of the PROTEIN ternary complex formation demonstrated that the reduced biological potency of PROTEIN resulted from a decreased ability of the PROTEIN ( PROTEIN1 2 complex to couple with the soluble portion of PROTEIN2 ,AIMed.d174.s1472
3460,AIMed.d174,False,These data imply that PROTEIN1 induced dimerization of PROTEIN is not the driving force in promoting formation of the hexameric ( PROTEIN2 PROTEIN PROTEIN 2 complex.,AIMed.d174.s1473
3461,AIMed.d174,False,These data imply that PROTEIN1 induced dimerization of PROTEIN2 is not the driving force in promoting formation of the hexameric ( PROTEIN PROTEIN PROTEIN 2 complex.,AIMed.d174.s1473
3462,AIMed.d174,False,These data imply that PROTEIN1 induced dimerization of PROTEIN is not the driving force in promoting formation of the hexameric ( PROTEIN PROTEIN PROTEIN2 2 complex.,AIMed.d174.s1473
3463,AIMed.d174,False,These data imply that PROTEIN1 induced dimerization of PROTEIN is not the driving force in promoting formation of the hexameric ( PROTEIN PROTEIN2 PROTEIN 2 complex.,AIMed.d174.s1473
3464,AIMed.d174,False,These data imply that PROTEIN induced dimerization of PROTEIN1 is not the driving force in promoting formation of the hexameric ( PROTEIN2 PROTEIN PROTEIN 2 complex.,AIMed.d174.s1473
3465,AIMed.d174,False,These data imply that PROTEIN induced dimerization of PROTEIN is not the driving force in promoting formation of the hexameric ( PROTEIN1 PROTEIN PROTEIN2 2 complex.,AIMed.d174.s1473
3466,AIMed.d174,True,These data imply that PROTEIN induced dimerization of PROTEIN is not the driving force in promoting formation of the hexameric ( PROTEIN1 PROTEIN2 PROTEIN 2 complex.,AIMed.d174.s1473
3467,AIMed.d174,False,These data imply that PROTEIN induced dimerization of PROTEIN1 is not the driving force in promoting formation of the hexameric ( PROTEIN PROTEIN PROTEIN2 2 complex.,AIMed.d174.s1473
3468,AIMed.d174,False,These data imply that PROTEIN induced dimerization of PROTEIN1 is not the driving force in promoting formation of the hexameric ( PROTEIN PROTEIN2 PROTEIN 2 complex.,AIMed.d174.s1473
3469,AIMed.d174,False,These data imply that PROTEIN induced dimerization of PROTEIN is not the driving force in promoting formation of the hexameric ( PROTEIN PROTEIN1 PROTEIN2 2 complex.,AIMed.d174.s1473
3470,AIMed.d174,True,A model is presented whereby the trimeric complex of PROTEIN1 PROTEIN2 and PROTEIN forms before the functional hexamer.,AIMed.d174.s1474
3471,AIMed.d174,False,A model is presented whereby the trimeric complex of PROTEIN1 PROTEIN and PROTEIN2 forms before the functional hexamer.,AIMed.d174.s1474
3472,AIMed.d174,False,A model is presented whereby the trimeric complex of PROTEIN PROTEIN1 and PROTEIN2 forms before the functional hexamer.,AIMed.d174.s1474
3473,AIMed.d174,False,Due to its increased affinity for the PROTEIN1 but its decreased ability to couple with PROTEIN2 we suggest that a stable PROTEIN dimer may be an efficient PROTEIN antagonist.,AIMed.d174.s1475
3474,AIMed.d174,False,Due to its increased affinity for the PROTEIN but its decreased ability to couple with PROTEIN1 we suggest that a stable PROTEIN dimer may be an efficient PROTEIN2 antagonist.,AIMed.d174.s1475
3475,AIMed.d174,True,Due to its increased affinity for the PROTEIN but its decreased ability to couple with PROTEIN1 we suggest that a stable PROTEIN2 dimer may be an efficient PROTEIN antagonist.,AIMed.d174.s1475
3476,AIMed.d174,False,Due to its increased affinity for the PROTEIN1 but its decreased ability to couple with PROTEIN we suggest that a stable PROTEIN dimer may be an efficient PROTEIN2 antagonist.,AIMed.d174.s1475
3477,AIMed.d174,True,Due to its increased affinity for the PROTEIN1 but its decreased ability to couple with PROTEIN we suggest that a stable PROTEIN2 dimer may be an efficient PROTEIN antagonist.,AIMed.d174.s1475
3478,AIMed.d174,False,Due to its increased affinity for the PROTEIN but its decreased ability to couple with PROTEIN we suggest that a stable PROTEIN1 dimer may be an efficient PROTEIN2 antagonist.,AIMed.d174.s1475
3479,AIMed.d175,True,Physical interaction of mammalian PROTEIN1 with PROTEIN2 ,AIMed.d175.s1476
3480,AIMed.d175,False, PROTEIN1 was originally identified as a Start gene in budding yeast and has been shown to be required for association of PROTEIN2 with cyclins.,AIMed.d175.s1477
3481,AIMed.d175,False, PROTEIN1 is a PROTEIN2 that controls progression through G1 of the mammalian cell cycle.,AIMed.d175.s1479
3482,AIMed.d175,False,We have detected a specific association of PROTEIN with the molecular chaperon PROTEIN1 and a 44-kDa protein that we identify as mammalian PROTEIN2 ,AIMed.d175.s1480
3483,AIMed.d175,True,We have detected a specific association of PROTEIN1 with the molecular chaperon PROTEIN2 and a 44-kDa protein that we identify as mammalian PROTEIN ,AIMed.d175.s1480
3484,AIMed.d175,True,We have detected a specific association of PROTEIN1 with the molecular chaperon PROTEIN and a 44-kDa protein that we identify as mammalian PROTEIN2 ,AIMed.d175.s1480
3485,AIMed.d175,True,A physical interaction between PROTEIN and PROTEIN suggests that PROTEIN1 may regulate the mammalian cell cycle through a direct effect on PROTEIN2 ,AIMed.d175.s1481
3486,AIMed.d175,False,A physical interaction between PROTEIN and PROTEIN1 suggests that PROTEIN may regulate the mammalian cell cycle through a direct effect on PROTEIN2 ,AIMed.d175.s1481
3487,AIMed.d175,False,A physical interaction between PROTEIN1 and PROTEIN suggests that PROTEIN may regulate the mammalian cell cycle through a direct effect on PROTEIN2 ,AIMed.d175.s1481
3488,AIMed.d175,False,A physical interaction between PROTEIN and PROTEIN1 suggests that PROTEIN2 may regulate the mammalian cell cycle through a direct effect on PROTEIN ,AIMed.d175.s1481
3489,AIMed.d175,False,A physical interaction between PROTEIN1 and PROTEIN suggests that PROTEIN2 may regulate the mammalian cell cycle through a direct effect on PROTEIN ,AIMed.d175.s1481
3490,AIMed.d175,True,A physical interaction between PROTEIN1 and PROTEIN2 suggests that PROTEIN may regulate the mammalian cell cycle through a direct effect on PROTEIN ,AIMed.d175.s1481
3491,AIMed.d175,False,Association of PROTEIN1 with both PROTEIN and PROTEIN may also imply a mechanistic link between the functions of PROTEIN and PROTEIN2 ,AIMed.d175.s1482
3492,AIMed.d175,False,Association of PROTEIN1 with both PROTEIN and PROTEIN may also imply a mechanistic link between the functions of PROTEIN2 and PROTEIN ,AIMed.d175.s1482
3493,AIMed.d175,True,Association of PROTEIN1 with both PROTEIN2 and PROTEIN may also imply a mechanistic link between the functions of PROTEIN and PROTEIN ,AIMed.d175.s1482
3494,AIMed.d175,True,Association of PROTEIN1 with both PROTEIN and PROTEIN2 may also imply a mechanistic link between the functions of PROTEIN and PROTEIN ,AIMed.d175.s1482
3495,AIMed.d175,False,Association of PROTEIN with both PROTEIN and PROTEIN may also imply a mechanistic link between the functions of PROTEIN1 and PROTEIN2 ,AIMed.d175.s1482
3496,AIMed.d175,False,Association of PROTEIN with both PROTEIN1 and PROTEIN may also imply a mechanistic link between the functions of PROTEIN and PROTEIN2 ,AIMed.d175.s1482
3497,AIMed.d175,False,Association of PROTEIN with both PROTEIN and PROTEIN1 may also imply a mechanistic link between the functions of PROTEIN and PROTEIN2 ,AIMed.d175.s1482
3498,AIMed.d175,False,Association of PROTEIN with both PROTEIN1 and PROTEIN may also imply a mechanistic link between the functions of PROTEIN2 and PROTEIN ,AIMed.d175.s1482
3499,AIMed.d175,False,Association of PROTEIN with both PROTEIN and PROTEIN1 may also imply a mechanistic link between the functions of PROTEIN2 and PROTEIN ,AIMed.d175.s1482
3500,AIMed.d175,False,Association of PROTEIN with both PROTEIN1 and PROTEIN2 may also imply a mechanistic link between the functions of PROTEIN and PROTEIN ,AIMed.d175.s1482
3501,AIMed.d176,True,"Interactions of PROTEIN1 a mediator of PROTEIN assembly, with heat shock proteins PROTEIN2 and PROTEIN ",AIMed.d176.s1483
3502,AIMed.d176,True,"Interactions of PROTEIN1 a mediator of PROTEIN assembly, with heat shock proteins PROTEIN and PROTEIN2 ",AIMed.d176.s1483
3503,AIMed.d176,False,"Interactions of PROTEIN1 a mediator of PROTEIN2 assembly, with heat shock proteins PROTEIN and PROTEIN ",AIMed.d176.s1483
3504,AIMed.d176,False,"Interactions of PROTEIN a mediator of PROTEIN assembly, with heat shock proteins PROTEIN1 and PROTEIN2 ",AIMed.d176.s1483
3505,AIMed.d176,False,"Interactions of PROTEIN a mediator of PROTEIN1 assembly, with heat shock proteins PROTEIN2 and PROTEIN ",AIMed.d176.s1483
3506,AIMed.d176,False,"Interactions of PROTEIN a mediator of PROTEIN1 assembly, with heat shock proteins PROTEIN and PROTEIN2 ",AIMed.d176.s1483
3507,AIMed.d176,False,"Previous studies on the assembly of PROTEIN1 ( PROTEIN complexes in vitro have suggested that PROTEIN2 assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.",AIMed.d176.s1484
3508,AIMed.d176,False,"Previous studies on the assembly of PROTEIN1 ( PROTEIN2 complexes in vitro have suggested that PROTEIN assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.",AIMed.d176.s1484
3509,AIMed.d176,False,"Previous studies on the assembly of PROTEIN ( PROTEIN1 complexes in vitro have suggested that PROTEIN2 assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.",AIMed.d176.s1484
3510,AIMed.d176,False,"One of these proteins, PROTEIN1 appears transiently during assembly and is not a component of functionally mature PROTEIN2 complexes.",AIMed.d176.s1485
3511,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN1 ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN2 .",AIMed.d176.s1486
3512,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN1 complexes containing PROTEIN2 ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3513,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN1 ( PROTEIN , PROTEIN2 and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3514,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN1 ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN2 complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3515,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN1 ( PROTEIN2 , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3516,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN1 ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN2 and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3517,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN1 ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN2 ( PROTEIN .",AIMed.d176.s1486
3518,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN1 can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN2 ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3519,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN1 complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN2 .",AIMed.d176.s1486
3520,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN1 and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN2 .",AIMed.d176.s1486
3521,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN1 complexes containing PROTEIN and PROTEIN ( PROTEIN2 .",AIMed.d176.s1486
3522,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN1 , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN2 .",AIMed.d176.s1486
3523,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN1 and PROTEIN ( PROTEIN2 .",AIMed.d176.s1486
3524,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN1 ( PROTEIN2 .",AIMed.d176.s1486
3525,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN1 can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN2 .",AIMed.d176.s1486
3526,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN1 complexes containing PROTEIN ( PROTEIN , PROTEIN2 and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3527,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN1 complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN2 complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3528,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN1 complexes containing PROTEIN ( PROTEIN2 , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3529,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN1 complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN2 and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3530,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN1 complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN2 ( PROTEIN .",AIMed.d176.s1486
3531,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN1 can, on the one hand, inhibit formation of mature PROTEIN2 complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3532,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN1 and immunophilins and, on the other, enhance recovery of early PROTEIN2 complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3533,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN1 , PROTEIN2 and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3534,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN1 and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN2 and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3535,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN1 and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN2 ( PROTEIN .",AIMed.d176.s1486
3536,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN1 can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN2 and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3537,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN1 , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN2 complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3538,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN1 complexes containing PROTEIN2 and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3539,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN1 complexes containing PROTEIN and PROTEIN2 ( PROTEIN .",AIMed.d176.s1486
3540,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN1 can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN2 complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3541,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN1 , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN2 and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3542,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN1 , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN2 ( PROTEIN .",AIMed.d176.s1486
3543,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN1 can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN2 , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3544,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN1 and PROTEIN2 ( PROTEIN .",AIMed.d176.s1486
3545,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN1 can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN2 and PROTEIN ( PROTEIN .",AIMed.d176.s1486
3546,AIMed.d176,False,"In the present study we observe that a monoclonal antibody specific for PROTEIN1 can, on the one hand, inhibit formation of mature PROTEIN complexes containing PROTEIN ( PROTEIN , PROTEIN and immunophilins and, on the other, enhance recovery of early PROTEIN complexes containing PROTEIN and PROTEIN2 ( PROTEIN .",AIMed.d176.s1486
3547,AIMed.d176,False,This observation supports a model in which PROTEIN functions at an intermediate stage of PROTEIN1 assembly to facilitate formation of subsequent PROTEIN2 complexes lacking PROTEIN ,AIMed.d176.s1487
3548,AIMed.d176,False,This observation supports a model in which PROTEIN1 functions at an intermediate stage of PROTEIN2 assembly to facilitate formation of subsequent PROTEIN complexes lacking PROTEIN ,AIMed.d176.s1487
3549,AIMed.d176,False,This observation supports a model in which PROTEIN functions at an intermediate stage of PROTEIN1 assembly to facilitate formation of subsequent PROTEIN complexes lacking PROTEIN2 ,AIMed.d176.s1487
3550,AIMed.d176,False,This observation supports a model in which PROTEIN1 functions at an intermediate stage of PROTEIN assembly to facilitate formation of subsequent PROTEIN2 complexes lacking PROTEIN ,AIMed.d176.s1487
3551,AIMed.d176,False,This observation supports a model in which PROTEIN functions at an intermediate stage of PROTEIN assembly to facilitate formation of subsequent PROTEIN1 complexes lacking PROTEIN2 ,AIMed.d176.s1487
3552,AIMed.d176,False,This observation supports a model in which PROTEIN1 functions at an intermediate stage of PROTEIN assembly to facilitate formation of subsequent PROTEIN complexes lacking PROTEIN2 ,AIMed.d176.s1487
3553,AIMed.d176,False,Since PROTEIN is typically found in a complex with PROTEIN1 and PROTEIN2 we have further characterized its interactions with these proteins.,AIMed.d176.s1488
3554,AIMed.d176,True,Since PROTEIN1 is typically found in a complex with PROTEIN2 and PROTEIN we have further characterized its interactions with these proteins.,AIMed.d176.s1488
3555,AIMed.d176,True,Since PROTEIN1 is typically found in a complex with PROTEIN and PROTEIN2 we have further characterized its interactions with these proteins.,AIMed.d176.s1488
3556,AIMed.d176,False, PROTEIN can bind either PROTEIN1 or PROTEIN2 independently and in an ATP-independent manner.,AIMed.d176.s1489
3557,AIMed.d176,True, PROTEIN1 can bind either PROTEIN or PROTEIN2 independently and in an ATP-independent manner.,AIMed.d176.s1489
3558,AIMed.d176,True, PROTEIN1 can bind either PROTEIN2 or PROTEIN independently and in an ATP-independent manner.,AIMed.d176.s1489
3559,AIMed.d176,False,"Since PROTEIN1 and PROTEIN do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN PROTEIN PROTEIN2 complex.",AIMed.d176.s1490
3560,AIMed.d176,False,"Since PROTEIN1 and PROTEIN do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN PROTEIN2 PROTEIN complex.",AIMed.d176.s1490
3561,AIMed.d176,False,"Since PROTEIN1 and PROTEIN2 do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN PROTEIN PROTEIN complex.",AIMed.d176.s1490
3562,AIMed.d176,False,"Since PROTEIN1 and PROTEIN do not readily associate on their own, it appears that PROTEIN2 is the central organizing component of an PROTEIN PROTEIN PROTEIN complex.",AIMed.d176.s1490
3563,AIMed.d176,False,"Since PROTEIN1 and PROTEIN do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN2 PROTEIN PROTEIN complex.",AIMed.d176.s1490
3564,AIMed.d176,False,"Since PROTEIN and PROTEIN do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN PROTEIN1 PROTEIN2 complex.",AIMed.d176.s1490
3565,AIMed.d176,False,"Since PROTEIN and PROTEIN1 do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN PROTEIN PROTEIN2 complex.",AIMed.d176.s1490
3566,AIMed.d176,False,"Since PROTEIN and PROTEIN do not readily associate on their own, it appears that PROTEIN1 is the central organizing component of an PROTEIN PROTEIN PROTEIN2 complex.",AIMed.d176.s1490
3567,AIMed.d176,False,"Since PROTEIN and PROTEIN do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN1 PROTEIN PROTEIN2 complex.",AIMed.d176.s1490
3568,AIMed.d176,False,"Since PROTEIN and PROTEIN1 do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN PROTEIN2 PROTEIN complex.",AIMed.d176.s1490
3569,AIMed.d176,False,"Since PROTEIN and PROTEIN do not readily associate on their own, it appears that PROTEIN1 is the central organizing component of an PROTEIN PROTEIN2 PROTEIN complex.",AIMed.d176.s1490
3570,AIMed.d176,True,"Since PROTEIN and PROTEIN do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN1 PROTEIN2 PROTEIN complex.",AIMed.d176.s1490
3571,AIMed.d176,False,"Since PROTEIN and PROTEIN1 do not readily associate on their own, it appears that PROTEIN2 is the central organizing component of an PROTEIN PROTEIN PROTEIN complex.",AIMed.d176.s1490
3572,AIMed.d176,False,"Since PROTEIN and PROTEIN1 do not readily associate on their own, it appears that PROTEIN is the central organizing component of an PROTEIN2 PROTEIN PROTEIN complex.",AIMed.d176.s1490
3573,AIMed.d176,False,"Since PROTEIN and PROTEIN do not readily associate on their own, it appears that PROTEIN1 is the central organizing component of an PROTEIN2 PROTEIN PROTEIN complex.",AIMed.d176.s1490
3574,AIMed.d176,False,"Mutational analysis of PROTEIN indicates that the N terminus is required for PROTEIN binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding PROTEIN1 and PROTEIN2 ",AIMed.d176.s1491
3575,AIMed.d176,False,"Mutational analysis of PROTEIN indicates that the N terminus is required for PROTEIN1 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding PROTEIN2 and PROTEIN ",AIMed.d176.s1491
3576,AIMed.d176,True,"Mutational analysis of PROTEIN1 indicates that the N terminus is required for PROTEIN binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding PROTEIN2 and PROTEIN ",AIMed.d176.s1491
3577,AIMed.d176,False,"Mutational analysis of PROTEIN indicates that the N terminus is required for PROTEIN1 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding PROTEIN and PROTEIN2 ",AIMed.d176.s1491
3578,AIMed.d176,True,"Mutational analysis of PROTEIN1 indicates that the N terminus is required for PROTEIN binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding PROTEIN and PROTEIN2 ",AIMed.d176.s1491
3579,AIMed.d176,True,"Mutational analysis of PROTEIN1 indicates that the N terminus is required for PROTEIN2 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding PROTEIN and PROTEIN ",AIMed.d176.s1491
3580,AIMed.d176,True,The PROTEIN1 PROTEIN2 PROTEIN multichaperone complex is highly dynamic and does not appear to be affected by the PROTEIN binding drug geldanamycin.,AIMed.d176.s1492
3581,AIMed.d176,False,The PROTEIN PROTEIN1 PROTEIN2 multichaperone complex is highly dynamic and does not appear to be affected by the PROTEIN binding drug geldanamycin.,AIMed.d176.s1492
3582,AIMed.d176,False,The PROTEIN PROTEIN1 PROTEIN multichaperone complex is highly dynamic and does not appear to be affected by the PROTEIN2 binding drug geldanamycin.,AIMed.d176.s1492
3583,AIMed.d176,False,The PROTEIN1 PROTEIN PROTEIN2 multichaperone complex is highly dynamic and does not appear to be affected by the PROTEIN binding drug geldanamycin.,AIMed.d176.s1492
3584,AIMed.d176,False,The PROTEIN1 PROTEIN PROTEIN multichaperone complex is highly dynamic and does not appear to be affected by the PROTEIN2 binding drug geldanamycin.,AIMed.d176.s1492
3585,AIMed.d176,False,The PROTEIN PROTEIN PROTEIN1 multichaperone complex is highly dynamic and does not appear to be affected by the PROTEIN2 binding drug geldanamycin.,AIMed.d176.s1492
3586,AIMed.d176,False,The interactions of PROTEIN and PROTEIN in intermediate PROTEIN1 complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN or in mature PROTEIN2 complexes (hsp90).,AIMed.d176.s1493
3587,AIMed.d176,False,The interactions of PROTEIN and PROTEIN1 in intermediate PROTEIN2 complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3588,AIMed.d176,False,The interactions of PROTEIN and PROTEIN in intermediate PROTEIN1 complexes are shown to be distinct from their separate interactions in early PROTEIN2 complexes ( PROTEIN or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3589,AIMed.d176,False,The interactions of PROTEIN and PROTEIN in intermediate PROTEIN1 complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN2 or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3590,AIMed.d176,False,The interactions of PROTEIN1 and PROTEIN in intermediate PROTEIN2 complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3591,AIMed.d176,False,The interactions of PROTEIN and PROTEIN1 in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN or in mature PROTEIN2 complexes (hsp90).,AIMed.d176.s1493
3592,AIMed.d176,False,The interactions of PROTEIN and PROTEIN in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN1 complexes ( PROTEIN or in mature PROTEIN2 complexes (hsp90).,AIMed.d176.s1493
3593,AIMed.d176,False,The interactions of PROTEIN and PROTEIN in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN1 or in mature PROTEIN2 complexes (hsp90).,AIMed.d176.s1493
3594,AIMed.d176,False,The interactions of PROTEIN1 and PROTEIN in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN or in mature PROTEIN2 complexes (hsp90).,AIMed.d176.s1493
3595,AIMed.d176,False,The interactions of PROTEIN and PROTEIN1 in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN2 complexes ( PROTEIN or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3596,AIMed.d176,False,The interactions of PROTEIN and PROTEIN1 in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN2 or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3597,AIMed.d176,True,The interactions of PROTEIN1 and PROTEIN2 in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3598,AIMed.d176,False,The interactions of PROTEIN and PROTEIN in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN1 complexes ( PROTEIN2 or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3599,AIMed.d176,False,The interactions of PROTEIN1 and PROTEIN in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN2 complexes ( PROTEIN or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3600,AIMed.d176,False,The interactions of PROTEIN1 and PROTEIN in intermediate PROTEIN complexes are shown to be distinct from their separate interactions in early PROTEIN complexes ( PROTEIN2 or in mature PROTEIN complexes (hsp90).,AIMed.d176.s1493
3601,AIMed.d176,False,"From these results, it appears that PROTEIN1 is a key mediator in the chaperoned assembly and functional maturation of PROTEIN2 complexes.",AIMed.d176.s1494
3602,AIMed.d177,True,We have selected such mutations in the transcription factor PROTEIN1 that affect its ability to heterodimerize with PROTEIN2 ,AIMed.d177.s1503
3603,AIMed.d179,False, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 and its association with PROTEIN and the PROTEIN ,AIMed.d179.s1519
3604,AIMed.d179,False, PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2 substrate 1 and its association with PROTEIN and the PROTEIN ,AIMed.d179.s1519
3605,AIMed.d179,False, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 substrate 1 and its association with PROTEIN and the PROTEIN2 ,AIMed.d179.s1519
3606,AIMed.d179,False, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 and its association with PROTEIN and the PROTEIN ,AIMed.d179.s1519
3607,AIMed.d179,False, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 substrate 1 and its association with PROTEIN2 and the PROTEIN ,AIMed.d179.s1519
3608,AIMed.d179,False, PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2 receptor substrate 1 and its association with PROTEIN and the PROTEIN ,AIMed.d179.s1519
3609,AIMed.d179,False, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 and its association with PROTEIN and the PROTEIN2 ,AIMed.d179.s1519
3610,AIMed.d179,False, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 and its association with PROTEIN and the PROTEIN ,AIMed.d179.s1519
3611,AIMed.d179,False, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 and its association with PROTEIN2 and the PROTEIN ,AIMed.d179.s1519
3612,AIMed.d179,False, PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 and its association with PROTEIN and the PROTEIN2 ,AIMed.d179.s1519
3613,AIMed.d179,True, PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2 and its association with PROTEIN and the PROTEIN ,AIMed.d179.s1519
3614,AIMed.d179,False, PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN and its association with PROTEIN2 and the PROTEIN ,AIMed.d179.s1519
3615,AIMed.d179,True, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 and its association with PROTEIN and the PROTEIN2 ,AIMed.d179.s1519
3616,AIMed.d179,False, PROTEIN stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 and its association with PROTEIN1 and the PROTEIN2 ,AIMed.d179.s1519
3617,AIMed.d179,True, PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 and its association with PROTEIN2 and the PROTEIN ,AIMed.d179.s1519
3618,AIMed.d179,False,The growth-promoting effects of PROTEIN1 on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the PROTEIN2 PROTEIN which belongs to the family of G protein-coupled receptors.,AIMed.d179.s1520
3619,AIMed.d179,False,The growth-promoting effects of PROTEIN1 on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the PROTEIN PROTEIN2 which belongs to the family of G protein-coupled receptors.,AIMed.d179.s1520
3620,AIMed.d179,False,The growth-promoting effects of PROTEIN on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the PROTEIN1 PROTEIN2 which belongs to the family of G protein-coupled receptors.,AIMed.d179.s1520
3621,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 ( PROTEIN2 , the major cytoplasmic substrate of the PROTEIN ",AIMed.d179.s1522
3622,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN1 , the major cytoplasmic substrate of the PROTEIN2 ",AIMed.d179.s1522
3623,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN1 , the major cytoplasmic substrate of the PROTEIN2 receptor.",AIMed.d179.s1522
3624,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 ( PROTEIN2 , the major cytoplasmic substrate of the PROTEIN ",AIMed.d179.s1522
3625,AIMed.d179,True,"In the present study, we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN2 , the major cytoplasmic substrate of the PROTEIN ",AIMed.d179.s1522
3626,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN2 ",AIMed.d179.s1522
3627,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN2 receptor.",AIMed.d179.s1522
3628,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN ",AIMed.d179.s1522
3629,AIMed.d179,True,"In the present study, we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN ",AIMed.d179.s1522
3630,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN1 receptor.",AIMed.d179.s1522
3631,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN2 ",AIMed.d179.s1522
3632,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN2 ",AIMed.d179.s1522
3633,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN2 receptor.",AIMed.d179.s1522
3634,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN2 receptor.",AIMed.d179.s1522
3635,AIMed.d179,False,"In the present study, we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2 receptor substrate 1 ( PROTEIN , the major cytoplasmic substrate of the PROTEIN ",AIMed.d179.s1522
3636,AIMed.d179,True,"The PROTEIN1 induced phosphorylation of PROTEIN2 was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.",AIMed.d179.s1523
3637,AIMed.d179,True,"Following PROTEIN stimulation, we observed a time- and dose-dependent association of PROTEIN1 with the PROTEIN regulatory subunit of PROTEIN2 ( PROTEIN .",AIMed.d179.s1525
3638,AIMed.d179,False,"Following PROTEIN1 stimulation, we observed a time- and dose-dependent association of PROTEIN2 with the PROTEIN regulatory subunit of PROTEIN ( PROTEIN .",AIMed.d179.s1525
3639,AIMed.d179,True,"Following PROTEIN stimulation, we observed a time- and dose-dependent association of PROTEIN1 with the PROTEIN regulatory subunit of PROTEIN ( PROTEIN2 .",AIMed.d179.s1525
3640,AIMed.d179,False,"Following PROTEIN stimulation, we observed a time- and dose-dependent association of PROTEIN1 with the PROTEIN2 regulatory subunit of PROTEIN ( PROTEIN .",AIMed.d179.s1525
3641,AIMed.d179,False,"Following PROTEIN1 stimulation, we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of PROTEIN2 ( PROTEIN .",AIMed.d179.s1525
3642,AIMed.d179,False,"Following PROTEIN stimulation, we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of PROTEIN1 ( PROTEIN2 .",AIMed.d179.s1525
3643,AIMed.d179,False,"Following PROTEIN stimulation, we observed a time- and dose-dependent association of PROTEIN with the PROTEIN1 regulatory subunit of PROTEIN2 ( PROTEIN .",AIMed.d179.s1525
3644,AIMed.d179,False,"Following PROTEIN1 stimulation, we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of PROTEIN ( PROTEIN2 .",AIMed.d179.s1525
3645,AIMed.d179,False,"Following PROTEIN1 stimulation, we observed a time- and dose-dependent association of PROTEIN with the PROTEIN2 regulatory subunit of PROTEIN ( PROTEIN .",AIMed.d179.s1525
3646,AIMed.d179,False,"Following PROTEIN stimulation, we observed a time- and dose-dependent association of PROTEIN with the PROTEIN1 regulatory subunit of PROTEIN ( PROTEIN2 .",AIMed.d179.s1525
3647,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN1 immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN2 might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3648,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN1 immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN2 to activate PROTEIN ",AIMed.d179.s1526
3649,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN1 immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN2 which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3650,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN1 immunoprecipitates from PROTEIN2 treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3651,AIMed.d179,False,"In addition, activation of PROTEIN1 was detected in anti- PROTEIN2 immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3652,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN1 immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN2 ",AIMed.d179.s1526
3653,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN1 might be one mechanism used by PROTEIN2 to activate PROTEIN ",AIMed.d179.s1526
3654,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN1 which leads to the rapid recruitment of PROTEIN2 might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3655,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN1 treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN2 might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3656,AIMed.d179,False,"In addition, activation of PROTEIN1 was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN2 might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3657,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN1 might be one mechanism used by PROTEIN to activate PROTEIN2 ",AIMed.d179.s1526
3658,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN1 which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN2 to activate PROTEIN ",AIMed.d179.s1526
3659,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN1 treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN2 to activate PROTEIN ",AIMed.d179.s1526
3660,AIMed.d179,False,"In addition, activation of PROTEIN1 was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN2 to activate PROTEIN ",AIMed.d179.s1526
3661,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN1 to activate PROTEIN2 ",AIMed.d179.s1526
3662,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN1 treated cells, suggesting that tyrosine phosphorylation of PROTEIN2 which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3663,AIMed.d179,False,"In addition, activation of PROTEIN1 was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN2 which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3664,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN1 which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN2 ",AIMed.d179.s1526
3665,AIMed.d179,False,"In addition, activation of PROTEIN1 was detected in anti- PROTEIN immunoprecipitates from PROTEIN2 treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN ",AIMed.d179.s1526
3666,AIMed.d179,False,"In addition, activation of PROTEIN was detected in anti- PROTEIN immunoprecipitates from PROTEIN1 treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN2 ",AIMed.d179.s1526
3667,AIMed.d179,False,"In addition, activation of PROTEIN1 was detected in anti- PROTEIN immunoprecipitates from PROTEIN treated cells, suggesting that tyrosine phosphorylation of PROTEIN which leads to the rapid recruitment of PROTEIN might be one mechanism used by PROTEIN to activate PROTEIN2 ",AIMed.d179.s1526
3668,AIMed.d179,False,We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the PROTEIN PROTEIN complex may contribute to the activation of the PROTEIN1 pathway by PROTEIN2 ,AIMed.d179.s1527
3669,AIMed.d179,False,We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the PROTEIN PROTEIN1 complex may contribute to the activation of the PROTEIN2 pathway by PROTEIN ,AIMed.d179.s1527
3670,AIMed.d179,False,We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the PROTEIN1 PROTEIN complex may contribute to the activation of the PROTEIN2 pathway by PROTEIN ,AIMed.d179.s1527
3671,AIMed.d179,False,We have previously reported that tyrosine phosphorylation of PROTEIN1 and its association with the PROTEIN PROTEIN complex may contribute to the activation of the PROTEIN2 pathway by PROTEIN ,AIMed.d179.s1527
3672,AIMed.d179,False,We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the PROTEIN PROTEIN1 complex may contribute to the activation of the PROTEIN pathway by PROTEIN2 ,AIMed.d179.s1527
3673,AIMed.d179,False,We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the PROTEIN1 PROTEIN complex may contribute to the activation of the PROTEIN pathway by PROTEIN2 ,AIMed.d179.s1527
3674,AIMed.d179,False,We have previously reported that tyrosine phosphorylation of PROTEIN1 and its association with the PROTEIN PROTEIN complex may contribute to the activation of the PROTEIN pathway by PROTEIN2 ,AIMed.d179.s1527
3675,AIMed.d179,True,We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the PROTEIN1 PROTEIN2 complex may contribute to the activation of the PROTEIN pathway by PROTEIN ,AIMed.d179.s1527
3676,AIMed.d179,True,We have previously reported that tyrosine phosphorylation of PROTEIN1 and its association with the PROTEIN PROTEIN2 complex may contribute to the activation of the PROTEIN pathway by PROTEIN ,AIMed.d179.s1527
3677,AIMed.d179,True,We have previously reported that tyrosine phosphorylation of PROTEIN1 and its association with the PROTEIN2 PROTEIN complex may contribute to the activation of the PROTEIN pathway by PROTEIN ,AIMed.d179.s1527
3678,AIMed.d179,True,We report here that PROTEIN1 also interacts with tyrosine-phosphorylated PROTEIN2 in response to PROTEIN ,AIMed.d179.s1528
3679,AIMed.d179,False,We report here that PROTEIN also interacts with tyrosine-phosphorylated PROTEIN1 in response to PROTEIN2 ,AIMed.d179.s1528
3680,AIMed.d179,False,We report here that PROTEIN1 also interacts with tyrosine-phosphorylated PROTEIN in response to PROTEIN2 ,AIMed.d179.s1528
3681,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN1 and the PROTEIN receptor.",AIMed.d179.s1529
3682,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN1 G protein-coupled receptor and the PROTEIN2 ",AIMed.d179.s1529
3683,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN1 G protein-coupled receptor and the PROTEIN2 receptor.",AIMed.d179.s1529
3684,AIMed.d179,False,"Taken together, our results suggest that PROTEIN1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN2 G protein-coupled receptor and the PROTEIN receptor.",AIMed.d179.s1529
3685,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN1 PROTEIN2 G protein-coupled receptor and the PROTEIN receptor.",AIMed.d179.s1529
3686,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN1 and the PROTEIN2 ",AIMed.d179.s1529
3687,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN1 and the PROTEIN2 receptor.",AIMed.d179.s1529
3688,AIMed.d179,False,"Taken together, our results suggest that PROTEIN1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN2 and the PROTEIN ",AIMed.d179.s1529
3689,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN1 PROTEIN2 and the PROTEIN ",AIMed.d179.s1529
3690,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN and the PROTEIN1 receptor.",AIMed.d179.s1529
3691,AIMed.d179,False,"Taken together, our results suggest that PROTEIN1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN and the PROTEIN2 ",AIMed.d179.s1529
3692,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN1 PROTEIN and the PROTEIN2 ",AIMed.d179.s1529
3693,AIMed.d179,False,"Taken together, our results suggest that PROTEIN1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN PROTEIN and the PROTEIN2 receptor.",AIMed.d179.s1529
3694,AIMed.d179,False,"Taken together, our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN1 PROTEIN and the PROTEIN2 receptor.",AIMed.d179.s1529
3695,AIMed.d179,False,"Taken together, our results suggest that PROTEIN1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the PROTEIN2 PROTEIN and the PROTEIN ",AIMed.d179.s1529
3696,AIMed.d180,False," PROTEIN1 ( PROTEIN PROTEIN2 PROTEIN , a PROTEIN ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3697,AIMed.d180,False," PROTEIN ( PROTEIN1 PROTEIN2 PROTEIN , a PROTEIN ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3698,AIMed.d180,False," PROTEIN ( PROTEIN PROTEIN1 PROTEIN2 , a PROTEIN ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3699,AIMed.d180,True," PROTEIN ( PROTEIN PROTEIN1 PROTEIN , a PROTEIN ( PROTEIN2 substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3700,AIMed.d180,True," PROTEIN ( PROTEIN PROTEIN1 PROTEIN , a PROTEIN2 ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3701,AIMed.d180,False," PROTEIN1 ( PROTEIN2 PROTEIN PROTEIN , a PROTEIN ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3702,AIMed.d180,False," PROTEIN1 ( PROTEIN PROTEIN PROTEIN2 , a PROTEIN ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3703,AIMed.d180,True," PROTEIN1 ( PROTEIN PROTEIN PROTEIN , a PROTEIN ( PROTEIN2 substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3704,AIMed.d180,True," PROTEIN1 ( PROTEIN PROTEIN PROTEIN , a PROTEIN2 ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3705,AIMed.d180,False," PROTEIN ( PROTEIN1 PROTEIN PROTEIN2 , a PROTEIN ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3706,AIMed.d180,True," PROTEIN ( PROTEIN1 PROTEIN PROTEIN , a PROTEIN ( PROTEIN2 substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3707,AIMed.d180,True," PROTEIN ( PROTEIN1 PROTEIN PROTEIN , a PROTEIN2 ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3708,AIMed.d180,True," PROTEIN ( PROTEIN PROTEIN PROTEIN1 , a PROTEIN ( PROTEIN2 substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3709,AIMed.d180,True," PROTEIN ( PROTEIN PROTEIN PROTEIN1 , a PROTEIN2 ( PROTEIN substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3710,AIMed.d180,False," PROTEIN ( PROTEIN PROTEIN PROTEIN , a PROTEIN1 ( PROTEIN2 substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.",AIMed.d180.s1532
3711,AIMed.d180,False,"In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN1 and the PROTEIN2 PROTEIN ( PROTEIN .",AIMed.d180.s1533
3712,AIMed.d180,True,"In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN1 and the PROTEIN PROTEIN2 ( PROTEIN .",AIMed.d180.s1533
3713,AIMed.d180,True,"In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN1 and the PROTEIN PROTEIN ( PROTEIN2 .",AIMed.d180.s1533
3714,AIMed.d180,False,"In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN and the PROTEIN1 PROTEIN2 ( PROTEIN .",AIMed.d180.s1533
3715,AIMed.d180,False,"In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN and the PROTEIN1 PROTEIN ( PROTEIN2 .",AIMed.d180.s1533
3716,AIMed.d180,False,"In the yeast-based cloning system, the only strong interaction that was detected between PROTEIN and the PROTEIN PROTEIN1 ( PROTEIN2 .",AIMed.d180.s1533
3717,AIMed.d180,True, PROTEIN1 phosphorylates PROTEIN2 on serine 41.,AIMed.d180.s1534
3718,AIMed.d180,False,"Surprisingly, the N-terminal third of PROTEIN1 alone bound PROTEIN more strongly than did intact PROTEIN2 suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN ",AIMed.d180.s1536
3719,AIMed.d180,False,"Surprisingly, the N-terminal third of PROTEIN alone bound PROTEIN more strongly than did intact PROTEIN1 suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN2 ",AIMed.d180.s1536
3720,AIMed.d180,True,"Surprisingly, the N-terminal third of PROTEIN alone bound PROTEIN1 more strongly than did intact PROTEIN2 suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN ",AIMed.d180.s1536
3721,AIMed.d180,False,"Surprisingly, the N-terminal third of PROTEIN1 alone bound PROTEIN more strongly than did intact PROTEIN suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN2 ",AIMed.d180.s1536
3722,AIMed.d180,True,"Surprisingly, the N-terminal third of PROTEIN1 alone bound PROTEIN2 more strongly than did intact PROTEIN suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN ",AIMed.d180.s1536
3723,AIMed.d180,False,"Surprisingly, the N-terminal third of PROTEIN alone bound PROTEIN1 more strongly than did intact PROTEIN suggesting that the protein's C-terminus may play a role in modulating the interaction with PROTEIN2 ",AIMed.d180.s1536
3724,AIMed.d180,True,"These results, along with other recent findings, suggest a novel role for the interaction between PROTEIN1 and PROTEIN2 ",AIMed.d180.s1537
3725,AIMed.d182,True,Structure of the PROTEIN1 oncoprotein bound to the PROTEIN2 tumor suppressor transactivation domain.,AIMed.d182.s1545
3726,AIMed.d182,True,The PROTEIN1 oncoprotein is a cellular inhibitor of the PROTEIN2 tumor suppressor in that it can bind the transactivation domain of PROTEIN and downregulate its ability to activate transcription.,AIMed.d182.s1546
3727,AIMed.d182,True,The PROTEIN1 oncoprotein is a cellular inhibitor of the PROTEIN tumor suppressor in that it can bind the transactivation domain of PROTEIN2 and downregulate its ability to activate transcription.,AIMed.d182.s1546
3728,AIMed.d182,False,The PROTEIN oncoprotein is a cellular inhibitor of the PROTEIN1 tumor suppressor in that it can bind the transactivation domain of PROTEIN2 and downregulate its ability to activate transcription.,AIMed.d182.s1546
3729,AIMed.d182,False,"In certain cancers, PROTEIN1 amplification is a common event and contributes to the inactivation of PROTEIN2 ",AIMed.d182.s1547
3730,AIMed.d182,True,The crystal structure of the 109-residue amino-terminal domain of PROTEIN1 bound to a 15-residue transactivation domain peptide of PROTEIN2 revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN peptide binds as an amphipathic alpha helix.,AIMed.d182.s1548
3731,AIMed.d182,False,The crystal structure of the 109-residue amino-terminal domain of PROTEIN bound to a 15-residue transactivation domain peptide of PROTEIN1 revealed that PROTEIN2 has a deep hydrophobic cleft on which the PROTEIN peptide binds as an amphipathic alpha helix.,AIMed.d182.s1548
3732,AIMed.d182,False,The crystal structure of the 109-residue amino-terminal domain of PROTEIN bound to a 15-residue transactivation domain peptide of PROTEIN1 revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN2 peptide binds as an amphipathic alpha helix.,AIMed.d182.s1548
3733,AIMed.d182,False,The crystal structure of the 109-residue amino-terminal domain of PROTEIN1 bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN2 has a deep hydrophobic cleft on which the PROTEIN peptide binds as an amphipathic alpha helix.,AIMed.d182.s1548
3734,AIMed.d182,False,The crystal structure of the 109-residue amino-terminal domain of PROTEIN1 bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN2 peptide binds as an amphipathic alpha helix.,AIMed.d182.s1548
3735,AIMed.d182,True,The crystal structure of the 109-residue amino-terminal domain of PROTEIN bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN1 has a deep hydrophobic cleft on which the PROTEIN2 peptide binds as an amphipathic alpha helix.,AIMed.d182.s1548
3736,AIMed.d182,False,"The interface relies on the steric complementarity between the PROTEIN cleft and the hydrophobic face of the PROTEIN1 alpha helix and, in particular, on a triad of PROTEIN amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN2 cleft.",AIMed.d182.s1549
3737,AIMed.d182,False,"The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the PROTEIN2 alpha helix and, in particular, on a triad of PROTEIN amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN cleft.",AIMed.d182.s1549
3738,AIMed.d182,False,"The interface relies on the steric complementarity between the PROTEIN cleft and the hydrophobic face of the PROTEIN1 alpha helix and, in particular, on a triad of PROTEIN2 amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN cleft.",AIMed.d182.s1549
3739,AIMed.d182,False,"The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the PROTEIN alpha helix and, in particular, on a triad of PROTEIN amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN2 cleft.",AIMed.d182.s1549
3740,AIMed.d182,True,"The interface relies on the steric complementarity between the PROTEIN cleft and the hydrophobic face of the PROTEIN alpha helix and, in particular, on a triad of PROTEIN1 amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN2 cleft.",AIMed.d182.s1549
3741,AIMed.d182,False,"The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the PROTEIN alpha helix and, in particular, on a triad of PROTEIN2 amino acids-Phe19, Trp23, and Leu26-which insert deep into the PROTEIN cleft.",AIMed.d182.s1549
3742,AIMed.d182,False,"These same PROTEIN1 residues are also involved in transactivation, supporting the hypothesis that PROTEIN2 inactivates PROTEIN by concealing its transactivation domain.",AIMed.d182.s1550
3743,AIMed.d182,True,"These same PROTEIN residues are also involved in transactivation, supporting the hypothesis that PROTEIN1 inactivates PROTEIN2 by concealing its transactivation domain.",AIMed.d182.s1550
3744,AIMed.d182,False,"These same PROTEIN1 residues are also involved in transactivation, supporting the hypothesis that PROTEIN inactivates PROTEIN2 by concealing its transactivation domain.",AIMed.d182.s1550
3745,AIMed.d183,False,The cytokine-activated tyrosine kinase PROTEIN1 activates PROTEIN in a PROTEIN2 dependent manner.,AIMed.d183.s1552
3746,AIMed.d183,False,The cytokine-activated tyrosine kinase PROTEIN activates PROTEIN1 in a PROTEIN2 dependent manner.,AIMed.d183.s1552
3747,AIMed.d183,True,The cytokine-activated tyrosine kinase PROTEIN1 activates PROTEIN2 in a PROTEIN dependent manner.,AIMed.d183.s1552
3748,AIMed.d183,False, PROTEIN1 a member of the Janus kinase superfamily was found to interact functionally with PROTEIN a central component of the PROTEIN PROTEIN2 signal transduction pathway.,AIMed.d183.s1553
3749,AIMed.d183,True, PROTEIN1 a member of the Janus kinase superfamily was found to interact functionally with PROTEIN2 a central component of the PROTEIN PROTEIN signal transduction pathway.,AIMed.d183.s1553
3750,AIMed.d183,False, PROTEIN1 a member of the Janus kinase superfamily was found to interact functionally with PROTEIN a central component of the PROTEIN2 PROTEIN signal transduction pathway.,AIMed.d183.s1553
3751,AIMed.d183,False, PROTEIN a member of the Janus kinase superfamily was found to interact functionally with PROTEIN1 a central component of the PROTEIN PROTEIN2 signal transduction pathway.,AIMed.d183.s1553
3752,AIMed.d183,False, PROTEIN a member of the Janus kinase superfamily was found to interact functionally with PROTEIN a central component of the PROTEIN1 PROTEIN2 signal transduction pathway.,AIMed.d183.s1553
3753,AIMed.d183,False, PROTEIN a member of the Janus kinase superfamily was found to interact functionally with PROTEIN1 a central component of the PROTEIN2 PROTEIN signal transduction pathway.,AIMed.d183.s1553
3754,AIMed.d183,False, PROTEIN1 and several other cytokines that are known to activate PROTEIN were also found to stimulate PROTEIN2 activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3755,AIMed.d183,False, PROTEIN1 and several other cytokines that are known to activate PROTEIN were also found to stimulate PROTEIN activity toward PROTEIN2 in mammalian cells.,AIMed.d183.s1554
3756,AIMed.d183,False, PROTEIN1 and several other cytokines that are known to activate PROTEIN were also found to stimulate PROTEIN2 kinase activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3757,AIMed.d183,True, PROTEIN1 and several other cytokines that are known to activate PROTEIN2 were also found to stimulate PROTEIN activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3758,AIMed.d183,False, PROTEIN1 and several other cytokines that are known to activate PROTEIN2 kinase were also found to stimulate PROTEIN activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3759,AIMed.d183,True, PROTEIN and several other cytokines that are known to activate PROTEIN were also found to stimulate PROTEIN1 activity toward PROTEIN2 in mammalian cells.,AIMed.d183.s1554
3760,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN kinase were also found to stimulate PROTEIN1 activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3761,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN1 were also found to stimulate PROTEIN2 activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3762,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN1 kinase were also found to stimulate PROTEIN2 activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3763,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN were also found to stimulate PROTEIN1 kinase activity toward PROTEIN2 in mammalian cells.,AIMed.d183.s1554
3764,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN1 were also found to stimulate PROTEIN activity toward PROTEIN2 in mammalian cells.,AIMed.d183.s1554
3765,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN1 kinase were also found to stimulate PROTEIN activity toward PROTEIN2 in mammalian cells.,AIMed.d183.s1554
3766,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN1 were also found to stimulate PROTEIN2 kinase activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3767,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN1 kinase were also found to stimulate PROTEIN2 kinase activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3768,AIMed.d183,False, PROTEIN and several other cytokines that are known to activate PROTEIN1 kinase were also found to stimulate PROTEIN activity toward PROTEIN in mammalian cells.,AIMed.d183.s1554
3769,AIMed.d183,True,"In the baculovirus coexpression system, PROTEIN1 was activated by PROTEIN2 in the presence of PROTEIN ",AIMed.d183.s1555
3770,AIMed.d183,False,"In the baculovirus coexpression system, PROTEIN1 was activated by PROTEIN in the presence of PROTEIN2 ",AIMed.d183.s1555
3771,AIMed.d183,False,"In the baculovirus coexpression system, PROTEIN was activated by PROTEIN1 in the presence of PROTEIN2 ",AIMed.d183.s1555
3772,AIMed.d183,True,"Under these conditions, a ternary complex of PROTEIN1 PROTEIN2 and PROTEIN was observed.",AIMed.d183.s1556
3773,AIMed.d183,False,"Under these conditions, a ternary complex of PROTEIN PROTEIN1 and PROTEIN2 was observed.",AIMed.d183.s1556
3774,AIMed.d183,False,"Under these conditions, a ternary complex of PROTEIN1 PROTEIN and PROTEIN2 was observed.",AIMed.d183.s1556
3775,AIMed.d183,False,"In contrast, in the absence of PROTEIN coexpression of PROTEIN1 and PROTEIN resulted in an overall decrease in the PROTEIN2 kinase activity.",AIMed.d183.s1557
3776,AIMed.d183,False,"In contrast, in the absence of PROTEIN coexpression of PROTEIN1 and PROTEIN2 resulted in an overall decrease in the PROTEIN kinase activity.",AIMed.d183.s1557
3777,AIMed.d183,False,"In contrast, in the absence of PROTEIN1 coexpression of PROTEIN2 and PROTEIN resulted in an overall decrease in the PROTEIN kinase activity.",AIMed.d183.s1557
3778,AIMed.d183,False,"In contrast, in the absence of PROTEIN coexpression of PROTEIN and PROTEIN1 resulted in an overall decrease in the PROTEIN2 kinase activity.",AIMed.d183.s1557
3779,AIMed.d183,False,"In contrast, in the absence of PROTEIN1 coexpression of PROTEIN and PROTEIN resulted in an overall decrease in the PROTEIN2 kinase activity.",AIMed.d183.s1557
3780,AIMed.d183,False,"In contrast, in the absence of PROTEIN1 coexpression of PROTEIN and PROTEIN2 resulted in an overall decrease in the PROTEIN kinase activity.",AIMed.d183.s1557
3781,AIMed.d183,False,"In addition, PROTEIN1 phosphorylated PROTEIN at sites different from those phosphorylated by PROTEIN2 ",AIMed.d183.s1558
3782,AIMed.d183,True,"In addition, PROTEIN1 phosphorylated PROTEIN2 at sites different from those phosphorylated by PROTEIN ",AIMed.d183.s1558
3783,AIMed.d183,True,"In addition, PROTEIN phosphorylated PROTEIN1 at sites different from those phosphorylated by PROTEIN2 ",AIMed.d183.s1558
3784,AIMed.d183,True,"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of PROTEIN1 coimmunoprecipitated with PROTEIN2 in lysates of cells in which PROTEIN was activated as judged by its state of tyrosine phosphorylation.",AIMed.d183.s1559
3785,AIMed.d183,False,"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of PROTEIN coimmunoprecipitated with PROTEIN1 in lysates of cells in which PROTEIN2 was activated as judged by its state of tyrosine phosphorylation.",AIMed.d183.s1559
3786,AIMed.d183,False,"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of PROTEIN1 coimmunoprecipitated with PROTEIN in lysates of cells in which PROTEIN2 was activated as judged by its state of tyrosine phosphorylation.",AIMed.d183.s1559
3787,AIMed.d183,True,"Taken together, these data suggest that PROTEIN1 and PROTEIN2 cooperate to activate PROTEIN ",AIMed.d183.s1560
3788,AIMed.d183,False,"Taken together, these data suggest that PROTEIN1 and PROTEIN cooperate to activate PROTEIN2 ",AIMed.d183.s1560
3789,AIMed.d183,False,"Taken together, these data suggest that PROTEIN and PROTEIN1 cooperate to activate PROTEIN2 ",AIMed.d183.s1560
3790,AIMed.d184,False, PROTEIN induced interaction of primary HIV-1 PROTEIN1 glycoproteins with the chemokine receptor PROTEIN2 ,AIMed.d184.s1561
3791,AIMed.d184,False, PROTEIN1 induced interaction of primary HIV-1 PROTEIN glycoproteins with the chemokine receptor PROTEIN2 ,AIMed.d184.s1561
3792,AIMed.d184,True, PROTEIN1 induced interaction of primary HIV-1 PROTEIN2 glycoproteins with the chemokine receptor PROTEIN ,AIMed.d184.s1561
3793,AIMed.d184,False,"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, PROTEIN1 and PROTEIN respectively, as well as the primary receptor PROTEIN2 (refs 1-6).",AIMed.d184.s1562
3794,AIMed.d184,False,"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, PROTEIN and PROTEIN1 respectively, as well as the primary receptor PROTEIN2 (refs 1-6).",AIMed.d184.s1562
3795,AIMed.d184,False,"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, PROTEIN1 and PROTEIN2 respectively, as well as the primary receptor PROTEIN (refs 1-6).",AIMed.d184.s1562
3796,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN1 interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN ligands, PROTEIN and PROTEIN2 (refs 7, 8).",AIMed.d184.s1563
3797,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN ligands, PROTEIN1 and PROTEIN2 (refs 7, 8).",AIMed.d184.s1563
3798,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN1 ligands, PROTEIN and PROTEIN2 (refs 7, 8).",AIMed.d184.s1563
3799,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN1 and inhibits the binding of the natural PROTEIN ligands, PROTEIN and PROTEIN2 (refs 7, 8).",AIMed.d184.s1563
3800,AIMed.d184,False,"Here we show that a complex of PROTEIN1 the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN ligands, PROTEIN and PROTEIN2 (refs 7, 8).",AIMed.d184.s1563
3801,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN1 interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN ligands, PROTEIN2 and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3802,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN1 interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN2 ligands, PROTEIN and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3803,AIMed.d184,True,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN1 interacts specifically with PROTEIN2 and inhibits the binding of the natural PROTEIN ligands, PROTEIN and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3804,AIMed.d184,True,"Here we show that a complex of PROTEIN1 the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN2 interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN ligands, PROTEIN and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3805,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN1 ligands, PROTEIN2 and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3806,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN1 and inhibits the binding of the natural PROTEIN ligands, PROTEIN2 and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3807,AIMed.d184,False,"Here we show that a complex of PROTEIN1 the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN ligands, PROTEIN2 and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3808,AIMed.d184,False,"Here we show that a complex of PROTEIN the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN1 and inhibits the binding of the natural PROTEIN2 ligands, PROTEIN and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3809,AIMed.d184,False,"Here we show that a complex of PROTEIN1 the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN and inhibits the binding of the natural PROTEIN2 ligands, PROTEIN and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3810,AIMed.d184,True,"Here we show that a complex of PROTEIN1 the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble PROTEIN interacts specifically with PROTEIN2 and inhibits the binding of the natural PROTEIN ligands, PROTEIN and PROTEIN (refs 7, 8).",AIMed.d184.s1563
3811,AIMed.d184,True,The apparent affinity of the interaction between PROTEIN1 and PROTEIN2 was dramatically lower in the absence of soluble PROTEIN ,AIMed.d184.s1564
3812,AIMed.d184,False,The apparent affinity of the interaction between PROTEIN1 and PROTEIN was dramatically lower in the absence of soluble PROTEIN2 ,AIMed.d184.s1564
3813,AIMed.d184,False,The apparent affinity of the interaction between PROTEIN and PROTEIN1 was dramatically lower in the absence of soluble PROTEIN2 ,AIMed.d184.s1564
3814,AIMed.d184,True,"Additionally, in the absence of PROTEIN an interaction between a two-domain PROTEIN1 fragment and PROTEIN2 was observed.",AIMed.d184.s1565
3815,AIMed.d184,False,"Additionally, in the absence of PROTEIN1 an interaction between a two-domain PROTEIN fragment and PROTEIN2 was observed.",AIMed.d184.s1565
3816,AIMed.d184,False,"Additionally, in the absence of PROTEIN1 an interaction between a two-domain PROTEIN2 fragment and PROTEIN was observed.",AIMed.d184.s1565
3817,AIMed.d184,True,"A PROTEIN1 fragment retaining the PROTEIN binding site and overlapping epitopes was able to interact with PROTEIN2 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.",AIMed.d184.s1566
3818,AIMed.d184,False,"A PROTEIN fragment retaining the PROTEIN1 binding site and overlapping epitopes was able to interact with PROTEIN2 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.",AIMed.d184.s1566
3819,AIMed.d184,True,"A PROTEIN1 fragment retaining the PROTEIN2 binding site and overlapping epitopes was able to interact with PROTEIN only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.",AIMed.d184.s1566
3820,AIMed.d184,False,Neutralizing antibodies directed against either PROTEIN1 induced or V3 epitopes on PROTEIN2 blocked the interaction of PROTEIN PROTEIN complexes with PROTEIN ,AIMed.d184.s1567
3821,AIMed.d184,False,Neutralizing antibodies directed against either PROTEIN1 induced or V3 epitopes on PROTEIN blocked the interaction of PROTEIN PROTEIN2 complexes with PROTEIN ,AIMed.d184.s1567
3822,AIMed.d184,False,Neutralizing antibodies directed against either PROTEIN1 induced or V3 epitopes on PROTEIN blocked the interaction of PROTEIN PROTEIN complexes with PROTEIN2 ,AIMed.d184.s1567
3823,AIMed.d184,False,Neutralizing antibodies directed against either PROTEIN1 induced or V3 epitopes on PROTEIN blocked the interaction of PROTEIN2 PROTEIN complexes with PROTEIN ,AIMed.d184.s1567
3824,AIMed.d184,False,Neutralizing antibodies directed against either PROTEIN induced or V3 epitopes on PROTEIN1 blocked the interaction of PROTEIN PROTEIN2 complexes with PROTEIN ,AIMed.d184.s1567
3825,AIMed.d184,False,Neutralizing antibodies directed against either PROTEIN induced or V3 epitopes on PROTEIN1 blocked the interaction of PROTEIN PROTEIN complexes with PROTEIN2 ,AIMed.d184.s1567
3826,AIMed.d184,False,Neutralizing antibodies directed against either PROTEIN induced or V3 epitopes on PROTEIN1 blocked the interaction of PROTEIN2 PROTEIN complexes with PROTEIN ,AIMed.d184.s1567
3827,AIMed.d184,True,Neutralizing antibodies directed against either PROTEIN induced or V3 epitopes on PROTEIN blocked the interaction of PROTEIN PROTEIN1 complexes with PROTEIN2 ,AIMed.d184.s1567
3828,AIMed.d184,True,Neutralizing antibodies directed against either PROTEIN induced or V3 epitopes on PROTEIN blocked the interaction of PROTEIN1 PROTEIN2 complexes with PROTEIN ,AIMed.d184.s1567
3829,AIMed.d184,True,Neutralizing antibodies directed against either PROTEIN induced or V3 epitopes on PROTEIN blocked the interaction of PROTEIN1 PROTEIN complexes with PROTEIN2 ,AIMed.d184.s1567
3830,AIMed.d184,False,These results suggest that HIV-1 attachment to PROTEIN1 creates a high-affinity binding site for PROTEIN2 leading to membrane fusion and virus entry.,AIMed.d184.s1568
3831,AIMed.d185,False," PROTEIN1 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the PROTEIN2 receptor intracellular domain.",AIMed.d185.s1569
3832,AIMed.d185,True," PROTEIN1 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the PROTEIN2 intracellular domain.",AIMed.d185.s1569
3833,AIMed.d185,False," PROTEIN recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the PROTEIN1 receptor intracellular domain.",AIMed.d185.s1569
3834,AIMed.d185,False,"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the PROTEIN1 ( PROTEIN2 receptor, the STAT proteins activated by PROTEIN in different cell populations were first defined using electrophoretic mobility shift assays.",AIMed.d185.s1571
3835,AIMed.d185,False,"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the PROTEIN1 ( PROTEIN receptor, the STAT proteins activated by PROTEIN2 in different cell populations were first defined using electrophoretic mobility shift assays.",AIMed.d185.s1571
3836,AIMed.d185,False,To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment t PROTEIN PROTEIN1 the STAT proteins activated by PROTEIN in different cell populations were first defined using electrophoretic mobility shift assays.,AIMed.d185.s1571
3837,AIMed.d185,False,To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment PROTEIN1 PROTEIN the STAT proteins activated by PROTEIN2 in different cell populations were first defined using electrophoretic mobility shift assays.,AIMed.d185.s1571
3838,AIMed.d185,False,To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment t PROTEIN2 PROTEIN1 the STAT proteins activated by PROTEIN in different cell populations were first defined using electrophoretic mobility shift assays.,AIMed.d185.s1571
3839,AIMed.d185,False,To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment t PROTEIN PROTEIN1 the STAT proteins activated by PROTEIN2 in different cell populations were first defined using electrophoretic mobility shift assays.,AIMed.d185.s1571
3840,AIMed.d185,False,"In all cells tested, PROTEIN activated PROTEIN1 and PROTEIN2 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.",AIMed.d185.s1572
3841,AIMed.d185,True,"In all cells tested, PROTEIN1 activated PROTEIN2 and PROTEIN and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.",AIMed.d185.s1572
3842,AIMed.d185,True,"In all cells tested, PROTEIN1 activated PROTEIN and PROTEIN2 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.",AIMed.d185.s1572
3843,AIMed.d185,False, PROTEIN1 also activated PROTEIN in Ba/F3 cells that stably expressed the murine PROTEIN2 receptor.,AIMed.d185.s1573
3844,AIMed.d185,False, PROTEIN also activated PROTEIN1 in Ba/F3 cells that stably expressed the murine PROTEIN2 receptor.,AIMed.d185.s1573
3845,AIMed.d185,False, PROTEIN also activated PROTEIN in Ba/F3 cells that stably expressed the murine PROTEIN1 ,AIMed.d185.s1573
3846,AIMed.d185,True, PROTEIN1 also activated PROTEIN2 in Ba/F3 cells that stably expressed the murine PROTEIN ,AIMed.d185.s1573
3847,AIMed.d185,False, PROTEIN1 also activated PROTEIN in Ba/F3 cells that stably expressed the murine PROTEIN2 ,AIMed.d185.s1573
3848,AIMed.d185,False, PROTEIN also activated PROTEIN1 in Ba/F3 cells that stably expressed the murine PROTEIN2 ,AIMed.d185.s1573
3849,AIMed.d185,False,"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1 receptor were found to be redundantly required for receptor function and for activation of PROTEIN but not for PROTEIN or Stat5.",AIMed.d185.s1574
3850,AIMed.d185,False,"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1 were found to be redundantly required for receptor function and for activation of PROTEIN but not for PROTEIN2 or Stat5.",AIMed.d185.s1574
3851,AIMed.d185,True,"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1 were found to be redundantly required for receptor function and for activation of PROTEIN2 but not for PROTEIN or Stat5.",AIMed.d185.s1574
3852,AIMed.d185,False,"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1 receptor were found to be redundantly required for receptor function and for activation of PROTEIN but not for PROTEIN2 or Stat5.",AIMed.d185.s1574
3853,AIMed.d185,False,"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN1 receptor were found to be redundantly required for receptor function and for activation of PROTEIN2 but not for PROTEIN or Stat5.",AIMed.d185.s1574
3854,AIMed.d185,False,"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine PROTEIN receptor were found to be redundantly required for receptor function and for activation of PROTEIN1 but not for PROTEIN2 or Stat5.",AIMed.d185.s1574
3855,AIMed.d185,False,Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN1 and blocked PROTEIN2 induced PROTEIN phosphorylation in a cell-free system.,AIMed.d185.s1575
3856,AIMed.d185,False,Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN1 but not PROTEIN2 and blocked PROTEIN induced PROTEIN phosphorylation in a cell-free system.,AIMed.d185.s1575
3857,AIMed.d185,False,Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN1 and blocked PROTEIN induced PROTEIN2 phosphorylation in a cell-free system.,AIMed.d185.s1575
3858,AIMed.d185,False,Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN1 but not PROTEIN and blocked PROTEIN2 induced PROTEIN phosphorylation in a cell-free system.,AIMed.d185.s1575
3859,AIMed.d185,False,Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN and blocked PROTEIN1 induced PROTEIN2 phosphorylation in a cell-free system.,AIMed.d185.s1575
3860,AIMed.d185,False,Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN1 but not PROTEIN and blocked PROTEIN induced PROTEIN2 phosphorylation in a cell-free system.,AIMed.d185.s1575
3861,AIMed.d185,False,"In contrast, tyrosine-phosphorylated peptides containing Tyr374 or Tyr396 did not interact with PROTEIN1 or block PROTEIN2 activation.",AIMed.d185.s1576
3862,AIMed.d185,False,These data demonstrate that PROTEIN but not PROTEIN1 or PROTEIN is directly recruited to the ligand-activated PROTEIN2 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3863,AIMed.d185,False,These data demonstrate that PROTEIN but not PROTEIN1 or PROTEIN2 is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3864,AIMed.d185,False,These data demonstrate that PROTEIN1 but not PROTEIN2 or PROTEIN is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3865,AIMed.d185,False,These data demonstrate that PROTEIN but not PROTEIN1 or PROTEIN is directly recruited to the ligand-activated PROTEIN2 by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3866,AIMed.d185,False,These data demonstrate that PROTEIN but not PROTEIN or PROTEIN1 is directly recruited to the ligand-activated PROTEIN2 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3867,AIMed.d185,False,These data demonstrate that PROTEIN1 but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN2 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3868,AIMed.d185,False,These data demonstrate that PROTEIN but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN1 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3869,AIMed.d185,False,These data demonstrate that PROTEIN1 but not PROTEIN or PROTEIN2 is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3870,AIMed.d185,False,These data demonstrate that PROTEIN but not PROTEIN or PROTEIN1 is directly recruited to the ligand-activated PROTEIN2 by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3871,AIMed.d185,True,These data demonstrate that PROTEIN1 but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN2 by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.,AIMed.d185.s1577
3872,AIMed.d187,True,Interaction of PROTEIN1 with PROTEIN2 binding and inhibition of amyloid formation.,AIMed.d187.s1585
3873,AIMed.d187,False,Aggregated PROTEIN1 ( PROTEIN2 is a key component of the amyloid depositions found in the brains of patients with Alzheimer's disease.,AIMed.d187.s1586
3874,AIMed.d187,False,The analysis of complexes of PROTEIN1 with CSF proteins in a KBr gradient revealed an association of PROTEIN2 only with free proteins and not with lipoprotein particles.,AIMed.d187.s1588
3875,AIMed.d187,False," PROTEIN ( PROTEIN1 , a second major CSF protein, formed SDS-stable complexes with PROTEIN and significantly decreased the rate of PROTEIN2 fibril formation.",AIMed.d187.s1589
3876,AIMed.d187,False," PROTEIN1 ( PROTEIN2 , a second major CSF protein, formed SDS-stable complexes with PROTEIN and significantly decreased the rate of PROTEIN fibril formation.",AIMed.d187.s1589
3877,AIMed.d187,True," PROTEIN ( PROTEIN1 , a second major CSF protein, formed SDS-stable complexes with PROTEIN2 and significantly decreased the rate of PROTEIN fibril formation.",AIMed.d187.s1589
3878,AIMed.d187,False," PROTEIN1 ( PROTEIN , a second major CSF protein, formed SDS-stable complexes with PROTEIN and significantly decreased the rate of PROTEIN2 fibril formation.",AIMed.d187.s1589
3879,AIMed.d187,False," PROTEIN ( PROTEIN , a second major CSF protein, formed SDS-stable complexes with PROTEIN1 and significantly decreased the rate of PROTEIN2 fibril formation.",AIMed.d187.s1589
3880,AIMed.d187,True," PROTEIN1 ( PROTEIN , a second major CSF protein, formed SDS-stable complexes with PROTEIN2 and significantly decreased the rate of PROTEIN fibril formation.",AIMed.d187.s1589
3881,AIMed.d187,False,"In physiological buffers and CSF, PROTEIN1 exclusively decreased the level of PROTEIN2 pentamers.",AIMed.d187.s1590
3882,AIMed.d187,True,Endogenous PROTEIN1 PROTEIN2 complexes were detected in human CSF by immunoprecipitation.,AIMed.d187.s1591
3883,AIMed.d187,True,"Using site-directed mutagenesis and computer-assisted modelling, we identified amino acid residues on the surface of the PROTEIN1 monomer that interact with PROTEIN2 ",AIMed.d187.s1592
3884,AIMed.d187,False,We propose that PROTEIN1 binding proteins play a key role in the modulation of PROTEIN2 aggregation and normally prevent amyloid formation in biological fluids and in the brain.,AIMed.d187.s1594
3885,AIMed.d190,True,Discrete protein interactions with the PROTEIN1 PROTEIN2 complex in PROTEIN and PROTEIN mediated myeloid cell proliferation.,AIMed.d190.s1610
3886,AIMed.d190,False,Discrete protein interactions with the PROTEIN1 PROTEIN complex in PROTEIN and PROTEIN2 mediated myeloid cell proliferation.,AIMed.d190.s1610
3887,AIMed.d190,False,Discrete protein interactions with the PROTEIN1 PROTEIN complex in PROTEIN2 and PROTEIN mediated myeloid cell proliferation.,AIMed.d190.s1610
3888,AIMed.d190,False,Discrete protein interactions with the PROTEIN PROTEIN1 complex in PROTEIN and PROTEIN2 mediated myeloid cell proliferation.,AIMed.d190.s1610
3889,AIMed.d190,False,Discrete protein interactions with the PROTEIN PROTEIN1 complex in PROTEIN2 and PROTEIN mediated myeloid cell proliferation.,AIMed.d190.s1610
3890,AIMed.d190,False,Discrete protein interactions with the PROTEIN PROTEIN complex in PROTEIN1 and PROTEIN2 mediated myeloid cell proliferation.,AIMed.d190.s1610
3891,AIMed.d190,False,Hemopoietic cell proliferation is mediated by non-tyrosine and tyrosine kinases that signal via uncommon and common sets of downstream effector molecules including the PROTEIN1 PROTEIN2 ,AIMed.d190.s1611
3892,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the PROTEIN2 PROTEIN complex with signaling proteins upon activation of non-tyrosine ( PROTEIN and tyrosine kinase ( PROTEIN receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3893,AIMed.d190,True,In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN1 PROTEIN2 complex with signaling proteins upon activation of non-tyrosine ( PROTEIN and tyrosine kinase ( PROTEIN receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3894,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN1 PROTEIN complex with signaling proteins upon activation of non-tyrosine ( PROTEIN and tyrosine kinase ( PROTEIN2 receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3895,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN1 PROTEIN complex with signaling proteins upon activation of non-tyrosine ( PROTEIN2 and tyrosine kinase ( PROTEIN receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3896,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the PROTEIN PROTEIN2 complex with signaling proteins upon activation of non-tyrosine ( PROTEIN and tyrosine kinase ( PROTEIN receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3897,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the PROTEIN PROTEIN complex with signaling proteins upon activation of non-tyrosine ( PROTEIN and tyrosine kinase ( PROTEIN2 receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3898,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN1 and the interaction of the PROTEIN PROTEIN complex with signaling proteins upon activation of non-tyrosine ( PROTEIN2 and tyrosine kinase ( PROTEIN receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3899,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN PROTEIN1 complex with signaling proteins upon activation of non-tyrosine ( PROTEIN and tyrosine kinase ( PROTEIN2 receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3900,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN PROTEIN1 complex with signaling proteins upon activation of non-tyrosine ( PROTEIN2 and tyrosine kinase ( PROTEIN receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3901,AIMed.d190,False,In the present study we evaluated tyrosine phosphorylation of PROTEIN and the interaction of the PROTEIN PROTEIN complex with signaling proteins upon activation of non-tyrosine ( PROTEIN1 and tyrosine kinase ( PROTEIN2 receptors leading to myeloid cell proliferation.,AIMed.d190.s1612
3902,AIMed.d190,False,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN and PROTEIN1 ligands, namely: PROTEIN and PROTEIN2 induce PROTEIN tyrosine phosphorylation.",AIMed.d190.s1613
3903,AIMed.d190,False,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN and PROTEIN1 ligands, namely: PROTEIN and PROTEIN induce PROTEIN2 tyrosine phosphorylation.",AIMed.d190.s1613
3904,AIMed.d190,False,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN1 and PROTEIN2 ligands, namely: PROTEIN and PROTEIN induce PROTEIN tyrosine phosphorylation.",AIMed.d190.s1613
3905,AIMed.d190,False,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN and PROTEIN1 ligands, namely: PROTEIN2 and PROTEIN induce PROTEIN tyrosine phosphorylation.",AIMed.d190.s1613
3906,AIMed.d190,True,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN and PROTEIN ligands, namely: PROTEIN and PROTEIN1 induce PROTEIN2 tyrosine phosphorylation.",AIMed.d190.s1613
3907,AIMed.d190,False,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN1 and PROTEIN ligands, namely: PROTEIN and PROTEIN2 induce PROTEIN tyrosine phosphorylation.",AIMed.d190.s1613
3908,AIMed.d190,False,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN and PROTEIN ligands, namely: PROTEIN1 and PROTEIN2 induce PROTEIN tyrosine phosphorylation.",AIMed.d190.s1613
3909,AIMed.d190,False,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN1 and PROTEIN ligands, namely: PROTEIN and PROTEIN induce PROTEIN2 tyrosine phosphorylation.",AIMed.d190.s1613
3910,AIMed.d190,True,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN and PROTEIN ligands, namely: PROTEIN1 and PROTEIN induce PROTEIN2 tyrosine phosphorylation.",AIMed.d190.s1613
3911,AIMed.d190,False,"By using the growth factor dependent M-07e cell line, we found that both PROTEIN1 and PROTEIN ligands, namely: PROTEIN2 and PROTEIN induce PROTEIN tyrosine phosphorylation.",AIMed.d190.s1613
3912,AIMed.d190,True,In these cells the adaptor protein PROTEIN1 constitutively binds a substantial fraction of PROTEIN2 through the N-terminal SH3 domain.,AIMed.d190.s1614
3913,AIMed.d190,False,"In vitro experiments showed that the stable PROTEIN PROTEIN1 complex interacts, through the PROTEIN2 SH2 domain, with the PROTEIN activated PROTEIN ",AIMed.d190.s1615
3914,AIMed.d190,False,"In vitro experiments showed that the stable PROTEIN PROTEIN1 complex interacts, through the PROTEIN SH2 domain, with the PROTEIN activated PROTEIN2 ",AIMed.d190.s1615
3915,AIMed.d190,True,"In vitro experiments showed that the stable PROTEIN1 PROTEIN2 complex interacts, through the PROTEIN SH2 domain, with the PROTEIN activated PROTEIN ",AIMed.d190.s1615
3916,AIMed.d190,False,"In vitro experiments showed that the stable PROTEIN PROTEIN1 complex interacts, through the PROTEIN SH2 domain, with the PROTEIN2 activated PROTEIN ",AIMed.d190.s1615
3917,AIMed.d190,True,"In vitro experiments showed that the stable PROTEIN PROTEIN complex interacts, through the PROTEIN1 SH2 domain, with the PROTEIN activated PROTEIN2 ",AIMed.d190.s1615
3918,AIMed.d190,False,"In vitro experiments showed that the stable PROTEIN1 PROTEIN complex interacts, through the PROTEIN2 SH2 domain, with the PROTEIN activated PROTEIN ",AIMed.d190.s1615
3919,AIMed.d190,False,"In vitro experiments showed that the stable PROTEIN PROTEIN complex interacts, through the PROTEIN1 SH2 domain, with the PROTEIN2 activated PROTEIN ",AIMed.d190.s1615
3920,AIMed.d190,False,"In vitro experiments showed that the stable PROTEIN1 PROTEIN complex interacts, through the PROTEIN SH2 domain, with the PROTEIN activated PROTEIN2 ",AIMed.d190.s1615
3921,AIMed.d190,True,"In vitro experiments showed that the stable PROTEIN PROTEIN complex interacts, through the PROTEIN SH2 domain, with the PROTEIN1 activated PROTEIN2 ",AIMed.d190.s1615
3922,AIMed.d190,False,"In vitro experiments showed that the stable PROTEIN1 PROTEIN complex interacts, through the PROTEIN SH2 domain, with the PROTEIN2 activated PROTEIN ",AIMed.d190.s1615
3923,AIMed.d190,False,By contrast stimulation with PROTEIN1 leads to the formation of a PROTEIN2 complex containing PROTEIN ,AIMed.d190.s1616
3924,AIMed.d190,False,By contrast stimulation with PROTEIN1 leads to the formation of a PROTEIN complex containing PROTEIN2 ,AIMed.d190.s1616
3925,AIMed.d190,True,By contrast stimulation with PROTEIN leads to the formation of a PROTEIN1 complex containing PROTEIN2 ,AIMed.d190.s1616
3926,AIMed.d190,False,In vitro and in vivo experiments support the hypothesis that PROTEIN1 mediates the association of PROTEIN with PROTEIN2 ,AIMed.d190.s1617
3927,AIMed.d190,True,In vitro and in vivo experiments support the hypothesis that PROTEIN mediates the association of PROTEIN1 with PROTEIN2 ,AIMed.d190.s1617
3928,AIMed.d190,False,In vitro and in vivo experiments support the hypothesis that PROTEIN1 mediates the association of PROTEIN2 with PROTEIN ,AIMed.d190.s1617
3929,AIMed.d190,False,"Moreover we found that, upon PROTEIN stimulation, the PROTEIN PROTEIN1 complex recruits PROTEIN probably via PROTEIN2 ",AIMed.d190.s1618
3930,AIMed.d190,False,"Moreover we found that, upon PROTEIN1 stimulation, the PROTEIN PROTEIN2 complex recruits PROTEIN probably via PROTEIN ",AIMed.d190.s1618
3931,AIMed.d190,True,"Moreover we found that, upon PROTEIN stimulation, the PROTEIN1 PROTEIN2 complex recruits PROTEIN probably via PROTEIN ",AIMed.d190.s1618
3932,AIMed.d190,False,"Moreover we found that, upon PROTEIN stimulation, the PROTEIN PROTEIN1 complex recruits PROTEIN2 probably via PROTEIN ",AIMed.d190.s1618
3933,AIMed.d190,False,"Moreover we found that, upon PROTEIN1 stimulation, the PROTEIN PROTEIN complex recruits PROTEIN probably via PROTEIN2 ",AIMed.d190.s1618
3934,AIMed.d190,False,"Moreover we found that, upon PROTEIN stimulation, the PROTEIN1 PROTEIN complex recruits PROTEIN probably via PROTEIN2 ",AIMed.d190.s1618
3935,AIMed.d190,True,"Moreover we found that, upon PROTEIN stimulation, the PROTEIN PROTEIN complex recruits PROTEIN1 probably via PROTEIN2 ",AIMed.d190.s1618
3936,AIMed.d190,False,"Moreover we found that, upon PROTEIN1 stimulation, the PROTEIN2 PROTEIN complex recruits PROTEIN probably via PROTEIN ",AIMed.d190.s1618
3937,AIMed.d190,False,"Moreover we found that, upon PROTEIN1 stimulation, the PROTEIN PROTEIN complex recruits PROTEIN2 probably via PROTEIN ",AIMed.d190.s1618
3938,AIMed.d190,False,"Moreover we found that, upon PROTEIN stimulation, the PROTEIN1 PROTEIN complex recruits PROTEIN2 probably via PROTEIN ",AIMed.d190.s1618
3939,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN1 PROTEIN2 are present in different complexes.,AIMed.d190.s1619
3940,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN1 PROTEIN and PROTEIN PROTEIN2 are present in different complexes.,AIMed.d190.s1619
3941,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN1 was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN PROTEIN2 are present in different complexes.,AIMed.d190.s1619
3942,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN1 immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN PROTEIN2 are present in different complexes.,AIMed.d190.s1619
3943,AIMed.d190,False,By contrast the PROTEIN1 exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN PROTEIN2 are present in different complexes.,AIMed.d190.s1619
3944,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN1 and PROTEIN PROTEIN2 are present in different complexes.,AIMed.d190.s1619
3945,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN1 PROTEIN and PROTEIN2 PROTEIN are present in different complexes.,AIMed.d190.s1619
3946,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN1 was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN2 PROTEIN are present in different complexes.,AIMed.d190.s1619
3947,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN1 immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN2 PROTEIN are present in different complexes.,AIMed.d190.s1619
3948,AIMed.d190,False,By contrast the PROTEIN1 exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN2 PROTEIN are present in different complexes.,AIMed.d190.s1619
3949,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN1 and PROTEIN2 PROTEIN are present in different complexes.,AIMed.d190.s1619
3950,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN1 was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN2 PROTEIN and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3951,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN1 immunoprecipitates suggesting that PROTEIN2 PROTEIN and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3952,AIMed.d190,False,By contrast the PROTEIN1 exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN2 PROTEIN and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3953,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN1 PROTEIN2 and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3954,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN1 was not detected in anti- PROTEIN2 immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3955,AIMed.d190,True,By contrast the PROTEIN1 exchanger factor ( PROTEIN2 was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3956,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN1 was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN2 and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3957,AIMed.d190,False,By contrast the PROTEIN1 exchanger factor ( PROTEIN was not detected in anti- PROTEIN2 immunoprecipitates suggesting that PROTEIN PROTEIN and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3958,AIMed.d190,False,By contrast the PROTEIN exchanger factor ( PROTEIN was not detected in anti- PROTEIN1 immunoprecipitates suggesting that PROTEIN PROTEIN2 and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3959,AIMed.d190,False,By contrast the PROTEIN1 exchanger factor ( PROTEIN was not detected in anti- PROTEIN immunoprecipitates suggesting that PROTEIN PROTEIN2 and PROTEIN PROTEIN are present in different complexes.,AIMed.d190.s1619
3960,AIMed.d190,False,Taken together our results demonstrate that PROTEIN1 plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with PROTEIN2 PROTEIN complex when non-tyrosine or tyrosine kinase receptors are activated.,AIMed.d190.s1620
3961,AIMed.d190,True,Taken together our results demonstrate that PROTEIN plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with PROTEIN1 PROTEIN2 complex when non-tyrosine or tyrosine kinase receptors are activated.,AIMed.d190.s1620
3962,AIMed.d190,False,Taken together our results demonstrate that PROTEIN1 plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with PROTEIN PROTEIN2 complex when non-tyrosine or tyrosine kinase receptors are activated.,AIMed.d190.s1620
3963,AIMed.d192,False,Activation of PROTEIN1 mediated by PROTEIN converting enzyme.,AIMed.d192.s1635
3964,AIMed.d192,True,Activation of PROTEIN1 mediated by PROTEIN2 ,AIMed.d192.s1635
3965,AIMed.d192,False,Activation of PROTEIN1 mediated by PROTEIN2 converting enzyme.,AIMed.d192.s1635
3966,AIMed.d192,False,Activation of PROTEIN1 inducing factor mediated by PROTEIN2 ,AIMed.d192.s1635
3967,AIMed.d192,False,Activation of PROTEIN1 inducing factor mediated by PROTEIN2 converting enzyme.,AIMed.d192.s1635
3968,AIMed.d192,False,Activation of PROTEIN mediated by PROTEIN1 ,AIMed.d192.s1635
3969,AIMed.d192,False,The PROTEIN ( PROTEIN converting enzyme ( PROTEIN1 processes the inactive PROTEIN2 precursor to the proinflammatory cytokine.,AIMed.d192.s1636
3970,AIMed.d192,False,The PROTEIN ( PROTEIN1 converting enzyme ( PROTEIN processes the inactive PROTEIN2 precursor to the proinflammatory cytokine.,AIMed.d192.s1636
3971,AIMed.d192,False,The PROTEIN1 ( PROTEIN converting enzyme ( PROTEIN processes the inactive PROTEIN2 precursor to the proinflammatory cytokine.,AIMed.d192.s1636
3972,AIMed.d192,False,The PROTEIN1 ( PROTEIN processes the inactive PROTEIN2 precursor to the proinflamma PROTEIN kine.,AIMed.d192.s1636
3973,AIMed.d192,True,The PROTEIN ( PROTEIN1 converting enzyme ( PROTEIN2 processes the inactive PROTEIN precursor to the proinflammatory cytokine.,AIMed.d192.s1636
3974,AIMed.d192,True,The PROTEIN1 ( PROTEIN converting enzyme ( PROTEIN2 processes the inactive PROTEIN precursor to the proinflammatory cytokine.,AIMed.d192.s1636
3975,AIMed.d192,False,The PROTEIN1 ( PROTEIN2 processes the inactive PROTEIN precursor to the proinflamma PROTEIN kine.,AIMed.d192.s1636
3976,AIMed.d192,False,The PROTEIN1 ( PROTEIN2 converting enzyme ( PROTEIN processes the inactive PROTEIN precursor to the proinflammatory cytokine.,AIMed.d192.s1636
3977,AIMed.d192,False,The PROTEIN1 (I PROTEIN processes the inactive I PROTEIN recursor to the proinflamma PROTEIN2 kine.,AIMed.d192.s1636
3978,AIMed.d192,False,The PROTEIN1 ( PROTEIN converting enzyme ( PROTEIN processes the inactive PROTEIN precursor to the proinflammatory cytokine.,AIMed.d192.s1636
3979,AIMed.d192,False," PROTEIN was also shown to cleave the precursor of PROTEIN1 inducing factor ( PROTEIN2 at the authentic processing site with high efficiency, thereby activating PROTEIN and facilitating its export.",AIMed.d192.s1637
3980,AIMed.d192,True," PROTEIN1 was also shown to cleave the precursor of PROTEIN ( PROTEIN2 at the authentic processing site with high efficiency, thereby activating PROTEIN and facilitating its export.",AIMed.d192.s1637
3981,AIMed.d192,False," PROTEIN was also shown to cleave the precursor of PROTEIN ( PROTEIN1 at the authentic processing site with high efficiency, thereby activating PROTEIN2 and facilitating its export.",AIMed.d192.s1637
3982,AIMed.d192,False," PROTEIN was also shown to cleave the precursor of PROTEIN1 ( PROTEIN2 at the authentic processing site with high efficiency, thereby activating PROTEIN and facilitating its export.",AIMed.d192.s1637
3983,AIMed.d192,False," PROTEIN1 was also shown to cleave the precursor of PROTEIN2 inducing factor ( PROTEIN at the authentic processing site with high efficiency, thereby activating PROTEIN and facilitating its export.",AIMed.d192.s1637
3984,AIMed.d192,False," PROTEIN was also shown to cleave the precursor of PROTEIN1 inducing factor ( PROTEIN at the authentic processing site with high efficiency, thereby activating PROTEIN2 and facilitating its export.",AIMed.d192.s1637
3985,AIMed.d192,False," PROTEIN was also shown to cleave the precursor of PROTEIN1 ( PROTEIN at the authentic processing site with high efficiency, thereby activating PROTEIN and facilitating its export.",AIMed.d192.s1637
3986,AIMed.d192,True," PROTEIN1 was also shown to cleave the precursor of PROTEIN ( PROTEIN at the authentic processing site with high efficiency, thereby activating PROTEIN2 and facilitating its export.",AIMed.d192.s1637
3987,AIMed.d192,True," PROTEIN1 was also shown to cleave the precursor of PROTEIN2 ( PROTEIN at the authentic processing site with high efficiency, thereby activating PROTEIN and facilitating its export.",AIMed.d192.s1637
3988,AIMed.d192,False," PROTEIN was also shown to cleave the precursor of PROTEIN1 ( PROTEIN at the authentic processing site with high efficiency, thereby activating PROTEIN2 and facilitating its export.",AIMed.d192.s1637
3989,AIMed.d192,False,Lipopolysaccharide-activated PROTEIN1 deficient (ICE-/-) Kupffer cells synthesized the PROTEIN2 precursor but failed to process it into the active form.,AIMed.d192.s1638
3990,AIMed.d192,False, PROTEIN1 and PROTEIN2 were diminished in the sera of PROTEIN /- mice exposed to Propionibacterium acnes and lipopolysaccharide.,AIMed.d192.s1639
3991,AIMed.d192,False, PROTEIN1 and PROTEIN were diminished in the sera of PROTEIN2 /- mice exposed to Propionibacterium acnes and lipopolysaccharide.,AIMed.d192.s1639
3992,AIMed.d192,False, PROTEIN and PROTEIN1 were diminished in the sera of PROTEIN2 /- mice exposed to Propionibacterium acnes and lipopolysaccharide.,AIMed.d192.s1639
3993,AIMed.d193,True,Physical and functional interactions between the transcriptional inhibitors PROTEIN1 and PROTEIN2 Evidence toward a novel mechanism regulating muscle-specific gene expression.,AIMed.d193.s1641
3994,AIMed.d193,False,"We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor, PROTEIN2 that interacts with the transcriptional inhibitor PROTEIN PROTEIN ",AIMed.d193.s1642
3995,AIMed.d193,False,"We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor, PROTEIN that interacts with the transcriptional inhibitor PROTEIN2 PROTEIN ",AIMed.d193.s1642
3996,AIMed.d193,False,"We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor, PROTEIN that interacts with the transcriptional inhibitor PROTEIN PROTEIN2 ",AIMed.d193.s1642
3997,AIMed.d193,True,"We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN transcription factor, PROTEIN1 that interacts with the transcriptional inhibitor PROTEIN2 PROTEIN ",AIMed.d193.s1642
3998,AIMed.d193,True,"We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN transcription factor, PROTEIN1 that interacts with the transcriptional inhibitor PROTEIN PROTEIN2 ",AIMed.d193.s1642
3999,AIMed.d193,False,"We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN transcription factor, PROTEIN that interacts with the transcriptional inhibitor PROTEIN1 PROTEIN2 ",AIMed.d193.s1642
4000,AIMed.d193,False,"As expected, overexpression of either PROTEIN PROTEIN or PROTEIN1 effectively inhibited the activation of the muscle-specific PROTEIN2 promoter by the myogenic transcription factor PROTEIN ",AIMed.d193.s1644
4001,AIMed.d193,False,"As expected, overexpression of either PROTEIN PROTEIN or PROTEIN1 effectively inhibited the activation of the muscle-specific PROTEIN promoter by the myogenic transcription factor PROTEIN2 ",AIMed.d193.s1644
4002,AIMed.d193,False,"As expected, overexpression of either PROTEIN1 PROTEIN or PROTEIN2 effectively inhibited the activation of the muscle-specific PROTEIN promoter by the myogenic transcription factor PROTEIN ",AIMed.d193.s1644
4003,AIMed.d193,False,"As expected, overexpression of either PROTEIN PROTEIN1 or PROTEIN2 effectively inhibited the activation of the muscle-specific PROTEIN promoter by the myogenic transcription factor PROTEIN ",AIMed.d193.s1644
4004,AIMed.d193,False,"As expected, overexpression of either PROTEIN PROTEIN or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN1 promoter by the myogenic transcription factor PROTEIN2 ",AIMed.d193.s1644
4005,AIMed.d193,False,"As expected, overexpression of either PROTEIN1 PROTEIN or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN2 promoter by the myogenic transcription factor PROTEIN ",AIMed.d193.s1644
4006,AIMed.d193,False,"As expected, overexpression of either PROTEIN PROTEIN1 or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN2 promoter by the myogenic transcription factor PROTEIN ",AIMed.d193.s1644
4007,AIMed.d193,False,"As expected, overexpression of either PROTEIN1 PROTEIN or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN promoter by the myogenic transcription factor PROTEIN2 ",AIMed.d193.s1644
4008,AIMed.d193,False,"As expected, overexpression of either PROTEIN PROTEIN1 or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN promoter by the myogenic transcription factor PROTEIN2 ",AIMed.d193.s1644
4009,AIMed.d193,False,"As expected, overexpression of either PROTEIN1 PROTEIN2 or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN promoter by the myogenic transcription factor PROTEIN ",AIMed.d193.s1644
4010,AIMed.d193,False,"Moreover, while PROTEIN1 inhibited the PROTEIN2 promoter, it acted as a weak transactivator on an artificial promoter consisting of three tandem copies of the consensus myogenic factor DNA binding site.",AIMed.d193.s1646
4011,AIMed.d193,False,"Further investigation indicated that the PROTEIN1 PROTEIN heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN PROTEIN2 ",AIMed.d193.s1647
4012,AIMed.d193,False,"Further investigation indicated that the PROTEIN PROTEIN1 heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN PROTEIN2 ",AIMed.d193.s1647
4013,AIMed.d193,False,"Further investigation indicated that the PROTEIN PROTEIN heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN1 PROTEIN2 ",AIMed.d193.s1647
4014,AIMed.d193,True,"Further investigation indicated that the PROTEIN1 PROTEIN2 heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN PROTEIN ",AIMed.d193.s1647
4015,AIMed.d193,False,"Further investigation indicated that the PROTEIN1 PROTEIN heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN2 PROTEIN ",AIMed.d193.s1647
4016,AIMed.d193,False,"Further investigation indicated that the PROTEIN PROTEIN1 heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by PROTEIN2 PROTEIN ",AIMed.d193.s1647
4017,AIMed.d193,False,"Additional analysis revealed the presence of transcripts for both the activating ( PROTEIN1 and inhibitory ( PROTEIN2 isoforms in differentiating C2C12 cultures, suggesting that both isoforms might participate in regulating the differentiation process.",AIMed.d193.s1648
4018,AIMed.d195,True,Competitive binding of PROTEIN1 and PROTEIN to the PROTEIN2 ,AIMed.d195.s1660
4019,AIMed.d195,True,Competitive binding of PROTEIN and PROTEIN1 to the PROTEIN2 ,AIMed.d195.s1660
4020,AIMed.d195,False,Competitive binding of PROTEIN1 and PROTEIN2 to the PROTEIN ,AIMed.d195.s1660
4021,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN1 family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4022,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1 a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4023,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN1 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4024,AIMed.d195,True,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN2 and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4025,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1 PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4026,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4027,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN2 subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4028,AIMed.d195,True,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4029,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4030,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1 a member of the spectrin/ PROTEIN2 family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4031,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN1 family of PROTEIN2 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4032,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN1 family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN2 and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4033,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN1 family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2 PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4034,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN1 family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4035,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN1 family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN2 subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4036,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN1 family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4037,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN2 family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4038,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1 a member of the spectrin/ PROTEIN family of PROTEIN2 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4039,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1 a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN2 and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4040,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1 a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2 PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4041,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1 a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4042,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1 a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN2 subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4043,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN1 a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4044,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN2 a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4045,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN1 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN2 and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4046,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN1 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2 PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4047,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN1 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4048,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN1 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN2 subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4049,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN1 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4050,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN2 binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4051,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1 PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN2 and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4052,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and PROTEIN subunits of the PROTEIN2 and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4053,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN1 subunits of the PROTEIN2 and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4054,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN1 and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4055,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN2 and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4056,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1 PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4057,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1 PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN2 subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4058,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN1 PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4059,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2 PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4060,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and PROTEIN2 subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4061,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4062,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN2 and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4063,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN1 subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4064,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN2 subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain.",AIMed.d195.s1662
4065,AIMed.d195,False,"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of PROTEIN1 suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. PROTEIN a member of the spectrin/ PROTEIN family of PROTEIN binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain.",AIMed.d195.s1662
4066,AIMed.d195,False,"Intriguingly, PROTEIN1 PROTEIN2 binding is directly antagonized by Ca2+/ PROTEIN ",AIMed.d195.s1663
4067,AIMed.d195,False,"Intriguingly, PROTEIN1 PROTEIN binding is directly antagonized by Ca2+/ PROTEIN2 ",AIMed.d195.s1663
4068,AIMed.d195,False,"Intriguingly, PROTEIN PROTEIN1 binding is directly antagonized by Ca2+/ PROTEIN2 ",AIMed.d195.s1663
4069,AIMed.d196,True, PROTEIN1 interacts with protein phosphatases PROTEIN2 and PROTEIN and disrupts a G2/M cell-cycle checkpoint.,AIMed.d196.s1665
4070,AIMed.d196,False, PROTEIN interacts with protein phosphatases PROTEIN1 and PROTEIN2 and disrupts a G2/M cell-cycle checkpoint.,AIMed.d196.s1665
4071,AIMed.d196,True, PROTEIN1 interacts with protein phosphatases PROTEIN and PROTEIN2 and disrupts a G2/M cell-cycle checkpoint.,AIMed.d196.s1665
4072,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN1 ( PROTEIN , as well as PROTEIN2 ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4073,AIMed.d196,True,"We observed that the protein PROTEIN1 interacted with protein PROTEIN ( PROTEIN , as well as PROTEIN2 ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4074,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN ( PROTEIN , as well as PROTEIN1 ( PROTEIN2 in mammalian cells.",AIMed.d196.s1669
4075,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN1 catalytic subunit ( PROTEIN , as well as PROTEIN2 ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4076,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN ( PROTEIN1 , as well as PROTEIN2 ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4077,AIMed.d196,True,"We observed that the protein PROTEIN1 interacted with protein PROTEIN2 ( PROTEIN , as well as PROTEIN ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4078,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN1 ( PROTEIN , as well as PROTEIN ( PROTEIN2 in mammalian cells.",AIMed.d196.s1669
4079,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN1 ( PROTEIN , as well as PROTEIN ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4080,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN1 ( PROTEIN2 , as well as PROTEIN ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4081,AIMed.d196,True,"We observed that the protein PROTEIN1 interacted with protein PROTEIN ( PROTEIN , as well as PROTEIN ( PROTEIN2 in mammalian cells.",AIMed.d196.s1669
4082,AIMed.d196,False,"We observed that the protein PROTEIN1 interacted with protein PROTEIN2 catalytic subunit ( PROTEIN , as well as PROTEIN ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4083,AIMed.d196,True,"We observed that the protein PROTEIN1 interacted with protein PROTEIN ( PROTEIN2 , as well as PROTEIN ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4084,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN1 catalytic subunit ( PROTEIN , as well as PROTEIN ( PROTEIN2 in mammalian cells.",AIMed.d196.s1669
4085,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN catalytic subunit ( PROTEIN1 , as well as PROTEIN ( PROTEIN2 in mammalian cells.",AIMed.d196.s1669
4086,AIMed.d196,False,"We observed that the protein PROTEIN interacted with protein PROTEIN1 catalytic subunit ( PROTEIN2 , as well as PROTEIN ( PROTEIN in mammalian cells.",AIMed.d196.s1669
4087,AIMed.d196,True,Thus PROTEIN1 is a cellular oncogene that targets PROTEIN2 and PROTEIN both of which are targets for oncogenic viruses and chemical tumour promoters.,AIMed.d196.s1673
4088,AIMed.d196,True,Thus PROTEIN1 is a cellular oncogene that targets PROTEIN and PROTEIN2 both of which are targets for oncogenic viruses and chemical tumour promoters.,AIMed.d196.s1673
4089,AIMed.d196,False,Thus PROTEIN is a cellular oncogene that targets PROTEIN1 and PROTEIN2 both of which are targets for oncogenic viruses and chemical tumour promoters.,AIMed.d196.s1673
4090,AIMed.d197,False,Analysis of the human PROTEIN1 human PROTEIN2 receptor binding interface at the amino acid level: proposed mechanism of interaction.,AIMed.d197.s1675
4091,AIMed.d197,True,Analysis of the human PROTEIN1 human PROTEIN2 binding interface at the amino acid level: proposed mechanism of interaction.,AIMed.d197.s1675
4092,AIMed.d197,False,Analysis of the human PROTEIN human PROTEIN1 binding interface at the amino acid level: proposed mechanism of interaction.,AIMed.d197.s1675
4093,AIMed.d197,True,The interaction between PROTEIN1 ( PROTEIN and PROTEIN2 ( PROTEIN is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4094,AIMed.d197,True,The interaction between PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN2 is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4095,AIMed.d197,False,The interaction between PROTEIN1 ( PROTEIN2 and PROTEIN ( PROTEIN is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4096,AIMed.d197,False,The interaction between PROTEIN1 ( PROTEIN and PROTEIN ( PROTEIN is the initial and most specific step in the PROTEIN2 signaling pathway.,AIMed.d197.s1676
4097,AIMed.d197,False,The interaction between PROTEIN1 ( PROTEIN and PROTEIN2 receptor ( PROTEIN is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4098,AIMed.d197,False,The interaction between PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN2 is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4099,AIMed.d197,True,The interaction between PROTEIN ( PROTEIN1 and PROTEIN2 ( PROTEIN is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4100,AIMed.d197,False,The interaction between PROTEIN ( PROTEIN and PROTEIN1 ( PROTEIN is the initial and most specific step in the PROTEIN2 signaling pathway.,AIMed.d197.s1676
4101,AIMed.d197,False,The interaction between PROTEIN ( PROTEIN and PROTEIN1 receptor ( PROTEIN is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4102,AIMed.d197,False,The interaction between PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN2 is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4103,AIMed.d197,False,The interaction between PROTEIN ( PROTEIN and PROTEIN ( PROTEIN1 is the initial and most specific step in the PROTEIN2 signaling pathway.,AIMed.d197.s1676
4104,AIMed.d197,True,The interaction between PROTEIN ( PROTEIN and PROTEIN1 receptor ( PROTEIN2 is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4105,AIMed.d197,False,The interaction between PROTEIN ( PROTEIN1 and PROTEIN ( PROTEIN is the initial and most specific step in the PROTEIN2 signaling pathway.,AIMed.d197.s1676
4106,AIMed.d197,False,The interaction between PROTEIN ( PROTEIN1 and PROTEIN2 receptor ( PROTEIN is the initial and most specific step in the PROTEIN signaling pathway.,AIMed.d197.s1676
4107,AIMed.d197,False,The interaction between PROTEIN ( PROTEIN and PROTEIN1 receptor ( PROTEIN is the initial and most specific step in the PROTEIN2 signaling pathway.,AIMed.d197.s1676
4108,AIMed.d197,True,We studied the human PROTEIN ( PROTEIN1 / PROTEIN2 binding interface by a combination of molecular modelling and site-directed mutagenesis.,AIMed.d197.s1678
4109,AIMed.d197,True,We studied the human PROTEIN1 ( PROTEIN / PROTEIN2 binding interface by a combination of molecular modelling and site-directed mutagenesis.,AIMed.d197.s1678
4110,AIMed.d197,False,We studied the human PROTEIN1 ( PROTEIN2 / PROTEIN binding interface by a combination of molecular modelling and site-directed mutagenesis.,AIMed.d197.s1678
4111,AIMed.d197,True,"Following this hypothesis, we altered in PROTEIN1 and PROTEIN2 residues predicted to reside in the contact region and to interact with each other.",AIMed.d197.s1681
4112,AIMed.d197,True,We studied the capacity of these mutants to form an PROTEIN1 PROTEIN2 complex and their ability to transduce the signal.,AIMed.d197.s1682
4113,AIMed.d198,False,Mutagenesis studies of the human PROTEIN1 Establishment of structure-function relationships.,AIMed.d198.s1686
4114,AIMed.d198,False,Mutagenesis of the PROTEIN1 ( PROTEIN permits analysis of the contribution that individual amino acid residues make to PROTEIN ( PROTEIN binding.,AIMed.d198.s1687
4115,AIMed.d198,False,Mutagenesis of the PROTEIN1 receptor ( PROTEIN permits analysis of the contribution that individual amino acid residues make to PROTEIN ( PROTEIN2 binding.,AIMed.d198.s1687
4116,AIMed.d198,True,Mutagenesis of the PROTEIN1 receptor ( PROTEIN2 permits analysis of the contribution that individual amino acid residues make to PROTEIN ( PROTEIN binding.,AIMed.d198.s1687
4117,AIMed.d198,False,Mutagenesis of the PROTEIN1 receptor ( PROTEIN permits analysis of the contribution that individual amino acid residues make to PROTEIN2 ( PROTEIN binding.,AIMed.d198.s1687
4118,AIMed.d198,False,Mutagenesis of the PROTEIN1 ( PROTEIN permits analysis of the contribution that individual amino acid residues make to PROTEIN ( PROTEIN2 binding.,AIMed.d198.s1687
4119,AIMed.d198,False,Mutagenesis of the PROTEIN1 ( PROTEIN2 permits analysis of the contribution that individual amino acid residues make to PROTEIN ( PROTEIN binding.,AIMed.d198.s1687
4120,AIMed.d198,False,Mutagenesis of the PROTEIN1 ( PROTEIN permits analysis of the contribution that individual amino acid residues make to PROTEIN2 ( PROTEIN binding.,AIMed.d198.s1687
4121,AIMed.d198,False,Mutagenesis of the PROTEIN ( PROTEIN1 permits analysis of the contribution that individual amino acid residues make to PROTEIN ( PROTEIN2 binding.,AIMed.d198.s1687
4122,AIMed.d198,False,Mutagenesis of the PROTEIN ( PROTEIN permits analysis of the contribution that individual amino acid residues make to PROTEIN1 ( PROTEIN2 binding.,AIMed.d198.s1687
4123,AIMed.d198,False,Mutagenesis of the PROTEIN ( PROTEIN1 permits analysis of the contribution that individual amino acid residues make to PROTEIN2 ( PROTEIN binding.,AIMed.d198.s1687
4124,AIMed.d198,False,"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1 binding protein, PROTEIN of the PROTEIN2 ",AIMed.d198.s1688
4125,AIMed.d198,True,"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1 binding protein, PROTEIN2 of the PROTEIN ",AIMed.d198.s1688
4126,AIMed.d198,False,We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1 PROTEIN of the PROTEIN ,AIMed.d198.s1688
4127,AIMed.d198,False,We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN PROTEIN1 of the PROTEIN2 ,AIMed.d198.s1688
4128,AIMed.d198,False,We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1 PROTEIN of the PROTEIN2 ,AIMed.d198.s1688
4129,AIMed.d198,False,We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as PROTEIN1 PROTEIN2 of the PROTEIN ,AIMed.d198.s1688
4130,AIMed.d198,False,Site-specific mutants were expressed in Escherichia coli as soluble PROTEIN1 and analyzed for PROTEIN2 binding in several different assay formats.,AIMed.d198.s1690
4131,AIMed.d198,False,"In addition, selected mutant proteins were expressed as full-length PROTEIN1 on the surface of COS cells and analyzed for 125I- PROTEIN2 binding in receptor binding assays.",AIMed.d198.s1691
4132,AIMed.d198,False,"Using these methods, we have identified residues that appear to be involved in PROTEIN1 binding as well as other residues, most of which are conserved in receptors of the cytokine receptor family, that appear to be necessary for the proper folding and/or stability of the PROTEIN2 ",AIMed.d198.s1692
4133,AIMed.d199,False,"Stimulation of PROTEIN1 ( PROTEIN2 results in a variety of functional effects, including regulation of epithelial cell growth and differentiation.",AIMed.d199.s1695
4134,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN IIIb and PROTEIN1 IIIc, that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.",AIMed.d199.s1696
4135,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1 IIIb and PROTEIN that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.",AIMed.d199.s1696
4136,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN IIIb and PROTEIN that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.",AIMed.d199.s1696
4137,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN IIIb and PROTEIN1 that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.",AIMed.d199.s1696
4138,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1 and PROTEIN that result from alternative splicing of exon III of the PROTEIN2 gene encoding the ligand binding domain.",AIMed.d199.s1696
4139,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1 IIIb and PROTEIN2 IIIc, that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4140,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN IIIb and PROTEIN2 IIIc, that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4141,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN IIIb and PROTEIN1 that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4142,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1 and PROTEIN2 IIIc, that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4143,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN2 IIIb and PROTEIN that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4144,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1 IIIb and PROTEIN2 that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4145,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1 IIIb and PROTEIN that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4146,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN IIIb and PROTEIN2 that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4147,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN1 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN2 and PROTEIN that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4148,AIMed.d199,False,"In order to characterize the signaling pathway through which PROTEIN regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, PROTEIN1 and PROTEIN2 that result from alternative splicing of exon III of the PROTEIN gene encoding the ligand binding domain.",AIMed.d199.s1696
4149,AIMed.d199,False,"Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN1 expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4150,AIMed.d199,False,"Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN1 expressing cells responded only to PROTEIN2 ",AIMed.d199.s1697
4151,AIMed.d199,False,"Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1 -2, -4, and -6, while PROTEIN2 expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4152,AIMed.d199,False,"Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN2 expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4153,AIMed.d199,False,"Expression of PROTEIN1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN2 expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4154,AIMed.d199,False,"Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN1 IIIb-expressing cells responded only to PROTEIN2 ",AIMed.d199.s1697
4155,AIMed.d199,False,"Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1 -2, -4, and -6, while PROTEIN2 IIIb-expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4156,AIMed.d199,False,"Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN2 IIIb-expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4157,AIMed.d199,False,"Expression of PROTEIN1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN2 IIIb-expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4158,AIMed.d199,False,"Expression of PROTEIN IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN1 -2, -4, and -6, while PROTEIN expressing cells responded only to PROTEIN2 ",AIMed.d199.s1697
4159,AIMed.d199,False,"Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN expressing cells responded only to PROTEIN2 ",AIMed.d199.s1697
4160,AIMed.d199,False,"Expression of PROTEIN1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN expressing cells responded only to PROTEIN2 ",AIMed.d199.s1697
4161,AIMed.d199,False,"Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN2 -2, -4, and -6, while PROTEIN expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4162,AIMed.d199,False,"Expression of PROTEIN1 in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN2 -2, -4, and -6, while PROTEIN expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4163,AIMed.d199,False,"Expression of PROTEIN1 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including PROTEIN -2, -4, and -6, while PROTEIN expressing cells responded only to PROTEIN ",AIMed.d199.s1697
4164,AIMed.d199,False,Activation of PROTEIN1 upon ligand binding resulted in activation of PROTEIN2 pathway.,AIMed.d199.s1698
4165,AIMed.d199,False, PROTEIN1 utilizes two different pools of adapter protein PROTEIN to link to PROTEIN2 ,AIMed.d199.s1699
4166,AIMed.d199,False, PROTEIN1 utilizes two different pools of adapter protein PROTEIN2 to link to PROTEIN ,AIMed.d199.s1699
4167,AIMed.d199,False, PROTEIN utilizes two different pools of adapter protein PROTEIN1 to link to PROTEIN2 ,AIMed.d199.s1699
4168,AIMed.d199,True,Activated PROTEIN1 predominantly interacts with PROTEIN2 ,AIMed.d199.s1700
4169,AIMed.d199,False, PROTEIN1 in complex with a previously identified 90-kDa protein and designated protein PROTEIN2 ,AIMed.d199.s1701
4170,AIMed.d199,False,Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of PROTEIN1 suggesting that the 66-kDa protein may play an important role in PROTEIN2 specific signaling.,AIMed.d199.s1705
4171,AIMed.d199,False,"In addition to this unique pathway, PROTEIN1 also links to PROTEIN2 ",AIMed.d199.s1706
4172,AIMed.d199,False, PROTEIN1 complex via the adapter protein PROTEIN2 ,AIMed.d199.s1707
4173,AIMed.d199,False,"Furthermore, activated PROTEIN1 was not able to induce dissociation of PROTEIN2 ",AIMed.d199.s1708
4174,AIMed.d199,False, PROTEIN1 complex following PROTEIN2 phosphorylation.,AIMed.d199.s1709
4175,AIMed.d199,False,"In summary, PROTEIN1 signaling pathway utilizes two PROTEIN containing complexes; PROTEIN2 ",AIMed.d199.s1710
4176,AIMed.d199,False,"In summary, PROTEIN1 signaling pathway utilizes two PROTEIN2 containing complexes; PROTEIN ",AIMed.d199.s1710
4177,AIMed.d199,False,"In summary, PROTEIN signaling pathway utilizes two PROTEIN1 containing complexes; PROTEIN2 ",AIMed.d199.s1710
4178,AIMed.d199,True, PROTEIN and PROTEIN1 PROTEIN2 ,AIMed.d199.s1712
4179,AIMed.d199,False, PROTEIN1 and PROTEIN2 PROTEIN ,AIMed.d199.s1712
4180,AIMed.d199,False, PROTEIN1 and PROTEIN PROTEIN2 ,AIMed.d199.s1712
4181,AIMed.d199,False, PROTEIN these two complexes may alternatively link PROTEIN1 to PROTEIN2 ,AIMed.d199.s1714
4182,AIMed.d199,False, PROTEIN1 these two complexes may alternatively link PROTEIN to PROTEIN2 ,AIMed.d199.s1714
4183,AIMed.d199,False, PROTEIN1 these two complexes may alternatively link PROTEIN2 to PROTEIN ,AIMed.d199.s1714
4184,AIMed.d199,False,"Finally, activated PROTEIN1 was also found to result in phosphorylation of PROTEIN but reduced phosphorylation of PROTEIN2 ",AIMed.d199.s1715
4185,AIMed.d199,False,"Finally, activated PROTEIN1 was also found to result in phosphorylation of PROTEIN2 but reduced phosphorylation of PROTEIN ",AIMed.d199.s1715
4186,AIMed.d199,False,"Finally, activated PROTEIN was also found to result in phosphorylation of PROTEIN1 but reduced phosphorylation of PROTEIN2 ",AIMed.d199.s1715
4187,AIMed.d202,False,Crystal str PROTEIN1 PROTEIN complexed with PROTEIN2 ,AIMed.d202.s1737
4188,AIMed.d202,False,Crystal stru PROTEIN2 PROTEIN1 complexed with PROTEIN ,AIMed.d202.s1737
4189,AIMed.d202,True,Crystal stru PROTEIN PROTEIN1 complexed with PROTEIN2 ,AIMed.d202.s1737
4190,AIMed.d202,False, PROTEIN1 ( PROTEIN2 is an important mediator of inflammatory disease.,AIMed.d202.s1738
4191,AIMed.d202,False,"The PROTEIN1 family currently consists of two agonists, PROTEIN and PROTEIN and one antagonist, PROTEIN2 ",AIMed.d202.s1739
4192,AIMed.d202,False,"The PROTEIN1 family currently consists of two agonists, PROTEIN2 and PROTEIN and one antagonist, PROTEIN ",AIMed.d202.s1739
4193,AIMed.d202,False,"The PROTEIN1 family currently consists of two agonists, PROTEIN and PROTEIN2 and one antagonist, PROTEIN ",AIMed.d202.s1739
4194,AIMed.d202,False,"The PROTEIN family currently consists of two agonists, PROTEIN1 and PROTEIN and one antagonist, PROTEIN2 ",AIMed.d202.s1739
4195,AIMed.d202,False,"The PROTEIN family currently consists of two agonists, PROTEIN and PROTEIN1 and one antagonist, PROTEIN2 ",AIMed.d202.s1739
4196,AIMed.d202,False,"The PROTEIN family currently consists of two agonists, PROTEIN1 and PROTEIN2 and one antagonist, PROTEIN ",AIMed.d202.s1739
4197,AIMed.d202,False,Each of these molecules binds to PROTEIN2 PROTEIN1 ( PROTEIN .,AIMed.d202.s1740
4198,AIMed.d202,False,Each of these molecules binds to PROTEIN PROTEIN1 ( PROTEIN2 .,AIMed.d202.s1740
4199,AIMed.d202,False,Each of these molecules binds to PROTEIN1 PROTEIN ( PROTEIN2 .,AIMed.d202.s1740
4200,AIMed.d202,True,The binding of PROTEIN or PROTEIN1 to PROTEIN2 is an early step in PROTEIN signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.,AIMed.d202.s1741
4201,AIMed.d202,False,The binding of PROTEIN1 or PROTEIN2 to PROTEIN is an early step in PROTEIN signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.,AIMed.d202.s1741
4202,AIMed.d202,False,The binding of PROTEIN or PROTEIN1 to PROTEIN is an early step in PROTEIN2 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.,AIMed.d202.s1741
4203,AIMed.d202,True,The binding of PROTEIN1 or PROTEIN to PROTEIN2 is an early step in PROTEIN signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.,AIMed.d202.s1741
4204,AIMed.d202,False,The binding of PROTEIN or PROTEIN to PROTEIN1 is an early step in PROTEIN2 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.,AIMed.d202.s1741
4205,AIMed.d202,False,The binding of PROTEIN1 or PROTEIN to PROTEIN is an early step in PROTEIN2 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.,AIMed.d202.s1741
4206,AIMed.d202,True,Here we report the three-dimensional structure of PROTEIN1 bound to the extracellular domain of PROTEIN2 ( PROTEIN at 2.5 A resolution.,AIMed.d202.s1742
4207,AIMed.d202,False,Here we report the three-dimensional structure of PROTEIN bound to the extracellular domain of PROTEIN1 ( PROTEIN2 at 2.5 A resolution.,AIMed.d202.s1742
4208,AIMed.d202,True,Here we report the three-dimensional structure of PROTEIN1 bound to the extracellular domain of PROTEIN ( PROTEIN2 at 2.5 A resolution.,AIMed.d202.s1742
4209,AIMed.d202,True, PROTEIN1 binds to PROTEIN2 with a 1:1 stoichiometry.,AIMed.d202.s1743
4210,AIMed.d202,True,The crystal structure shows that PROTEIN1 consists of three immunoglobulin-like domains which wrap around PROTEIN2 in a manner distinct from the structures of previously described cytokine-receptor complexes.,AIMed.d202.s1744
4211,AIMed.d204,False,"The catalytic domain of activated PROTEIN1 ( PROTEIN2 is absolutely required for interaction with its specific inhibitor, PROTEIN ( PROTEIN .",AIMed.d204.s1756
4212,AIMed.d204,True,"The catalytic domain of activated PROTEIN ( PROTEIN1 is absolutely required for interaction with its specific inhibitor, PROTEIN2 ( PROTEIN .",AIMed.d204.s1756
4213,AIMed.d204,True,"The catalytic domain of activated PROTEIN ( PROTEIN1 is absolutely required for interaction with its specific inhibitor, PROTEIN ( PROTEIN2 .",AIMed.d204.s1756
4214,AIMed.d204,False,"The catalytic domain of activated PROTEIN1 ( PROTEIN is absolutely required for interaction with its specific inhibitor, PROTEIN2 ( PROTEIN .",AIMed.d204.s1756
4215,AIMed.d204,False,"The catalytic domain of activated PROTEIN1 ( PROTEIN is absolutely required for interaction with its specific inhibitor, PROTEIN ( PROTEIN2 .",AIMed.d204.s1756
4216,AIMed.d204,False,"The catalytic domain of activated PROTEIN ( PROTEIN is absolutely required for interaction with its specific inhibitor, PROTEIN1 ( PROTEIN2 .",AIMed.d204.s1756
4217,AIMed.d204,False,"Here, we describe the production of PROTEIN1 ( PROTEIN and wild-type and mutant human PROTEIN2 ( PROTEIN proteins in SF9 cells by the baculovirus expression system.",AIMed.d204.s1757
4218,AIMed.d204,False,"Here, we describe the production of PROTEIN ( PROTEIN1 and wild-type and mutant human PROTEIN2 ( PROTEIN proteins in SF9 cells by the baculovirus expression system.",AIMed.d204.s1757
4219,AIMed.d204,False,"Here, we describe the production of PROTEIN ( PROTEIN and wild-type and mutant human PROTEIN1 ( PROTEIN2 proteins in SF9 cells by the baculovirus expression system.",AIMed.d204.s1757
4220,AIMed.d204,False,"Here, we describe the production of PROTEIN1 ( PROTEIN2 and wild-type and mutant human PROTEIN ( PROTEIN proteins in SF9 cells by the baculovirus expression system.",AIMed.d204.s1757
4221,AIMed.d204,False,"Here, we describe the production of PROTEIN1 ( PROTEIN and wild-type and mutant human PROTEIN ( PROTEIN2 proteins in SF9 cells by the baculovirus expression system.",AIMed.d204.s1757
4222,AIMed.d204,False,"Here, we describe the production of PROTEIN ( PROTEIN1 and wild-type and mutant human PROTEIN ( PROTEIN2 proteins in SF9 cells by the baculovirus expression system.",AIMed.d204.s1757
4223,AIMed.d204,False,"Wild-type PROTEIN as well as the PROTEIN mutant lacking the C-terminal hemopexin-like domain [des-(248-450)- PROTEIN1 , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate.",AIMed.d204.s1758
4224,AIMed.d204,False,"Wild-type PROTEIN1 as well as the PROTEIN mutant lacking the C-terminal hemopexin-like domain [des-(248-450)- PROTEIN , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate.",AIMed.d204.s1758
4225,AIMed.d204,False,"Wild-type PROTEIN as well as the PROTEIN1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)- PROTEIN , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate.",AIMed.d204.s1758
4226,AIMed.d204,False,"Wild-type PROTEIN1 as well as the PROTEIN mutant lacking the C-terminal hemopexin-like domain [des-(248-450)- PROTEIN2 , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN or 4-aminophenylmercuric acetate.",AIMed.d204.s1758
4227,AIMed.d204,False,"Wild-type PROTEIN as well as the PROTEIN1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)- PROTEIN2 , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN or 4-aminophenylmercuric acetate.",AIMed.d204.s1758
4228,AIMed.d204,False,"Wild-type PROTEIN1 as well as the PROTEIN2 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)- PROTEIN , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN or 4-aminophenylmercuric acetate.",AIMed.d204.s1758
4229,AIMed.d204,False,"Deletion of the complete active-site [des-(161-228)- PROTEIN within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN1 proteins which are unable to digest PROTEIN2 or PROTEIN ",AIMed.d204.s1760
4230,AIMed.d204,False,"Deletion of the complete active-site [des-(161-228)- PROTEIN1 within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN2 proteins which are unable to digest PROTEIN or PROTEIN ",AIMed.d204.s1760
4231,AIMed.d204,False,"Deletion of the complete active-site [des-(161-228)- PROTEIN within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN1 proteins which are unable to digest PROTEIN or PROTEIN2 ",AIMed.d204.s1760
4232,AIMed.d204,False,"Deletion of the complete active-site [des-(161-228)- PROTEIN1 within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN proteins which are unable to digest PROTEIN2 or PROTEIN ",AIMed.d204.s1760
4233,AIMed.d204,False,"Deletion of the complete active-site [des-(161-228)- PROTEIN within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN proteins which are unable to digest PROTEIN1 or PROTEIN2 ",AIMed.d204.s1760
4234,AIMed.d204,False,"Deletion of the complete active-site [des-(161-228)- PROTEIN1 within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of PROTEIN proteins which are unable to digest PROTEIN or PROTEIN2 ",AIMed.d204.s1760
4235,AIMed.d204,False,"In addition to co-immunoprecipitation analysis, we have established a rapid and sensitive ELISA assay using immobilized PROTEIN1 to determine the structural requirements of PROTEIN2 to form complexes with its inhibitor.",AIMed.d204.s1761
4236,AIMed.d204,True,Only the activated and not the latent forms of wild-type and C-terminal mutant des-(248-450)- PROTEIN1 proteins are able to form complexes with PROTEIN2 ,AIMed.d204.s1762
4237,AIMed.d204,False,"Neither mutation of His199, nor deletion mutants des-(161-228)- PROTEIN1 and des-(161-228/248-450)- PROTEIN2 interact with PROTEIN ",AIMed.d204.s1763
4238,AIMed.d204,False,"Neither mutation of His199, nor deletion mutants des-(161-228)- PROTEIN1 and des-(161-228/248-450)- PROTEIN interact with PROTEIN2 ",AIMed.d204.s1763
4239,AIMed.d204,False,"Neither mutation of His199, nor deletion mutants des-(161-228)- PROTEIN and des-(161-228/248-450)- PROTEIN1 interact with PROTEIN2 ",AIMed.d204.s1763
4240,AIMed.d204,False,This demonstrates that the C-terminal hemopexin domain of PROTEIN1 in contrast to the corresponding regions of PROTEIN and PROTEIN2 does not interact with PROTEIN ,AIMed.d204.s1764
4241,AIMed.d204,False,This demonstrates that the C-terminal hemopexin domain of PROTEIN1 in contrast to the corresponding regions of PROTEIN and PROTEIN does not interact with PROTEIN2 ,AIMed.d204.s1764
4242,AIMed.d204,False,This demonstrates that the C-terminal hemopexin domain of PROTEIN1 in contrast to the corresponding regions of PROTEIN2 and PROTEIN does not interact with PROTEIN ,AIMed.d204.s1764
4243,AIMed.d204,True,This demonstrates that the C-terminal hemopexin domain of PROTEIN in contrast to the corresponding regions of PROTEIN and PROTEIN1 does not interact with PROTEIN2 ,AIMed.d204.s1764
4244,AIMed.d204,False,This demonstrates that the C-terminal hemopexin domain of PROTEIN in contrast to the corresponding regions of PROTEIN1 and PROTEIN2 does not interact with PROTEIN ,AIMed.d204.s1764
4245,AIMed.d204,True,This demonstrates that the C-terminal hemopexin domain of PROTEIN in contrast to the corresponding regions of PROTEIN1 and PROTEIN does not interact with PROTEIN2 ,AIMed.d204.s1764
4246,AIMed.d204,False,"In summary, we have shown that the integrity of the catalytic domain of PROTEIN and its ability to bind Zn2+ is absolutely required for complex formation with PROTEIN1 which further underlines the importance of this region for proper regulation of enzymatic activity of PROTEIN2 ",AIMed.d204.s1765
4247,AIMed.d204,True,"In summary, we have shown that the integrity of the catalytic domain of PROTEIN1 and its ability to bind Zn2+ is absolutely required for complex formation with PROTEIN2 which further underlines the importance of this region for proper regulation of enzymatic activity of PROTEIN ",AIMed.d204.s1765
4248,AIMed.d204,False,"In summary, we have shown that the integrity of the catalytic domain of PROTEIN1 and its ability to bind Zn2+ is absolutely required for complex formation with PROTEIN which further underlines the importance of this region for proper regulation of enzymatic activity of PROTEIN2 ",AIMed.d204.s1765
4249,AIMed.d205,False,Thymocyte activation induces the association of PROTEIN1 and PROTEIN2 with PROTEIN ,AIMed.d205.s1766
4250,AIMed.d205,True,Thymocyte activation induces the association of PROTEIN and PROTEIN1 with PROTEIN2 ,AIMed.d205.s1766
4251,AIMed.d205,True,Thymocyte activation induces the association of PROTEIN1 and PROTEIN with PROTEIN2 ,AIMed.d205.s1766
4252,AIMed.d205,False,Antibody-mediated cross-linking studies or studies on PROTEIN1 knockout mice implicate PROTEIN2 as a co-stimulatory or negative regulatory molecule.,AIMed.d205.s1768
4253,AIMed.d205,False,Y429 and Y441 occur in an imperfect PROTEIN1 ( PROTEIN2 -like sequence.,AIMed.d205.s1770
4254,AIMed.d205,False,We investigated whether PROTEIN1 which binds to tyrosine-phosphorylated PROTEIN interacts with PROTEIN2 following T cell activation.,AIMed.d205.s1771
4255,AIMed.d205,True,We investigated whether PROTEIN1 which binds to tyrosine-phosphorylated PROTEIN2 interacts with PROTEIN following T cell activation.,AIMed.d205.s1771
4256,AIMed.d205,False,We investigated whether PROTEIN which binds to tyrosine-phosphorylated PROTEIN1 interacts with PROTEIN2 following T cell activation.,AIMed.d205.s1771
4257,AIMed.d205,False," PROTEIN1 activity and the regulatory PROTEIN2 subunit of PROTEIN associated with PROTEIN in pervanadate-stimulated, but not in unstimulated thymocytes.",AIMed.d205.s1772
4258,AIMed.d205,False," PROTEIN1 activity and the regulatory PROTEIN subunit of PROTEIN2 associated with PROTEIN in pervanadate-stimulated, but not in unstimulated thymocytes.",AIMed.d205.s1772
4259,AIMed.d205,False," PROTEIN1 activity and the regulatory PROTEIN subunit of PROTEIN associated with PROTEIN2 in pervanadate-stimulated, but not in unstimulated thymocytes.",AIMed.d205.s1772
4260,AIMed.d205,False," PROTEIN activity and the regulatory PROTEIN1 subunit of PROTEIN2 associated with PROTEIN in pervanadate-stimulated, but not in unstimulated thymocytes.",AIMed.d205.s1772
4261,AIMed.d205,False," PROTEIN activity and the regulatory PROTEIN1 subunit of PROTEIN associated with PROTEIN2 in pervanadate-stimulated, but not in unstimulated thymocytes.",AIMed.d205.s1772
4262,AIMed.d205,True," PROTEIN activity and the regulatory PROTEIN subunit of PROTEIN1 associated with PROTEIN2 in pervanadate-stimulated, but not in unstimulated thymocytes.",AIMed.d205.s1772
4263,AIMed.d205,False,Cellular PROTEIN1 as well as the recombinant Src homology 2 (SH2) domains of PROTEIN2 bound a tyrosine-phosphorylated peptide encompassing Y463 with approximately threefold greater affinity than a doubly tyrosine-phosphorylated Y429-Y441 peptide.,AIMed.d205.s1773
4264,AIMed.d205,False,A PROTEIN1 ( PROTEIN2 associated with PROTEIN and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.,AIMed.d205.s1775
4265,AIMed.d205,True,A PROTEIN ( PROTEIN1 associated with PROTEIN2 and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.,AIMed.d205.s1775
4266,AIMed.d205,True,A PROTEIN1 ( PROTEIN associated with PROTEIN2 and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.,AIMed.d205.s1775
4267,AIMed.d205,False,We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PROTEIN1 and PROTEIN2 to PROTEIN ,AIMed.d205.s1776
4268,AIMed.d205,True,We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PROTEIN and PROTEIN1 to PROTEIN2 ,AIMed.d205.s1776
4269,AIMed.d205,True,We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PROTEIN1 and PROTEIN to PROTEIN2 ,AIMed.d205.s1776
4270,AIMed.d206,False,"As PROTEIN1 forms complexes with beta 1 integrins and the integrins are known to regulate keratinocyte behaviour, we investigated PROTEIN2 expression and function in human epidermal keratinocytes.",AIMed.d206.s1779
4271,AIMed.d206,False,"There was extensive co-localisation of PROTEIN1 and beta 1 integrins on microvilli and at cell-cell borders of basal keratinocytes; however, in contrast to the integrins, PROTEIN2 was not found in focal adhesions.",AIMed.d206.s1781
4272,AIMed.d206,False, PROTEIN1 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of PROTEIN and PROTEIN2 but not of cadherins.,AIMed.d206.s1782
4273,AIMed.d206,False, PROTEIN1 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of PROTEIN2 and PROTEIN but not of cadherins.,AIMed.d206.s1782
4274,AIMed.d206,False, PROTEIN was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of PROTEIN1 and PROTEIN2 but not of cadherins.,AIMed.d206.s1782
4275,AIMed.d206,False, PROTEIN1 was associated with alpha 3 beta 1 but not alpha 5 beta 1; small amounts of PROTEIN2 also co-immunoprecipitated with antibodies to alpha 2 beta 1 and alpha 6 beta 4.,AIMed.d206.s1783
4276,AIMed.d206,False,Antibodies to PROTEIN1 did not affect the proportion of keratinocytes that adhered to PROTEIN2 PROTEIN and PROTEIN but did inhibit motility of keratinocytes on tissue culture plastic.,AIMed.d206.s1784
4277,AIMed.d206,False,Antibodies to PROTEIN1 did not affect the proportion of keratinocytes that adhered to PROTEIN PROTEIN2 and PROTEIN but did inhibit motility of keratinocytes on tissue culture plastic.,AIMed.d206.s1784
4278,AIMed.d206,False,Antibodies to PROTEIN1 did not affect the proportion of keratinocytes that adhered to PROTEIN PROTEIN and PROTEIN2 but did inhibit motility of keratinocytes on tissue culture plastic.,AIMed.d206.s1784
4279,AIMed.d206,False,Antibodies to PROTEIN did not affect the proportion of keratinocytes that adhered to PROTEIN1 PROTEIN2 and PROTEIN but did inhibit motility of keratinocytes on tissue culture plastic.,AIMed.d206.s1784
4280,AIMed.d206,False,Antibodies to PROTEIN did not affect the proportion of keratinocytes that adhered to PROTEIN1 PROTEIN and PROTEIN2 but did inhibit motility of keratinocytes on tissue culture plastic.,AIMed.d206.s1784
4281,AIMed.d206,False,Antibodies to PROTEIN did not affect the proportion of keratinocytes that adhered to PROTEIN PROTEIN1 and PROTEIN2 but did inhibit motility of keratinocytes on tissue culture plastic.,AIMed.d206.s1784
4282,AIMed.d206,False,"Like antibodies to the PROTEIN1 subunit, anti- PROTEIN2 inhibited suspension-induced terminal differentiation.",AIMed.d206.s1785
4283,AIMed.d207,False, PROTEIN1 prevents PROTEIN PROTEIN2 containing PROTEIN complexes formation in terminally differentiated myocytes.,AIMed.d207.s1787
4284,AIMed.d207,False, PROTEIN1 prevents PROTEIN2 PROTEIN containing PROTEIN complexes formation in terminally differentiated myocytes.,AIMed.d207.s1787
4285,AIMed.d207,False, PROTEIN1 prevents PROTEIN PROTEIN containing PROTEIN2 complexes formation in terminally differentiated myocytes.,AIMed.d207.s1787
4286,AIMed.d207,True, PROTEIN prevents PROTEIN1 PROTEIN2 containing PROTEIN complexes formation in terminally differentiated myocytes.,AIMed.d207.s1787
4287,AIMed.d207,False, PROTEIN prevents PROTEIN PROTEIN1 containing PROTEIN2 complexes formation in terminally differentiated myocytes.,AIMed.d207.s1787
4288,AIMed.d207,False, PROTEIN prevents PROTEIN1 PROTEIN containing PROTEIN2 complexes formation in terminally differentiated myocytes.,AIMed.d207.s1787
4289,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN protein PROTEIN2 and the pocket proteins PROTEIN PROTEIN and PROTEIN PROTEIN ,AIMed.d207.s1788
4290,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN1 and the pocket proteins PROTEIN PROTEIN2 and PROTEIN PROTEIN ,AIMed.d207.s1788
4291,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN1 protein PROTEIN2 and the pocket proteins PROTEIN PROTEIN and PROTEIN PROTEIN ,AIMed.d207.s1788
4292,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN1 and the pocket proteins PROTEIN PROTEIN and PROTEIN PROTEIN2 ,AIMed.d207.s1788
4293,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN1 and the pocket proteins PROTEIN PROTEIN and PROTEIN2 PROTEIN ,AIMed.d207.s1788
4294,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN1 and the pocket proteins PROTEIN2 PROTEIN and PROTEIN PROTEIN ,AIMed.d207.s1788
4295,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN PROTEIN2 and PROTEIN PROTEIN ,AIMed.d207.s1788
4296,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN2 protein PROTEIN and the pocket proteins PROTEIN PROTEIN and PROTEIN PROTEIN ,AIMed.d207.s1788
4297,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN PROTEIN and PROTEIN PROTEIN2 ,AIMed.d207.s1788
4298,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN PROTEIN and PROTEIN2 PROTEIN ,AIMed.d207.s1788
4299,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN2 PROTEIN and PROTEIN PROTEIN ,AIMed.d207.s1788
4300,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN1 protein PROTEIN and the pocket proteins PROTEIN PROTEIN2 and PROTEIN PROTEIN ,AIMed.d207.s1788
4301,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN PROTEIN1 and PROTEIN PROTEIN2 ,AIMed.d207.s1788
4302,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN PROTEIN1 and PROTEIN2 PROTEIN ,AIMed.d207.s1788
4303,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN1 PROTEIN2 and PROTEIN PROTEIN ,AIMed.d207.s1788
4304,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN1 protein PROTEIN and the pocket proteins PROTEIN PROTEIN and PROTEIN PROTEIN2 ,AIMed.d207.s1788
4305,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN1 protein PROTEIN and the pocket proteins PROTEIN PROTEIN and PROTEIN2 PROTEIN ,AIMed.d207.s1788
4306,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN1 protein PROTEIN and the pocket proteins PROTEIN2 PROTEIN and PROTEIN PROTEIN ,AIMed.d207.s1788
4307,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN PROTEIN and PROTEIN1 PROTEIN2 ,AIMed.d207.s1788
4308,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN1 PROTEIN and PROTEIN PROTEIN2 ,AIMed.d207.s1788
4309,AIMed.d207,False,Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN ( PROTEIN protein PROTEIN and the pocket proteins PROTEIN1 PROTEIN and PROTEIN2 PROTEIN ,AIMed.d207.s1788
4310,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN1 PROTEIN2 ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4311,AIMed.d207,False,"An PROTEIN1 complex containing mainly PROTEIN and PROTEIN2 PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4312,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN1 PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2 PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4313,AIMed.d207,True,"An PROTEIN complex containing mainly PROTEIN1 and PROTEIN2 PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4314,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN1 PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN2 complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4315,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN1 PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4316,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN1 PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN2 G1/S complex).",AIMed.d207.s1791
4317,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN1 PROTEIN ( PROTEIN2 G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4318,AIMed.d207,False,"An PROTEIN1 complex containing mainly PROTEIN and PROTEIN PROTEIN2 ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4319,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN1 ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2 PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4320,AIMed.d207,True,"An PROTEIN complex containing mainly PROTEIN1 and PROTEIN PROTEIN2 ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4321,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN1 ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN2 complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4322,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN1 ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4323,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN1 ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN2 G1/S complex).",AIMed.d207.s1791
4324,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN1 ( PROTEIN2 G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4325,AIMed.d207,False,"An PROTEIN1 complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2 PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4326,AIMed.d207,False,"An PROTEIN1 complex containing mainly PROTEIN2 and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4327,AIMed.d207,False,"An PROTEIN1 complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN2 complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4328,AIMed.d207,False,"An PROTEIN1 complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4329,AIMed.d207,False,"An PROTEIN1 complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN2 G1/S complex).",AIMed.d207.s1791
4330,AIMed.d207,False,"An PROTEIN1 complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN2 G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4331,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN1 and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2 PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4332,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN1 PROTEIN containing PROTEIN2 complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4333,AIMed.d207,True,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN1 PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4334,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN1 PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN2 G1/S complex).",AIMed.d207.s1791
4335,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN1 G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN2 PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4336,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN1 and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN2 complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4337,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN1 and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4338,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN1 and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN2 G1/S complex).",AIMed.d207.s1791
4339,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN1 and PROTEIN PROTEIN ( PROTEIN2 G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4340,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN1 containing PROTEIN2 complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4341,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN1 complex of proliferating myoblasts ( PROTEIN2 G1/S complex).",AIMed.d207.s1791
4342,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN1 G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN2 complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4343,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN1 containing PROTEIN complex of proliferating myoblasts ( PROTEIN2 G1/S complex).",AIMed.d207.s1791
4344,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN1 G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN G1/S complex).",AIMed.d207.s1791
4345,AIMed.d207,False,"An PROTEIN complex containing mainly PROTEIN and PROTEIN PROTEIN ( PROTEIN1 G0/G1 complex) appears when DNA synthesis arrests, replacing the PROTEIN PROTEIN containing PROTEIN complex of proliferating myoblasts ( PROTEIN2 G1/S complex).",AIMed.d207.s1791
4346,AIMed.d207,False,"In differentiating C2C12 cells, PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN1 DNA binding activity and the cdks inhibitor PROTEIN2 downstream effector PROTEIN are induced.",AIMed.d207.s1793
4347,AIMed.d207,False,"In differentiating C2C12 cells, PROTEIN1 complexes switch and DNA synthesis in response to serum are prevented when PROTEIN2 DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN are induced.",AIMed.d207.s1793
4348,AIMed.d207,False,"In differentiating C2C12 cells, PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN1 DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN2 are induced.",AIMed.d207.s1793
4349,AIMed.d207,False,"In differentiating C2C12 cells, PROTEIN1 complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN2 downstream effector PROTEIN are induced.",AIMed.d207.s1793
4350,AIMed.d207,False,"In differentiating C2C12 cells, PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN1 downstream effector PROTEIN2 are induced.",AIMed.d207.s1793
4351,AIMed.d207,False,"In differentiating C2C12 cells, PROTEIN1 complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN2 are induced.",AIMed.d207.s1793
4352,AIMed.d207,True,"Thus, during myogenic differentiation, formation of PROTEIN1 and PROTEIN PROTEIN2 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.",AIMed.d207.s1794
4353,AIMed.d207,False,"Thus, during myogenic differentiation, formation of PROTEIN and PROTEIN1 PROTEIN2 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.",AIMed.d207.s1794
4354,AIMed.d207,True,"Thus, during myogenic differentiation, formation of PROTEIN1 and PROTEIN2 PROTEIN containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.",AIMed.d207.s1794
4355,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN1 ( PROTEIN2 PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4356,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN1 PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4357,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN1 PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4358,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN1 PROTEIN2 chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4359,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN1 PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4360,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN1 PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN2 PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4361,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1 PROTEIN ( PROTEIN2 PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4362,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN1 PROTEIN chimerae, we found that estrogen directed PROTEIN2 activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4363,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN1 ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4364,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN1 ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4365,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN1 ( PROTEIN PROTEIN2 chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4366,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN1 ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4367,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN1 ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN2 PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4368,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1 PROTEIN2 ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4369,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN1 ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN2 activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4370,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN1 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4371,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN1 chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4372,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN1 containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4373,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN1 PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4374,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1 PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4375,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN1 activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4376,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN1 chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4377,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN1 to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4378,AIMed.d207,True,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN1 PROTEIN2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4379,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1 PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4380,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN1 activation prevents the reassociation of PROTEIN PROTEIN2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4381,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN1 chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4382,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN1 chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN2 PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4383,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1 PROTEIN ( PROTEIN PROTEIN2 chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4384,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN1 chimerae, we found that estrogen directed PROTEIN2 activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4385,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN1 PROTEIN to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4386,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1 PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4387,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN1 activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN2 containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4388,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1 PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN2 PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4389,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN1 activation prevents the reassociation of PROTEIN2 PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4390,AIMed.d207,False,"Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing PROTEIN1 PROTEIN ( PROTEIN PROTEIN chimerae, we found that estrogen directed PROTEIN2 activation prevents the reassociation of PROTEIN PROTEIN to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle.",AIMed.d207.s1795
4391,AIMed.d207,False,"Our data indicate that, in differentiating myocytes, one mechanism through which PROTEIN1 induces permanent cell cycle arrest involves PROTEIN2 upregulation and suppression of the proliferation-associated cdks-containing PROTEIN complexes formation.",AIMed.d207.s1796
4392,AIMed.d207,False,"Our data indicate that, in differentiating myocytes, one mechanism through which PROTEIN induces permanent cell cycle arrest involves PROTEIN1 upregulation and suppression of the proliferation-associated cdks-containing PROTEIN2 complexes formation.",AIMed.d207.s1796
4393,AIMed.d207,False,"Our data indicate that, in differentiating myocytes, one mechanism through which PROTEIN1 induces permanent cell cycle arrest involves PROTEIN upregulation and suppression of the proliferation-associated cdks-containing PROTEIN2 complexes formation.",AIMed.d207.s1796
4394,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4395,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4396,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4397,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4398,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4399,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4400,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN and TRAFs) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4401,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4402,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN2 and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4403,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4404,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 PROTEIN PROTEIN PROTEIN2 PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4405,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4406,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4407,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and TRAFs) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4408,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4409,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4410,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4411,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN1 and PROTEIN2 forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4412,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN2 and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4413,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN2 and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4414,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN2 and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4415,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN PROTEIN1 and TRAFs) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4416,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4417,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN1 PROTEIN2 PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4418,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4419,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN1 PROTEIN PROTEIN2 PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4420,AIMed.d208,False,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN PROTEIN PROTEIN1 PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4421,AIMed.d208,True,The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors ( PROTEIN PROTEIN1 PROTEIN PROTEIN PROTEIN PROTEIN and TRAFs) associated with both of the PROTEIN2 and PROTEIN forms of the TNF receptor and with other members of the TNF receptor superfamily.,AIMed.d208.s1803
4422,AIMed.d209,True,Human PROTEIN1 was first characterized as a PROTEIN2 binding protein based on the properties of its carboxyl-terminal domain.,AIMed.d209.s1806
4423,AIMed.d209,False,Human PROTEIN1 was first characterized as a PROTEIN2 based on the properties of its carboxyl-terminal domain.,AIMed.d209.s1806
4424,AIMed.d209,False,Human PROTEIN was first characterized as a PROTEIN1 based on the properties of its carboxyl-terminal domain.,AIMed.d209.s1806
4425,AIMed.d209,True,We now show that full-length PROTEIN1 interacts with activated PROTEIN2 in mammalian cells and defines a minimum region of 434 aa required for efficient PROTEIN binding.,AIMed.d209.s1807
4426,AIMed.d209,False,We now show that full-length PROTEIN1 interacts with activated PROTEIN in mammalian cells and defines a minimum region of 434 aa required for efficient PROTEIN2 binding.,AIMed.d209.s1807
4427,AIMed.d209,False,We now show that full-length PROTEIN interacts with activated PROTEIN1 in mammalian cells and defines a minimum region of 434 aa required for efficient PROTEIN2 binding.,AIMed.d209.s1807
4428,AIMed.d209,False," PROTEIN1 interacts with the ""effector domain"" of PROTEIN and employs some PROTEIN determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN2 a known PROTEIN effector.",AIMed.d209.s1808
4429,AIMed.d209,True," PROTEIN1 interacts with the ""effector domain"" of PROTEIN2 and employs some PROTEIN determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN a known PROTEIN effector.",AIMed.d209.s1808
4430,AIMed.d209,False," PROTEIN1 interacts with the ""effector domain"" of PROTEIN and employs some PROTEIN2 determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN a known PROTEIN effector.",AIMed.d209.s1808
4431,AIMed.d209,False," PROTEIN1 interacts with the ""effector domain"" of PROTEIN and employs some PROTEIN determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN a known PROTEIN2 effector.",AIMed.d209.s1808
4432,AIMed.d209,False," PROTEIN interacts with the ""effector domain"" of PROTEIN1 and employs some PROTEIN determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN2 a known PROTEIN effector.",AIMed.d209.s1808
4433,AIMed.d209,False," PROTEIN interacts with the ""effector domain"" of PROTEIN and employs some PROTEIN1 determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN2 a known PROTEIN effector.",AIMed.d209.s1808
4434,AIMed.d209,True," PROTEIN interacts with the ""effector domain"" of PROTEIN and employs some PROTEIN determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN1 a known PROTEIN2 effector.",AIMed.d209.s1808
4435,AIMed.d209,False," PROTEIN interacts with the ""effector domain"" of PROTEIN1 and employs some PROTEIN2 determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN a known PROTEIN effector.",AIMed.d209.s1808
4436,AIMed.d209,False," PROTEIN interacts with the ""effector domain"" of PROTEIN1 and employs some PROTEIN determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN a known PROTEIN2 effector.",AIMed.d209.s1808
4437,AIMed.d209,False," PROTEIN interacts with the ""effector domain"" of PROTEIN and employs some PROTEIN1 determinants that are common to, and others that are distinct from, those required for the binding of PROTEIN a known PROTEIN2 effector.",AIMed.d209.s1808
4438,AIMed.d209,False,"The same domain of PROTEIN1 that binds PROTEIN also interacts with 14-3-3 proteins, extending the similarity between PROTEIN and other PROTEIN2 effectors.",AIMed.d209.s1809
4439,AIMed.d209,False,"The same domain of PROTEIN that binds PROTEIN also interacts with 14-3-3 proteins, extending the similarity between PROTEIN1 and other PROTEIN2 effectors.",AIMed.d209.s1809
4440,AIMed.d209,False,"The same domain of PROTEIN that binds PROTEIN1 also interacts with 14-3-3 proteins, extending the similarity between PROTEIN and other PROTEIN2 effectors.",AIMed.d209.s1809
4441,AIMed.d209,False,"The same domain of PROTEIN1 that binds PROTEIN also interacts with 14-3-3 proteins, extending the similarity between PROTEIN2 and other PROTEIN effectors.",AIMed.d209.s1809
4442,AIMed.d209,True,"The same domain of PROTEIN1 that binds PROTEIN2 also interacts with 14-3-3 proteins, extending the similarity between PROTEIN and other PROTEIN effectors.",AIMed.d209.s1809
4443,AIMed.d209,False,"The same domain of PROTEIN that binds PROTEIN1 also interacts with 14-3-3 proteins, extending the similarity between PROTEIN2 and other PROTEIN effectors.",AIMed.d209.s1809
4444,AIMed.d209,True,"When expressed in mammalian cells, the PROTEIN1 binding domain of PROTEIN2 can act as a dominant negative signal transduction blocker.",AIMed.d209.s1810
4445,AIMed.d209,True,This PROTEIN1 sequence shows preferential binding to the PROTEIN2 domain in vitro.,AIMed.d209.s1812
4446,AIMed.d209,True,"Moreover, the amino-terminal domain of PROTEIN1 directly associates with, and is tyrosine phosphorylated by, PROTEIN2 ",AIMed.d209.s1813
4447,AIMed.d211,False,"Through their interaction with the ErbB family of receptors ( PROTEIN PROTEIN1 and PROTEIN2 , neuregulins help to regulate cell growth and differentiation in many tissues.",AIMed.d211.s1829
4448,AIMed.d211,False,"Through their interaction with the ErbB family of receptors ( PROTEIN1 PROTEIN2 and PROTEIN , neuregulins help to regulate cell growth and differentiation in many tissues.",AIMed.d211.s1829
4449,AIMed.d211,False,"Through their interaction with the ErbB family of receptors ( PROTEIN1 PROTEIN and PROTEIN2 , neuregulins help to regulate cell growth and differentiation in many tissues.",AIMed.d211.s1829
4450,AIMed.d211,False,The encoded product of the PROTEIN gene has a motif structure similar to that of neuregulins and an alternative splicing site in the PROTEIN1 PROTEIN2 -like domain gives rise to two isoforms (alpha and beta).,AIMed.d211.s1831
4451,AIMed.d211,False,The encoded product of the PROTEIN1 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the PROTEIN2 PROTEIN -like domain gives rise to two isoforms (alpha and beta).,AIMed.d211.s1831
4452,AIMed.d211,False,The encoded product of the PROTEIN1 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the PROTEIN PROTEIN2 -like domain gives rise to two isoforms (alpha and beta).,AIMed.d211.s1831
4453,AIMed.d211,False,Recombinant PROTEIN induces the tyrosine-phosphorylation of PROTEIN1 PROTEIN2 and PROTEIN in cell lines expressing all of these ErbB-family receptors.,AIMed.d211.s1833
4454,AIMed.d211,False,Recombinant PROTEIN induces the tyrosine-phosphorylation of PROTEIN1 PROTEIN and PROTEIN2 in cell lines expressing all of these ErbB-family receptors.,AIMed.d211.s1833
4455,AIMed.d211,True,Recombinant PROTEIN1 induces the tyrosine-phosphorylation of PROTEIN2 PROTEIN and PROTEIN in cell lines expressing all of these ErbB-family receptors.,AIMed.d211.s1833
4456,AIMed.d211,False,Recombinant PROTEIN induces the tyrosine-phosphorylation of PROTEIN PROTEIN1 and PROTEIN2 in cell lines expressing all of these ErbB-family receptors.,AIMed.d211.s1833
4457,AIMed.d211,True,Recombinant PROTEIN1 induces the tyrosine-phosphorylation of PROTEIN PROTEIN2 and PROTEIN in cell lines expressing all of these ErbB-family receptors.,AIMed.d211.s1833
4458,AIMed.d211,True,Recombinant PROTEIN1 induces the tyrosine-phosphorylation of PROTEIN PROTEIN and PROTEIN2 in cell lines expressing all of these ErbB-family receptors.,AIMed.d211.s1833
4459,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN and/or PROTEIN1 suggesting that signalling by PROTEIN is mediated by PROTEIN and/or PROTEIN2 receptors.",AIMed.d211.s1834
4460,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN1 and/or PROTEIN suggesting that signalling by PROTEIN is mediated by PROTEIN and/or PROTEIN2 receptors.",AIMed.d211.s1834
4461,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with PROTEIN and/or PROTEIN suggesting that signalling by PROTEIN is mediated by PROTEIN and/or PROTEIN2 receptors.",AIMed.d211.s1834
4462,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN and/or PROTEIN suggesting that signalling by PROTEIN1 is mediated by PROTEIN and/or PROTEIN2 receptors.",AIMed.d211.s1834
4463,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN and/or PROTEIN suggesting that signalling by PROTEIN is mediated by PROTEIN1 and/or PROTEIN2 receptors.",AIMed.d211.s1834
4464,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN1 and/or PROTEIN2 suggesting that signalling by PROTEIN is mediated by PROTEIN and/or PROTEIN receptors.",AIMed.d211.s1834
4465,AIMed.d211,True,"However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with PROTEIN and/or PROTEIN2 suggesting that signalling by PROTEIN is mediated by PROTEIN and/or PROTEIN receptors.",AIMed.d211.s1834
4466,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN and/or PROTEIN1 suggesting that signalling by PROTEIN2 is mediated by PROTEIN and/or PROTEIN receptors.",AIMed.d211.s1834
4467,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN and/or PROTEIN1 suggesting that signalling by PROTEIN is mediated by PROTEIN2 and/or PROTEIN receptors.",AIMed.d211.s1834
4468,AIMed.d211,True,"However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with PROTEIN2 and/or PROTEIN suggesting that signalling by PROTEIN is mediated by PROTEIN and/or PROTEIN receptors.",AIMed.d211.s1834
4469,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN1 and/or PROTEIN suggesting that signalling by PROTEIN2 is mediated by PROTEIN and/or PROTEIN receptors.",AIMed.d211.s1834
4470,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN1 and/or PROTEIN suggesting that signalling by PROTEIN is mediated by PROTEIN2 and/or PROTEIN receptors.",AIMed.d211.s1834
4471,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with PROTEIN and/or PROTEIN suggesting that signalling by PROTEIN2 is mediated by PROTEIN and/or PROTEIN receptors.",AIMed.d211.s1834
4472,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN1 only activates those with PROTEIN and/or PROTEIN suggesting that signalling by PROTEIN is mediated by PROTEIN2 and/or PROTEIN receptors.",AIMed.d211.s1834
4473,AIMed.d211,False,"However, in cell lines with defined combinations of ErbBs, PROTEIN only activates those with PROTEIN and/or PROTEIN suggesting that signalling by PROTEIN1 is mediated by PROTEIN2 and/or PROTEIN receptors.",AIMed.d211.s1834
4474,AIMed.d213,False,"In addition, previous work indicated that PROTEIN1 and PROTEIN2 might be involved in PROTEIN mediated repression.",AIMed.d213.s1846
4475,AIMed.d213,False,"In addition, previous work indicated that PROTEIN1 and PROTEIN might be involved in PROTEIN2 mediated repression.",AIMed.d213.s1846
4476,AIMed.d213,False,"In addition, previous work indicated that PROTEIN and PROTEIN1 might be involved in PROTEIN2 mediated repression.",AIMed.d213.s1846
4477,AIMed.d213,False,We show that the physical interaction between PROTEIN1 and PROTEIN a coactivator for PROTEIN is not sufficient for repression of PROTEIN2 mediated transcription.,AIMed.d213.s1851
4478,AIMed.d213,False,We show that the physical interaction between PROTEIN1 and PROTEIN a coactivator for PROTEIN2 is not sufficient for repression of PROTEIN mediated transcription.,AIMed.d213.s1851
4479,AIMed.d213,True,We show that the physical interaction between PROTEIN1 and PROTEIN2 a coactivator for PROTEIN is not sufficient for repression of PROTEIN mediated transcription.,AIMed.d213.s1851
4480,AIMed.d213,False,We show that the physical interaction between PROTEIN and PROTEIN a coactivator for PROTEIN1 is not sufficient for repression of PROTEIN2 mediated transcription.,AIMed.d213.s1851
4481,AIMed.d213,False,We show that the physical interaction between PROTEIN and PROTEIN1 a coactivator for PROTEIN is not sufficient for repression of PROTEIN2 mediated transcription.,AIMed.d213.s1851
4482,AIMed.d213,True,We show that the physical interaction between PROTEIN and PROTEIN1 a coactivator for PROTEIN2 is not sufficient for repression of PROTEIN mediated transcription.,AIMed.d213.s1851
4483,AIMed.d213,False,Repression of PROTEIN1 directed transcription may be accomplished through direct physical interaction between PROTEIN2 and this activator.,AIMed.d213.s1853
4484,AIMed.d213,False,"In contrast, physical interaction is not necessary for PROTEIN1 to repress PROTEIN2 and PROTEIN mediated transcription.",AIMed.d213.s1854
4485,AIMed.d213,False,"In contrast, physical interaction is not necessary for PROTEIN1 to repress PROTEIN and PROTEIN2 mediated transcription.",AIMed.d213.s1854
4486,AIMed.d213,False,"In contrast, physical interaction is not necessary for PROTEIN to repress PROTEIN1 and PROTEIN2 mediated transcription.",AIMed.d213.s1854
4487,AIMed.d214,True,Proto-oncoprotein PROTEIN1 interacts with PROTEIN2 in activated thymocytes and peripheral T cells.,AIMed.d214.s1857
4488,AIMed.d214,True,The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN2 PROTEIN and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4489,AIMed.d214,False,The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the PROTEIN2 and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4490,AIMed.d214,True,The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN2 and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4491,AIMed.d214,True,The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN and PROTEIN2 which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4492,AIMed.d214,False,The molecular adapter PROTEIN1 is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN2 homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4493,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN1 and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN2 PROTEIN and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4494,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN1 PROTEIN2 and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4495,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN1 PROTEIN and PROTEIN2 which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4496,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN1 homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN2 PROTEIN and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4497,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN1 and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN2 and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4498,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN1 and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN and PROTEIN2 which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4499,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN1 and associates with PROTEIN2 homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4500,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN1 and PROTEIN2 which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4501,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN1 homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN2 and PROTEIN which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4502,AIMed.d214,False,The molecular adapter PROTEIN is rapidly tyrosine phosphorylated following stimulation through the PROTEIN and associates with PROTEIN1 homology domain-2 (SH2)/SH3 domain-containing adapters such as PROTEIN PROTEIN and PROTEIN2 which interact with guanine nucleotide exchange factors specific for the Ras family.,AIMed.d214.s1858
4503,AIMed.d214,False,This suggests that PROTEIN1 may link PROTEIN2 activation to molecules that regulate GTP binding proteins.,AIMed.d214.s1859
4504,AIMed.d214,False,"The SH2/SH3-containing protein PROTEIN1 also contains a guanine nucleotide exchange factor domain, and PROTEIN2 has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the PROTEIN ",AIMed.d214.s1860
4505,AIMed.d214,False,"The SH2/SH3-containing protein PROTEIN also contains a guanine nucleotide exchange factor domain, and PROTEIN1 has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the PROTEIN2 ",AIMed.d214.s1860
4506,AIMed.d214,False,"The SH2/SH3-containing protein PROTEIN1 also contains a guanine nucleotide exchange factor domain, and PROTEIN has a crucial role in thymocyte development and activation of peripheral T cells following stimulation through the PROTEIN2 ",AIMed.d214.s1860
4507,AIMed.d214,False,Here we show that PROTEIN and PROTEIN1 form inducible molecular complexes in PROTEIN2 activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.,AIMed.d214.s1861
4508,AIMed.d214,True,Here we show that PROTEIN1 and PROTEIN2 form inducible molecular complexes in PROTEIN activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.,AIMed.d214.s1861
4509,AIMed.d214,False,Here we show that PROTEIN1 and PROTEIN form inducible molecular complexes in PROTEIN2 activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.,AIMed.d214.s1861
4510,AIMed.d214,True, PROTEIN1 PROTEIN2 interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN in which PROTEIN is hyperphosphorylated on tyrosine residues.,AIMed.d214.s1862
4511,AIMed.d214,False, PROTEIN PROTEIN1 interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN2 in which PROTEIN is hyperphosphorylated on tyrosine residues.,AIMed.d214.s1862
4512,AIMed.d214,False, PROTEIN PROTEIN1 interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN in which PROTEIN2 is hyperphosphorylated on tyrosine residues.,AIMed.d214.s1862
4513,AIMed.d214,False, PROTEIN1 PROTEIN interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN2 in which PROTEIN is hyperphosphorylated on tyrosine residues.,AIMed.d214.s1862
4514,AIMed.d214,False, PROTEIN1 PROTEIN interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN in which PROTEIN2 is hyperphosphorylated on tyrosine residues.,AIMed.d214.s1862
4515,AIMed.d214,False, PROTEIN PROTEIN interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor PROTEIN1 in which PROTEIN2 is hyperphosphorylated on tyrosine residues.,AIMed.d214.s1862
4516,AIMed.d214,False,The interaction between PROTEIN and PROTEIN1 is directly mediated via the SH2 domain of PROTEIN and is dependent on tyrosine phosphorylation of PROTEIN2 ,AIMed.d214.s1863
4517,AIMed.d214,True,The interaction between PROTEIN1 and PROTEIN2 is directly mediated via the SH2 domain of PROTEIN and is dependent on tyrosine phosphorylation of PROTEIN ,AIMed.d214.s1863
4518,AIMed.d214,False,The interaction between PROTEIN and PROTEIN1 is directly mediated via the SH2 domain of PROTEIN2 and is dependent on tyrosine phosphorylation of PROTEIN ,AIMed.d214.s1863
4519,AIMed.d214,False,The interaction between PROTEIN1 and PROTEIN is directly mediated via the SH2 domain of PROTEIN and is dependent on tyrosine phosphorylation of PROTEIN2 ,AIMed.d214.s1863
4520,AIMed.d214,False,The interaction between PROTEIN and PROTEIN is directly mediated via the SH2 domain of PROTEIN1 and is dependent on tyrosine phosphorylation of PROTEIN2 ,AIMed.d214.s1863
4521,AIMed.d214,False,The interaction between PROTEIN1 and PROTEIN is directly mediated via the SH2 domain of PROTEIN2 and is dependent on tyrosine phosphorylation of PROTEIN ,AIMed.d214.s1863
4522,AIMed.d214,True,"In addition, we show that the conserved motif Y699 MTP present in PROTEIN1 is the binding site for the PROTEIN2 SH2 domain in vitro.",AIMed.d214.s1864
4523,AIMed.d214,False,These data imply that PROTEIN1 is a molecular adapter that regulates the function of PROTEIN2 in thymocytes and peripheral T cells.,AIMed.d214.s1865
4524,AIMed.d215,True,Induction of cell migration by PROTEIN1 cleavage of PROTEIN2 ,AIMed.d215.s1866
4525,AIMed.d215,True,Specific cleavage of PROTEIN1 ( PROTEIN by PROTEIN2 ( PROTEIN was shown to induce migration of breast epithelial cells.,AIMed.d215.s1868
4526,AIMed.d215,True,Specific cleavage of PROTEIN ( PROTEIN1 by PROTEIN2 ( PROTEIN was shown to induce migration of breast epithelial cells.,AIMed.d215.s1868
4527,AIMed.d215,False,Specific cleavage of PROTEIN ( PROTEIN by PROTEIN1 ( PROTEIN2 was shown to induce migration of breast epithelial cells.,AIMed.d215.s1868
4528,AIMed.d215,False,Specific cleavage of PROTEIN1 ( PROTEIN2 by PROTEIN ( PROTEIN was shown to induce migration of breast epithelial cells.,AIMed.d215.s1868
4529,AIMed.d215,True,Specific cleavage of PROTEIN1 ( PROTEIN by PROTEIN ( PROTEIN2 was shown to induce migration of breast epithelial cells.,AIMed.d215.s1868
4530,AIMed.d215,True,Specific cleavage of PROTEIN ( PROTEIN1 by PROTEIN ( PROTEIN2 was shown to induce migration of breast epithelial cells.,AIMed.d215.s1868
4531,AIMed.d215,False," PROTEIN1 cleaved the PROTEIN gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN2 that triggers cell motility.",AIMed.d215.s1869
4532,AIMed.d215,False," PROTEIN1 cleaved the PROTEIN2 subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN that triggers cell motility.",AIMed.d215.s1869
4533,AIMed.d215,True," PROTEIN1 cleaved the PROTEIN2 gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN that triggers cell motility.",AIMed.d215.s1869
4534,AIMed.d215,False," PROTEIN cleaved the PROTEIN1 subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN2 that triggers cell motility.",AIMed.d215.s1869
4535,AIMed.d215,False," PROTEIN cleaved the PROTEIN1 gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN2 that triggers cell motility.",AIMed.d215.s1869
4536,AIMed.d215,False," PROTEIN cleaved the PROTEIN1 gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on PROTEIN that triggers cell motility.",AIMed.d215.s1869
4537,AIMed.d215,True,Cleavage of PROTEIN1 by PROTEIN2 and the resulting activation of the PROTEIN cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.,AIMed.d215.s1871
4538,AIMed.d215,False,Cleavage of PROTEIN1 by PROTEIN and the resulting activation of the PROTEIN2 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.,AIMed.d215.s1871
4539,AIMed.d215,False,Cleavage of PROTEIN by PROTEIN1 and the resulting activation of the PROTEIN2 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.,AIMed.d215.s1871
4540,AIMed.d216,False,The PROTEIN PROTEIN1 complex: structural basis for GTPase activation and its loss in oncogenic PROTEIN2 mutants.,AIMed.d216.s1872
4541,AIMed.d216,True,The PROTEIN1 PROTEIN2 complex: structural basis for GTPase activation and its loss in oncogenic PROTEIN mutants.,AIMed.d216.s1872
4542,AIMed.d216,False,The PROTEIN1 PROTEIN complex: structural basis for GTPase activation and its loss in oncogenic PROTEIN2 mutants.,AIMed.d216.s1872
4543,AIMed.d216,False,The three-dimensional structure of the complex between human PROTEIN bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN PROTEIN1 ( PROTEIN2 in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.,AIMed.d216.s1873
4544,AIMed.d216,True,The three-dimensional structure of the complex between human PROTEIN1 bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN PROTEIN ( PROTEIN2 in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.,AIMed.d216.s1873
4545,AIMed.d216,False,The three-dimensional structure of the complex between human PROTEIN bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN1 PROTEIN ( PROTEIN2 in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.,AIMed.d216.s1873
4546,AIMed.d216,True,The three-dimensional structure of the complex between human PROTEIN1 bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN PROTEIN2 ( PROTEIN in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.,AIMed.d216.s1873
4547,AIMed.d216,False,The three-dimensional structure of the complex between human PROTEIN bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN1 PROTEIN2 ( PROTEIN in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.,AIMed.d216.s1873
4548,AIMed.d216,False,The three-dimensional structure of the complex between human PROTEIN1 bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human PROTEIN2 PROTEIN ( PROTEIN in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.,AIMed.d216.s1873
4549,AIMed.d216,False,An arginine side chain (arginine-789) of PROTEIN1 is supplied into the active site of PROTEIN2 to neutralize developing charges in the transition state.,AIMed.d216.s1875
4550,AIMed.d216,True,"The switch II region of PROTEIN1 is stabilized by PROTEIN2 thus allowing glutamine-61 of PROTEIN mutation of which activates the oncogenic potential, to participate in catalysis.",AIMed.d216.s1876
4551,AIMed.d216,False,"The switch II region of PROTEIN is stabilized by PROTEIN1 thus allowing glutamine-61 of PROTEIN2 mutation of which activates the oncogenic potential, to participate in catalysis.",AIMed.d216.s1876
4552,AIMed.d216,False,"The switch II region of PROTEIN1 is stabilized by PROTEIN thus allowing glutamine-61 of PROTEIN2 mutation of which activates the oncogenic potential, to participate in catalysis.",AIMed.d216.s1876
4553,AIMed.d216,False,Glycine-12 in the transition state mimic is within van der Waals distance of both arginine-789 of PROTEIN1 and glutamine-61 of PROTEIN2 and even its mutation to alanine would disturb the arrangements of residues in the transition state.,AIMed.d216.s1878
4554,AIMed.d217,False,Characterization of PROTEIN1 ( PROTEIN2 PROTEIN - PROTEIN interaction.,AIMed.d217.s1879
4555,AIMed.d217,False,Characterization of PROTEIN ( PROTEIN1 PROTEIN2 - PROTEIN interaction.,AIMed.d217.s1879
4556,AIMed.d217,False,Characterization of PROTEIN ( PROTEIN1 PROTEIN - PROTEIN2 ligand interaction.,AIMed.d217.s1879
4557,AIMed.d217,True,Characterization of PROTEIN ( PROTEIN1 PROTEIN - PROTEIN2 interaction.,AIMed.d217.s1879
4558,AIMed.d217,False,Characterization of PROTEIN1 ( PROTEIN PROTEIN2 - PROTEIN interaction.,AIMed.d217.s1879
4559,AIMed.d217,False,Characterization of PROTEIN1 ( PROTEIN PROTEIN - PROTEIN2 ligand interaction.,AIMed.d217.s1879
4560,AIMed.d217,True,Characterization of PROTEIN1 ( PROTEIN PROTEIN - PROTEIN2 interaction.,AIMed.d217.s1879
4561,AIMed.d217,False,Characterization of PROTEIN ( PROTEIN PROTEIN1 - PROTEIN2 ligand interaction.,AIMed.d217.s1879
4562,AIMed.d217,True,Characterization of PROTEIN ( PROTEIN PROTEIN1 - PROTEIN2 interaction.,AIMed.d217.s1879
4563,AIMed.d217,False,Characterization of PROTEIN ( PROTEIN PROTEIN - PROTEIN1 interaction.,AIMed.d217.s1879
4564,AIMed.d217,False,The death-inducing receptor PROTEIN is activated when cross-linked by the type II membrane protein PROTEIN1 ( PROTEIN2 .,AIMed.d217.s1880
4565,AIMed.d217,True,The death-inducing receptor PROTEIN1 is activated when cross-linked by the type II membrane protein PROTEIN ( PROTEIN2 .,AIMed.d217.s1880
4566,AIMed.d217,True,The death-inducing receptor PROTEIN is activated when cross-linked by the type II membrane protein PROTEIN1 ligand ( PROTEIN2 .,AIMed.d217.s1880
4567,AIMed.d217,True,The death-inducing receptor PROTEIN1 is activated when cross-linked by the type II membrane protein PROTEIN2 ( PROTEIN .,AIMed.d217.s1880
4568,AIMed.d217,False,The death-inducing receptor PROTEIN is activated when cross-linked by the type II membrane protein PROTEIN1 ( PROTEIN .,AIMed.d217.s1880
4569,AIMed.d217,False,The death-inducing receptor PROTEIN1 is activated when cross-linked by the type II membrane protein PROTEIN2 ligand ( PROTEIN .,AIMed.d217.s1880
4570,AIMed.d217,False,"When human soluble PROTEIN1 (sFasL, containing the extracellular portion) was expressed in human embryo kidney 293 cells, the three N-linked glycans of each PROTEIN2 monomer were found to be essential for efficient secretion.",AIMed.d217.s1881
4571,AIMed.d217,False,"Based on the structure of the closely related PROTEIN1 PROTEIN complex, a molecular model of the PROTEIN homotrimer bound to three PROTEIN2 molecules was generated using knowledge-based protein modeling methods.",AIMed.d217.s1882
4572,AIMed.d217,False,"Based on the structure of the closely related PROTEIN1 PROTEIN complex, a molecular model of the PROTEIN2 homotrimer bound to three PROTEIN molecules was generated using knowledge-based protein modeling methods.",AIMed.d217.s1882
4573,AIMed.d217,True,"Based on the structure of the closely related PROTEIN1 PROTEIN2 complex, a molecular model of the PROTEIN homotrimer bound to three PROTEIN molecules was generated using knowledge-based protein modeling methods.",AIMed.d217.s1882
4574,AIMed.d217,True,"Based on the structure of the closely related PROTEIN PROTEIN complex, a molecular model of the PROTEIN1 homotrimer bound to three PROTEIN2 molecules was generated using knowledge-based protein modeling methods.",AIMed.d217.s1882
4575,AIMed.d217,False,"Based on the structure of the closely related PROTEIN PROTEIN1 complex, a molecular model of the PROTEIN homotrimer bound to three PROTEIN2 molecules was generated using knowledge-based protein modeling methods.",AIMed.d217.s1882
4576,AIMed.d217,False,"Based on the structure of the closely related PROTEIN PROTEIN1 complex, a molecular model of the PROTEIN2 homotrimer bound to three PROTEIN molecules was generated using knowledge-based protein modeling methods.",AIMed.d217.s1882
4577,AIMed.d217,False,"Mutants P206R, P206D, and P206F displayed reduced cytotoxicity toward PROTEIN1 positive cells with a concomitant decrease in the binding affinity for the recombinant PROTEIN2 immunoglobulin Fc fusion proteins.",AIMed.d217.s1885
4578,AIMed.d217,True,"Although the cytotoxic activity of mutant Y218D was unaltered, mutant Y218R was inactive, correlating with the prediction that Tyr-218 of PROTEIN1 interacts with a cluster of three basic amino acid side chains of PROTEIN2 ",AIMed.d217.s1886
4579,AIMed.d218,False, PROTEIN1 ( PROTEIN2 is a hematopoietin important for megakaryocyte proliferation and production of blood platelets.,AIMed.d218.s1889
4580,AIMed.d218,True,"We sought to characterize how PROTEIN1 binds and activates its receptor, PROTEIN2 ",AIMed.d218.s1890
4581,AIMed.d218,False,The PROTEIN1 like domain of PROTEIN (TPO1-153) has been fused to the PROTEIN2 coat protein of M13 bacteriophage.,AIMed.d218.s1891
4582,AIMed.d218,False,The PROTEIN1 like domain of PROTEIN2 (TPO1-153) has been fused to the PROTEIN coat protein of M13 bacteriophage.,AIMed.d218.s1891
4583,AIMed.d218,False,The PROTEIN like domain of PROTEIN1 (TPO1-153) has been fused to the PROTEIN2 coat protein of M13 bacteriophage.,AIMed.d218.s1891
4584,AIMed.d218,False,Phage enzyme-linked immunosorbent assay was used to determine affinities for binding to both the PROTEIN1 receptor and five anti- PROTEIN2 153 monoclonal antibodies.,AIMed.d218.s1893
4585,AIMed.d218,False,"In contrast, the other three monoclonal antibodies, which were effective at blocking PROTEIN1 activity but did not block initial binding of PROTEIN2 to its receptor, had epitopes predominantly on helix or 3.",AIMed.d218.s1897
4586,AIMed.d218,False,These results suggest that PROTEIN1 has two distinct receptor-binding sites that function to dimerize PROTEIN2 receptors in a sequential fashion.,AIMed.d218.s1898
4587,AIMed.d219,False, PROTEIN negatively regulates PROTEIN1 activity by interactions with the PROTEIN2 cysteine-rich domain.,AIMed.d219.s1899
4588,AIMed.d219,True, PROTEIN1 negatively regulates PROTEIN2 activity by interactions with the PROTEIN cysteine-rich domain.,AIMed.d219.s1899
4589,AIMed.d219,True, PROTEIN1 negatively regulates PROTEIN activity by interactions with the PROTEIN2 cysteine-rich domain.,AIMed.d219.s1899
4590,AIMed.d219,False,"Although PROTEIN1 is a critical effector of PROTEIN signaling and transformation, the mechanism by which PROTEIN2 promotes PROTEIN activation is complex and remains poorly understood.",AIMed.d219.s1900
4591,AIMed.d219,False,"Although PROTEIN1 is a critical effector of PROTEIN2 signaling and transformation, the mechanism by which PROTEIN promotes PROTEIN activation is complex and remains poorly understood.",AIMed.d219.s1900
4592,AIMed.d219,False,"Although PROTEIN1 is a critical effector of PROTEIN signaling and transformation, the mechanism by which PROTEIN promotes PROTEIN2 activation is complex and remains poorly understood.",AIMed.d219.s1900
4593,AIMed.d219,False,"Although PROTEIN is a critical effector of PROTEIN1 signaling and transformation, the mechanism by which PROTEIN2 promotes PROTEIN activation is complex and remains poorly understood.",AIMed.d219.s1900
4594,AIMed.d219,False,"Although PROTEIN is a critical effector of PROTEIN signaling and transformation, the mechanism by which PROTEIN1 promotes PROTEIN2 activation is complex and remains poorly understood.",AIMed.d219.s1900
4595,AIMed.d219,False,"Although PROTEIN is a critical effector of PROTEIN1 signaling and transformation, the mechanism by which PROTEIN promotes PROTEIN2 activation is complex and remains poorly understood.",AIMed.d219.s1900
4596,AIMed.d219,False,We recently reported that PROTEIN interaction with the PROTEIN1 ( PROTEIN2 residues 139-184) may be required for PROTEIN activation.,AIMed.d219.s1901
4597,AIMed.d219,True,We recently reported that PROTEIN1 interaction with the PROTEIN2 ( PROTEIN residues 139-184) may be required for PROTEIN activation.,AIMed.d219.s1901
4598,AIMed.d219,False,We recently reported that PROTEIN interaction with the PROTEIN1 ( PROTEIN residues 139-184) may be required for PROTEIN2 activation.,AIMed.d219.s1901
4599,AIMed.d219,False,We recently reported that PROTEIN interaction with the PROTEIN1 ( PROTEIN residues 139-184) may be required for PROTEIN activation.,AIMed.d219.s1901
4600,AIMed.d219,True,We recently reported that PROTEIN1 interaction with the PROTEIN ( PROTEIN2 residues 139-184) may be required for PROTEIN activation.,AIMed.d219.s1901
4601,AIMed.d219,False,We recently reported that PROTEIN interaction with the PROTEIN cysteine-rich domain ( PROTEIN1 residues 139-184) may be required for PROTEIN2 activation.,AIMed.d219.s1901
4602,AIMed.d219,False,We recently reported that PROTEIN interaction with the PROTEIN1 cysteine-rich domain ( PROTEIN2 residues 139-184) may be required for PROTEIN activation.,AIMed.d219.s1901
4603,AIMed.d219,False,We recently reported that PROTEIN1 interaction with the PROTEIN ( PROTEIN residues 139-184) may be required for PROTEIN2 activation.,AIMed.d219.s1901
4604,AIMed.d219,False,We recently reported that PROTEIN1 interaction with the PROTEIN2 cysteine-rich domain ( PROTEIN residues 139-184) may be required for PROTEIN activation.,AIMed.d219.s1901
4605,AIMed.d219,False,We recently reported that PROTEIN interaction with the PROTEIN1 cysteine-rich domain ( PROTEIN residues 139-184) may be required for PROTEIN2 activation.,AIMed.d219.s1901
4606,AIMed.d219,False,The PROTEIN1 is located in the NH2-terminal negative regulatory domain of PROTEIN2 and is highly homologous to cysteine-rich domains found in protein kinase C family members.,AIMed.d219.s1902
4607,AIMed.d219,False,Recent studies indicate that the structural integrity of the PROTEIN1 is also critical for PROTEIN2 interaction with 14-3-3 proteins.,AIMed.d219.s1903
4608,AIMed.d219,False,"However, whether 14-3-3 proteins interact directly with the PROTEIN1 and how this interaction may mediate PROTEIN2 function has not been determined.",AIMed.d219.s1904
4609,AIMed.d219,True,"In the present study, we demonstrate that PROTEIN1 binds directly to the isolated PROTEIN2 ",AIMed.d219.s1905
4610,AIMed.d219,True,"Moreover, mutation of PROTEIN1 residues 143-145 impairs binding of 14-3-3, but not PROTEIN2 to the PROTEIN ",AIMed.d219.s1906
4611,AIMed.d219,True,"Moreover, mutation of PROTEIN1 residues 143-145 impairs binding of 14-3-3, but not PROTEIN to the PROTEIN2 ",AIMed.d219.s1906
4612,AIMed.d219,False,"Moreover, mutation of PROTEIN residues 143-145 impairs binding of 14-3-3, but not PROTEIN1 to the PROTEIN2 ",AIMed.d219.s1906
4613,AIMed.d219,False,"Thus, 14-3-3 interaction with the PROTEIN1 may serve in negative regulation of PROTEIN2 function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN to promote subsequent events necessary for full activation of PROTEIN ",AIMed.d219.s1908
4614,AIMed.d219,False,"Thus, 14-3-3 interaction with the PROTEIN may serve in negative regulation of PROTEIN1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN2 to promote subsequent events necessary for full activation of PROTEIN ",AIMed.d219.s1908
4615,AIMed.d219,False,"Thus, 14-3-3 interaction with the PROTEIN may serve in negative regulation of PROTEIN1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN to promote subsequent events necessary for full activation of PROTEIN2 ",AIMed.d219.s1908
4616,AIMed.d219,False,"Thus, 14-3-3 interaction with the PROTEIN1 may serve in negative regulation of PROTEIN function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN2 to promote subsequent events necessary for full activation of PROTEIN ",AIMed.d219.s1908
4617,AIMed.d219,False,"Thus, 14-3-3 interaction with the PROTEIN1 may serve in negative regulation of PROTEIN function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN to promote subsequent events necessary for full activation of PROTEIN2 ",AIMed.d219.s1908
4618,AIMed.d219,False,"Thus, 14-3-3 interaction with the PROTEIN may serve in negative regulation of PROTEIN function by facilitating dissociation of 14-3-3 from the NH2 terminus of PROTEIN1 to promote subsequent events necessary for full activation of PROTEIN2 ",AIMed.d219.s1908
4619,AIMed.d220,False,Interactions between PROTEIN and the PROTEIN1 Identification of two ligand binding domains in soluble PROTEIN2 by affinity separation and chemical cross-linking.,AIMed.d220.s1909
4620,AIMed.d220,False,Interactions between PROTEIN1 and the PROTEIN receptor. Identification of two ligand binding domains in soluble PROTEIN2 by affinity separation and chemical cross-linking.,AIMed.d220.s1909
4621,AIMed.d220,False,Interactions between PROTEIN and the PROTEIN1 receptor. Identification of two ligand binding domains in soluble PROTEIN2 by affinity separation and chemical cross-linking.,AIMed.d220.s1909
4622,AIMed.d220,True,Interactions between PROTEIN1 and the PROTEIN2 Identification of two ligand binding domains in soluble PROTEIN by affinity separation and chemical cross-linking.,AIMed.d220.s1909
4623,AIMed.d220,False,Interactions between PROTEIN and the PROTEIN1 receptor. Identification of two ligand binding domains in soluble PROTEIN by affinity separation and chemical cross-linking.,AIMed.d220.s1909
4624,AIMed.d220,False,Interactions between PROTEIN1 and the PROTEIN2 receptor. Identification of two ligand binding domains in soluble PROTEIN by affinity separation and chemical cross-linking.,AIMed.d220.s1909
4625,AIMed.d220,False,"The extracellular domain of the h PROTEIN1 PROTEIN expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN ( PROTEIN2 .",AIMed.d220.s1910
4626,AIMed.d220,False,"The extracellular domain of the hu PROTEIN2 PROTEIN1 expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN ( PROTEIN .",AIMed.d220.s1910
4627,AIMed.d220,False,"The extracellular domain of the h PROTEIN1 PROTEIN expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN2 ( PROTEIN .",AIMed.d220.s1910
4628,AIMed.d220,True,"The extracellular domain of the hu PROTEIN PROTEIN1 expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN ( PROTEIN2 .",AIMed.d220.s1910
4629,AIMed.d220,False,"The extracellular domain of the h PROTEIN PROTEIN expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN1 ( PROTEIN2 .",AIMed.d220.s1910
4630,AIMed.d220,True,"The extracellular domain of the hu PROTEIN PROTEIN1 expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for PROTEIN2 ( PROTEIN .",AIMed.d220.s1910
4631,AIMed.d220,False,Two distinct ligand binding domains of PROTEIN1 were isolated from proteolytic digests of the receptor by affinity separation on immobilized PROTEIN2 ,AIMed.d220.s1911
4632,AIMed.d220,False,"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1 receptor in binding PROTEIN ",AIMed.d220.s1920
4633,AIMed.d220,True,"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1 in binding PROTEIN2 ",AIMed.d220.s1920
4634,AIMed.d220,False,"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1 receptor in binding PROTEIN2 ",AIMed.d220.s1920
4635,AIMed.d222,False,"The protein product of PROTEIN proto-oncogene is known to interact with several proteins, including PROTEIN PROTEIN1 and PROTEIN2 and is thought to regulate signalling by many cell surface receptors.",AIMed.d222.s1928
4636,AIMed.d222,False,"The protein product of PROTEIN proto-oncogene is known to interact with several proteins, including PROTEIN1 PROTEIN and PROTEIN2 and is thought to regulate signalling by many cell surface receptors.",AIMed.d222.s1928
4637,AIMed.d222,True,"The protein product of PROTEIN1 proto-oncogene is known to interact with several proteins, including PROTEIN PROTEIN and PROTEIN2 and is thought to regulate signalling by many cell surface receptors.",AIMed.d222.s1928
4638,AIMed.d222,False,"The protein product of PROTEIN proto-oncogene is known to interact with several proteins, including PROTEIN1 PROTEIN2 and PROTEIN and is thought to regulate signalling by many cell surface receptors.",AIMed.d222.s1928
4639,AIMed.d222,True,"The protein product of PROTEIN1 proto-oncogene is known to interact with several proteins, including PROTEIN PROTEIN2 and PROTEIN and is thought to regulate signalling by many cell surface receptors.",AIMed.d222.s1928
4640,AIMed.d222,True,"The protein product of PROTEIN1 proto-oncogene is known to interact with several proteins, including PROTEIN2 PROTEIN and PROTEIN and is thought to regulate signalling by many cell surface receptors.",AIMed.d222.s1928
4641,AIMed.d222,False,"The precise function of PROTEIN1 in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN2 is a negative regulator of the PROTEIN ",AIMed.d222.s1929
4642,AIMed.d222,False,"The precise function of PROTEIN in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN1 is a negative regulator of the PROTEIN2 receptor.",AIMed.d222.s1929
4643,AIMed.d222,True,"The precise function of PROTEIN in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN1 is a negative regulator of the PROTEIN2 ",AIMed.d222.s1929
4644,AIMed.d222,False,"The precise function of PROTEIN1 in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN is a negative regulator of the PROTEIN2 receptor.",AIMed.d222.s1929
4645,AIMed.d222,False,"The precise function of PROTEIN1 in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN is a negative regulator of the PROTEIN2 ",AIMed.d222.s1929
4646,AIMed.d222,False,"The precise function of PROTEIN in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that PROTEIN is a negative regulator of the PROTEIN1 ",AIMed.d222.s1929
4647,AIMed.d222,True,"The screen identified interactions involving PROTEIN1 and two 14-3-3 isoforms, PROTEIN human unconventional myosin IC, and a recently identified SH3 domain containing protein, PROTEIN2 ",AIMed.d222.s1931
4648,AIMed.d222,True,"The screen identified interactions involving PROTEIN1 and two 14-3-3 isoforms, PROTEIN2 human unconventional myosin IC, and a recently identified SH3 domain containing protein, PROTEIN ",AIMed.d222.s1931
4649,AIMed.d222,False,"The screen identified interactions involving PROTEIN and two 14-3-3 isoforms, PROTEIN1 human unconventional myosin IC, and a recently identified SH3 domain containing protein, PROTEIN2 ",AIMed.d222.s1931
4650,AIMed.d224,False, PROTEIN and PROTEIN1 dependent PROTEIN2 surface expression correlates with the binding of an MHC class I leader peptide.,AIMed.d224.s1945
4651,AIMed.d224,False, PROTEIN1 and PROTEIN2 dependent PROTEIN surface expression correlates with the binding of an MHC class I leader peptide.,AIMed.d224.s1945
4652,AIMed.d224,False, PROTEIN1 and PROTEIN dependent PROTEIN2 surface expression correlates with the binding of an MHC class I leader peptide.,AIMed.d224.s1945
4653,AIMed.d224,False,We demonstrate that PROTEIN1 surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to PROTEIN2 ,AIMed.d224.s1949
4654,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN1 and PROTEIN and that PROTEIN2 expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4655,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN1 and PROTEIN and that PROTEIN expression is PROTEIN2 dependent and tapasin-dependent.,AIMed.d224.s1950
4656,AIMed.d224,False,Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN2 and PROTEIN and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4657,AIMed.d224,True,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the PROTEIN ( PROTEIN2 and PROTEIN and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4658,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN1 and PROTEIN2 and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4659,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1 ( PROTEIN2 and PROTEIN and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4660,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN and PROTEIN and that PROTEIN1 expression is PROTEIN2 dependent and tapasin-dependent.,AIMed.d224.s1950
4661,AIMed.d224,False,Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN and PROTEIN and that PROTEIN2 expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4662,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the PROTEIN ( PROTEIN and PROTEIN and that PROTEIN2 expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4663,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN and PROTEIN1 and that PROTEIN2 expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4664,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1 ( PROTEIN and PROTEIN and that PROTEIN2 expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4665,AIMed.d224,False,Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN and PROTEIN and that PROTEIN expression is PROTEIN2 dependent and tapasin-dependent.,AIMed.d224.s1950
4666,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the PROTEIN ( PROTEIN and PROTEIN and that PROTEIN expression is PROTEIN2 dependent and tapasin-dependent.,AIMed.d224.s1950
4667,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN and PROTEIN1 and that PROTEIN expression is PROTEIN2 dependent and tapasin-dependent.,AIMed.d224.s1950
4668,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1 ( PROTEIN and PROTEIN and that PROTEIN expression is PROTEIN2 dependent and tapasin-dependent.,AIMed.d224.s1950
4669,AIMed.d224,False,Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that PROTEIN2 associates with the PROTEIN ( PROTEIN and PROTEIN and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4670,AIMed.d224,False,Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN ( PROTEIN and PROTEIN2 and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4671,AIMed.d224,False,Further studies on the interaction of PROTEIN1 with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN2 ( PROTEIN and PROTEIN and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4672,AIMed.d224,True,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the PROTEIN ( PROTEIN and PROTEIN2 and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4673,AIMed.d224,True,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN1 associates with the PROTEIN2 ( PROTEIN and PROTEIN and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4674,AIMed.d224,False,Further studies on the interaction of PROTEIN with molecules in the endoplasmic reticulum revealed that PROTEIN associates with the PROTEIN1 ( PROTEIN and PROTEIN2 and that PROTEIN expression is PROTEIN dependent and tapasin-dependent.,AIMed.d224.s1950
4675,AIMed.d224,True,"In addition, PROTEIN1 dissociates from PROTEIN2 upon binding of MHC class I leader sequence peptides.",AIMed.d224.s1951
4676,AIMed.d224,False,The correlation between PROTEIN1 and MHC class I surface expression might be relevant to the function of PROTEIN2 ,AIMed.d224.s1953
4677,AIMed.d224,False,"Our results also show that, although these PROTEIN1 binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the PROTEIN complex and loaded onto PROTEIN2 molecules.",AIMed.d224.s1954
4678,AIMed.d224,False,"Our results also show that, although these PROTEIN1 binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the PROTEIN2 complex and loaded onto PROTEIN molecules.",AIMed.d224.s1954
4679,AIMed.d224,False,"Our results also show that, although these PROTEIN binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the PROTEIN1 complex and loaded onto PROTEIN2 molecules.",AIMed.d224.s1954
